<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://me-pedia.org/w/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Siggycat</id>
	<title>MEpedia - User contributions [en]</title>
	<link rel="self" type="application/atom+xml" href="https://me-pedia.org/w/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Siggycat"/>
	<link rel="alternate" type="text/html" href="https://me-pedia.org/wiki/Special:Contributions/Siggycat"/>
	<updated>2026-05-01T11:02:14Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Marcie_Zinn&amp;diff=78397</id>
		<title>Marcie Zinn</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Marcie_Zinn&amp;diff=78397"/>
		<updated>2019-12-04T03:01:39Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:tried to delete article about me. YOU delete my name and photo. I withdraw my permission to use me on your site.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Cleanup|date=Dec 2019|reason=References needed for bio info.}}&lt;br /&gt;
[[File:Marcie Zinn.png|200px|thumb|right]]&lt;br /&gt;
[[Category:Researchers]]&lt;br /&gt;
[[Category:Clinicians]]&lt;br /&gt;
[[Category:US researchers]]&lt;br /&gt;
[[Category:People with ME, CFS, and/or FMS]]&lt;br /&gt;
[[Category:Psychological paradigm critics]]&lt;br /&gt;
[[Category:PACE trial critics]]&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Talk:SwLORETA&amp;diff=78395</id>
		<title>Talk:SwLORETA</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Talk:SwLORETA&amp;diff=78395"/>
		<updated>2019-12-04T02:56:52Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:delete the swLORETA page.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;== Capitalization in title -- [[User:Kmdenmark|Kmdenmark]] ([[User talk:Kmdenmark|talk]]) 15:28, December 3, 2019 (EST) ==&lt;br /&gt;
&lt;br /&gt;
The template will not allow the first letter of a title to be lower case, therefore, &#039;swLORETA&#039; as a title is unavailable. Would &#039;SWLORETA&#039; be better than &#039;SwLORETA&#039;? Or &#039;Standardized weighting LORETA&#039;? [[User:Kmdenmark|Kmdenmark]] ([[User talk:Kmdenmark|talk]]) 15:28, December 3, 2019 (EST)&lt;br /&gt;
&lt;br /&gt;
OMG. Just delete the post. Your suggestions are not correct. No, I&#039;ll delete the post. This is not worth it.&lt;br /&gt;
Know that I&#039;ll be checking and will flag it when someone  incorrectly writes about what we do.&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Marcie_Zinn&amp;diff=78332</id>
		<title>Marcie Zinn</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Marcie_Zinn&amp;diff=78332"/>
		<updated>2019-12-02T21:07:09Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:changed incorrect information&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Cleanup|date=Dec 2019|reason=No References needed.}}&lt;br /&gt;
[[File:Marcie Zinn.png|200px|thumb|right]]&amp;lt;blockquote&amp;gt;&#039;&#039;&#039;Marcie Zinn&#039;&#039;&#039; Ph.D. is a research psychologist in Psychophysiology, Rehabilitation, Cognitive Neuroscience and Data Science conducting [[myalgic encephalomyelitis]] (ME) and [[chronic fatigue syndrome]] (CFS) research with her husband, [[Mark Zinn]], at their nonprofit, the Neurocognitive Research Institute. The Marcie&#039;s research interests include the study of brain dysfunction in chronic disease, such as [[myalgic encephalomyelitis|myalgic encephalomyelitis or ME.]] Marcie and her husband, Mark also founded the NeuroCognitive Research Institute (www.thencri.org)*. Her early research and career interests were in Performance Neuroscience and Psychology, but after being diagnosed in 2009 with herpes viral encephalitis which developed into [[Myalgic Encephalomyelitis]], her interest turned toward using her extensive [[QEEG|qEEG**]] and neuroscience skills for research in [[ME]]***. Under the leadership of Dr. [[Jose Montoya]], she conducted a pilot study to look at cognitive dysfunction using [[QEEG|qEEG]] methods. While continuing to collaborate with Jose Montoya at Stanford, she and her husband [[Mark Zinn|Mark]]  have published research using brain network modeling in the study of [[ME]] [[brain]] dysfunction.&amp;lt;/blockquote&amp;gt;REFERENCES:&lt;br /&gt;
&lt;br /&gt;
&amp;lt;nowiki&amp;gt;*&amp;lt;/nowiki&amp;gt;the NeuroCognitive Research Institute, a 501c3 organization (this is a not-for-profit business, not an article, post, comment or anything, but here is the reference).&lt;br /&gt;
&lt;br /&gt;
&amp;lt;nowiki&amp;gt;**&amp;lt;/nowiki&amp;gt;Quantitative EEG (&#039;&#039;&#039;qEEG&#039;&#039;&#039;) is the analysis of the digitized EEG, and in lay terms this sometimes is also called “Brain Mapping”. The &#039;&#039;&#039;qEEG&#039;&#039;&#039; is an extension of the analysis of the visual EEG interpretation which may assist and even augment our understanding of the EEG and brain function.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;nowiki&amp;gt;***&amp;lt;/nowiki&amp;gt;What this encyclopedia is about.&lt;br /&gt;
&lt;br /&gt;
==ME/CFS Common Data Element (CDE) Project==&lt;br /&gt;
Member of the Pain Working Group and the Neurologic/Cognitive/CNS Imaging Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project sponsored by the [[National Institute of Neurological Disorders and Stroke]] and the [[Centers for Disease Control and Prevention]].&amp;lt;ref&amp;gt;{{Cite web|url=https://www.commondataelements.ninds.nih.gov/Myalgic%20Encephalomyelitis/Chronic%20Fatigue%20Syndrome#pane-138|title=Complete Myalgic Encephalomyelitis/Chronic Fatigue Syndrome CDE Roster|last=|first=|authorlink=|last2=|first2=|authorlink2=|date=|website=NIH|archive-url=|archive-date=|dead-url=|access-date=2019-10-11}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Advocacy==&lt;br /&gt;
* Dr. Zinn signed the second and third [[open letter to the Lancet|open letters to the editor of &#039;&#039;The Lancet&#039;&#039;]] urging the editor to commission a fully independent review of the [[PACE trial]], which the journal published in 2011. &lt;br /&gt;
* Feb 10, 2016, [http://www.virology.ws/2016/02/10/open-letter-lancet-again/ An open letter to The Lancet, again - Virology blog] &lt;br /&gt;
* June 19, 2018, [http://www.virology.ws/2018/06/19/trial-by-error-an-open-letter-to-the-lancet-two-years-on/ Trial By Error: An Open Letter to The Lancet, Two Years On - Virology blog] &lt;br /&gt;
==Notable studies==&lt;br /&gt;
* June, 2004: &#039;&#039;Development of a Self-Report Inventory to Assess Cognitive Dysfunction in Musicians.&#039;&#039; ProQuest Information and Learning Company, Ann Arbor, Michigan.  &lt;br /&gt;
* March, 2005: &#039;&#039;The Hippocampus in Music Learning and Performance&#039;&#039; (March, 2005). Presentation at the annual Brain Awareness Week event sponsored by Dana Alliance for Brain Initiatives, Dublin, CA.  &lt;br /&gt;
* Mar 2014, Cortical hypoactivation during resting eLORETA suggests central nervous system pathology in patients with chronic fatigue syndrome (Conference paper, 2014 Stanford Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Symposium: Advances in Clinical Care and Translational Research for health care providers, Stanford School of Medicine, Palo Alto, CA&amp;lt;ref name=&amp;quot;Zinn, 2014&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/290628295_Cortical_hypoactivation_during_resting_eLORETA_suggests_central_nervous_system_pathology_in_patients_with_chronic_fatigue_syndrome (Abstract - full text on request)]  &lt;br /&gt;
* Mar 2014,  &#039;&#039;EEG peak alpha frequency is associated with chronic fatigue syndrome: a case-control observational study&#039;&#039;. Invited presentation at the 2014 Stanford Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Symposium : Advances in Clinical Care and Translational Research; March 19, 2014, Stanford University Dept. of Medicine, Palo Alto, CA.1.     &lt;br /&gt;
* &#039;&#039;EEG peak alpha frequency is associated with chronic fatigue syndrome: a case-control observational study&#039;&#039;. Invited presentation at the 2014 Stanford Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Symposium : Advances in Clinical Care and Translational Research; March 19, 2014, Stanford University Dept. of Medicine, Palo Alto, CA.  &lt;br /&gt;
*2015, Myalgic Encephalomyelitis: Symptoms and [[Biomarker]]s&amp;lt;ref name=&amp;quot;Zinn, 2015&amp;quot; /&amp;gt; - [http://www.ncbi.nlm.nih.gov/pubmed/26411464 (Full Text)]&lt;br /&gt;
*2015,  Zinn, M.L. &amp;amp; Zinn, M.A. Psychophysiology for Performing Artists. In M. S. Schwartz &amp;amp; F. Andrasik, Eds: Biofeedback: A Practitioners Guide (4th ed.), New York: Guilford.&lt;br /&gt;
*2016, Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with [[Myalgic Encephalomyelitis]]: A Pilot Study&amp;lt;ref name=&amp;quot;Zinn, 2016&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/294258397_Intrinsic_Functional_Hypoconnectivity_in_Core_Neurocognitive_Networks_Suggests_Central_Nervous_System_Pathology_in_Patients_with_Myalgic_Encephalomyelitis_A_Pilot_Study (Full Text)] &lt;br /&gt;
*2016, [[QEEG|qEEG]] / LORETA in Assessment of Neurocognitive Impairment in a Patient with Chronic Fatigue Syndrome: A Case Report&amp;lt;ref name=&amp;quot;Zinn ML, 2016&amp;quot; /&amp;gt; [https://sciforschenonline.org/journals/clinical-research/CLROA-2-110.php (Full Text)] &lt;br /&gt;
*2016, Functional Neural Network Connectivity in Myalgic Encephalomyelitis&amp;lt;ref name=&amp;quot;Zinn&amp;amp;Zinn, 2016&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/297453164_NeuroRegulation_httpwwwisnrorg_Functional_Neural_Network_Connectivity_in_Myalgic_Encephalomyelitis (Full Text)]&lt;br /&gt;
*2017, Small-world network analysis of cortical connectivity in [[Chronic Fatigue Syndrome]] using quantitative [[EEG]].&amp;lt;ref&amp;gt;{{Cite journal|last=Zinn|first=Mark Alan|author-link=Mark Zinn|last2=Zinn|first2=Marcie L.|author-link2=Marcie Zinn|last3=Jason|first3=Leonard A.|author-link3=Leonard Jason|date=2017-12-07|title=Small-World Network Analysis of Cortical Connectivity in Chronic Fatigue Syndrome Using Quantitative EEG|url=http://www.neuroregulation.org/article/view/17838|journal=NeuroRegulation|language=en|volume=4|issue=3-4|pages=125|doi=10.15540/nr.4.3-4.125|issn=2373-0587|via=}}&amp;lt;/ref&amp;gt; [https://www.researchgate.net/publication/321717868_Small-World_Network_Analysis_of_Cortical_Connectivity_in_Chronic_Fatigue_Syndrome_Using_Quantitative_EEG (Full Text)]&lt;br /&gt;
*2018, Cortical hypoactivation during resting EEG suggests central nervous system pathology in patients with [[chronic fatigue syndrome]]&amp;lt;ref&amp;gt;{{Cite journal|last=Zinn|first=M.A.|author-link=Mark Davis|last2=Zinn|first2=M.L.|author-link2=Marcie Zinn|last3=Valencia|first3=I.|author-link3=Ian Valencia|last4=Jason|first4=L.A.|author-link4=Leonard Jason|last5=Montoya|first5=J.G.|author-link5=Jose Montoya|date=Jul 2018|title=Cortical hypoactivation during resting EEG suggests central nervous system pathology in patients with chronic fatigue syndrome|url=https://linkinghub.elsevier.com/retrieve/pii/S0301051118304071|journal=Biological Psychology|language=en|volume=136|issue=|pages=87–99|doi=10.1016/j.biopsycho.2018.05.016|pmc=|pmid=29802861|quote=|via=}}&amp;lt;/ref&amp;gt; [https://www.sciencedirect.com/science/article/pii/S0301051118304071 (Abstract)]&lt;br /&gt;
&lt;br /&gt;
==Talks and interviews==&lt;br /&gt;
&lt;br /&gt;
*2016, [https://www.youtube.com/watch?v=aN0Fh0kiUiI &amp;quot;qEEG LORETA CFS Case study - Sci Forschen Inc.&amp;quot;]  &lt;br /&gt;
&lt;br /&gt;
==Online presence==&lt;br /&gt;
&lt;br /&gt;
*[https://www.ncbi.nlm.nih.gov/pubmed/?term=Zinn%20ML%5BAuthor%5D&amp;amp;cauthor=true&amp;amp;cauthor_uid=26869373 PubMed]&lt;br /&gt;
*[https://www.researchgate.net/profile/Dr_Marcie_Zinn ResearchGate]&lt;br /&gt;
*[https://www.linkedin.com/in/marcie-zinn-795083a8/ LinkedIn]&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
&lt;br /&gt;
*[http://www.selfgrowth.com/experts/marcie_zinn.html &amp;quot;Marcie Zinn Ph.D., NCTM&amp;quot; bio]&lt;br /&gt;
*[https://www.thencri.org NeuroCognitive Research Institute]&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
&lt;br /&gt;
*[[Mark Zinn]]&lt;br /&gt;
*[[qEEG|eLORETA]]&lt;br /&gt;
*swLORETA&lt;br /&gt;
*qEEG&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references responsive=&amp;quot;0&amp;quot;&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn, Zinn, 2015&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn            | first1 = Marcie              | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn            | first2 = Mark                | authorlink2 = Mark Zinn&lt;br /&gt;
| title   = Myalgic Encephalomyelitis: Symptoms and Biomarkers&lt;br /&gt;
| journal = Current Neuropharmacology   | volume = 13   | issue = 5   | page = 701-34.&lt;br /&gt;
| date    = 2015&lt;br /&gt;
| pmid    = 26411464&lt;br /&gt;
| doi     = 10.2174/1570159X13666150928105725&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn, Zinn 2014&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn        | first1 = Mark A        | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn        | first2 = Marcie        | last3   = Norris      | first3 = Jane          | authorlink3 = Jane Norris&lt;br /&gt;
| last4   = Valencia    | first4 = Ian           | authorlink4 = Ian Valencia&lt;br /&gt;
| last5   = Montoya     | first5 = Jose G        | authorlink5 = Jose Montoya&lt;br /&gt;
| title   = Cortical hypoactivation during resting eLORETA suggests central nervous system pathology in patients with chronic fatigue syndrome&lt;br /&gt;
| journal = Conference: 2014 Stanford Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Symposium  | volume =    | issue =   | page = &lt;br /&gt;
| date    = 2014&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn, Zinn 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| title   = Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with Myalgic Encephalomyelitis: A Pilot Study&lt;br /&gt;
| journal = Applied Psychophysiology and Biofeedback  | volume = 41   | issue = 3   | page = 283-300&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = 26869373&lt;br /&gt;
| doi     = 10.1007/s10484-016-9331-3&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn ML, Zinn MA, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| title   = qEEG / LORETA in Assessment of Neurocognitive Impairment in a Patient with Chronic Fatigue Syndrome: A Case Report&lt;br /&gt;
| journal = Clinical Research: Open Access  | volume = 2   | issue = 1   | page =&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = 26869373&lt;br /&gt;
| doi     = 10.16966/2469-6714.110&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn&amp;amp;Zinn, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| title   = Functional Neural Network Connectivity in Myalgic Encephalomyelitis&lt;br /&gt;
| journal = NeuroRegulation   | volume = 3   | issue = 1   | page = 28-50&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = &lt;br /&gt;
| doi     = 10.15540/nr.3.1.28&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;/references&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Researchers]]&lt;br /&gt;
[[Category:Clinicians]]&lt;br /&gt;
[[Category:US researchers]]&lt;br /&gt;
[[Category:People with ME, CFS, and/or FMS]]&lt;br /&gt;
[[Category:Psychological paradigm critics]]&lt;br /&gt;
[[Category:PACE trial critics]]&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Marcie_Zinn&amp;diff=78331</id>
		<title>Marcie Zinn</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Marcie_Zinn&amp;diff=78331"/>
		<updated>2019-12-02T21:05:23Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:changed incorrect information&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Cleanup|date=Dec 2019|reason=No References needed.}}&lt;br /&gt;
[[File:Marcie Zinn.png|200px|thumb|right]]&amp;lt;blockquote&amp;gt;&#039;&#039;&#039;Marcie Zinn&#039;&#039;&#039; Ph.D. is a research psychologist in Psychophysiology, Rehabilitation, Cognitive Neuroscience and Data Science conducting [[myalgic encephalomyelitis]] (ME) and [[chronic fatigue syndrome]] (CFS) research with her husband, [[Mark Zinn]], at their nonprofit, the Neurocognitive Research Institute. The Marcie&#039;s research interests include the study of brain dysfunction in chronic disease, such as [[myalgic encephalomyelitis|myalgic encephalomyelitis or ME.]] Marcie and her husband, Mark also founded the NeuroCognitive Research Institute (www.thencri.org)*. Her early research and career interests were in Performance Neuroscience and Psychology, but after being diagnosed in 2009 with herpes viral encephalitis which developed into [[Myalgic Encephalomyelitis]], her interest turned toward using her extensive [[QEEG|qEEG**]] and neuroscience skills for research in [[ME]]***. Under the leadership of Dr. [[Jose Montoya]], she conducted a pilot study to look at cognitive dysfunction using [[QEEG|qEEG]] methods. While continuing to collaborate with Jose Montoya at Stanford, she and her husband [[Mark Zinn|Mark]]  have published research using brain network modeling in the study of [[ME]] [[brain]] dysfunction.&amp;lt;/blockquote&amp;gt;REFERENCES:&lt;br /&gt;
&lt;br /&gt;
&amp;lt;nowiki&amp;gt;*&amp;lt;/nowiki&amp;gt;the NeuroCognitive Research Institute, a 501c3 organization (this is a not-for-profit business, not an article, post, comment or anything, but here is the reference).&lt;br /&gt;
&lt;br /&gt;
&amp;lt;nowiki&amp;gt;**&amp;lt;/nowiki&amp;gt;Quantitative EEG (&#039;&#039;&#039;qEEG&#039;&#039;&#039;) is the analysis of the digitized EEG, and in lay terms this sometimes is also called “Brain Mapping”. The &#039;&#039;&#039;qEEG&#039;&#039;&#039; is an extension of the analysis of the visual EEG interpretation which may assist and even augment our understanding of the EEG and brain function.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;nowiki&amp;gt;***&amp;lt;/nowiki&amp;gt;What this encyclopedia is about.&lt;br /&gt;
&lt;br /&gt;
==ME/CFS Common Data Element (CDE) Project==&lt;br /&gt;
Member of the Pain Working Group and the Neurologic/Cognitive/CNS Imaging Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project sponsored by the [[National Institute of Neurological Disorders and Stroke]] and the [[Centers for Disease Control and Prevention]].&amp;lt;ref&amp;gt;{{Cite web|url=https://www.commondataelements.ninds.nih.gov/Myalgic%20Encephalomyelitis/Chronic%20Fatigue%20Syndrome#pane-138|title=Complete Myalgic Encephalomyelitis/Chronic Fatigue Syndrome CDE Roster|last=|first=|authorlink=|last2=|first2=|authorlink2=|date=|website=NIH|archive-url=|archive-date=|dead-url=|access-date=2019-10-11}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Advocacy==&lt;br /&gt;
* Dr. Zinn signed the second and third [[open letter to the Lancet|open letters to the editor of &#039;&#039;The Lancet&#039;&#039;]] urging the editor to commission a fully independent review of the [[PACE trial]], which the journal published in 2011. &lt;br /&gt;
* Feb 10, 2016, [http://www.virology.ws/2016/02/10/open-letter-lancet-again/ An open letter to The Lancet, again - Virology blog] &lt;br /&gt;
* June 19, 2018, [http://www.virology.ws/2018/06/19/trial-by-error-an-open-letter-to-the-lancet-two-years-on/ Trial By Error: An Open Letter to The Lancet, Two Years On - Virology blog] &lt;br /&gt;
==Notable studies==&lt;br /&gt;
* June, 2004: &#039;&#039;Development of a Self-Report Inventory to Assess Cognitive Dysfunction in Musicians.&#039;&#039; ProQuest Information and Learning Company, Ann Arbor, Michigan.  &lt;br /&gt;
* March, 2005: &#039;&#039;The Hippocampus in Music Learning and Performance&#039;&#039; (March, 2005). Presentation at the annual Brain Awareness Week event sponsored by Dana Alliance for Brain Initiatives, Dublin, CA.  &lt;br /&gt;
* Mar 2014, Cortical hypoactivation during resting eLORETA suggests central nervous system pathology in patients with chronic fatigue syndrome (Conference paper, 2014 Stanford Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Symposium: Advances in Clinical Care and Translational Research for health care providers, Stanford School of Medicine, Palo Alto, CA&amp;lt;ref name=&amp;quot;Zinn, 2014&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/290628295_Cortical_hypoactivation_during_resting_eLORETA_suggests_central_nervous_system_pathology_in_patients_with_chronic_fatigue_syndrome (Abstract - full text on request)]  &lt;br /&gt;
* Mar 2014,  &#039;&#039;EEG peak alpha frequency is associated with chronic fatigue syndrome: a case-control observational study&#039;&#039;. Invited presentation at the 2014 Stanford Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Symposium : Advances in Clinical Care and Translational Research; March 19, 2014, Stanford University Dept. of Medicine, Palo Alto, CA.1.     &lt;br /&gt;
* &#039;&#039;EEG peak alpha frequency is associated with chronic fatigue syndrome: a case-control observational study&#039;&#039;. Invited presentation at the 2014 Stanford Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Symposium : Advances in Clinical Care and Translational Research; March 19, 2014, Stanford University Dept. of Medicine, Palo Alto, CA.  &lt;br /&gt;
*2015, Myalgic Encephalomyelitis: Symptoms and [[Biomarker]]s&amp;lt;ref name=&amp;quot;Zinn, 2015&amp;quot; /&amp;gt; - [http://www.ncbi.nlm.nih.gov/pubmed/26411464 (Full Text)]&lt;br /&gt;
*2015,  Zinn, M.L. &amp;amp; Zinn, M.A. Psychophysiology for Performing Artists. In M. S. Schwartz &amp;amp; F. Andrasik, Eds: Biofeedback: A Practitioners Guide (4th ed.), New York: Guilford.&lt;br /&gt;
*2016, Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with [[Myalgic Encephalomyelitis]]: A Pilot Study&amp;lt;ref name=&amp;quot;Zinn, 2016&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/294258397_Intrinsic_Functional_Hypoconnectivity_in_Core_Neurocognitive_Networks_Suggests_Central_Nervous_System_Pathology_in_Patients_with_Myalgic_Encephalomyelitis_A_Pilot_Study (Full Text)] &lt;br /&gt;
*2016, [[QEEG|qEEG]] / LORETA in Assessment of Neurocognitive Impairment in a Patient with Chronic Fatigue Syndrome: A Case Report&amp;lt;ref name=&amp;quot;Zinn ML, 2016&amp;quot; /&amp;gt; [https://sciforschenonline.org/journals/clinical-research/CLROA-2-110.php (Full Text)] &lt;br /&gt;
*2016, Functional Neural Network Connectivity in Myalgic Encephalomyelitis&amp;lt;ref name=&amp;quot;Zinn&amp;amp;Zinn, 2016&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/297453164_NeuroRegulation_httpwwwisnrorg_Functional_Neural_Network_Connectivity_in_Myalgic_Encephalomyelitis (Full Text)]&lt;br /&gt;
*2017, Small-world network analysis of cortical connectivity in [[Chronic Fatigue Syndrome]] using quantitative [[EEG]].&amp;lt;ref&amp;gt;{{Cite journal|last=Zinn|first=Mark Alan|author-link=Mark Zinn|last2=Zinn|first2=Marcie L.|author-link2=Marcie Zinn|last3=Jason|first3=Leonard A.|author-link3=Leonard Jason|date=2017-12-07|title=Small-World Network Analysis of Cortical Connectivity in Chronic Fatigue Syndrome Using Quantitative EEG|url=http://www.neuroregulation.org/article/view/17838|journal=NeuroRegulation|language=en|volume=4|issue=3-4|pages=125|doi=10.15540/nr.4.3-4.125|issn=2373-0587|via=}}&amp;lt;/ref&amp;gt; [https://www.researchgate.net/publication/321717868_Small-World_Network_Analysis_of_Cortical_Connectivity_in_Chronic_Fatigue_Syndrome_Using_Quantitative_EEG (Full Text)]&lt;br /&gt;
*2018, Cortical hypoactivation during resting EEG suggests central nervous system pathology in patients with [[chronic fatigue syndrome]]&amp;lt;ref&amp;gt;{{Cite journal|last=Zinn|first=M.A.|author-link=Mark Davis|last2=Zinn|first2=M.L.|author-link2=Marcie Zinn|last3=Valencia|first3=I.|author-link3=Ian Valencia|last4=Jason|first4=L.A.|author-link4=Leonard Jason|last5=Montoya|first5=J.G.|author-link5=Jose Montoya|date=Jul 2018|title=Cortical hypoactivation during resting EEG suggests central nervous system pathology in patients with chronic fatigue syndrome|url=https://linkinghub.elsevier.com/retrieve/pii/S0301051118304071|journal=Biological Psychology|language=en|volume=136|issue=|pages=87–99|doi=10.1016/j.biopsycho.2018.05.016|pmc=|pmid=29802861|quote=|via=}}&amp;lt;/ref&amp;gt; [https://www.sciencedirect.com/science/article/pii/S0301051118304071 (Abstract)]&lt;br /&gt;
&lt;br /&gt;
==Talks and interviews==&lt;br /&gt;
&lt;br /&gt;
*2016, [https://www.youtube.com/watch?v=aN0Fh0kiUiI &amp;quot;qEEG LORETA CFS Case study - Sci Forschen Inc.&amp;quot;]  &lt;br /&gt;
&lt;br /&gt;
==Online presence==&lt;br /&gt;
&lt;br /&gt;
*[https://www.ncbi.nlm.nih.gov/pubmed/?term=Zinn%20ML%5BAuthor%5D&amp;amp;cauthor=true&amp;amp;cauthor_uid=26869373 PubMed]&lt;br /&gt;
*[https://www.researchgate.net/profile/Dr_Marcie_Zinn ResearchGate]&lt;br /&gt;
*[https://www.linkedin.com/in/marcie-zinn-795083a8/ LinkedIn]&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
&lt;br /&gt;
*[http://www.selfgrowth.com/experts/marcie_zinn.html &amp;quot;Marcie Zinn Ph.D., NCTM&amp;quot; bio]&lt;br /&gt;
*[https://www.thencri.org NeuroCognitive Research Institute]&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
&lt;br /&gt;
*[[Mark Zinn]]&lt;br /&gt;
*[[qEEG|eLORETA]]&lt;br /&gt;
*swLORETA&lt;br /&gt;
*qEEG&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references responsive=&amp;quot;0&amp;quot;&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn, Zinn, 2015&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn            | first1 = Marcie              | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn            | first2 = Mark                | authorlink2 = Mark Zinn&lt;br /&gt;
| title   = Myalgic Encephalomyelitis: Symptoms and Biomarkers&lt;br /&gt;
| journal = Current Neuropharmacology   | volume = 13   | issue = 5   | page = 701-34.&lt;br /&gt;
| date    = 2015&lt;br /&gt;
| pmid    = 26411464&lt;br /&gt;
| doi     = 10.2174/1570159X13666150928105725&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn, Zinn 2014&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn        | first1 = Mark A        | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn        | first2 = Marcie        | last3   = Norris      | first3 = Jane          | authorlink3 = Jane Norris&lt;br /&gt;
| last4   = Valencia    | first4 = Ian           | authorlink4 = Ian Valencia&lt;br /&gt;
| last5   = Montoya     | first5 = Jose G        | authorlink5 = Jose Montoya&lt;br /&gt;
| title   = Cortical hypoactivation during resting eLORETA suggests central nervous system pathology in patients with chronic fatigue syndrome&lt;br /&gt;
| journal = Conference: 2014 Stanford Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Symposium  | volume =    | issue =   | page = &lt;br /&gt;
| date    = 2014&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Zinn, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| title   = Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with Myalgic Encephalomyelitis: A Pilot Study&lt;br /&gt;
| journal = Applied Psychophysiology and Biofeedback  | volume = 41   | issue = 3   | page = 283-300&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = 26869373&lt;br /&gt;
| doi     = 10.1007/s10484-016-9331-3&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn ML, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| title   = qEEG / LORETA in Assessment of Neurocognitive Impairment in a Patient with Chronic Fatigue Syndrome: A Case Report&lt;br /&gt;
| journal = Clinical Research: Open Access  | volume = 2   | issue = 1   | page =&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = 26869373&lt;br /&gt;
| doi     = 10.16966/2469-6714.110&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn&amp;amp;Zinn, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| title   = Functional Neural Network Connectivity in Myalgic Encephalomyelitis&lt;br /&gt;
| journal = NeuroRegulation   | volume = 3   | issue = 1   | page = 28-50&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = &lt;br /&gt;
| doi     = 10.15540/nr.3.1.28&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;/references&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Researchers]]&lt;br /&gt;
[[Category:Clinicians]]&lt;br /&gt;
[[Category:US researchers]]&lt;br /&gt;
[[Category:People with ME, CFS, and/or FMS]]&lt;br /&gt;
[[Category:Psychological paradigm critics]]&lt;br /&gt;
[[Category:PACE trial critics]]&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Marcie_Zinn&amp;diff=78330</id>
		<title>Marcie Zinn</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Marcie_Zinn&amp;diff=78330"/>
		<updated>2019-12-02T21:02:08Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:changed incorrect information&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Cleanup|date=Dec 2019|reason=No References needed.}}&lt;br /&gt;
[[File:Marcie Zinn.png|200px|thumb|right]]&amp;lt;blockquote&amp;gt;&#039;&#039;&#039;Marcie Zinn&#039;&#039;&#039; Ph.D. is a research psychologist in Psychophysiology, Rehabilitation, Cognitive Neuroscience and Data Science conducting [[myalgic encephalomyelitis]] (ME) and [[chronic fatigue syndrome]] (CFS) research with her husband, [[Mark Zinn]], at their nonprofit, the Neurocognitive Research Institute. The Marcie&#039;s research interests include the study of brain dysfunction in chronic disease, such as [[myalgic encephalomyelitis|myalgic encephalomyelitis or ME.]] Marcie and her husband, Mark also founded the NeuroCognitive Research Institute (www.thencri.org)*. Her early research and career interests were in Performance Neuroscience and Psychology, but after being diagnosed in 2009 with herpes viral encephalitis which developed into [[Myalgic Encephalomyelitis]], her interest turned toward using her extensive [[QEEG|qEEG**]] and neuroscience skills for research in [[ME]]***. Under the leadership of Dr. [[Jose Montoya]], she conducted a pilot study to look at cognitive dysfunction using [[QEEG|qEEG]] methods. While continuing to collaborate with Jose Montoya at Stanford, she and her husband [[Mark Zinn|Mark]]  have published research using brain network modeling in the study of [[ME]] [[brain]] dysfunction.&amp;lt;/blockquote&amp;gt;REFERENCES:&lt;br /&gt;
&lt;br /&gt;
&amp;lt;nowiki&amp;gt;*&amp;lt;/nowiki&amp;gt;the NeuroCognitive Research Institute, a 501c3 organization (this is a not-for-profit business, not an article, post, comment or anything, but here is the reference).&lt;br /&gt;
&lt;br /&gt;
&amp;lt;nowiki&amp;gt;**&amp;lt;/nowiki&amp;gt;Quantitative EEG (&#039;&#039;&#039;qEEG&#039;&#039;&#039;) is the analysis of the digitized EEG, and in lay terms this sometimes is also called “Brain Mapping”. The &#039;&#039;&#039;qEEG&#039;&#039;&#039; is an extension of the analysis of the visual EEG interpretation which may assist and even augment our understanding of the EEG and brain function.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;nowiki&amp;gt;***&amp;lt;/nowiki&amp;gt;What this encyclopedia is about.&lt;br /&gt;
&lt;br /&gt;
==ME/CFS Common Data Element (CDE) Project==&lt;br /&gt;
Member of the Pain Working Group and the Neurologic/Cognitive/CNS Imaging Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project sponsored by the [[National Institute of Neurological Disorders and Stroke]] and the [[Centers for Disease Control and Prevention]].&amp;lt;ref&amp;gt;{{Cite web|url=https://www.commondataelements.ninds.nih.gov/Myalgic%20Encephalomyelitis/Chronic%20Fatigue%20Syndrome#pane-138|title=Complete Myalgic Encephalomyelitis/Chronic Fatigue Syndrome CDE Roster|last=|first=|authorlink=|last2=|first2=|authorlink2=|date=|website=NIH|archive-url=|archive-date=|dead-url=|access-date=2019-10-11}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Advocacy==&lt;br /&gt;
* Dr. Zinn signed the second and third [[open letter to the Lancet|open letters to the editor of &#039;&#039;The Lancet&#039;&#039;]] urging the editor to commission a fully independent review of the [[PACE trial]], which the journal published in 2011. &lt;br /&gt;
* Feb 10, 2016, [http://www.virology.ws/2016/02/10/open-letter-lancet-again/ An open letter to The Lancet, again - Virology blog] &lt;br /&gt;
* June 19, 2018, [http://www.virology.ws/2018/06/19/trial-by-error-an-open-letter-to-the-lancet-two-years-on/ Trial By Error: An Open Letter to The Lancet, Two Years On - Virology blog] &lt;br /&gt;
==Notable studies==&lt;br /&gt;
* June, 2004: &#039;&#039;Development of a Self-Report Inventory to Assess Cognitive Dysfunction in Musicians.&#039;&#039; ProQuest Information and Learning Company, Ann Arbor, Michigan.  &lt;br /&gt;
* March, 2005: &#039;&#039;The Hippocampus in Music Learning and Performance&#039;&#039; (March, 2005). Presentation at the annual Brain Awareness Week event sponsored by Dana Alliance for Brain Initiatives, Dublin, CA.  &lt;br /&gt;
* Mar 2014, Cortical hypoactivation during resting eLORETA suggests central nervous system pathology in patients with chronic fatigue syndrome (Conference paper, 2014 Stanford Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Symposium: Advances in Clinical Care and Translational Research for health care providers, Stanford School of Medicine, Palo Alto, CA&amp;lt;ref name=&amp;quot;Zinn, 2014&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/290628295_Cortical_hypoactivation_during_resting_eLORETA_suggests_central_nervous_system_pathology_in_patients_with_chronic_fatigue_syndrome (Abstract - full text on request)]  &lt;br /&gt;
* Mar 2014,  &#039;&#039;EEG peak alpha frequency is associated with chronic fatigue syndrome: a case-control observational study&#039;&#039;. Invited presentation at the 2014 Stanford Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Symposium : Advances in Clinical Care and Translational Research; March 19, 2014, Stanford University Dept. of Medicine, Palo Alto, CA.1.     &lt;br /&gt;
* &#039;&#039;EEG peak alpha frequency is associated with chronic fatigue syndrome: a case-control observational study&#039;&#039;. Invited presentation at the 2014 Stanford Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Symposium : Advances in Clinical Care and Translational Research; March 19, 2014, Stanford University Dept. of Medicine, Palo Alto, CA.  &lt;br /&gt;
*2015, Myalgic Encephalomyelitis: Symptoms and [[Biomarker]]s&amp;lt;ref name=&amp;quot;Zinn, 2015&amp;quot; /&amp;gt; - [http://www.ncbi.nlm.nih.gov/pubmed/26411464 (Full Text)]&lt;br /&gt;
*2015,  Zinn, M.L. &amp;amp; Zinn, M.A. Psychophysiology for Performing Artists. In M. S. Schwartz &amp;amp; F. Andrasik, Eds: Biofeedback: A Practitioners Guide (4th ed.), New York: Guilford.&lt;br /&gt;
*2016, Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with [[Myalgic Encephalomyelitis]]: A Pilot Study&amp;lt;ref name=&amp;quot;Zinn, 2016&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/294258397_Intrinsic_Functional_Hypoconnectivity_in_Core_Neurocognitive_Networks_Suggests_Central_Nervous_System_Pathology_in_Patients_with_Myalgic_Encephalomyelitis_A_Pilot_Study (Full Text)] &lt;br /&gt;
*2016, [[QEEG|qEEG]] / LORETA in Assessment of Neurocognitive Impairment in a Patient with Chronic Fatigue Syndrome: A Case Report&amp;lt;ref name=&amp;quot;Zinn ML, 2016&amp;quot; /&amp;gt; [https://sciforschenonline.org/journals/clinical-research/CLROA-2-110.php (Full Text)] &lt;br /&gt;
*2016, Functional Neural Network Connectivity in Myalgic Encephalomyelitis&amp;lt;ref name=&amp;quot;Zinn&amp;amp;Zinn, 2016&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/297453164_NeuroRegulation_httpwwwisnrorg_Functional_Neural_Network_Connectivity_in_Myalgic_Encephalomyelitis (Full Text)]&lt;br /&gt;
*2017, Small-world network analysis of cortical connectivity in [[Chronic Fatigue Syndrome]] using quantitative [[EEG]].&amp;lt;ref&amp;gt;{{Cite journal|last=Zinn|first=Mark Alan|author-link=Mark Zinn|last2=Zinn|first2=Marcie L.|author-link2=Marcie Zinn|last3=Jason|first3=Leonard A.|author-link3=Leonard Jason|date=2017-12-07|title=Small-World Network Analysis of Cortical Connectivity in Chronic Fatigue Syndrome Using Quantitative EEG|url=http://www.neuroregulation.org/article/view/17838|journal=NeuroRegulation|language=en|volume=4|issue=3-4|pages=125|doi=10.15540/nr.4.3-4.125|issn=2373-0587|via=}}&amp;lt;/ref&amp;gt; [https://www.researchgate.net/publication/321717868_Small-World_Network_Analysis_of_Cortical_Connectivity_in_Chronic_Fatigue_Syndrome_Using_Quantitative_EEG (Full Text)]&lt;br /&gt;
*2018, Cortical hypoactivation during resting EEG suggests central nervous system pathology in patients with [[chronic fatigue syndrome]]&amp;lt;ref&amp;gt;{{Cite journal|last=Zinn|first=M.A.|author-link=Mark Davis|last2=Zinn|first2=M.L.|author-link2=Marcie Zinn|last3=Valencia|first3=I.|author-link3=Ian Valencia|last4=Jason|first4=L.A.|author-link4=Leonard Jason|last5=Montoya|first5=J.G.|author-link5=Jose Montoya|date=Jul 2018|title=Cortical hypoactivation during resting EEG suggests central nervous system pathology in patients with chronic fatigue syndrome|url=https://linkinghub.elsevier.com/retrieve/pii/S0301051118304071|journal=Biological Psychology|language=en|volume=136|issue=|pages=87–99|doi=10.1016/j.biopsycho.2018.05.016|pmc=|pmid=29802861|quote=|via=}}&amp;lt;/ref&amp;gt; [https://www.sciencedirect.com/science/article/pii/S0301051118304071 (Abstract)]&lt;br /&gt;
&lt;br /&gt;
==Talks and interviews==&lt;br /&gt;
&lt;br /&gt;
*2016, [https://www.youtube.com/watch?v=aN0Fh0kiUiI &amp;quot;qEEG LORETA CFS Case study - Sci Forschen Inc.&amp;quot;]  &lt;br /&gt;
&lt;br /&gt;
==Online presence==&lt;br /&gt;
&lt;br /&gt;
*[https://www.ncbi.nlm.nih.gov/pubmed/?term=Zinn%20ML%5BAuthor%5D&amp;amp;cauthor=true&amp;amp;cauthor_uid=26869373 PubMed]&lt;br /&gt;
*[https://www.researchgate.net/profile/Dr_Marcie_Zinn ResearchGate]&lt;br /&gt;
*[https://www.linkedin.com/in/marcie-zinn-795083a8/ LinkedIn]&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
&lt;br /&gt;
*[http://www.selfgrowth.com/experts/marcie_zinn.html &amp;quot;Marcie Zinn Ph.D., NCTM&amp;quot; bio]&lt;br /&gt;
*[https://www.thencri.org NeuroCognitive Research Institute]&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
&lt;br /&gt;
*[[Mark Zinn]]&lt;br /&gt;
*[[qEEG|eLORETA]]&lt;br /&gt;
*swLORETA&lt;br /&gt;
*qEEG&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references responsive=&amp;quot;0&amp;quot;&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn, Zinn, 2015&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn            | first1 = Marcie              | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn            | first2 = Mark                | authorlink2 = Mark Zinn&lt;br /&gt;
| title   = Myalgic Encephalomyelitis: Symptoms and Biomarkers&lt;br /&gt;
| journal = Current Neuropharmacology   | volume = 13   | issue = 5   | page = 701-34.&lt;br /&gt;
| date    = 2015&lt;br /&gt;
| pmid    = 26411464&lt;br /&gt;
| doi     = 10.2174/1570159X13666150928105725&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn, 2014&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn        | first1 = Mark A        | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn        | first2 = Marcie        | last3   = Norris      | first3 = Jane          | authorlink3 = Jane Norris&lt;br /&gt;
| last4   = Valencia    | first4 = Ian           | authorlink4 = Ian Valencia&lt;br /&gt;
| last5   = Montoya     | first5 = Jose G        | authorlink5 = Jose Montoya&lt;br /&gt;
| title   = Cortical hypoactivation during resting eLORETA suggests central nervous system pathology in patients with chronic fatigue syndrome&lt;br /&gt;
| journal = Conference: 2014 Stanford Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Symposium  | volume =    | issue =   | page = &lt;br /&gt;
| date    = 2014&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| title   = Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with Myalgic Encephalomyelitis: A Pilot Study&lt;br /&gt;
| journal = Applied Psychophysiology and Biofeedback  | volume = 41   | issue = 3   | page = 283-300&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = 26869373&lt;br /&gt;
| doi     = 10.1007/s10484-016-9331-3&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn ML, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| title   = qEEG / LORETA in Assessment of Neurocognitive Impairment in a Patient with Chronic Fatigue Syndrome: A Case Report&lt;br /&gt;
| journal = Clinical Research: Open Access  | volume = 2   | issue = 1   | page =&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = 26869373&lt;br /&gt;
| doi     = 10.16966/2469-6714.110&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn&amp;amp;Zinn, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| title   = Functional Neural Network Connectivity in Myalgic Encephalomyelitis&lt;br /&gt;
| journal = NeuroRegulation   | volume = 3   | issue = 1   | page = 28-50&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = &lt;br /&gt;
| doi     = 10.15540/nr.3.1.28&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;/references&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Researchers]]&lt;br /&gt;
[[Category:Clinicians]]&lt;br /&gt;
[[Category:US researchers]]&lt;br /&gt;
[[Category:People with ME, CFS, and/or FMS]]&lt;br /&gt;
[[Category:Psychological paradigm critics]]&lt;br /&gt;
[[Category:PACE trial critics]]&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Marcie_Zinn&amp;diff=78329</id>
		<title>Marcie Zinn</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Marcie_Zinn&amp;diff=78329"/>
		<updated>2019-12-02T20:52:23Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:changed incorrect information&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Cleanup|date=Dec 2019|reason=No References needed.}}&lt;br /&gt;
[[File:Marcie Zinn.png|200px|thumb|right]]&amp;lt;blockquote&amp;gt;&#039;&#039;&#039;Marcie Zinn&#039;&#039;&#039; Ph.D. is a research psychologist in Psychophysiology, Rehabilitation, Cognitive Neuroscience and Data Science conducting [[myalgic encephalomyelitis]] (ME) and [[chronic fatigue syndrome]] (CFS) research with her husband, [[Mark Zinn]], at their nonprofit, the Neurocognitive Research Institute. The Marcie&#039;s research interests include the study of brain dysfunction in chronic disease, such as [[myalgic encephalomyelitis|myalgic encephalomyelitis or ME.]] Marcie and her husband, Mark also founded the NeuroCognitive Research Institute (www.thencri.org)*. Her early research and career interests were in Performance Neuroscience and Psychology, but after being diagnosed in 2009 with herpes viral encephalitis which developed into [[Myalgic Encephalomyelitis]], her interest turned toward using her extensive [[QEEG|qEEG**]] and neuroscience skills for research in [[ME]]***. Under the leadership of Dr. [[Jose Montoya]], she conducted a pilot study to look at cognitive dysfunction using [[QEEG|qEEG]] methods. While continuing to collaborate with Jose Montoya at Stanford, she and her husband [[Mark Zinn|Mark]]  have published research using brain network modeling in the study of [[ME]] [[brain]] dysfunction.&amp;lt;/blockquote&amp;gt;REFERENCES:&lt;br /&gt;
&lt;br /&gt;
&amp;lt;nowiki&amp;gt;*&amp;lt;/nowiki&amp;gt;the NeuroCognitive Research Institute, a 501c3 organization (this is a not-for-profit business, not an article, post, comment or anything, but here is the reference).&lt;br /&gt;
&lt;br /&gt;
&amp;lt;nowiki&amp;gt;**&amp;lt;/nowiki&amp;gt;Quantitative EEG (&#039;&#039;&#039;qEEG&#039;&#039;&#039;) is the analysis of the digitized EEG, and in lay terms this sometimes is also called “Brain Mapping”. The &#039;&#039;&#039;qEEG&#039;&#039;&#039; is an extension of the analysis of the visual EEG interpretation which may assist and even augment our understanding of the EEG and brain function.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;nowiki&amp;gt;***&amp;lt;/nowiki&amp;gt;What this encyclopedia is about.&lt;br /&gt;
&lt;br /&gt;
==ME/CFS Common Data Element (CDE) Project==&lt;br /&gt;
Member of the Pain Working Group and the Neurologic/Cognitive/CNS Imaging Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project sponsored by the [[National Institute of Neurological Disorders and Stroke]] and the [[Centers for Disease Control and Prevention]].&amp;lt;ref&amp;gt;{{Cite web|url=https://www.commondataelements.ninds.nih.gov/Myalgic%20Encephalomyelitis/Chronic%20Fatigue%20Syndrome#pane-138|title=Complete Myalgic Encephalomyelitis/Chronic Fatigue Syndrome CDE Roster|last=|first=|authorlink=|last2=|first2=|authorlink2=|date=|website=NIH|archive-url=|archive-date=|dead-url=|access-date=2019-10-11}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Advocacy==&lt;br /&gt;
* Dr. Zinn signed the second and third [[open letter to the Lancet|open letters to the editor of &#039;&#039;The Lancet&#039;&#039;]] urging the editor to commission a fully independent review of the [[PACE trial]], which the journal published in 2011. &lt;br /&gt;
* Feb 10, 2016, [http://www.virology.ws/2016/02/10/open-letter-lancet-again/ An open letter to The Lancet, again - Virology blog] &lt;br /&gt;
* June 19, 2018, [http://www.virology.ws/2018/06/19/trial-by-error-an-open-letter-to-the-lancet-two-years-on/ Trial By Error: An Open Letter to The Lancet, Two Years On - Virology blog] &lt;br /&gt;
==Notable studies==&lt;br /&gt;
* June, 2004: &#039;&#039;Development of a Self-Report Inventory to Develop Cognitive Dysfunction in Musicians.&#039;&#039; ProQuest Information and Learning Company, Ann Arbor, Michigan.  &lt;br /&gt;
* March, 2005: &#039;&#039;The Hippocampus in Music Learning and Performance&#039;&#039; (March, 2005). Presentation at the annual Brain Awareness Week event sponsored by Dana Alliance for Brain Initiatives, Dublin, CA.  &lt;br /&gt;
* Mar 2014, Cortical hypoactivation during resting eLORETA suggests central nervous system pathology in patients with chronic fatigue syndrome (Conference paper, 2014 Stanford Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Symposium: Advances in Clinical Care and Translational Research for health care providers, At Stanford School of Medicine, Palo Alto, CA&amp;lt;ref name=&amp;quot;Zinn, 2014&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/290628295_Cortical_hypoactivation_during_resting_eLORETA_suggests_central_nervous_system_pathology_in_patients_with_chronic_fatigue_syndrome (Abstract - full text on request)]  &lt;br /&gt;
* Mar 2014,  &#039;&#039;EEG peak alpha frequency is associated with chronic fatigue syndrome: a case-control observational study&#039;&#039;. Invited presentation at the 2014 Stanford Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Symposium : Advances in Clinical Care and Translational Research; March 19, 2014, Stanford University Dept. of Medicine, Palo Alto, CA.1.     &lt;br /&gt;
* &#039;&#039;EEG peak alpha frequency is associated with chronic fatigue syndrome: a case-control observational study&#039;&#039;. Invited presentation at the 2014 Stanford Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Symposium : Advances in Clinical Care and Translational Research; March 19, 2014, Stanford University Dept. of Medicine, Palo Alto, CA.  &lt;br /&gt;
*2015, Myalgic Encephalomyelitis: Symptoms and [[Biomarker]]s&amp;lt;ref name=&amp;quot;Zinn, 2015&amp;quot; /&amp;gt; - [http://www.ncbi.nlm.nih.gov/pubmed/26411464 (Full Text)]&lt;br /&gt;
*2015,  Zinn, M.L. &amp;amp; Zinn, M.A. Psychophysiology for Performing Artists. In M. S. Schwartz &amp;amp; F. Andrasik, Eds: Biofeedback: A Practitioners Guide (4th ed.), New York: Guilford.&lt;br /&gt;
*2016, Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with [[Myalgic Encephalomyelitis]]: A Pilot Study&amp;lt;ref name=&amp;quot;Zinn, 2016&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/294258397_Intrinsic_Functional_Hypoconnectivity_in_Core_Neurocognitive_Networks_Suggests_Central_Nervous_System_Pathology_in_Patients_with_Myalgic_Encephalomyelitis_A_Pilot_Study (Full Text)] &lt;br /&gt;
*2016, [[QEEG|qEEG]] / LORETA in Assessment of Neurocognitive Impairment in a Patient with Chronic Fatigue Syndrome: A Case Report&amp;lt;ref name=&amp;quot;Zinn ML, 2016&amp;quot; /&amp;gt; [https://sciforschenonline.org/journals/clinical-research/CLROA-2-110.php (Full Text)] &lt;br /&gt;
*2016, Functional Neural Network Connectivity in Myalgic Encephalomyelitis&amp;lt;ref name=&amp;quot;Zinn&amp;amp;Zinn, 2016&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/297453164_NeuroRegulation_httpwwwisnrorg_Functional_Neural_Network_Connectivity_in_Myalgic_Encephalomyelitis (Full Text)]&lt;br /&gt;
*2017, Small-world network analysis of cortical connectivity in [[Chronic Fatigue Syndrome]] using quantitative [[EEG]].&amp;lt;ref&amp;gt;{{Cite journal|last=Zinn|first=Mark Alan|author-link=Mark Zinn|last2=Zinn|first2=Marcie L.|author-link2=Marcie Zinn|last3=Jason|first3=Leonard A.|author-link3=Leonard Jason|date=2017-12-07|title=Small-World Network Analysis of Cortical Connectivity in Chronic Fatigue Syndrome Using Quantitative EEG|url=http://www.neuroregulation.org/article/view/17838|journal=NeuroRegulation|language=en|volume=4|issue=3-4|pages=125|doi=10.15540/nr.4.3-4.125|issn=2373-0587|via=}}&amp;lt;/ref&amp;gt; [https://www.researchgate.net/publication/321717868_Small-World_Network_Analysis_of_Cortical_Connectivity_in_Chronic_Fatigue_Syndrome_Using_Quantitative_EEG (Full Text)]&lt;br /&gt;
*2018, Cortical hypoactivation during resting EEG suggests central nervous system pathology in patients with [[chronic fatigue syndrome]]&amp;lt;ref&amp;gt;{{Cite journal|last=Zinn|first=M.A.|author-link=Mark Davis|last2=Zinn|first2=M.L.|author-link2=Marcie Zinn|last3=Valencia|first3=I.|author-link3=Ian Valencia|last4=Jason|first4=L.A.|author-link4=Leonard Jason|last5=Montoya|first5=J.G.|author-link5=Jose Montoya|date=Jul 2018|title=Cortical hypoactivation during resting EEG suggests central nervous system pathology in patients with chronic fatigue syndrome|url=https://linkinghub.elsevier.com/retrieve/pii/S0301051118304071|journal=Biological Psychology|language=en|volume=136|issue=|pages=87–99|doi=10.1016/j.biopsycho.2018.05.016|pmc=|pmid=29802861|quote=|via=}}&amp;lt;/ref&amp;gt; [https://www.sciencedirect.com/science/article/pii/S0301051118304071 (Abstract)]&lt;br /&gt;
&lt;br /&gt;
==Talks and interviews==&lt;br /&gt;
&lt;br /&gt;
*2016, [https://www.youtube.com/watch?v=aN0Fh0kiUiI &amp;quot;qEEG LORETA CFS Case study - Sci Forschen Inc.&amp;quot;]  &lt;br /&gt;
&lt;br /&gt;
==Online presence==&lt;br /&gt;
&lt;br /&gt;
*[https://www.ncbi.nlm.nih.gov/pubmed/?term=Zinn%20ML%5BAuthor%5D&amp;amp;cauthor=true&amp;amp;cauthor_uid=26869373 PubMed]&lt;br /&gt;
*[https://www.researchgate.net/profile/Dr_Marcie_Zinn ResearchGate]&lt;br /&gt;
*[https://www.linkedin.com/in/marcie-zinn-795083a8/ LinkedIn]&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
&lt;br /&gt;
*[http://www.selfgrowth.com/experts/marcie_zinn.html &amp;quot;Marcie Zinn Ph.D., NCTM&amp;quot; bio]&lt;br /&gt;
*[https://www.thencri.org NeuroCognitive Research Institute]&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
&lt;br /&gt;
*[[Mark Zinn]]&lt;br /&gt;
*[[qEEG|eLORETA]]&lt;br /&gt;
*swLORETA&lt;br /&gt;
*qEEG&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn, Zinn, 2015&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn            | first1 = Marcie              | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn            | first2 = Mark                | authorlink2 = Mark Zinn&lt;br /&gt;
| title   = Myalgic Encephalomyelitis: Symptoms and Biomarkers&lt;br /&gt;
| journal = Current Neuropharmacology   | volume = 13   | issue = 5   | page = 701-34.&lt;br /&gt;
| date    = 2015&lt;br /&gt;
| pmid    = 26411464&lt;br /&gt;
| doi     = 10.2174/1570159X13666150928105725&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn, 2014&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn        | first1 = Mark A        | authorlink1 = Mark Zinn&lt;br /&gt;
| last2   = Zinn        | first2 = Marcie        | authorlink1 = Marcie Zinn&lt;br /&gt;
| last3   = Norris      | first3 = Jane          | authorlink3 = Jane Norris&lt;br /&gt;
| last4   = Valencia    | first4 = Ian           | authorlink4 = Ian Valencia&lt;br /&gt;
| last5   = Montoya     | first5 = Jose G        | authorlink5 = Jose Montoya&lt;br /&gt;
| title   = Cortical hypoactivation during resting eLORETA suggests central nervous system pathology in patients with chronic fatigue syndrome&lt;br /&gt;
| journal = Conference: 2014 Stanford Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Symposium  | volume =    | issue =   | page = &lt;br /&gt;
| date    = 2014&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| title   = Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with Myalgic Encephalomyelitis: A Pilot Study&lt;br /&gt;
| journal = Applied Psychophysiology and Biofeedback  | volume = 41   | issue = 3   | page = 283-300&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = 26869373&lt;br /&gt;
| doi     = 10.1007/s10484-016-9331-3&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn ML, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| title   = qEEG / LORETA in Assessment of Neurocognitive Impairment in a Patient with Chronic Fatigue Syndrome: A Case Report&lt;br /&gt;
| journal = Clinical Research: Open Access  | volume = 2   | issue = 1   | page =&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = 26869373&lt;br /&gt;
| doi     = 10.16966/2469-6714.110&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn&amp;amp;Zinn, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| title   = Functional Neural Network Connectivity in Myalgic Encephalomyelitis&lt;br /&gt;
| journal = NeuroRegulation   | volume = 3   | issue = 1   | page = 28-50&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = &lt;br /&gt;
| doi     = 10.15540/nr.3.1.28&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;/references&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Researchers]]&lt;br /&gt;
[[Category:Clinicians]]&lt;br /&gt;
[[Category:US researchers]]&lt;br /&gt;
[[Category:People with ME, CFS, and/or FMS]]&lt;br /&gt;
[[Category:Psychological paradigm critics]]&lt;br /&gt;
[[Category:PACE trial critics]]&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Marcie_Zinn&amp;diff=78328</id>
		<title>Marcie Zinn</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Marcie_Zinn&amp;diff=78328"/>
		<updated>2019-12-02T20:50:11Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:changed incorrect information&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Cleanup|date=Dec 2019|reason=No References needed.}}&lt;br /&gt;
[[File:Marcie Zinn.png|200px|thumb|right]]&amp;lt;blockquote&amp;gt;&#039;&#039;&#039;Marcie Zinn&#039;&#039;&#039; Ph.D. is a research psychologist in Psychophysiology, Rehabilitation, Cognitive Neuroscience and Data Science conducting [[myalgic encephalomyelitis]] (ME) and [[chronic fatigue syndrome]] (CFS) research with her husband, [[Mark Zinn]], at their nonprofit, the Neurocognitive Research Institute. The Marcie&#039;s research interests include the study of brain dysfunction in chronic disease, such as [[myalgic encephalomyelitis|myalgic encephalomyelitis or ME.]] Marcie and her husband, Mark also founded the NeuroCognitive Research Institute (www.thencri.org)*. Her early research and career interests were in Performance Neuroscience and Psychology, but after being diagnosed in 2009 with herpes viral encephalitis which developed into [[Myalgic Encephalomyelitis]], her interest turned toward using her extensive [[QEEG|qEEG**]] and neuroscience skills for research in [[ME]]***. Under the leadership of Dr. [[Jose Montoya]], she conducted a pilot study to look at cognitive dysfunction using [[QEEG|qEEG]] methods. While continuing to collaborate with Jose Montoya at Stanford, she and her husband [[Mark Zinn|Mark]]  have published research using brain network modeling in the study of [[ME]] [[brain]] dysfunction.&amp;lt;/blockquote&amp;gt;REFERENCES:&lt;br /&gt;
&lt;br /&gt;
&amp;lt;nowiki&amp;gt;*&amp;lt;/nowiki&amp;gt;the NeuroCognitive Research Institute, a 501c3 organization (this is a not-for-profit business, not an article, post, comment or anything, but here is the reference).&lt;br /&gt;
&lt;br /&gt;
&amp;lt;nowiki&amp;gt;**&amp;lt;/nowiki&amp;gt;Quantitative EEG (&#039;&#039;&#039;qEEG&#039;&#039;&#039;) is the analysis of the digitized EEG, and in lay terms this sometimes is also called “Brain Mapping”. The &#039;&#039;&#039;qEEG&#039;&#039;&#039; is an extension of the analysis of the visual EEG interpretation which may assist and even augment our understanding of the EEG and brain function.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;nowiki&amp;gt;***&amp;lt;/nowiki&amp;gt;What this encyclopedia is about.&lt;br /&gt;
&lt;br /&gt;
==ME/CFS Common Data Element (CDE) Project==&lt;br /&gt;
Member of the Pain Working Group and the Neurologic/Cognitive/CNS Imaging Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project sponsored by the [[National Institute of Neurological Disorders and Stroke]] and the [[Centers for Disease Control and Prevention]].&amp;lt;ref&amp;gt;{{Cite web|url=https://www.commondataelements.ninds.nih.gov/Myalgic%20Encephalomyelitis/Chronic%20Fatigue%20Syndrome#pane-138|title=Complete Myalgic Encephalomyelitis/Chronic Fatigue Syndrome CDE Roster|last=|first=|authorlink=|last2=|first2=|authorlink2=|date=|website=NIH|archive-url=|archive-date=|dead-url=|access-date=2019-10-11}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Advocacy==&lt;br /&gt;
* Dr. Zinn signed the second and third [[open letter to the Lancet|open letters to the editor of &#039;&#039;The Lancet&#039;&#039;]] urging the editor to commission a fully independent review of the [[PACE trial]], which the journal published in 2011. &lt;br /&gt;
* Feb 10, 2016, [http://www.virology.ws/2016/02/10/open-letter-lancet-again/ An open letter to The Lancet, again - Virology blog] &lt;br /&gt;
* June 19, 2018, [http://www.virology.ws/2018/06/19/trial-by-error-an-open-letter-to-the-lancet-two-years-on/ Trial By Error: An Open Letter to The Lancet, Two Years On - Virology blog] &lt;br /&gt;
==Notable studies==&lt;br /&gt;
* June, 2004: &#039;&#039;Development of a Self-Report Inventory to Develop Cognitive Dysfunction in Musicians.&#039;&#039; ProQuest Information and Learning Company, Ann Arbor, Michigan.  &lt;br /&gt;
* March, 2005: &#039;&#039;The Hippocampus in Music Learning and Performance&#039;&#039; (March, 2005). Presentation at the annual Brain Awareness Week event sponsored by Dana Alliance for Brain Initiatives, Dublin, CA.  &lt;br /&gt;
* Mar 2014, Cortical hypoactivation during resting eLORETA suggests central nervous system pathology in patients with chronic fatigue syndrome (Conference paper, 2014 Stanford Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Symposium: Advances in Clinical Care and Translational Research for health care providers, At Stanford School of Medicine, Palo Alto, CA&amp;lt;ref name=&amp;quot;Zinn, 2014&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/290628295_Cortical_hypoactivation_during_resting_eLORETA_suggests_central_nervous_system_pathology_in_patients_with_chronic_fatigue_syndrome (Abstract - full text on request)]  &lt;br /&gt;
* Mar 2014,  &#039;&#039;EEG peak alpha frequency is associated with chronic fatigue syndrome: a case-control observational study&#039;&#039;. Invited presentation at the 2014 Stanford Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Symposium : Advances in Clinical Care and Translational Research; March 19, 2014, Stanford University Dept. of Medicine, Palo Alto, CA.1.     &lt;br /&gt;
* &#039;&#039;EEG peak alpha frequency is associated with chronic fatigue syndrome: a case-control observational study&#039;&#039;. Invited presentation at the 2014 Stanford Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Symposium : Advances in Clinical Care and Translational Research; March 19, 2014, Stanford University Dept. of Medicine, Palo Alto, CA.  &lt;br /&gt;
*2015, Myalgic Encephalomyelitis: Symptoms and [[Biomarker]]s&amp;lt;ref name=&amp;quot;Zinn, 2015&amp;quot; /&amp;gt; - [http://www.ncbi.nlm.nih.gov/pubmed/26411464 (Full Text)]&lt;br /&gt;
*2015,  Zinn, M.L. &amp;amp; Zinn, M.A. Psychophysiology for Performing Artists. In M. S. Schwartz &amp;amp; F. Andrasik, Eds: Biofeedback: A Practitioners Guide (4th ed.), New York: Guilford.&lt;br /&gt;
*2016, Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with [[Myalgic Encephalomyelitis]]: A Pilot Study&amp;lt;ref name=&amp;quot;Zinn, 2016&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/294258397_Intrinsic_Functional_Hypoconnectivity_in_Core_Neurocognitive_Networks_Suggests_Central_Nervous_System_Pathology_in_Patients_with_Myalgic_Encephalomyelitis_A_Pilot_Study (Full Text)] &lt;br /&gt;
*2016, [[QEEG|qEEG]] / LORETA in Assessment of Neurocognitive Impairment in a Patient with Chronic Fatigue Syndrome: A Case Report&amp;lt;ref name=&amp;quot;Zinn ML, 2016&amp;quot; /&amp;gt; [https://sciforschenonline.org/journals/clinical-research/CLROA-2-110.php (Full Text)] &lt;br /&gt;
*2016, Functional Neural Network Connectivity in Myalgic Encephalomyelitis&amp;lt;ref name=&amp;quot;Zinn&amp;amp;Zinn, 2016&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/297453164_NeuroRegulation_httpwwwisnrorg_Functional_Neural_Network_Connectivity_in_Myalgic_Encephalomyelitis (Full Text)]&lt;br /&gt;
*2017, Small-world network analysis of cortical connectivity in [[Chronic Fatigue Syndrome]] using quantitative [[EEG]].&amp;lt;ref&amp;gt;{{Cite journal|last=Zinn|first=Mark Alan|author-link=Mark Zinn|last2=Zinn|first2=Marcie L.|author-link2=Marcie Zinn|last3=Jason|first3=Leonard A.|author-link3=Leonard Jason|date=2017-12-07|title=Small-World Network Analysis of Cortical Connectivity in Chronic Fatigue Syndrome Using Quantitative EEG|url=http://www.neuroregulation.org/article/view/17838|journal=NeuroRegulation|language=en|volume=4|issue=3-4|pages=125|doi=10.15540/nr.4.3-4.125|issn=2373-0587|via=}}&amp;lt;/ref&amp;gt; [https://www.researchgate.net/publication/321717868_Small-World_Network_Analysis_of_Cortical_Connectivity_in_Chronic_Fatigue_Syndrome_Using_Quantitative_EEG (Full Text)]&lt;br /&gt;
*2018, Cortical hypoactivation during resting EEG suggests central nervous system pathology in patients with [[chronic fatigue syndrome]]&amp;lt;ref&amp;gt;{{Cite journal|last=Zinn|first=M.A.|author-link=Mark Davis|last2=Zinn|first2=M.L.|author-link2=Marcie Zinn|last3=Valencia|first3=I.|author-link3=Ian Valencia|last4=Jason|first4=L.A.|author-link4=Leonard Jason|last5=Montoya|first5=J.G.|author-link5=Jose Montoya|date=Jul 2018|title=Cortical hypoactivation during resting EEG suggests central nervous system pathology in patients with chronic fatigue syndrome|url=https://linkinghub.elsevier.com/retrieve/pii/S0301051118304071|journal=Biological Psychology|language=en|volume=136|issue=|pages=87–99|doi=10.1016/j.biopsycho.2018.05.016|pmc=|pmid=29802861|quote=|via=}}&amp;lt;/ref&amp;gt; [https://www.sciencedirect.com/science/article/pii/S0301051118304071 (Abstract)]&lt;br /&gt;
&lt;br /&gt;
==Talks and interviews==&lt;br /&gt;
&lt;br /&gt;
*2016, [https://www.youtube.com/watch?v=aN0Fh0kiUiI &amp;quot;qEEG LORETA CFS Case study - Sci Forschen Inc.&amp;quot;]  &lt;br /&gt;
&lt;br /&gt;
==Online presence==&lt;br /&gt;
&lt;br /&gt;
*[https://www.ncbi.nlm.nih.gov/pubmed/?term=Zinn%20ML%5BAuthor%5D&amp;amp;cauthor=true&amp;amp;cauthor_uid=26869373 PubMed]&lt;br /&gt;
*[https://www.researchgate.net/profile/Dr_Marcie_Zinn ResearchGate]&lt;br /&gt;
*[https://www.linkedin.com/in/marcie-zinn-795083a8/ LinkedIn]&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
&lt;br /&gt;
*[http://www.selfgrowth.com/experts/marcie_zinn.html &amp;quot;Marcie Zinn Ph.D., NCTM&amp;quot; bio]&lt;br /&gt;
*[https://www.thencri.org NeuroCognitive Research Institute]&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
&lt;br /&gt;
*[[Mark Zinn]]&lt;br /&gt;
*[[qEEG|eLORETA]]&lt;br /&gt;
*swLORETA&lt;br /&gt;
*qEEG&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn, Zinn, 2015&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn            | first1 = Marcie              | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn            | first2 = Mark                | authorlink2 = Mark Zinn&lt;br /&gt;
| title   = Myalgic Encephalomyelitis: Symptoms and Biomarkers&lt;br /&gt;
| journal = Current Neuropharmacology   | volume = 13   | issue = 5   | page = 701-34.&lt;br /&gt;
| date    = 2015&lt;br /&gt;
| pmid    = 26411464&lt;br /&gt;
| doi     = 10.2174/1570159X13666150928105725&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn, 2014&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn        | first1 = Mark A        | authorlink1 = Mark Zinn&lt;br /&gt;
| last2   = Zinn        | first2 = Marcie        | authorlink1 = Marcie Zinn&lt;br /&gt;
| last3   = Norris      | first3 = Jane          | authorlink3 = Jane Norris&lt;br /&gt;
| last4   = Valencia    | first4 = Ian           | authorlink4 = Ian Valencia&lt;br /&gt;
| last5   = Montoya     | first5 = Jose G        | authorlink5 = Jose Montoya&lt;br /&gt;
| title   = Cortical hypoactivation during resting eLORETA suggests central nervous system pathology in patients with chronic fatigue syndrome&lt;br /&gt;
| journal = Conference: 2014 Stanford Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Symposium  | volume =    | issue =   | page = &lt;br /&gt;
| date    = 2014&lt;br /&gt;
| url    = https://www.researchgate.net/publication/290628295_Cortical_hypoactivation_during_resting_eLORETA_suggests_central_nervous_system_pathology_in_patients_with_chronic_fatigue_syndrome&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| title   = Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with Myalgic Encephalomyelitis: A Pilot Study&lt;br /&gt;
| journal = Applied Psychophysiology and Biofeedback  | volume = 41   | issue = 3   | page = 283-300&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = 26869373&lt;br /&gt;
| doi     = 10.1007/s10484-016-9331-3&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn ML, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| title   = qEEG / LORETA in Assessment of Neurocognitive Impairment in a Patient with Chronic Fatigue Syndrome: A Case Report&lt;br /&gt;
| journal = Clinical Research: Open Access  | volume = 2   | issue = 1   | page =&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = 26869373&lt;br /&gt;
| doi     = 10.16966/2469-6714.110&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn&amp;amp;Zinn, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| title   = Functional Neural Network Connectivity in Myalgic Encephalomyelitis&lt;br /&gt;
| journal = NeuroRegulation   | volume = 3   | issue = 1   | page = 28-50&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = &lt;br /&gt;
| doi     = 10.15540/nr.3.1.28&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;/references&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Researchers]]&lt;br /&gt;
[[Category:Clinicians]]&lt;br /&gt;
[[Category:US researchers]]&lt;br /&gt;
[[Category:People with ME, CFS, and/or FMS]]&lt;br /&gt;
[[Category:Psychological paradigm critics]]&lt;br /&gt;
[[Category:PACE trial critics]]&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Marcie_Zinn&amp;diff=78327</id>
		<title>Marcie Zinn</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Marcie_Zinn&amp;diff=78327"/>
		<updated>2019-12-02T20:48:21Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:changed incorrect information&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Cleanup|date=Dec 2019|reason=No References needed.}}&lt;br /&gt;
[[File:Marcie Zinn.png|200px|thumb|right]]&amp;lt;blockquote&amp;gt;&#039;&#039;&#039;Marcie Zinn&#039;&#039;&#039; Ph.D. is a research psychologist in Psychophysiology, Rehabilitation, Cognitive Neuroscience and Data Science conducting [[myalgic encephalomyelitis]] (ME) and [[chronic fatigue syndrome]] (CFS) research with her husband, [[Mark Zinn]], at their nonprofit, the Neurocognitive Research Institute. The Marcie&#039;s research interests include the study of brain dysfunction in chronic disease, such as [[myalgic encephalomyelitis|myalgic encephalomyelitis or ME.]] Marcie and her husband, Mark also founded the NeuroCognitive Research Institute (www.thencri.org)*. Her early research and career interests were in Performance Neuroscience and Psychology, but after being diagnosed in 2009 with herpes viral encephalitis which developed into [[Myalgic Encephalomyelitis]], her interest turned toward using her extensive [[QEEG|qEEG**]] and neuroscience skills for research in [[ME]]***. Under the leadership of Dr. [[Jose Montoya]], she conducted a pilot study to look at cognitive dysfunction using [[QEEG|qEEG]] methods. While continuing to collaborate with Jose Montoya at Stanford, she and her husband [[Mark Zinn|Mark]]  have published research using brain network modeling in the study of [[ME]] [[brain]] dysfunction.&amp;lt;/blockquote&amp;gt;REFERENCES:&lt;br /&gt;
&lt;br /&gt;
&amp;lt;nowiki&amp;gt;*&amp;lt;/nowiki&amp;gt;the NeuroCognitive Research Institute, a 501c3 organization (this is a not-for-profit business, not an article, post, comment or anything, but here is the reference).&lt;br /&gt;
&lt;br /&gt;
&amp;lt;nowiki&amp;gt;**&amp;lt;/nowiki&amp;gt;Quantitative EEG (&#039;&#039;&#039;qEEG&#039;&#039;&#039;) is the analysis of the digitized EEG, and in lay terms this sometimes is also called “Brain Mapping”. The &#039;&#039;&#039;qEEG&#039;&#039;&#039; is an extension of the analysis of the visual EEG interpretation which may assist and even augment our understanding of the EEG and brain function.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;nowiki&amp;gt;***&amp;lt;/nowiki&amp;gt;What this encyclopedia is about.&lt;br /&gt;
&lt;br /&gt;
==ME/CFS Common Data Element (CDE) Project==&lt;br /&gt;
Member of the Pain Working Group and the Neurologic/Cognitive/CNS Imaging Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project sponsored by the [[National Institute of Neurological Disorders and Stroke]] and the [[Centers for Disease Control and Prevention]].&amp;lt;ref&amp;gt;{{Cite web|url=https://www.commondataelements.ninds.nih.gov/Myalgic%20Encephalomyelitis/Chronic%20Fatigue%20Syndrome#pane-138|title=Complete Myalgic Encephalomyelitis/Chronic Fatigue Syndrome CDE Roster|last=|first=|authorlink=|last2=|first2=|authorlink2=|date=|website=NIH|archive-url=|archive-date=|dead-url=|access-date=2019-10-11}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Advocacy==&lt;br /&gt;
* Dr. Zinn signed the second and third [[open letter to the Lancet|open letters to the editor of &#039;&#039;The Lancet&#039;&#039;]] urging the editor to commission a fully independent review of the [[PACE trial]], which the journal published in 2011. &lt;br /&gt;
* Feb 10, 2016, [http://www.virology.ws/2016/02/10/open-letter-lancet-again/ An open letter to The Lancet, again - Virology blog] &lt;br /&gt;
* June 19, 2018, [http://www.virology.ws/2018/06/19/trial-by-error-an-open-letter-to-the-lancet-two-years-on/ Trial By Error: An Open Letter to The Lancet, Two Years On - Virology blog] &lt;br /&gt;
==Notable studies==&lt;br /&gt;
* June, 2004: &#039;&#039;Development of a Self-Report Inventory to Develop Cognitive Dysfunction in Musicians.&#039;&#039; ProQuest Information and Learning Company, Ann Arbor, Michigan.  &lt;br /&gt;
* March, 2005: &#039;&#039;The Hippocampus in Music Learning and Performance&#039;&#039; (March, 2005). Presentation at the annual Brain Awareness Week event sponsored by Dana Alliance for Brain Initiatives, Dublin, CA.  &lt;br /&gt;
* Mar 2014, Cortical hypoactivation during resting eLORETA suggests central nervous system pathology in patients with chronic fatigue syndrome (Conference paper, 2014 Stanford Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Symposium: Advances in Clinical Care and Translational Research for health care providers, At Stanford School of Medicine, Palo Alto, CA&amp;lt;ref name=&amp;quot;Zinn, 2014&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/290628295_Cortical_hypoactivation_during_resting_eLORETA_suggests_central_nervous_system_pathology_in_patients_with_chronic_fatigue_syndrome (Abstract - full text on request)]  &lt;br /&gt;
* Mar 2014,  &#039;&#039;EEG peak alpha frequency is associated with chronic fatigue syndrome: a case-control observational study&#039;&#039;. Invited presentation at the 2014 Stanford Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Symposium : Advances in Clinical Care and Translational Research; March 19, 2014, Stanford University Dept. of Medicine, Palo Alto, CA.1.     &lt;br /&gt;
* &#039;&#039;EEG peak alpha frequency is associated with chronic fatigue syndrome: a case-control observational study&#039;&#039;. Invited presentation at the 2014 Stanford Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Symposium : Advances in Clinical Care and Translational Research; March 19, 2014, Stanford University Dept. of Medicine, Palo Alto, CA.  &lt;br /&gt;
*2015, Myalgic Encephalomyelitis: Symptoms and [[Biomarker]]s&amp;lt;ref name=&amp;quot;Zinn, 2015&amp;quot; /&amp;gt; - [http://www.ncbi.nlm.nih.gov/pubmed/26411464 (Full Text)]&lt;br /&gt;
*2015,  Zinn, M.L. &amp;amp; Zinn, M.A. Psychophysiology for Performing Artists. In M. S. Schwartz &amp;amp; F. Andrasik, Eds: Biofeedback: A Practitioners Guide (4th ed.), New York: Guilford.&lt;br /&gt;
*2016, Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with [[Myalgic Encephalomyelitis]]: A Pilot Study&amp;lt;ref name=&amp;quot;Zinn, 2016&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/294258397_Intrinsic_Functional_Hypoconnectivity_in_Core_Neurocognitive_Networks_Suggests_Central_Nervous_System_Pathology_in_Patients_with_Myalgic_Encephalomyelitis_A_Pilot_Study (Full Text)] &lt;br /&gt;
*2016, [[QEEG|qEEG]] / LORETA in Assessment of Neurocognitive Impairment in a Patient with Chronic Fatigue Syndrome: A Case Report&amp;lt;ref name=&amp;quot;Zinn ML, 2016&amp;quot; /&amp;gt; [https://sciforschenonline.org/journals/clinical-research/CLROA-2-110.php (Full Text)] &lt;br /&gt;
*2016, Functional Neural Network Connectivity in Myalgic Encephalomyelitis&amp;lt;ref name=&amp;quot;Zinn&amp;amp;Zinn, 2016&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/297453164_NeuroRegulation_httpwwwisnrorg_Functional_Neural_Network_Connectivity_in_Myalgic_Encephalomyelitis (Full Text)]&lt;br /&gt;
*2017, Small-world network analysis of cortical connectivity in [[Chronic Fatigue Syndrome]] using quantitative [[EEG]].&amp;lt;ref&amp;gt;{{Cite journal|last=Zinn|first=Mark Alan|author-link=Mark Zinn|last2=Zinn|first2=Marcie L.|author-link2=Marcie Zinn|last3=Jason|first3=Leonard A.|author-link3=Leonard Jason|date=2017-12-07|title=Small-World Network Analysis of Cortical Connectivity in Chronic Fatigue Syndrome Using Quantitative EEG|url=http://www.neuroregulation.org/article/view/17838|journal=NeuroRegulation|language=en|volume=4|issue=3-4|pages=125|doi=10.15540/nr.4.3-4.125|issn=2373-0587|via=}}&amp;lt;/ref&amp;gt; [https://www.researchgate.net/publication/321717868_Small-World_Network_Analysis_of_Cortical_Connectivity_in_Chronic_Fatigue_Syndrome_Using_Quantitative_EEG (Full Text)]&lt;br /&gt;
*2018, Cortical hypoactivation during resting EEG suggests central nervous system pathology in patients with [[chronic fatigue syndrome]]&amp;lt;ref&amp;gt;{{Cite journal|last=Zinn|first=M.A.|author-link=Mark Davis|last2=Zinn|first2=M.L.|author-link2=Marcie Zinn|last3=Valencia|first3=I.|author-link3=Ian Valencia|last4=Jason|first4=L.A.|author-link4=Leonard Jason|last5=Montoya|first5=J.G.|author-link5=Jose Montoya|date=Jul 2018|title=Cortical hypoactivation during resting EEG suggests central nervous system pathology in patients with chronic fatigue syndrome|url=https://linkinghub.elsevier.com/retrieve/pii/S0301051118304071|journal=Biological Psychology|language=en|volume=136|issue=|pages=87–99|doi=10.1016/j.biopsycho.2018.05.016|pmc=|pmid=29802861|quote=|via=}}&amp;lt;/ref&amp;gt; [https://www.sciencedirect.com/science/article/pii/S0301051118304071 (Abstract)]&lt;br /&gt;
&lt;br /&gt;
==Talks and interviews==&lt;br /&gt;
&lt;br /&gt;
*2016, [https://www.youtube.com/watch?v=aN0Fh0kiUiI &amp;quot;qEEG LORETA CFS Case study - Sci Forschen Inc.&amp;quot;]  &lt;br /&gt;
&lt;br /&gt;
==Online presence==&lt;br /&gt;
&lt;br /&gt;
*[https://www.ncbi.nlm.nih.gov/pubmed/?term=Zinn%20ML%5BAuthor%5D&amp;amp;cauthor=true&amp;amp;cauthor_uid=26869373 PubMed]&lt;br /&gt;
*[https://www.researchgate.net/profile/Dr_Marcie_Zinn ResearchGate]&lt;br /&gt;
*[https://www.linkedin.com/in/marcie-zinn-795083a8/ LinkedIn]&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
&lt;br /&gt;
*[http://www.selfgrowth.com/experts/marcie_zinn.html &amp;quot;Marcie Zinn Ph.D., NCTM&amp;quot; bio]&lt;br /&gt;
*[https://www.thencri.org NeuroCognitive Research Institute]&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
&lt;br /&gt;
*[[Mark Zinn]]&lt;br /&gt;
*[[qEEG|eLORETA]]&lt;br /&gt;
*swLORETA&lt;br /&gt;
*qEEG&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Jason,Zinn, 2015&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn            | first1 = Marcie              | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn            | first2 = Mark                | authorlink2 = Mark Zinn&lt;br /&gt;
| title   = Myalgic Encephalomyelitis: Symptoms and Biomarkers&lt;br /&gt;
| journal = Current Neuropharmacology   | volume = 13   | issue = 5   | page = 701-34.&lt;br /&gt;
| date    = 2015&lt;br /&gt;
| pmid    = 26411464&lt;br /&gt;
| doi     = 10.2174/1570159X13666150928105725&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn, 2014&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn        | first1 = Mark A        | authorlink1 = Mark Zinn&lt;br /&gt;
| last2   = Zinn        | first2 = Marcie        | authorlink1 = Marcie Zinn&lt;br /&gt;
| last3   = Norris      | first3 = Jane          | authorlink3 = Jane Norris&lt;br /&gt;
| last4   = Valencia    | first4 = Ian           | authorlink4 = Ian Valencia&lt;br /&gt;
| last5   = Montoya     | first5 = Jose G        | authorlink5 = Jose Montoya&lt;br /&gt;
| title   = Cortical hypoactivation during resting eLORETA suggests central nervous system pathology in patients with chronic fatigue syndrome&lt;br /&gt;
| journal = Conference: 2014 Stanford Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Symposium  | volume =    | issue =   | page = &lt;br /&gt;
| date    = 2014&lt;br /&gt;
| url    = https://www.researchgate.net/publication/290628295_Cortical_hypoactivation_during_resting_eLORETA_suggests_central_nervous_system_pathology_in_patients_with_chronic_fatigue_syndrome&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| title   = Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with Myalgic Encephalomyelitis: A Pilot Study&lt;br /&gt;
| journal = Applied Psychophysiology and Biofeedback  | volume = 41   | issue = 3   | page = 283-300&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = 26869373&lt;br /&gt;
| doi     = 10.1007/s10484-016-9331-3&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn ML, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| title   = qEEG / LORETA in Assessment of Neurocognitive Impairment in a Patient with Chronic Fatigue Syndrome: A Case Report&lt;br /&gt;
| journal = Clinical Research: Open Access  | volume = 2   | issue = 1   | page =&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = 26869373&lt;br /&gt;
| doi     = 10.16966/2469-6714.110&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn&amp;amp;Zinn, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| title   = Functional Neural Network Connectivity in Myalgic Encephalomyelitis&lt;br /&gt;
| journal = NeuroRegulation   | volume = 3   | issue = 1   | page = 28-50&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = &lt;br /&gt;
| doi     = 10.15540/nr.3.1.28&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;/references&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Researchers]]&lt;br /&gt;
[[Category:Clinicians]]&lt;br /&gt;
[[Category:US researchers]]&lt;br /&gt;
[[Category:People with ME, CFS, and/or FMS]]&lt;br /&gt;
[[Category:Psychological paradigm critics]]&lt;br /&gt;
[[Category:PACE trial critics]]&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Marcie_Zinn&amp;diff=78326</id>
		<title>Marcie Zinn</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Marcie_Zinn&amp;diff=78326"/>
		<updated>2019-12-02T20:43:26Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:edited wrong information.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Cleanup|date=Dec 2019|reason=No References needed.}}&lt;br /&gt;
[[File:Marcie Zinn.png|200px|thumb|right]]&amp;lt;blockquote&amp;gt;&#039;&#039;&#039;Marcie Zinn&#039;&#039;&#039; Ph.D. is a research psychologist in Psychophysiology, Rehabilitation, Cognitive Neuroscience and Data Science conducting [[myalgic encephalomyelitis]] (ME) and [[chronic fatigue syndrome]] (CFS) research with her husband, [[Mark Zinn]], at their nonprofit, the Neurocognitive Research Institute. The Marcie&#039;s research interests include the study of brain dysfunction in chronic disease, such as [[myalgic encephalomyelitis|myalgic encephalomyelitis or ME.]] Marcie and her husband, Mark also founded the NeuroCognitive Research Institute (www.thencri.org)*. Her early research and career interests were in Performance Neuroscience and Psychology, but after being diagnosed in 2009 with herpes viral encephalitis which developed into [[Myalgic Encephalomyelitis]], her interest turned toward using her extensive [[QEEG|qEEG**]] and neuroscience skills for research in [[ME]]***. Under the leadership of Dr. [[Jose Montoya]], she conducted a pilot study to look at cognitive dysfunction using [[QEEG|qEEG]] methods. While continuing to collaborate with Jose Montoya at Stanford, she and her husband [[Mark Zinn|Mark]]  have published research using brain network modeling in the study of [[ME]] [[brain]] dysfunction.&amp;lt;/blockquote&amp;gt;REFERENCES:&lt;br /&gt;
&lt;br /&gt;
&amp;lt;nowiki&amp;gt;*&amp;lt;/nowiki&amp;gt;the NeuroCognitive Research Institute, a 501c3 organization (this is a not-for-profit business, not an article, post, comment or anything, but here is the reference).&lt;br /&gt;
&lt;br /&gt;
&amp;lt;nowiki&amp;gt;**&amp;lt;/nowiki&amp;gt;Quantitative EEG (&#039;&#039;&#039;qEEG&#039;&#039;&#039;) is the analysis of the digitized EEG, and in lay terms this sometimes is also called “Brain Mapping”. The &#039;&#039;&#039;qEEG&#039;&#039;&#039; is an extension of the analysis of the visual EEG interpretation which may assist and even augment our understanding of the EEG and brain function.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;nowiki&amp;gt;***&amp;lt;/nowiki&amp;gt;What this encyclopedia is about.&lt;br /&gt;
&lt;br /&gt;
==ME/CFS Common Data Element (CDE) Project==&lt;br /&gt;
Member of the Pain Working Group and the Neurologic/Cognitive/CNS Imaging Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project sponsored by the [[National Institute of Neurological Disorders and Stroke]] and the [[Centers for Disease Control and Prevention]].&amp;lt;ref&amp;gt;{{Cite web|url=https://www.commondataelements.ninds.nih.gov/Myalgic%20Encephalomyelitis/Chronic%20Fatigue%20Syndrome#pane-138|title=Complete Myalgic Encephalomyelitis/Chronic Fatigue Syndrome CDE Roster|last=|first=|authorlink=|last2=|first2=|authorlink2=|date=|website=NIH|archive-url=|archive-date=|dead-url=|access-date=2019-10-11}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Advocacy==&lt;br /&gt;
* Dr. Zinn signed the second and third [[open letter to the Lancet|open letters to the editor of &#039;&#039;The Lancet&#039;&#039;]] urging the editor to commission a fully independent review of the [[PACE trial]], which the journal published in 2011. &lt;br /&gt;
* Feb 10, 2016, [http://www.virology.ws/2016/02/10/open-letter-lancet-again/ An open letter to The Lancet, again - Virology blog] &lt;br /&gt;
* June 19, 2018, [http://www.virology.ws/2018/06/19/trial-by-error-an-open-letter-to-the-lancet-two-years-on/ Trial By Error: An Open Letter to The Lancet, Two Years On - Virology blog] &lt;br /&gt;
==Notable studies==&lt;br /&gt;
* June, 2004: &#039;&#039;Development of a Self-Report Inventory to Develop Cognitive Dysfunction in Musicians.&#039;&#039; ProQuest Information and Learning Company, Ann Arbor, Michigan.  &lt;br /&gt;
* March, 2005: &#039;&#039;The Hippocampus in Music Learning and Performance&#039;&#039; (March, 2005). Presentation at the annual Brain Awareness Week event sponsored by Dana Alliance for Brain Initiatives, Dublin, CA.  &lt;br /&gt;
* Mar 2014, Cortical hypoactivation during resting eLORETA suggests central nervous system pathology in patients with chronic fatigue syndrome (Conference paper, 2014 Stanford Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Symposium: Advances in Clinical Care and Translational Research for health care providers, At Stanford School of Medicine, Palo Alto, CA&amp;lt;ref name=&amp;quot;Zinn, 2014&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/290628295_Cortical_hypoactivation_during_resting_eLORETA_suggests_central_nervous_system_pathology_in_patients_with_chronic_fatigue_syndrome (Abstract - full text on request)]  &lt;br /&gt;
* Mar 2014,  &#039;&#039;EEG peak alpha frequency is associated with chronic fatigue syndrome: a case-control observational study&#039;&#039;. Invited presentation at the 2014 Stanford Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Symposium : Advances in Clinical Care and Translational Research; March 19, 2014, Stanford University Dept. of Medicine, Palo Alto, CA.1.     &lt;br /&gt;
* &#039;&#039;EEG peak alpha frequency is associated with chronic fatigue syndrome: a case-control observational study&#039;&#039;. Invited presentation at the 2014 Stanford Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Symposium : Advances in Clinical Care and Translational Research; March 19, 2014, Stanford University Dept. of Medicine, Palo Alto, CA.  &lt;br /&gt;
*2015, Myalgic Encephalomyelitis: Symptoms and [[Biomarker]]s&amp;lt;ref name=&amp;quot;Zinn, 2015&amp;quot; /&amp;gt; - [http://www.ncbi.nlm.nih.gov/pubmed/26411464 (Full Text)]&lt;br /&gt;
*2015,  Zinn, M.L. &amp;amp; Zinn, M.A. Psychophysiology for Performing Artists. In M. S. Schwartz &amp;amp; F. Andrasik, Eds: Biofeedback: A Practitioners Guide (4th ed.), New York: Guilford.&lt;br /&gt;
*2016, Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with [[Myalgic Encephalomyelitis]]: A Pilot Study&amp;lt;ref name=&amp;quot;Zinn, 2016&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/294258397_Intrinsic_Functional_Hypoconnectivity_in_Core_Neurocognitive_Networks_Suggests_Central_Nervous_System_Pathology_in_Patients_with_Myalgic_Encephalomyelitis_A_Pilot_Study (Full Text)] &lt;br /&gt;
*2016, [[QEEG|qEEG]] / LORETA in Assessment of Neurocognitive Impairment in a Patient with Chronic Fatigue Syndrome: A Case Report&amp;lt;ref name=&amp;quot;Zinn ML, 2016&amp;quot; /&amp;gt; [https://sciforschenonline.org/journals/clinical-research/CLROA-2-110.php (Full Text)] &lt;br /&gt;
*2016, Functional Neural Network Connectivity in Myalgic Encephalomyelitis&amp;lt;ref name=&amp;quot;Zinn&amp;amp;Zinn, 2016&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/297453164_NeuroRegulation_httpwwwisnrorg_Functional_Neural_Network_Connectivity_in_Myalgic_Encephalomyelitis (Full Text)]&lt;br /&gt;
*2017, Small-world network analysis of cortical connectivity in [[Chronic Fatigue Syndrome]] using quantitative [[EEG]].&amp;lt;ref&amp;gt;{{Cite journal|last=Zinn|first=Mark Alan|author-link=Mark Zinn|last2=Zinn|first2=Marcie L.|author-link2=Marcie Zinn|last3=Jason|first3=Leonard A.|author-link3=Leonard Jason|date=2017-12-07|title=Small-World Network Analysis of Cortical Connectivity in Chronic Fatigue Syndrome Using Quantitative EEG|url=http://www.neuroregulation.org/article/view/17838|journal=NeuroRegulation|language=en|volume=4|issue=3-4|pages=125|doi=10.15540/nr.4.3-4.125|issn=2373-0587|via=}}&amp;lt;/ref&amp;gt; [https://www.researchgate.net/publication/321717868_Small-World_Network_Analysis_of_Cortical_Connectivity_in_Chronic_Fatigue_Syndrome_Using_Quantitative_EEG (Full Text)]&lt;br /&gt;
*2018, Cortical hypoactivation during resting EEG suggests central nervous system pathology in patients with [[chronic fatigue syndrome]]&amp;lt;ref&amp;gt;{{Cite journal|last=Zinn|first=M.A.|author-link=Mark Davis|last2=Zinn|first2=M.L.|author-link2=Marcie Zinn|last3=Valencia|first3=I.|author-link3=Ian Valencia|last4=Jason|first4=L.A.|author-link4=Leonard Jason|last5=Montoya|first5=J.G.|author-link5=Jose Montoya|date=Jul 2018|title=Cortical hypoactivation during resting EEG suggests central nervous system pathology in patients with chronic fatigue syndrome|url=https://linkinghub.elsevier.com/retrieve/pii/S0301051118304071|journal=Biological Psychology|language=en|volume=136|issue=|pages=87–99|doi=10.1016/j.biopsycho.2018.05.016|pmc=|pmid=29802861|quote=|via=}}&amp;lt;/ref&amp;gt; [https://www.sciencedirect.com/science/article/pii/S0301051118304071 (Abstract)]&lt;br /&gt;
&lt;br /&gt;
==Talks and interviews==&lt;br /&gt;
&lt;br /&gt;
*2016, [https://www.youtube.com/watch?v=aN0Fh0kiUiI &amp;quot;qEEG LORETA CFS Case study - Sci Forschen Inc.&amp;quot;]  &lt;br /&gt;
&lt;br /&gt;
==Online presence==&lt;br /&gt;
&lt;br /&gt;
*[https://www.ncbi.nlm.nih.gov/pubmed/?term=Zinn%20ML%5BAuthor%5D&amp;amp;cauthor=true&amp;amp;cauthor_uid=26869373 PubMed]&lt;br /&gt;
*[https://www.researchgate.net/profile/Dr_Marcie_Zinn ResearchGate]&lt;br /&gt;
*[https://www.linkedin.com/in/marcie-zinn-795083a8/ LinkedIn]&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
&lt;br /&gt;
*[http://www.selfgrowth.com/experts/marcie_zinn.html &amp;quot;Marcie Zinn Ph.D., NCTM&amp;quot; bio]&lt;br /&gt;
*[https://www.thencri.org NeuroCognitive Research Institute]&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
&lt;br /&gt;
*[[Mark Zinn]]&lt;br /&gt;
*[[qEEG|eLORETA]]&lt;br /&gt;
*swLORETA&lt;br /&gt;
*qEEG&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Jason,Zinn, 2015&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Jason           | first1 = Leonard             | authorlink1 = Leonard Jason&lt;br /&gt;
| last2   = Zinn            | first2 = Marcie              | authorlink2 = Marcie Zinn&lt;br /&gt;
| last3   = Zinn            | first3 = Mark                | authorlink3 = Mark Zinn&lt;br /&gt;
| title   = Myalgic Encephalomyelitis: Symptoms and Biomarkers&lt;br /&gt;
| journal = Current Neuropharmacology   | volume = 13   | issue = 5   | page = 701-34.&lt;br /&gt;
| date    = 2015&lt;br /&gt;
| pmid    = 26411464&lt;br /&gt;
| doi     = 10.2174/1570159X13666150928105725&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn, 2014&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn        | first1 = Mark A        | authorlink1 = Mark Zinn&lt;br /&gt;
| last2   = Zinn        | first2 = Marcie        | authorlink1 = Marcie Zinn&lt;br /&gt;
| last3   = Norris      | first3 = Jane          | authorlink3 = Jane Norris&lt;br /&gt;
| last4   = Valencia    | first4 = Ian           | authorlink4 = Ian Valencia&lt;br /&gt;
| last5   = Montoya     | first5 = Jose G        | authorlink5 = Jose Montoya&lt;br /&gt;
| last6   = Maldonado   | first6 = Jose R        | authorlink6 = &lt;br /&gt;
| title   = Cortical hypoactivation during resting eLORETA suggests central nervous system pathology in patients with chronic fatigue syndrome&lt;br /&gt;
| journal = Conference: 2014 Stanford Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Symposium  | volume =    | issue =   | page = &lt;br /&gt;
| date    = 2014&lt;br /&gt;
| url    = https://www.researchgate.net/publication/290628295_Cortical_hypoactivation_during_resting_eLORETA_suggests_central_nervous_system_pathology_in_patients_with_chronic_fatigue_syndrome&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| title   = Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with Myalgic Encephalomyelitis: A Pilot Study&lt;br /&gt;
| journal = Applied Psychophysiology and Biofeedback  | volume = 41   | issue = 3   | page = 283-300&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = 26869373&lt;br /&gt;
| doi     = 10.1007/s10484-016-9331-3&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn ML, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| title   = qEEG / LORETA in Assessment of Neurocognitive Impairment in a Patient with Chronic Fatigue Syndrome: A Case Report&lt;br /&gt;
| journal = Clinical Research: Open Access  | volume = 2   | issue = 1   | page =&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = 26869373&lt;br /&gt;
| doi     = 10.16966/2469-6714.110&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn&amp;amp;Zinn, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| title   = Functional Neural Network Connectivity in Myalgic Encephalomyelitis&lt;br /&gt;
| journal = NeuroRegulation   | volume = 3   | issue = 1   | page = 28-50&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = &lt;br /&gt;
| doi     = 10.15540/nr.3.1.28&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;/references&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Researchers]]&lt;br /&gt;
[[Category:Clinicians]]&lt;br /&gt;
[[Category:US researchers]]&lt;br /&gt;
[[Category:People with ME, CFS, and/or FMS]]&lt;br /&gt;
[[Category:Psychological paradigm critics]]&lt;br /&gt;
[[Category:PACE trial critics]]&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Mark_Zinn&amp;diff=78325</id>
		<title>Mark Zinn</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Mark_Zinn&amp;diff=78325"/>
		<updated>2019-12-02T20:27:13Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:/* Education */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[File:Mark Zinn.png|200px|thumb|right|Source:LinkedIn]]&lt;br /&gt;
&#039;&#039;&#039;Mark Alan Zinn&#039;&#039;&#039;, PhD, is a specialist in autonomic neuroscience, conducting [[ME/CFS]] studies with his wife, [[Marcie Zinn]], PhD, in their nonprofit entity, [[the NeuroCognitive Research Institute]].&amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;{{Cite web|url=https://www.linkedin.com/in/mark-zinn-ph-d-2b756a5b/|title=Mark Zinn, Ph.D.|last=|first=|authorlink=|last2=|first2=|authorlink2=|date=|website=the Neurocognitive Research Institute|archive-url=https://www.theNCRI.org|archive-date=|dead-url=|access-date=2019-12-02}}&amp;lt;/ref&amp;gt; Mark was part of the [[Stanford ME/CFS Initiative|Chronic Fatigue Syndrome Initiative]] at Stanford between 2011 and 2014, working with Dr. [[Jose Montoya]]. Mark continues to collaborate with the [[Stanford ME/CFS Initiative|ME/CFS Initiative at Stanford Medicine]]. &lt;br /&gt;
&lt;br /&gt;
== Education ==&lt;br /&gt;
* 1993, Bachelor&#039;s degree, Piano Performance, University of Southern California&lt;br /&gt;
* 1996, Master&#039;s degree, Piano Performance from Northern Illinois University&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;&lt;br /&gt;
* 1999, Performance&#039;s Certificate, Piano Performance from Northern Illinois University&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;&lt;br /&gt;
* 2019, Ph.D. from De Paul University&amp;lt;ref name=&amp;quot;:1&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Advocacy ==&lt;br /&gt;
* 2016, Mark Zinn was one of the 42 signatories of the [[Open letter to the Lancet|Open Letter to the &#039;&#039;Lancet&#039;&#039;]] calling for the [[PACE trial]] data to be independently reanalysed.&amp;lt;ref&amp;gt;{{Cite web|url=http://www.virology.ws/2016/02/10/open-letter-lancet-again/|title=An open letter to The Lancet, again|website=www.virology.ws|access-date=2019-12-02}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Notable studies==&lt;br /&gt;
* Mar 2014 - Cortical hypoactivation during resting eLORETA suggests central nervous system pathology in patients with chronic fatigue syndrome (Conference paper, 2014 Stanford Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Symposium: Advances in Clinical Care and Translational Research for health care providers, At Stanford School of Medicine, Palo Alto, CA&amp;lt;ref name=&amp;quot;Zinn, 2014&amp;quot; /&amp;gt; - [https://www.researchgate.net/publication/290628295_Cortical_hypoactivation_during_resting_eLORETA_suggests_central_nervous_system_pathology_in_patients_with_chronic_fatigue_syndrome (Abstract - full text on request)]  &lt;br /&gt;
*2015 - Myalgic Encephalomyelitis: Symptoms and [[Biomarker]]s&amp;lt;ref name=&amp;quot;Jason,Zinn, 2015&amp;quot; /&amp;gt; - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761639/ (Full Text)] &lt;br /&gt;
*2016 - Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with [[Myalgic Encephalomyelitis]]: A Pilot Study&amp;lt;ref name=&amp;quot;Zinn, 2016&amp;quot; /&amp;gt; - [https://www.researchgate.net/publication/294258397_Intrinsic_Functional_Hypoconnectivity_in_Core_Neurocognitive_Networks_Suggests_Central_Nervous_System_Pathology_in_Patients_with_Myalgic_Encephalomyelitis_A_Pilot_Study (Full Text)]&lt;br /&gt;
*2016 - qEEG / LORETA in Assessment of Neurocognitive Impairment in a Patient with [[Chronic Fatigue Syndrome]]: A Case Report&amp;lt;ref name=&amp;quot;Zinn ML, 2016&amp;quot; /&amp;gt; - [https://sciforschenonline.org/journals/clinical-research/CLROA-2-110.php (Full Text)] &lt;br /&gt;
*2016 - Functional Neural Network Connectivity in [[Myalgic Encephalomyelitis]]&amp;lt;ref name=&amp;quot;Zinn&amp;amp;Zinn, 2016&amp;quot; /&amp;gt; - [https://www.researchgate.net/publication/297453164_NeuroRegulation_httpwwwisnrorg_Functional_Neural_Network_Connectivity_in_Myalgic_Encephalomyelitis (Full Text)]&lt;br /&gt;
*2017, Small-world network analysis of cortical connectivity in Chronic Fatigue Syndrome using quantitative [[EEG]]&amp;lt;ref&amp;gt;{{Cite journal|last=Zinn|first=Mark Alan|author-link=Mark Zinn|last2=Zinn|first2=Marcie L.|author-link2=Marcie Zinn|last3=Jason|first3=Leonard A.|author-link3=Leonard Jason|date=2017-12-07|title=Small-World Network Analysis of Cortical Connectivity in Chronic Fatigue Syndrome Using Quantitative EEG|url=http://www.neuroregulation.org/article/view/17838|journal=NeuroRegulation|language=en|volume=4|issue=3-4|pages=125|doi=10.15540/nr.4.3-4.125|issn=2373-0587|via=}}&amp;lt;/ref&amp;gt; - [https://www.researchgate.net/publication/321717868_Small-World_Network_Analysis_of_Cortical_Connectivity_in_Chronic_Fatigue_Syndrome_Using_Quantitative_EEG (Full Text)]&lt;br /&gt;
*2018 - Cortical hypoactivation during resting EEG suggests central nervous system pathology in patients with [[chronic fatigue syndrome]]&amp;lt;ref&amp;gt;{{Cite journal|last=Zinn|first=M.A.|author-link=Mark Davis|last2=Zinn|first2=M.L.|author-link2=Marcie Zinn|last3=Valencia|first3=I.|author-link3=Ian Valencia|last4=Jason|first4=L.A.|author-link4=Leonard Jason|last5=Montoya|first5=J.G.|author-link5=Jose Montoya|date=Jul 2018|title=Cortical hypoactivation during resting EEG suggests central nervous system pathology in patients with chronic fatigue syndrome|url=https://linkinghub.elsevier.com/retrieve/pii/S0301051118304071|journal=Biological Psychology|language=en|volume=136|issue=|pages=87–99|doi=10.1016/j.biopsycho.2018.05.016|pmc=|pmid=29802861|quote=|via=}}&amp;lt;/ref&amp;gt; - [https://www.sciencedirect.com/science/article/pii/S0301051118304071 (Abstract)]&lt;br /&gt;
*2019 - The Central Autonomic Network in Myalgic Encephalomyelitis Syndrome / Chronic Fatigue Syndrome, Doctoral Dissertation&amp;lt;ref name=&amp;quot;:1&amp;quot;&amp;gt;{{Cite journal|last=Zinn|first=Mark|date=2019-06-14|title=Small-World Network Analysis of Cortical Connectivity in Chronic Fatigue Syndrome using EEG|url=https://via.library.depaul.edu/csh_etd/297|journal=College of Science and Health Theses and Dissertations}}&amp;lt;/ref&amp;gt; - [https://via.library.depaul.edu/csh_etd/297/ (Abstract)]&lt;br /&gt;
&lt;br /&gt;
==Talks and interviews==&lt;br /&gt;
&lt;br /&gt;
==Online presence==&lt;br /&gt;
&lt;br /&gt;
*[https://www.linkedin.com/in/mark-zinn-2b756a5b LinkedIn]&lt;br /&gt;
*[https://www.researchgate.net/profile/Mark_Zinn ResearchGate]&lt;br /&gt;
*the NeuroCognitive Research Institute &lt;br /&gt;
==See also==&lt;br /&gt;
*[[Marcie Zinn]]&lt;br /&gt;
==Learn more==&lt;br /&gt;
* [https://www.thencri.org/ NeuroCognitive Research Institute]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Jason,Zinn, 2015&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Jason           | first1 = Leonard             | authorlink1 = Leonard Jason&lt;br /&gt;
| last2   = Zinn            | first2 = Marcie              | authorlink2 = Marcie Zinn&lt;br /&gt;
| last3   = Zinn            | first3 = Mark                | authorlink3 = Mark Zinn&lt;br /&gt;
| title   = Myalgic Encephalomyelitis: Symptoms and Biomarkers&lt;br /&gt;
| journal = Current Neuropharmacology   | volume = 13   | issue = 5   | page = 701-34.&lt;br /&gt;
| date    = 2015&lt;br /&gt;
| pmid    = 26411464&lt;br /&gt;
| doi     = 10.2174/1570159X13666150928105725&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn, 2014&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn        | first1 = Mark A        | authorlink1 = Mark Zinn&lt;br /&gt;
| last2   = May         | first2 = Marcie L      | authorlink2 = Marcie Zinn&lt;br /&gt;
| last3   = Norris      | first3 = Jane          | authorlink3 = Jane Norris&lt;br /&gt;
| last4   = Valencia    | first4 = Ian           | authorlink4 = Ian Valencia&lt;br /&gt;
| last5   = Montoya     | first5 = Jose G        | authorlink5 = Jose Montoya&lt;br /&gt;
| last6   = Maldonado   | first6 = Jose R        | authorlink6 = &lt;br /&gt;
| title   = Cortical hypoactivation during resting eLORETA suggests central nervous system pathology in patients with chronic fatigue syndrome&lt;br /&gt;
| journal = Conference: 2014 Stanford Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Symposium  | volume =    | issue =   | page = &lt;br /&gt;
| date    = 2014&lt;br /&gt;
| url    = https://www.researchgate.net/publication/290628295_Cortical_hypoactivation_during_resting_eLORETA_suggests_central_nervous_system_pathology_in_patients_with_chronic_fatigue_syndrome&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| last3   = Jason             | first3 = Leonard            | authorlink3 = Leonard Jason&lt;br /&gt;
| title   = Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with Myalgic Encephalomyelitis: A Pilot Study&lt;br /&gt;
| journal = Applied Psychophysiology and Biofeedback  | volume = 41   | issue = 3   | page = 283-300&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = 26869373&lt;br /&gt;
| doi     = 10.1007/s10484-016-9331-3&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn ML, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| last3   = Jason             | first3 = Leonard            | authorlink3 = Leonard Jason&lt;br /&gt;
| title   = qEEG / LORETA in Assessment of Neurocognitive Impairment in a Patient with Chronic Fatigue Syndrome: A Case Report&lt;br /&gt;
| journal = Clinical Research: Open Access  | volume = 2   | issue = 1   | page =&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = 26869373&lt;br /&gt;
| doi     = 10.16966/2469-6714.110&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn&amp;amp;Zinn, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| last3   = Jason             | first3 = Leonard            | authorlink3 = Leonard Jason&lt;br /&gt;
| title   = Functional Neural Network Connectivity in Myalgic Encephalomyelitis&lt;br /&gt;
| journal = NeuroRegulation   | volume = 3   | issue = 1   | page = 28-50&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = &lt;br /&gt;
| doi     = 10.15540/nr.3.1.28&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;/references&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Researchers]]&lt;br /&gt;
[[Category:US researchers]]&lt;br /&gt;
[[Category:Psychological paradigm critics]]&lt;br /&gt;
[[Category:PACE trial critics]]&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Mark_Zinn&amp;diff=78324</id>
		<title>Mark Zinn</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Mark_Zinn&amp;diff=78324"/>
		<updated>2019-12-02T20:24:49Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:incorrect entries&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[File:Mark Zinn.png|200px|thumb|right|Source:LinkedIn]]&lt;br /&gt;
&#039;&#039;&#039;Mark Alan Zinn&#039;&#039;&#039;, PhD, is a specialist in autonomic neuroscience, conducting [[ME/CFS]] studies with his wife, [[Marcie Zinn]], PhD, in their nonprofit entity, [[the NeuroCognitive Research Institute]].&amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;{{Cite web|url=https://www.linkedin.com/in/mark-zinn-ph-d-2b756a5b/|title=Mark Zinn, Ph.D.|last=|first=|authorlink=|last2=|first2=|authorlink2=|date=|website=the Neurocognitive Research Institute|archive-url=https://www.theNCRI.org|archive-date=|dead-url=|access-date=2019-12-02}}&amp;lt;/ref&amp;gt; Mark was part of the [[Stanford ME/CFS Initiative|Chronic Fatigue Syndrome Initiative]] at Stanford between 2011 and 2014, working with Dr. [[Jose Montoya]]. Mark continues to collaborate with the [[Stanford ME/CFS Initiative|ME/CFS Initiative at Stanford Medicine]]. &lt;br /&gt;
&lt;br /&gt;
== Education ==&lt;br /&gt;
* 1996, Master&#039;s degree, Piano Performance from Northern Illinois University&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;&lt;br /&gt;
* 1999, Performance&#039;s Certificate, Piano Performance from Northern Illinois University&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;&lt;br /&gt;
* 2019, Ph.D. from De Paul University in Community Psychology with [[Leonard Jason|Leonard A. Jason]], PhD as advisor&amp;lt;ref name=&amp;quot;:1&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Advocacy ==&lt;br /&gt;
* 2016, Mark Zinn was one of the 42 signatories of the [[Open letter to the Lancet|Open Letter to the &#039;&#039;Lancet&#039;&#039;]] calling for the [[PACE trial]] data to be independently reanalysed.&amp;lt;ref&amp;gt;{{Cite web|url=http://www.virology.ws/2016/02/10/open-letter-lancet-again/|title=An open letter to The Lancet, again|website=www.virology.ws|access-date=2019-12-02}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Notable studies==&lt;br /&gt;
* Mar 2014 - Cortical hypoactivation during resting eLORETA suggests central nervous system pathology in patients with chronic fatigue syndrome (Conference paper, 2014 Stanford Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Symposium: Advances in Clinical Care and Translational Research for health care providers, At Stanford School of Medicine, Palo Alto, CA&amp;lt;ref name=&amp;quot;Zinn, 2014&amp;quot; /&amp;gt; - [https://www.researchgate.net/publication/290628295_Cortical_hypoactivation_during_resting_eLORETA_suggests_central_nervous_system_pathology_in_patients_with_chronic_fatigue_syndrome (Abstract - full text on request)]  &lt;br /&gt;
*2015 - Myalgic Encephalomyelitis: Symptoms and [[Biomarker]]s&amp;lt;ref name=&amp;quot;Jason,Zinn, 2015&amp;quot; /&amp;gt; - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761639/ (Full Text)] &lt;br /&gt;
*2016 - Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with [[Myalgic Encephalomyelitis]]: A Pilot Study&amp;lt;ref name=&amp;quot;Zinn, 2016&amp;quot; /&amp;gt; - [https://www.researchgate.net/publication/294258397_Intrinsic_Functional_Hypoconnectivity_in_Core_Neurocognitive_Networks_Suggests_Central_Nervous_System_Pathology_in_Patients_with_Myalgic_Encephalomyelitis_A_Pilot_Study (Full Text)]&lt;br /&gt;
*2016 - qEEG / LORETA in Assessment of Neurocognitive Impairment in a Patient with [[Chronic Fatigue Syndrome]]: A Case Report&amp;lt;ref name=&amp;quot;Zinn ML, 2016&amp;quot; /&amp;gt; - [https://sciforschenonline.org/journals/clinical-research/CLROA-2-110.php (Full Text)] &lt;br /&gt;
*2016 - Functional Neural Network Connectivity in [[Myalgic Encephalomyelitis]]&amp;lt;ref name=&amp;quot;Zinn&amp;amp;Zinn, 2016&amp;quot; /&amp;gt; - [https://www.researchgate.net/publication/297453164_NeuroRegulation_httpwwwisnrorg_Functional_Neural_Network_Connectivity_in_Myalgic_Encephalomyelitis (Full Text)]&lt;br /&gt;
*2017, Small-world network analysis of cortical connectivity in Chronic Fatigue Syndrome using quantitative [[EEG]]&amp;lt;ref&amp;gt;{{Cite journal|last=Zinn|first=Mark Alan|author-link=Mark Zinn|last2=Zinn|first2=Marcie L.|author-link2=Marcie Zinn|last3=Jason|first3=Leonard A.|author-link3=Leonard Jason|date=2017-12-07|title=Small-World Network Analysis of Cortical Connectivity in Chronic Fatigue Syndrome Using Quantitative EEG|url=http://www.neuroregulation.org/article/view/17838|journal=NeuroRegulation|language=en|volume=4|issue=3-4|pages=125|doi=10.15540/nr.4.3-4.125|issn=2373-0587|via=}}&amp;lt;/ref&amp;gt; - [https://www.researchgate.net/publication/321717868_Small-World_Network_Analysis_of_Cortical_Connectivity_in_Chronic_Fatigue_Syndrome_Using_Quantitative_EEG (Full Text)]&lt;br /&gt;
*2018 - Cortical hypoactivation during resting EEG suggests central nervous system pathology in patients with [[chronic fatigue syndrome]]&amp;lt;ref&amp;gt;{{Cite journal|last=Zinn|first=M.A.|author-link=Mark Davis|last2=Zinn|first2=M.L.|author-link2=Marcie Zinn|last3=Valencia|first3=I.|author-link3=Ian Valencia|last4=Jason|first4=L.A.|author-link4=Leonard Jason|last5=Montoya|first5=J.G.|author-link5=Jose Montoya|date=Jul 2018|title=Cortical hypoactivation during resting EEG suggests central nervous system pathology in patients with chronic fatigue syndrome|url=https://linkinghub.elsevier.com/retrieve/pii/S0301051118304071|journal=Biological Psychology|language=en|volume=136|issue=|pages=87–99|doi=10.1016/j.biopsycho.2018.05.016|pmc=|pmid=29802861|quote=|via=}}&amp;lt;/ref&amp;gt; - [https://www.sciencedirect.com/science/article/pii/S0301051118304071 (Abstract)]&lt;br /&gt;
*2019 - The Central Autonomic Network in Myalgic Encephalomyelitis Syndrome / Chronic Fatigue Syndrome, Doctoral Dissertation&amp;lt;ref name=&amp;quot;:1&amp;quot;&amp;gt;{{Cite journal|last=Zinn|first=Mark|date=2019-06-14|title=Small-World Network Analysis of Cortical Connectivity in Chronic Fatigue Syndrome using EEG|url=https://via.library.depaul.edu/csh_etd/297|journal=College of Science and Health Theses and Dissertations}}&amp;lt;/ref&amp;gt; - [https://via.library.depaul.edu/csh_etd/297/ (Abstract)]&lt;br /&gt;
&lt;br /&gt;
==Talks and interviews==&lt;br /&gt;
&lt;br /&gt;
==Online presence==&lt;br /&gt;
&lt;br /&gt;
*[https://www.linkedin.com/in/mark-zinn-2b756a5b LinkedIn]&lt;br /&gt;
*[https://www.researchgate.net/profile/Mark_Zinn ResearchGate]&lt;br /&gt;
*the NeuroCognitive Research Institute &lt;br /&gt;
==See also==&lt;br /&gt;
*[[Marcie Zinn]]&lt;br /&gt;
==Learn more==&lt;br /&gt;
* [https://www.thencri.org/ NeuroCognitive Research Institute]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Jason,Zinn, 2015&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Jason           | first1 = Leonard             | authorlink1 = Leonard Jason&lt;br /&gt;
| last2   = Zinn            | first2 = Marcie              | authorlink2 = Marcie Zinn&lt;br /&gt;
| last3   = Zinn            | first3 = Mark                | authorlink3 = Mark Zinn&lt;br /&gt;
| title   = Myalgic Encephalomyelitis: Symptoms and Biomarkers&lt;br /&gt;
| journal = Current Neuropharmacology   | volume = 13   | issue = 5   | page = 701-34.&lt;br /&gt;
| date    = 2015&lt;br /&gt;
| pmid    = 26411464&lt;br /&gt;
| doi     = 10.2174/1570159X13666150928105725&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn, 2014&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn        | first1 = Mark A        | authorlink1 = Mark Zinn&lt;br /&gt;
| last2   = May         | first2 = Marcie L      | authorlink2 = Marcie Zinn&lt;br /&gt;
| last3   = Norris      | first3 = Jane          | authorlink3 = Jane Norris&lt;br /&gt;
| last4   = Valencia    | first4 = Ian           | authorlink4 = Ian Valencia&lt;br /&gt;
| last5   = Montoya     | first5 = Jose G        | authorlink5 = Jose Montoya&lt;br /&gt;
| last6   = Maldonado   | first6 = Jose R        | authorlink6 = &lt;br /&gt;
| title   = Cortical hypoactivation during resting eLORETA suggests central nervous system pathology in patients with chronic fatigue syndrome&lt;br /&gt;
| journal = Conference: 2014 Stanford Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Symposium  | volume =    | issue =   | page = &lt;br /&gt;
| date    = 2014&lt;br /&gt;
| url    = https://www.researchgate.net/publication/290628295_Cortical_hypoactivation_during_resting_eLORETA_suggests_central_nervous_system_pathology_in_patients_with_chronic_fatigue_syndrome&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| last3   = Jason             | first3 = Leonard            | authorlink3 = Leonard Jason&lt;br /&gt;
| title   = Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with Myalgic Encephalomyelitis: A Pilot Study&lt;br /&gt;
| journal = Applied Psychophysiology and Biofeedback  | volume = 41   | issue = 3   | page = 283-300&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = 26869373&lt;br /&gt;
| doi     = 10.1007/s10484-016-9331-3&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn ML, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| last3   = Jason             | first3 = Leonard            | authorlink3 = Leonard Jason&lt;br /&gt;
| title   = qEEG / LORETA in Assessment of Neurocognitive Impairment in a Patient with Chronic Fatigue Syndrome: A Case Report&lt;br /&gt;
| journal = Clinical Research: Open Access  | volume = 2   | issue = 1   | page =&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = 26869373&lt;br /&gt;
| doi     = 10.16966/2469-6714.110&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn&amp;amp;Zinn, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| last3   = Jason             | first3 = Leonard            | authorlink3 = Leonard Jason&lt;br /&gt;
| title   = Functional Neural Network Connectivity in Myalgic Encephalomyelitis&lt;br /&gt;
| journal = NeuroRegulation   | volume = 3   | issue = 1   | page = 28-50&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = &lt;br /&gt;
| doi     = 10.15540/nr.3.1.28&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;/references&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Researchers]]&lt;br /&gt;
[[Category:US researchers]]&lt;br /&gt;
[[Category:Psychological paradigm critics]]&lt;br /&gt;
[[Category:PACE trial critics]]&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Marcie_Zinn&amp;diff=78304</id>
		<title>Marcie Zinn</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Marcie_Zinn&amp;diff=78304"/>
		<updated>2019-12-01T23:24:28Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:my text&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[File:Marcie Zinn.png|200px|thumb|right]]&lt;br /&gt;
&#039;&#039;&#039;Marcie Zinn&#039;&#039;&#039; Ph.D. is a &#039;&#039;research psychologist in Psychophysiology, Rehabilitation, Cognitive Neuroscience and Data Science&#039;&#039; conducting [[myalgic encephalomyelitis]] (ME) and chronic fatigue syndrome (CFS) research with her husband, [[Mark Zinn]], at their nonprofit, [https://www.thencri.org the NeuroCognitive Research Institute] of California and Illinois. Marcie&#039;s research interests include the study of brain dysfunction in chronic disease, such as [[myalgic encephalomyelitis]]. Marcie and her husband, Mark also founded the Society for Neuroscience and Psychology in the Performing Arts. Her early research and career interests were in Performance Neuroscience and Psychology, but after being diagnosed in 2009 with herpes viral encephalitis which developed into [[Myalgic Encephalomyelitis]], her interest turned toward using her extensive [[QEEG|qEEG]] and neuroscience skills for research in [[ME]]. Under the leadership of Dr. [[Jose Montoya]], she conducted a pilot study to look at cognitive dysfunction using [[QEEG|qEEG]] methods. While continuing to collaborate with Jose Montoya at Stanford, she and her husband [[Mark Zinn|Mark]]  have published research using brain network modeling in the study of [[ME]] [[brain]] dysfunction. &lt;br /&gt;
&lt;br /&gt;
==ME/CFS Common Data Element (CDE) Project==&lt;br /&gt;
Member of the Pain Working Group and the Neurologic/Cognitive/CNS Imaging Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project sponsored by the [[National Institute of Neurological Disorders and Stroke]] and the [[Centers for Disease Control and Prevention]].&amp;lt;ref&amp;gt;{{Cite web|url=https://www.commondataelements.ninds.nih.gov/Myalgic%20Encephalomyelitis/Chronic%20Fatigue%20Syndrome#pane-138|title=Complete Myalgic Encephalomyelitis/Chronic Fatigue Syndrome CDE Roster|last=|first=|authorlink=|last2=|first2=|authorlink2=|date=|website=NIH|archive-url=|archive-date=|dead-url=|access-date=2019-10-11}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Advocacy==&lt;br /&gt;
* Dr. Zinn signed the second and third [[open letter to the Lancet|open letters to the editor of &#039;&#039;The Lancet&#039;&#039;]] urging the editor to commission a fully independent review of the [[PACE trial]], which the journal published in 2011. &lt;br /&gt;
* Feb 10, 2016, [http://www.virology.ws/2016/02/10/open-letter-lancet-again/ An open letter to The Lancet, again - Virology blog] &lt;br /&gt;
* June 19, 2018, [http://www.virology.ws/2018/06/19/trial-by-error-an-open-letter-to-the-lancet-two-years-on/ Trial By Error: An Open Letter to The Lancet, Two Years On - Virology blog] &lt;br /&gt;
==Notable studies==&lt;br /&gt;
* June, 2004: &#039;&#039;Development of a Self-Report Inventory to Develop Cognitive Dysfunction in Musicians.&#039;&#039; ProQuest Information and Learning Company, Ann Arbor, Michigan.  &lt;br /&gt;
* March, 2005: &#039;&#039;The Hippocampus in Music Learning and Performance&#039;&#039; (March, 2005). Presentation at the annual Brain Awareness Week event sponsored by Dana Alliance for Brain Initiatives, Dublin, CA.  &lt;br /&gt;
* Mar 2014, Cortical hypoactivation during resting eLORETA suggests central nervous system pathology in patients with chronic fatigue syndrome (Conference paper, 2014 Stanford Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Symposium: Advances in Clinical Care and Translational Research for health care providers, At Stanford School of Medicine, Palo Alto, CA&amp;lt;ref name=&amp;quot;Zinn, 2014&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/290628295_Cortical_hypoactivation_during_resting_eLORETA_suggests_central_nervous_system_pathology_in_patients_with_chronic_fatigue_syndrome (Abstract - full text on request)]  &lt;br /&gt;
* Mar 2014,  &#039;&#039;EEG peak alpha frequency is associated with chronic fatigue syndrome: a case-control observational study&#039;&#039;. Invited presentation at the 2014 Stanford Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Symposium : Advances in Clinical Care and Translational Research; March 19, 2014, Stanford University Dept. of Medicine, Palo Alto, CA.1.     &lt;br /&gt;
* &#039;&#039;EEG peak alpha frequency is associated with chronic fatigue syndrome: a case-control observational study&#039;&#039;. Invited presentation at the 2014 Stanford Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Symposium : Advances in Clinical Care and Translational Research; March 19, 2014, Stanford University Dept. of Medicine, Palo Alto, CA.  &lt;br /&gt;
*2015, Myalgic Encephalomyelitis: Symptoms and [[Biomarker]]s&amp;lt;ref name=&amp;quot;Jason,Zinn, 2015&amp;quot; /&amp;gt; [http://www.ncbi.nlm.nih.gov/pubmed/26411464 (Full Text)]&lt;br /&gt;
*2015,  Zinn, M.L. &amp;amp; Zinn, M.A. Psychophysiology for Performing Artists. In M. S. Schwartz &amp;amp; F. Andrasik, Eds: Biofeedback: A Practitioners Guide (4th ed.), New York: Guilford.&lt;br /&gt;
*2016, Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with [[Myalgic Encephalomyelitis]]: A Pilot Study&amp;lt;ref name=&amp;quot;Zinn, 2016&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/294258397_Intrinsic_Functional_Hypoconnectivity_in_Core_Neurocognitive_Networks_Suggests_Central_Nervous_System_Pathology_in_Patients_with_Myalgic_Encephalomyelitis_A_Pilot_Study (Full Text)] &lt;br /&gt;
*2016, [[QEEG|qEEG]] / LORETA in Assessment of Neurocognitive Impairment in a Patient with Chronic Fatigue Syndrome: A Case Report&amp;lt;ref name=&amp;quot;Zinn ML, 2016&amp;quot; /&amp;gt; [https://sciforschenonline.org/journals/clinical-research/CLROA-2-110.php (Full Text)] &lt;br /&gt;
*2016, Functional Neural Network Connectivity in Myalgic Encephalomyelitis&amp;lt;ref name=&amp;quot;Zinn&amp;amp;Zinn, 2016&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/297453164_NeuroRegulation_httpwwwisnrorg_Functional_Neural_Network_Connectivity_in_Myalgic_Encephalomyelitis (Full Text)]&lt;br /&gt;
*2017, Small-world network analysis of cortical connectivity in [[Chronic Fatigue Syndrome]] using quantitative [[EEG]].&amp;lt;ref&amp;gt;{{Cite journal|last=Zinn|first=Mark Alan|author-link=Mark Zinn|last2=Zinn|first2=Marcie L.|author-link2=Marcie Zinn|last3=Jason|first3=Leonard A.|author-link3=Leonard Jason|date=2017-12-07|title=Small-World Network Analysis of Cortical Connectivity in Chronic Fatigue Syndrome Using Quantitative EEG|url=http://www.neuroregulation.org/article/view/17838|journal=NeuroRegulation|language=en|volume=4|issue=3-4|pages=125|doi=10.15540/nr.4.3-4.125|issn=2373-0587|via=}}&amp;lt;/ref&amp;gt; [https://www.researchgate.net/publication/321717868_Small-World_Network_Analysis_of_Cortical_Connectivity_in_Chronic_Fatigue_Syndrome_Using_Quantitative_EEG (Full Text)]&lt;br /&gt;
*2018, Cortical hypoactivation during resting EEG suggests central nervous system pathology in patients with [[chronic fatigue syndrome]]&amp;lt;ref&amp;gt;{{Cite journal|last=Zinn|first=M.A.|author-link=Mark Davis|last2=Zinn|first2=M.L.|author-link2=Marcie Zinn|last3=Valencia|first3=I.|author-link3=Ian Valencia|last4=Jason|first4=L.A.|author-link4=Leonard Jason|last5=Montoya|first5=J.G.|author-link5=Jose Montoya|date=Jul 2018|title=Cortical hypoactivation during resting EEG suggests central nervous system pathology in patients with chronic fatigue syndrome|url=https://linkinghub.elsevier.com/retrieve/pii/S0301051118304071|journal=Biological Psychology|language=en|volume=136|issue=|pages=87–99|doi=10.1016/j.biopsycho.2018.05.016|pmc=|pmid=29802861|quote=|via=}}&amp;lt;/ref&amp;gt; [https://www.sciencedirect.com/science/article/pii/S0301051118304071 (Abstract)]&lt;br /&gt;
&lt;br /&gt;
==Talks and interviews==&lt;br /&gt;
&lt;br /&gt;
*2016, [https://www.youtube.com/watch?v=aN0Fh0kiUiI &amp;quot;qEEG LORETA CFS Case study - Sci Forschen Inc.&amp;quot;]  &lt;br /&gt;
&lt;br /&gt;
==Online presence==&lt;br /&gt;
&lt;br /&gt;
*[https://www.ncbi.nlm.nih.gov/pubmed/?term=Zinn%20ML%5BAuthor%5D&amp;amp;cauthor=true&amp;amp;cauthor_uid=26869373 PubMed]&lt;br /&gt;
*[https://www.researchgate.net/profile/Dr_Marcie_Zinn ResearchGate]&lt;br /&gt;
*[https://www.linkedin.com/in/marcie-zinn-795083a8/ LinkedIn]&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
&lt;br /&gt;
*[http://www.selfgrowth.com/experts/marcie_zinn.html &amp;quot;Marcie Zinn Ph.D., NCTM&amp;quot; bio]&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
&lt;br /&gt;
*[[Mark Zinn]]&lt;br /&gt;
*[[qEEG|eLORETA]]&lt;br /&gt;
*swLORETA&lt;br /&gt;
*qEEG&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Jason,Zinn, 2015&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Jason           | first1 = Leonard             | authorlink1 = Leonard Jason&lt;br /&gt;
| last2   = Zinn            | first2 = Marcie              | authorlink2 = Marcie Zinn&lt;br /&gt;
| last3   = Zinn            | first3 = Mark                | authorlink3 = Mark Zinn&lt;br /&gt;
| title   = Myalgic Encephalomyelitis: Symptoms and Biomarkers&lt;br /&gt;
| journal = Current Neuropharmacology   | volume = 13   | issue = 5   | page = 701-34.&lt;br /&gt;
| date    = 2015&lt;br /&gt;
| pmid    = 26411464&lt;br /&gt;
| doi     = 10.2174/1570159X13666150928105725&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn, 2014&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn        | first1 = Mark A        | authorlink1 = Mark Zinn&lt;br /&gt;
| last2   = May         | first2 = Marcie L      | authorlink2 = Marcie Zinn&lt;br /&gt;
| last3   = Norris      | first3 = Jane          | authorlink3 = Jane Norris&lt;br /&gt;
| last4   = Valencia    | first4 = Ian           | authorlink4 = Ian Valencia&lt;br /&gt;
| last5   = Montoya     | first5 = Jose G        | authorlink5 = Jose Montoya&lt;br /&gt;
| last6   = Maldonado   | first6 = Jose R        | authorlink6 = &lt;br /&gt;
| title   = Cortical hypoactivation during resting eLORETA suggests central nervous system pathology in patients with chronic fatigue syndrome&lt;br /&gt;
| journal = Conference: 2014 Stanford Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Symposium  | volume =    | issue =   | page = &lt;br /&gt;
| date    = 2014&lt;br /&gt;
| url    = https://www.researchgate.net/publication/290628295_Cortical_hypoactivation_during_resting_eLORETA_suggests_central_nervous_system_pathology_in_patients_with_chronic_fatigue_syndrome&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| last3   = Jason             | first3 = Leonard            | authorlink3 = Leonard Jason&lt;br /&gt;
| title   = Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with Myalgic Encephalomyelitis: A Pilot Study&lt;br /&gt;
| journal = Applied Psychophysiology and Biofeedback  | volume = 41   | issue = 3   | page = 283-300&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = 26869373&lt;br /&gt;
| doi     = 10.1007/s10484-016-9331-3&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn ML, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| last3   = Jason             | first3 = Leonard            | authorlink3 = Leonard Jason&lt;br /&gt;
| title   = qEEG / LORETA in Assessment of Neurocognitive Impairment in a Patient with Chronic Fatigue Syndrome: A Case Report&lt;br /&gt;
| journal = Clinical Research: Open Access  | volume = 2   | issue = 1   | page =&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = 26869373&lt;br /&gt;
| doi     = 10.16966/2469-6714.110&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn&amp;amp;Zinn, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| last3   = Jason             | first3 = Leonard            | authorlink3 = Leonard Jason&lt;br /&gt;
| title   = Functional Neural Network Connectivity in Myalgic Encephalomyelitis&lt;br /&gt;
| journal = NeuroRegulation   | volume = 3   | issue = 1   | page = 28-50&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = &lt;br /&gt;
| doi     = 10.15540/nr.3.1.28&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;/references&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Researchers]]&lt;br /&gt;
[[Category:US researchers]]&lt;br /&gt;
[[Category:People with ME, CFS, and/or FMS]]&lt;br /&gt;
[[Category:Psychological paradigm critics]]&lt;br /&gt;
[[Category:PACE trial critics]]&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Mark_Zinn&amp;diff=78302</id>
		<title>Mark Zinn</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Mark_Zinn&amp;diff=78302"/>
		<updated>2019-12-01T23:19:26Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:text&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[File:Mark Zinn.png|200px|thumb|right|Source:LinkedIn]]&lt;br /&gt;
&#039;&#039;&#039;Mark Zinn&#039;&#039;&#039;, PhD is a specialist in autonomic neuroscience, conducting ME/CFS studies with his wife, Marcie Zinn Ph.D. in their nonprofit entity, [https://www.thencri.org the NeuroCognitive Research Institute]. Mark was part of the Chronic Fatigue Syndrome Initiative at Stanford between 2011 and 2014, working with Dr. Jose Montoya. Mark continues to collaborate with the ME/CFS Initiative at Stanford Medicine. Mark Zinn was one of the 42 signatories of the Open Letter to the Lancet calling for the PACE trial data to be independently reanalysed.&amp;lt;ref&amp;gt;&amp;quot;An open letter to the Lancet - again&amp;quot;, Virology Blog, 10 Feb 2016&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Notable studies==&lt;br /&gt;
* Mar 2014 - Cortical hypoactivation during resting eLORETA suggests central nervous system pathology in patients with chronic fatigue syndrome (Conference paper, 2014 Stanford Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Symposium: Advances in Clinical Care and Translational Research for health care providers, At Stanford School of Medicine, Palo Alto, CA&amp;lt;ref name=&amp;quot;Zinn, 2014&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/290628295_Cortical_hypoactivation_during_resting_eLORETA_suggests_central_nervous_system_pathology_in_patients_with_chronic_fatigue_syndrome (Abstract - full text on request)]  &lt;br /&gt;
*2015 - Myalgic Encephalomyelitis: Symptoms and [[Biomarker]]s&amp;lt;ref name=&amp;quot;Jason,Zinn, 2015&amp;quot; /&amp;gt; [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761639/ (Full Text)] &lt;br /&gt;
*2016 - Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with [[Myalgic Encephalomyelitis]]: A Pilot Study&amp;lt;ref name=&amp;quot;Zinn, 2016&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/294258397_Intrinsic_Functional_Hypoconnectivity_in_Core_Neurocognitive_Networks_Suggests_Central_Nervous_System_Pathology_in_Patients_with_Myalgic_Encephalomyelitis_A_Pilot_Study (Full Text)]&lt;br /&gt;
*2016 - qEEG / LORETA in Assessment of Neurocognitive Impairment in a Patient with [[Chronic Fatigue Syndrome]]: A Case Report&amp;lt;ref name=&amp;quot;Zinn ML, 2016&amp;quot; /&amp;gt; [https://sciforschenonline.org/journals/clinical-research/CLROA-2-110.php (Full Text)] &lt;br /&gt;
*2016 - Functional Neural Network Connectivity in [[Myalgic Encephalomyelitis]]&amp;lt;ref name=&amp;quot;Zinn&amp;amp;Zinn, 2016&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/297453164_NeuroRegulation_httpwwwisnrorg_Functional_Neural_Network_Connectivity_in_Myalgic_Encephalomyelitis (Full Text)]&lt;br /&gt;
*2017, Small-world network analysis of cortical connectivity in Chronic Fatigue Syndrome using quantitative [[EEG]].&amp;lt;ref&amp;gt;{{Cite journal|last=Zinn|first=Mark Alan|author-link=Mark Zinn|last2=Zinn|first2=Marcie L.|author-link2=Marcie Zinn|last3=Jason|first3=Leonard A.|author-link3=Leonard Jason|date=2017-12-07|title=Small-World Network Analysis of Cortical Connectivity in Chronic Fatigue Syndrome Using Quantitative EEG|url=http://www.neuroregulation.org/article/view/17838|journal=NeuroRegulation|language=en|volume=4|issue=3-4|pages=125|doi=10.15540/nr.4.3-4.125|issn=2373-0587|via=}}&amp;lt;/ref&amp;gt; [https://www.researchgate.net/publication/321717868_Small-World_Network_Analysis_of_Cortical_Connectivity_in_Chronic_Fatigue_Syndrome_Using_Quantitative_EEG (Full Text)]&lt;br /&gt;
*2018 - Cortical hypoactivation during resting EEG suggests central nervous system pathology in patients with [[chronic fatigue syndrome]]&amp;lt;ref&amp;gt;{{Cite journal|last=Zinn|first=M.A.|author-link=Mark Davis|last2=Zinn|first2=M.L.|author-link2=Marcie Zinn|last3=Valencia|first3=I.|author-link3=Ian Valencia|last4=Jason|first4=L.A.|author-link4=Leonard Jason|last5=Montoya|first5=J.G.|author-link5=Jose Montoya|date=Jul 2018|title=Cortical hypoactivation during resting EEG suggests central nervous system pathology in patients with chronic fatigue syndrome|url=https://linkinghub.elsevier.com/retrieve/pii/S0301051118304071|journal=Biological Psychology|language=en|volume=136|issue=|pages=87–99|doi=10.1016/j.biopsycho.2018.05.016|pmc=|pmid=29802861|quote=|via=}}&amp;lt;/ref&amp;gt; [https://www.sciencedirect.com/science/article/pii/S0301051118304071 (Abstract)]&lt;br /&gt;
*2019 - The Central Autonomic Network in Myalgic Encephalomyelitis Syndrome / Chronic Fatigue Syndrome, Doctoral Dissertation.&lt;br /&gt;
&lt;br /&gt;
==Talks and interviews==&lt;br /&gt;
&lt;br /&gt;
==Online presence==&lt;br /&gt;
&lt;br /&gt;
*website, https//:www.thencri.org&lt;br /&gt;
*[https://www.linkedin.com/in/mark-zinn-2b756a5b LinkedIn]&lt;br /&gt;
*theNCRI (facebook)&lt;br /&gt;
*theNCRI (twitter)&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
&lt;br /&gt;
*[[Marcie Zinn]]&lt;br /&gt;
*Applied Neuroscience (Robert Thatcher, Ph.D.)&lt;br /&gt;
*Association for Applied Psychophysiology and Biofeedback (AAPB)&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Jason,Zinn, 2015&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Jason           | first1 = Leonard             | authorlink1 = Leonard Jason&lt;br /&gt;
| last2   = Zinn            | first2 = Marcie              | authorlink2 = Marcie Zinn&lt;br /&gt;
| last3   = Zinn            | first3 = Mark                | authorlink3 = Mark Zinn&lt;br /&gt;
| title   = Myalgic Encephalomyelitis: Symptoms and Biomarkers&lt;br /&gt;
| journal = Current Neuropharmacology   | volume = 13   | issue = 5   | page = 701-34.&lt;br /&gt;
| date    = 2015&lt;br /&gt;
| pmid    = 26411464&lt;br /&gt;
| doi     = 10.2174/1570159X13666150928105725&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn, 2014&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn        | first1 = Mark A        | authorlink1 = Mark Zinn&lt;br /&gt;
| last2   = May         | first2 = Marcie L      | authorlink2 = Marcie Zinn&lt;br /&gt;
| last3   = Norris      | first3 = Jane          | authorlink3 = Jane Norris&lt;br /&gt;
| last4   = Valencia    | first4 = Ian           | authorlink4 = Ian Valencia&lt;br /&gt;
| last5   = Montoya     | first5 = Jose G        | authorlink5 = Jose Montoya&lt;br /&gt;
| last6   = Maldonado   | first6 = Jose R        | authorlink6 = &lt;br /&gt;
| title   = Cortical hypoactivation during resting eLORETA suggests central nervous system pathology in patients with chronic fatigue syndrome&lt;br /&gt;
| journal = Conference: 2014 Stanford Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Symposium  | volume =    | issue =   | page = &lt;br /&gt;
| date    = 2014&lt;br /&gt;
| url    = https://www.researchgate.net/publication/290628295_Cortical_hypoactivation_during_resting_eLORETA_suggests_central_nervous_system_pathology_in_patients_with_chronic_fatigue_syndrome&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| last3   = Jason             | first3 = Leonard            | authorlink3 = Leonard Jason&lt;br /&gt;
| title   = Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with Myalgic Encephalomyelitis: A Pilot Study&lt;br /&gt;
| journal = Applied Psychophysiology and Biofeedback  | volume = 41   | issue = 3   | page = 283-300&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = 26869373&lt;br /&gt;
| doi     = 10.1007/s10484-016-9331-3&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn ML, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| last3   = Jason             | first3 = Leonard            | authorlink3 = Leonard Jason&lt;br /&gt;
| title   = qEEG / LORETA in Assessment of Neurocognitive Impairment in a Patient with Chronic Fatigue Syndrome: A Case Report&lt;br /&gt;
| journal = Clinical Research: Open Access  | volume = 2   | issue = 1   | page =&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = 26869373&lt;br /&gt;
| doi     = 10.16966/2469-6714.110&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn&amp;amp;Zinn, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| last3   = Jason             | first3 = Leonard            | authorlink3 = Leonard Jason&lt;br /&gt;
| title   = Functional Neural Network Connectivity in Myalgic Encephalomyelitis&lt;br /&gt;
| journal = NeuroRegulation   | volume = 3   | issue = 1   | page = 28-50&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = &lt;br /&gt;
| doi     = 10.15540/nr.3.1.28&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;/references&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Researchers]]&lt;br /&gt;
[[Category:US researchers]]&lt;br /&gt;
[[Category:Psychological paradigm critics]]&lt;br /&gt;
[[Category:PACE trial critics]]&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Marcie_Zinn&amp;diff=58237</id>
		<title>Marcie Zinn</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Marcie_Zinn&amp;diff=58237"/>
		<updated>2019-05-16T20:29:16Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[File:Marcie Zinn.png|200px|thumb|right]]&lt;br /&gt;
&#039;&#039;&#039;Marcie L. Zinn&#039;&#039;&#039; Ph.D., &#039;&#039;Research Psychologist in Psychophysiology, Rehabilitation, Cognitive Neuroscience and Data Science&#039;&#039; conducting [[myalgic encephalomyelitis]] (ME) research with her husband, [[Mark Zinn]],at their nonprofit, the NeuroCognitive Research Institute of California and Illinois. Marcie&#039;s research interests include the study of brain dysfunction in chronic disease, such as [[myalgic encephalomyelitis]]. Marcie and her husband, Mark also founded the Society for Neuroscience and Psychology in the Performing Arts. Her early research and career interests were in Performance Neuroscience and Psychology, but after being diagnosed in 2009 with herpes viral encephalitis which developed into [[Myalgic Encephalomyelitis]], her interest turned toward using her extensive [[QEEG|qEEG]] and neuroscience skills for research in [[ME]]. Under the leadership of Dr. [[Jose Montoya]], she conducted a pilot study to look at cognitive dysfunction using [[QEEG|qEEG]] methods. While continuing to collaborate with Jose Montoya at Stanford, she and her husband [[Mark Zinn|Mark]]  have published research using brain network modeling in the study of [[ME]] [[brain]] dysfunction. &lt;br /&gt;
&lt;br /&gt;
==ME/CFS Common Data Element (CDE) Project==&lt;br /&gt;
Member of the Pain Working Group and the Neurologic/Cognitive/CNS Imaging Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project sponsored by the [[National Institute of Neurological Disorders and Stroke]] and the [[Centers for Disease Control and Prevention]].&amp;lt;ref&amp;gt;https://www.commondataelements.ninds.nih.gov/ReportViewer.aspx?%2fnindscdereports%2fRoster&amp;amp;rs%3aCommand=Render&amp;amp;rc:Parameters=false&amp;amp;diseaseid=MECFS&amp;amp;custom:disableExcel=true&amp;amp;custom:disableXML=true&amp;amp;custom:disableCSV=true&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Advocacy==&lt;br /&gt;
* Dr. Zinn signed the second and third [[open letter to the Lancet|open letters to the editor of &#039;&#039;The Lancet&#039;&#039;]] urging the editor to commission a fully independent review of the [[PACE trial]], which the journal published in 2011. &lt;br /&gt;
:Feb 10, 2016, [http://www.virology.ws/2016/02/10/open-letter-lancet-again/ An open letter to The Lancet, again - Virology blog]&lt;br /&gt;
:June 19, 2018, [http://www.virology.ws/2018/06/19/trial-by-error-an-open-letter-to-the-lancet-two-years-on/ Trial By Error: An Open Letter to The Lancet, Two Years On - Virology blog]&lt;br /&gt;
&lt;br /&gt;
==Notable studies==&lt;br /&gt;
* June, 2004: &#039;&#039;Development of a Self-Report Inventory to Develop Cognitive Dysfunction in Musicians.&#039;&#039; ProQuest Information and Learning Company, Ann Arbor, Michigan.  &lt;br /&gt;
* March, 2005: &#039;&#039;The Hippocampus in Music Learning and Performance&#039;&#039; (March, 2005). Presentation at the annual Brain Awareness Week event sponsored by Dana Alliance for Brain Initiatives, Dublin, CA.  &lt;br /&gt;
* Mar 2014, Cortical hypoactivation during resting eLORETA suggests central nervous system pathology in patients with chronic fatigue syndrome (Conference paper, 2014 Stanford Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Symposium: Advances in Clinical Care and Translational Research for health care providers, At Stanford School of Medicine, Palo Alto, CA&amp;lt;ref name=&amp;quot;Zinn, 2014&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/290628295_Cortical_hypoactivation_during_resting_eLORETA_suggests_central_nervous_system_pathology_in_patients_with_chronic_fatigue_syndrome (Abstract - full text on request)]  &lt;br /&gt;
* Mar 2014,  &#039;&#039;EEG peak alpha frequency is associated with chronic fatigue syndrome: a case-control observational study&#039;&#039;. Invited presentation at the 2014 Stanford Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Symposium : Advances in Clinical Care and Translational Research; March 19, 2014, Stanford University Dept. of Medicine, Palo Alto, CA.1.     &lt;br /&gt;
* &#039;&#039;EEG peak alpha frequency is associated with chronic fatigue syndrome: a case-control observational study&#039;&#039;. Invited presentation at the 2014 Stanford Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Symposium : Advances in Clinical Care and Translational Research; March 19, 2014, Stanford University Dept. of Medicine, Palo Alto, CA.  &lt;br /&gt;
*2015, Myalgic Encephalomyelitis: Symptoms and [[Biomarker]]s&amp;lt;ref name=&amp;quot;Jason,Zinn, 2015&amp;quot; /&amp;gt; [http://www.ncbi.nlm.nih.gov/pubmed/26411464 (Full Text)]&lt;br /&gt;
*2015,  Zinn, M.L. &amp;amp; Zinn, M.A. Psychophysiology for Performing Artists. In M. S. Schwartz &amp;amp; F. Andrasik, Eds: Biofeedback: A Practitioners Guide (4th ed.), New York: Guilford.&lt;br /&gt;
*2016, Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with [[Myalgic Encephalomyelitis]]: A Pilot Study&amp;lt;ref name=&amp;quot;Zinn, 2016&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/294258397_Intrinsic_Functional_Hypoconnectivity_in_Core_Neurocognitive_Networks_Suggests_Central_Nervous_System_Pathology_in_Patients_with_Myalgic_Encephalomyelitis_A_Pilot_Study (Full Text)] &lt;br /&gt;
*2016, [[QEEG|qEEG]] / LORETA in Assessment of Neurocognitive Impairment in a Patient with Chronic Fatigue Syndrome: A Case Report&amp;lt;ref name=&amp;quot;Zinn ML, 2016&amp;quot; /&amp;gt; [https://sciforschenonline.org/journals/clinical-research/CLROA-2-110.php (Full Text)] &lt;br /&gt;
*2016, Functional Neural Network Connectivity in Myalgic Encephalomyelitis&amp;lt;ref name=&amp;quot;Zinn&amp;amp;Zinn, 2016&amp;quot; /&amp;gt; [https://www.researchgate.net/publication/297453164_NeuroRegulation_httpwwwisnrorg_Functional_Neural_Network_Connectivity_in_Myalgic_Encephalomyelitis (Full Text)]&lt;br /&gt;
*2017, Small-world network analysis of cortical connectivity in [[Chronic Fatigue Syndrome]] using quantitative [[EEG]].&amp;lt;ref&amp;gt;{{Cite journal|last=Zinn|first=Mark Alan|author-link=Mark Zinn|last2=Zinn|first2=Marcie L.|author-link2=Marcie Zinn|last3=Jason|first3=Leonard A.|author-link3=Leonard Jason|date=2017-12-07|title=Small-World Network Analysis of Cortical Connectivity in Chronic Fatigue Syndrome Using Quantitative EEG|url=http://www.neuroregulation.org/article/view/17838|journal=NeuroRegulation|language=en|volume=4|issue=3-4|pages=125|doi=10.15540/nr.4.3-4.125|issn=2373-0587|via=}}&amp;lt;/ref&amp;gt; [https://www.researchgate.net/publication/321717868_Small-World_Network_Analysis_of_Cortical_Connectivity_in_Chronic_Fatigue_Syndrome_Using_Quantitative_EEG (Full Text)]&lt;br /&gt;
*2018, Cortical hypoactivation during resting EEG suggests central nervous system pathology in patients with [[chronic fatigue syndrome]]&amp;lt;ref&amp;gt;{{Cite journal|last=Zinn|first=M.A.|author-link=Mark Davis|last2=Zinn|first2=M.L.|author-link2=Marcie Zinn|last3=Valencia|first3=I.|author-link3=Ian Valencia|last4=Jason|first4=L.A.|author-link4=Leonard Jason|last5=Montoya|first5=J.G.|author-link5=Jose Montoya|date=Jul 2018|title=Cortical hypoactivation during resting EEG suggests central nervous system pathology in patients with chronic fatigue syndrome|url=https://linkinghub.elsevier.com/retrieve/pii/S0301051118304071|journal=Biological Psychology|language=en|volume=136|issue=|pages=87–99|doi=10.1016/j.biopsycho.2018.05.016|pmc=|pmid=29802861|quote=|via=}}&amp;lt;/ref&amp;gt; [https://www.sciencedirect.com/science/article/pii/S0301051118304071 (Abstract)]&lt;br /&gt;
&lt;br /&gt;
==Talks &amp;amp; interviews==&lt;br /&gt;
&lt;br /&gt;
*2016, [https://www.youtube.com/watch?v=aN0Fh0kiUiI &amp;quot;qEEG LORETA CFS Case study - Sci Forschen Inc.&amp;quot;]  &lt;br /&gt;
&lt;br /&gt;
==Online presence==&lt;br /&gt;
&lt;br /&gt;
*[https://www.ncbi.nlm.nih.gov/pubmed/?term=Zinn%20ML%5BAuthor%5D&amp;amp;cauthor=true&amp;amp;cauthor_uid=26869373 PubMed]&lt;br /&gt;
*[https://www.researchgate.net/profile/Dr_Marcie_Zinn ResearchGate]&lt;br /&gt;
*[https://www.linkedin.com/in/marcie-zinn-795083a8/ LinkedIn]&lt;br /&gt;
&lt;br /&gt;
==Learn more==&lt;br /&gt;
&lt;br /&gt;
*[http://www.selfgrowth.com/experts/marcie_zinn.html &amp;quot;Marcie Zinn Ph.D., NCTM&amp;quot; bio]&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
&lt;br /&gt;
*[[Mark Zinn]]&lt;br /&gt;
*[[qEEG|eLORETA]]&lt;br /&gt;
*swLORETA&lt;br /&gt;
*qEEG&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Jason,Zinn, 2015&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Jason           | first1 = Leonard             | authorlink1 = Leonard Jason&lt;br /&gt;
| last2   = Zinn            | first2 = Marcie              | authorlink2 = Marcie Zinn&lt;br /&gt;
| last3   = Zinn            | first3 = Mark                | authorlink3 = Mark Zinn&lt;br /&gt;
| title   = Myalgic Encephalomyelitis: Symptoms and Biomarkers&lt;br /&gt;
| journal = Current Neuropharmacology   | volume = 13   | issue = 5   | page = 701-34.&lt;br /&gt;
| date    = 2015&lt;br /&gt;
| pmid    = 26411464&lt;br /&gt;
| doi     = 10.2174/1570159X13666150928105725&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn, 2014&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn        | first1 = Mark A        | authorlink1 = Mark Zinn&lt;br /&gt;
| last2   = May         | first2 = Marcie L      | authorlink2 = Marcie Zinn&lt;br /&gt;
| last3   = Norris      | first3 = Jane          | authorlink3 = Jane Norris&lt;br /&gt;
| last4   = Valencia    | first4 = Ian           | authorlink4 = Ian Valencia&lt;br /&gt;
| last5   = Montoya     | first5 = Jose G        | authorlink5 = Jose Montoya&lt;br /&gt;
| last6   = Maldonado   | first6 = Jose R        | authorlink6 = &lt;br /&gt;
| title   = Cortical hypoactivation during resting eLORETA suggests central nervous system pathology in patients with chronic fatigue syndrome&lt;br /&gt;
| journal = Conference: 2014 Stanford Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Symposium  | volume =    | issue =   | page = &lt;br /&gt;
| date    = 2014&lt;br /&gt;
| url    = https://www.researchgate.net/publication/290628295_Cortical_hypoactivation_during_resting_eLORETA_suggests_central_nervous_system_pathology_in_patients_with_chronic_fatigue_syndrome&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| last3   = Jason             | first3 = Leonard            | authorlink3 = Leonard Jason&lt;br /&gt;
| title   = Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with Myalgic Encephalomyelitis: A Pilot Study&lt;br /&gt;
| journal = Applied Psychophysiology and Biofeedback  | volume = 41   | issue = 3   | page = 283-300&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = 26869373&lt;br /&gt;
| doi     = 10.1007/s10484-016-9331-3&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn ML, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| last3   = Jason             | first3 = Leonard            | authorlink3 = Leonard Jason&lt;br /&gt;
| title   = qEEG / LORETA in Assessment of Neurocognitive Impairment in a Patient with Chronic Fatigue Syndrome: A Case Report&lt;br /&gt;
| journal = Clinical Research: Open Access  | volume = 2   | issue = 1   | page =&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = 26869373&lt;br /&gt;
| doi     = 10.16966/2469-6714.110&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;Zinn&amp;amp;Zinn, 2016&amp;quot;&amp;gt;{{Citation&lt;br /&gt;
| last1   = Zinn              | first1 = Marcie             | authorlink1 = Marcie Zinn&lt;br /&gt;
| last2   = Zinn              | first2 = Mark               | authorlink2 = Mark Zinn&lt;br /&gt;
| last3   = Jason             | first3 = Leonard            | authorlink3 = Leonard Jason&lt;br /&gt;
| title   = Functional Neural Network Connectivity in Myalgic Encephalomyelitis&lt;br /&gt;
| journal = NeuroRegulation   | volume = 3   | issue = 1   | page = 28-50&lt;br /&gt;
| date    = 2016&lt;br /&gt;
| pmid    = &lt;br /&gt;
| doi     = 10.15540/nr.3.1.28&lt;br /&gt;
}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;/references&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Researchers]]&lt;br /&gt;
[[Category:USA researchers]]&lt;br /&gt;
[[Category:People with ME, CFS, and/or FMS]]&lt;br /&gt;
[[Category:Psychological paradigm critics]]&lt;br /&gt;
[[Category:PACE trial critics]]&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=EEG&amp;diff=18224</id>
		<title>EEG</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=EEG&amp;diff=18224"/>
		<updated>2016-11-05T02:55:00Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:started references&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Cleanup | reason=Needs to be rewritten in encyclopedia format, and citations referenced for all statements made | date=September 2016}}&lt;br /&gt;
&lt;br /&gt;
[https://en.wikipedia.org/wiki/Electroencephalography Electroencephalography] (EEG)(Schomer &amp;amp; Lopez de Silva, 2011) is a noninvasive neuroimaging procedure which records electrical activity of the brain (Duffy et al., 1994). EEG MEG are the only direct measures ( of neural activity (i.e., collections of  neurons) and operates in the millisecond time domain, which is the same time domain of the brain and central nervous system. Due to these properties, it is the best and most sensitive measure of neural dynamics (activities of neural networks). &lt;br /&gt;
 &lt;br /&gt;
The last 70 years of neuroscience has established that most of brain&#039;s metabolism is used to create brain cell activity (summated synaptic potentials) operating on on the least-effort principle. This activity is mostly excitatory, some is inhibitory (slows things down) but it achieves a balance that optimizes the excitation and inhibition and produced electrical potentials, which we see at the scalp, in the form of the EEG. The EEG is a function of the electrical potentials in our brain, at the scalp. LORETA looks at the electrical potentials deeper into the brain. Only pyramidal neurons generate these potentials, and over 85% of our brains are made up of pyramidal neurons. All neurons generate all EEG frequencies, so the most important thing to remember is whether there is deregulation in a given region or network, with the frequency being secondary. &lt;br /&gt;
&lt;br /&gt;
2 Billion dollars during 1990s (decade of the brain) resulted in huge proliferation of knowledge and understanding in a much for fundamental way how the brain is wired, how the neurons are synchronized and how they “talk” to each other. We are very privileged to be able to take advantage of it. It has matured to the point that we can now apply it. The ultimate goal of bringing together all imaging modalities is good clinical outcome. In order to achieve that, it requires putting together all the imaging modalities and understanding where we are and understanding where the EEG is with respect to the other imaging modalities (structural MRI, functional MRI, PET scans, SPECT scans, EEG, MEG) and at all levels of phylogeny (animals to humans). There is a common coordinate system so we can relate the EEG to networks inside the brain and nodes and connections between nodes within the brain that are related to symptoms.&lt;br /&gt;
&lt;br /&gt;
The brain is organized in networks which operate on a millisecond time-scale. These networks are physical systems containing interdependent brain regions connected by nerves (bundles of nerve cells). Electrical neuroimaging of modules and hubs within the brain using structural MRI, DTI—this forms the infrastructure for the foundation for our understanding of the EEG. However, DTI, MRI structural imaging is the same whether you are alive or dead. Only the EEG, fMRI capture neuronal dynamics; however, the difference is that the fMRI has 10-20 second latency in order to measure anything whereas the EEG is in milliseconds. This near-instantaneous measurement aspect of EEG is crucial for examining brain dynamics, which, given the articles presented here appear to be very relevant for the study of ME. The time it takes for the brain to recruit a billion neurons across different network nodes varies from about 20ms to 80ms. Therefore, this means that network phase measures are completely INVISIBLE to the fMRI.Furthermore, the EEG spatial resolution, although not as high as fMRI, is quite accurate and sufficient for us to evaluate the dynamics of communication between large groups of neurons. What this means is that, if one is interested in brain dynamics and function, the EEG is the only modality that will capture it.&lt;br /&gt;
&lt;br /&gt;
The brain is not like a computer, as we once thought. It depends on information that flows in regulated loops which continually change, not in fixed circuits like computers. The brain primary task is prediction, by matching what is previously learned with new information &#039;on the fly.&#039; Our awareness is one step behind these predictions in that the brain has already represented our actions milliseconds before we perform them. Information flow is therefore a continual re-mapping that takes information from sensory systems and sends it to higher-order systems, which results in regulatory control which bring about adaption in homeostasis of feelings, actions, perceptions and consciousness. The EEG is therefore the only non-invasive and inexpensive measure of this continual temporal evolution of brain information in real time that is crucial for the understanding of cognitive and emotional functioning for healthy individuals as well as people with neurocognitive dysfunction.&lt;br /&gt;
&lt;br /&gt;
==Cortico-thalamic Integration==&lt;br /&gt;
&lt;br /&gt;
EEG patterns (rhythms) are primarily a fundamental property of brainstem-thalamo-cortical and corticothalamic dynamics regulated by many sub-thalamic brainstem systems including the ascending reticular activating system (ARAS), the locus coeruleus (LC) and the globus pallidus. It is these and other subcortical structures which regulate brain rhythms that produce the states of consciousness and cognition, producing cognitive abilities. More specifically, the networks which modulate arousal (vigilance) rhythms are some of the most important networks in the brain due to their function in the shift between arousal states ranging from the completely disconnected state to the fully alert, vigilant state [23-25]. The thalamus, part of the ascending reticular activating system (RAS)  provides two important functions within this circuit; first, to mediate sleep or low arousal (triggering sleep and wakefulness) and to perform memory consolidation during sleep. Therefore, any failure of the ability of the ARAS to regulate the thalamus efficiently  results in generalized reduction in information flow in extensive cortical regions causing reduced overall efficiency, slowed information processing speed, memory failures, attention problems and overall cognitive deficits.  &lt;br /&gt;
&lt;br /&gt;
Network, Central Executive Network, Default Mode Network, Intrinsic Connectivity Network, Salience Network, Small-world Network, Structural Connectivity, Functional Connectivity.&lt;br /&gt;
&lt;br /&gt;
==Notable Studies==&lt;br /&gt;
*2016, [https://www.dovepress.com/electroencephalogram-characteristics-in-patients-with-chronic-fatigue--peer-reviewed-article-NDT Electroencephalogram characteristics in patients with chronic fatigue syndrome] (January 28) &amp;quot;The spontaneous brain electrical activities in CFS patients were significantly reduced. The abnormal changes in the cerebral functions were localized at the right frontal and left occipital regions in CFS patients&amp;quot;&lt;br /&gt;
&lt;br /&gt;
*2016, [https://link.springer.com/article/10.1007%2Fs10484-016-9331-3]-Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with Myalgic Encephalomyelitis: A Pilot Study](February 11). &amp;quot;We found support for all three core networks of the Menon triple network model-the central executive network (CEN), salience network (SN), and the default mode network (DMN)- indicating hypo-connectivity in the Delta, Alpha, and Alpha-2 frequency bands in patients with ME compared to controls. In addition to the current source density resting state dysfunction in the occipital, parietal, posterior temporal and posterior cingulate, the disrupted connectivity of the CEN, SN, and DMN appears to be involved in cognitive impairment for patients with ME. This research suggests that disruptions in these regions and networks could be a core neurobiological feature of the disorder, representing underlying neural dysfunction.&amp;quot;  &lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[qEEG]]&lt;br /&gt;
&lt;br /&gt;
[[Category:Tests]]&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Marcie_Zinn&amp;diff=8414</id>
		<title>Marcie Zinn</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Marcie_Zinn&amp;diff=8414"/>
		<updated>2016-04-10T02:51:28Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:added article&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Marcie Zinn, Ph.D. (born 1951) is an experimental psychologist conducting ME research with her husband, Mark and Dr. Leonard Jason at the DePaul Center for Community Research. Marcie&#039;s research interests include the study of Myalgic Encephalomyelitis as well as Performing Arts Neuroscience and Psychology. Her early research and career interests we in Performance Neuroscience and Psychology, but after being diagnosed in 2009 with viral encephalitis which became Myalgic Encephalomyelitis, her interest turned toward using her extensive qEEG and neuroscience skills for research in ME. Under the leadership of Dr. Jose Montoya, she conducted a pilot study to look at cognitive dysfunction using qEEG methods. She and her husband Mark have recently moved to Chicago to work with Dr. Leonard Jason and have published four articles, all of which illustrate qEEG methods in the study of ME brain dysfunction.&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Notable_studies&amp;diff=8413</id>
		<title>Notable studies</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Notable_studies&amp;diff=8413"/>
		<updated>2016-04-10T02:37:20Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:added article&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;This page lists published ME/CFS studies that are notable, for particularly interesting findings, for controversial findings, or for their quality or their size.&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wikitable sortable&amp;quot;&lt;br /&gt;
! General category&lt;br /&gt;
! Year of publication&lt;br /&gt;
! Study title&lt;br /&gt;
! Author(s)&lt;br /&gt;
! Notes&lt;br /&gt;
! Cohort size&lt;br /&gt;
! Blinded (double, single, not)&lt;br /&gt;
&amp;lt;!--&lt;br /&gt;
! Peer-reviewed&lt;br /&gt;
! Randomized&lt;br /&gt;
! Placebo-controlled&lt;br /&gt;
! Subjects&lt;br /&gt;
! Study summary&lt;br /&gt;
--&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2015 || [[Institute of Medicine report]] || [[Ellen Wright Clayton]] (Chair), [[Margarita Alegría]], [[Lucinda Bateman]], [[Lily Chu]], [[Charles S. Cleeland]], [[Ronald Davis]], [[Betty Diamond]], [[Theodore Ganiats]], [[Betsy Keller]], [[Nancy Klimas]], [[A. Martin Lerner]], [[Cynthia Mulrow]], [[Benjamin Natelson]], [[Peter Rowe]], [[Michael Shelanski]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2015 || [[Pathways to prevention report]] || Green CR, Cowan P, Elk R, O&#039;Neil KM, Rasmussen AL || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2014 || [http://www.ncbi.nlm.nih.gov/pubmed/25274261 Two age peaks in the incidence of chronic fatigue syndrome/myalgic encephalomyelitis: a population-based registry study from Norway 2008–2012] || Bakken IJ, Tveito K, Gunnes N, Ghaderi S, Stoltenberg C, Trogstad L, Håberg SE, Magnus P || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2013 || [http://www.ncbi.nlm.nih.gov/pubmed/23576883 The prevalence of chronic fatigue syndrome/myalgic encephalomyelitis: a meta-analysis] || [[Samantha Johnston]], [[Ekua Weba Brenu]], [[Donald Staines]], [[Sonya Marshall-Gradisnik]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2011 || [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170215/ Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care] || [[Luis Nacul]], [[Eliana Lacerda]], [[Derek Pheby]], Peter Campion, Mariam Molokhia, Shagufta Fayyaz, Jose CDC Leite, Fiona Poland, Amanda Howe, Maria L Drachler || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2007 || [http://www.aihw.gov.au/publication-detail/?id=6442467990 The burden of disease and injury in Australia 2003] || [[Stephen Begg]], [[Theo Vos]], Barker B, Stevenson C, Stanley L, Lopez A || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2006 || [http://jid.oxfordjournals.org/content/193/5/664.full Prolonged Illness after infectious mononucleosis is associated with altered immunity but not with increased viral load] || Cameron, B., Bharadwaj, M., Burrows, J., Fazou, C., Wakefield, D., Hickie, I., Ffrench, R., Khanna, R. and A. Lloyd || See also [http://phoenixrising.me/research-2/the-dubbo-studies-a-model-of-post-infective-fatigue-emerging/model-of-post-infective-fatigue-forming-the-dubbo-studies Model of Post Infective Fatigue Forming: the Dubbo Studies] || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2006 || [http://www.ncbi.nlm.nih.gov/pubmed/16448567 Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr virus] || Vernon, S., Whistler, T., Cameron, B., Hickie, I., Reeves, W. and A. Lloyd || See also [http://phoenixrising.me/research-2/the-dubbo-studies-a-model-of-post-infective-fatigue-emerging/model-of-post-infective-fatigue-forming-the-dubbo-studies Model of Post Infective Fatigue Forming: the Dubbo Studies] || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2006 || [http://www.ncbi.nlm.nih.gov/pubmed/16950834 Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study] || [[I Hickie]], [[T Davenport]], [[D Wakefield]], Vollmer-Conna U, Cameron B, Vernon SD, Reeves WC, Lloyd A || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2005 || [http://www.ncbi.nlm.nih.gov/pubmed/15699087 A systematic review describing the prognosis of chronic fatigue syndrome] || [[Ruth Cairns]], [[Matthew Hotopf]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 1996 || [http://www.ncbi.nlm.nih.gov/pubmed/8873490 Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups] || [[Anthony Komaroff]], Fagioli LR, Doolittle TH, Gandek B, Gleit MA, Guerriero RT, Kornish RJ 2nd, Ware NC, Ware JE Jr, Bates DW || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2015 || [http://www.ncbi.nlm.nih.gov/m/pubmed/26615570/ Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome] || Landi A, Broadhurst D, [[Suzanne Vernon]], Tyrrell DL, Houghton M || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2015 || [http://www.ncbi.nlm.nih.gov/pubmed/?term=26079000 Distinct plasma immune signatures in ME/CFS are present early in the course of illness] || [[Mady Hornig]], [[Jose Montoya]], [[Nancy Klimas]], Levine S, Felsenstein D, [[Lucinda Bateman]], [[Daniel Peterson]], Gottschalk CG, Schultz AF, Che X, Eddy ML, [[Anthony Komaroff]], [[Ian Lipkin]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2014 || [http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0085387 Deficient EBV-specific B-and T-cell response in patients with chronic fatigue syndrome] || Madlen Loebel, Kristin Strohschein, Carolin Giannini, Uwe Koelsch, Sandra Bauer, Cornelia Doebis, Sybill Thomas, Nadine Unterwalder, Volker von Baehr, Petra Reinke, Michael Knops, Leif G. Hanitsch, Christian Meisel, Hans-Dieter Volk, [[Carmen Scheibenbogen]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2012 || [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464733/ Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis] || Ekua W Brenu, Mieke L van Driel, [[Donald Staines]], Kevin J Ashton, Sharni L Hardcastle, James Keane, Lotti Tajouri, [[Daniel Peterson]], Sandra B Ramos, [[Sonya Marshall-Gradisnik]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2011 || [http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0026358 Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study] || [[Øystein Fluge]] , Ove Bruland, Kristin Risa, Anette Storstein, Einar K. Kristoffersen, Dipak Sapkota, Halvor Næss, Olav Dahl, Harald Nyland, [[Olav Mella]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2010 || [http://www.ncbi.nlm.nih.gov/pubmed/20520837 Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26] || Fletcher MA, Zeng XR, Maher K || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2008 || [http://www.ncbi.nlm.nih.gov/pubmed/18775774 Neuroendocrine and immune network remodeling in chronic fatigue syndrome: an exploratory analysis] || Fuite J, [[Susan Vernon]], [[Gordon Broderick]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2008 || [http://www.ncbi.nlm.nih.gov/pubmed/18937577 Cytokine Polymorphisms Have a Synergistic Effect on Severity of the Acute Sickness Response to Infection] || Vollmer‐Conna U, Piraino B, Cameron B || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2007 || [http://www.ncbi.nlm.nih.gov/pubmed/17712757 Postinfective fatigue syndrome is not associated with altered cytokine production] || Vollmer-Conna U, Cameron B, Pavlovic D || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2006 || [http://www.ncbi.nlm.nih.gov/pubmed/16762155 A first study of cytokine genomic polymorphisms in CFS: positive association of TNF‐857 and IFNgamma 874 rare alleles] || Carlo‐Stella N, Badulli C, De S || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2005 || [http://www.ncbi.nlm.nih.gov/pubmed/16049290 Association of chronic fatigue syndrome with human leucocyte antigen class II alleles] || Smith J, Fritz EL, [[Jonathan Kerr]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: orange; font-weight: bold;&amp;quot; | Metabolic || 2014 || [http://www.ncbi.nlm.nih.gov/pubmed/24755065 Inability of myalgic encephalomyelitis/chronic fatigue syndrome patients to reproduce VO2peak indicates functional impairment] || [[Betsy Keller]], [[John Pryor]], [[Ludovic Giloteaux]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: orange; font-weight: bold;&amp;quot; | Metabolic || 2012 || [http://www.ncbi.nlm.nih.gov/pubmed/22210239 Differences in metabolite-detecting, adrenergic, and immune gene expression after moderate exercise in patients with chronic fatigue syndrome, patients with multiple sclerosis, and healthy controls] || AT White, [[Alan Light]], RW Hughen, TA Vanhaitsma, [[Kathleen Light]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: orange; font-weight: bold;&amp;quot; | Metabolic || 2009 || [http://www.ncbi.nlm.nih.gov/pubmed/19647494 Moderate exercise increases expression for sensory, adrenergic, and immune genes in chronic fatigue syndrome patients but not in normal subjects] || [[Alan Light]], AT White, RW Hughen, [[Kathleen Light]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: gray; font-weight: bold;&amp;quot; | Neurological || 2015 || [https://sciforschenonline.org/journals/clinical-research/CLROA-2-110.php Phase relationships are only measurable by the qEEG, giving us a unique window into the ME disease process] || [[ML Zinn]], [[MA Zinn]], [[L Jason]] || See also [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108033/ [Phase Reset of the Default Mode Network.] || ||&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: gray; font-weight: bold;&amp;quot; | Neurological || 2015 || [http://www.ncbi.nlm.nih.gov/pubmed/26411464 There is poor agreement among researchers and clinicians about case definitions. Key domains are discussed. ] || [[Leonard Jason]], ML Zinn, MA Zinn || See also [http://www.tandfonline.com/doi/abs/10.1080/21641846.2015.1041336 Lack of Agreement in Case Definitions hampers research.] || ||&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: gray; font-weight: bold;&amp;quot; | Neurological || 2015 || [http://www.ncbi.nlm.nih.gov/pubmed/?term=25353054 Right arcuate fasciculus abnormality in chronic fatigue syndrome] || [[Michael Zeineh]], Kang J, Atlas SW, Raman MM, Reiss AL, Norris JL, Valencia I, [[Jose Montoya]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: gray; font-weight: bold;&amp;quot; | Neurological || 2007 || [http://www.ncbi.nlm.nih.gov/pubmed/17617647 Symptoms of autonomic dysfunction in chronic fatigue syndrome] || [[Julia Newton]], O Okonkwo, K Sutcliffe, Seth A, Shin J, Jones DE || || || &lt;br /&gt;
|- &lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2015 || [http://www.ncbi.nlm.nih.gov/m/pubmed/26399744/ Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome] || [[Øystein Fluge]], [[Olav Mella]], Loebel M, Grabowski P, Heidecke H, Bauer S, Hanitsch LG, Wittke K, Meisel C, Reinke P, Volk HD, [[Carmen Scheibenbogen]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2015 || [http://www.ncbi.nlm.nih.gov/m/pubmed/26132314/ B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment] || [[Øystein Fluge]], [[Olav Mella]], Risa K, Lunde S, Alme K, Rekeland IG, Sapkota D, Kristoffersen EK, Sørland K, Bruland O, Dahl O || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2013 || [http://www.ncbi.nlm.nih.gov/m/pubmed/23480187/ Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls] || [[Amolak Bansal]], AS Bradley, B Ford || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2013 || [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891387/ Fibromyalgia Symptoms Are Reduced by Low-Dose Naltrexone: A Pilot Study] || [[Jarred Younger]], Sean Mackey || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2012 || [http://www.cdd.com.au/pdf/publications/All%20Publications/2013%20-%20The%20GI%20microbiome%20and%20its%20role%20in%20CFS%20-%20ACNEM%20paper.pdf/ The GI Microbiome and its Role in Chronic Fatigue Syndrome: A Summary of Bacteriotherapy] || Thomas J. Borody, Anna Nowak, Sarah Finalayson || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2011 || [http://www.ncbi.nlm.nih.gov/m/pubmed/22039471/ Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study] || [[Øystein Fluge]], [[Olav Mella]], Bruland O, Risa K, Storstein A, Kristoffersen EK, Sapkota D, Næss H, Dahl O, Nyland H || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2010 || [http://www.ncbi.nlm.nih.gov/pubmed/23359310 Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels] || [[Jarred Younger]], Noor N, McCue R, Mackey S || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2009 || [http://www.ncbi.nlm.nih.gov/m/pubmed/19566965/ Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series] || [[Øystein Fluge]], [[Olav Mella]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2008 || [https://www.researchgate.net/profile/Michael_Maes2/publication/23709068_Normalization_of_leaky_gut_in_chronic_fatigue_syndrome_CFS_is_accompanied_by_a_clinical_improvement_Effects_of_age_duration_of_illness_and_the_translocation_of_LPS_from_gram-negative_bacteria/links/55c0913f08ae092e9666c31b.pdf/ Normalization of leaky gut in Chronic Fatigue Syndrome (CFS) is accompanied by a clinical improvement] || Michael Maes, Jean-Claude Leunis || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightgreen; font-weight: bold;&amp;quot; | Psychological || 2011 || The [[PACE trial]] || [[Peter White]], KA Goldsmith, AL Johnson, L Potts, R Walwyn, JC DeCesare, HL Baber, M Burgess, LV Clark, DL Cox, [[Jessica Bavinton]], BJ Angus, [[Gabrielle Murphy]], M Murphy, H O&#039;Dowd, D Wilks, P McCrone, [[Trudie Chalder]], [[Michael Sharpe]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightgreen; font-weight: bold;&amp;quot; | Psychological || 2005 || [http://simonwessely.com/Downloads/Publications/CFS/176.pdf The Placebo Response in the Treatment of Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis] || Hyong Jin Cho, Matthew Hotopf, Simon Wessely || Found that the placebo response was actually lower in CFS patients || || &lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightgreen; font-weight: bold;&amp;quot; | Psychological || 2014 || [http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD003200.pub4/abstract Exercise therapy for chronic fatigue syndrome] || Cochrane: Lillebeth Larun, Kjetil G. Brurberg, Jan Odgaard-Jensen, Jonathan R Price ||  || || &lt;br /&gt;
&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Notable_studies&amp;diff=8412</id>
		<title>Notable studies</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Notable_studies&amp;diff=8412"/>
		<updated>2016-04-10T02:35:02Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:added article&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;This page lists published ME/CFS studies that are notable, for particularly interesting findings, for controversial findings, or for their quality or their size.&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wikitable sortable&amp;quot;&lt;br /&gt;
! General category&lt;br /&gt;
! Year of publication&lt;br /&gt;
! Study title&lt;br /&gt;
! Author(s)&lt;br /&gt;
! Notes&lt;br /&gt;
! Cohort size&lt;br /&gt;
! Blinded (double, single, not)&lt;br /&gt;
&amp;lt;!--&lt;br /&gt;
! Peer-reviewed&lt;br /&gt;
! Randomized&lt;br /&gt;
! Placebo-controlled&lt;br /&gt;
! Subjects&lt;br /&gt;
! Study summary&lt;br /&gt;
--&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2015 || [[Institute of Medicine report]] || [[Ellen Wright Clayton]] (Chair), [[Margarita Alegría]], [[Lucinda Bateman]], [[Lily Chu]], [[Charles S. Cleeland]], [[Ronald Davis]], [[Betty Diamond]], [[Theodore Ganiats]], [[Betsy Keller]], [[Nancy Klimas]], [[A. Martin Lerner]], [[Cynthia Mulrow]], [[Benjamin Natelson]], [[Peter Rowe]], [[Michael Shelanski]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2015 || [[Pathways to prevention report]] || Green CR, Cowan P, Elk R, O&#039;Neil KM, Rasmussen AL || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2014 || [http://www.ncbi.nlm.nih.gov/pubmed/25274261 Two age peaks in the incidence of chronic fatigue syndrome/myalgic encephalomyelitis: a population-based registry study from Norway 2008–2012] || Bakken IJ, Tveito K, Gunnes N, Ghaderi S, Stoltenberg C, Trogstad L, Håberg SE, Magnus P || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2013 || [http://www.ncbi.nlm.nih.gov/pubmed/23576883 The prevalence of chronic fatigue syndrome/myalgic encephalomyelitis: a meta-analysis] || [[Samantha Johnston]], [[Ekua Weba Brenu]], [[Donald Staines]], [[Sonya Marshall-Gradisnik]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2011 || [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170215/ Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care] || [[Luis Nacul]], [[Eliana Lacerda]], [[Derek Pheby]], Peter Campion, Mariam Molokhia, Shagufta Fayyaz, Jose CDC Leite, Fiona Poland, Amanda Howe, Maria L Drachler || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2007 || [http://www.aihw.gov.au/publication-detail/?id=6442467990 The burden of disease and injury in Australia 2003] || [[Stephen Begg]], [[Theo Vos]], Barker B, Stevenson C, Stanley L, Lopez A || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2006 || [http://jid.oxfordjournals.org/content/193/5/664.full Prolonged Illness after infectious mononucleosis is associated with altered immunity but not with increased viral load] || Cameron, B., Bharadwaj, M., Burrows, J., Fazou, C., Wakefield, D., Hickie, I., Ffrench, R., Khanna, R. and A. Lloyd || See also [http://phoenixrising.me/research-2/the-dubbo-studies-a-model-of-post-infective-fatigue-emerging/model-of-post-infective-fatigue-forming-the-dubbo-studies Model of Post Infective Fatigue Forming: the Dubbo Studies] || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2006 || [http://www.ncbi.nlm.nih.gov/pubmed/16448567 Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr virus] || Vernon, S., Whistler, T., Cameron, B., Hickie, I., Reeves, W. and A. Lloyd || See also [http://phoenixrising.me/research-2/the-dubbo-studies-a-model-of-post-infective-fatigue-emerging/model-of-post-infective-fatigue-forming-the-dubbo-studies Model of Post Infective Fatigue Forming: the Dubbo Studies] || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2006 || [http://www.ncbi.nlm.nih.gov/pubmed/16950834 Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study] || [[I Hickie]], [[T Davenport]], [[D Wakefield]], Vollmer-Conna U, Cameron B, Vernon SD, Reeves WC, Lloyd A || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2005 || [http://www.ncbi.nlm.nih.gov/pubmed/15699087 A systematic review describing the prognosis of chronic fatigue syndrome] || [[Ruth Cairns]], [[Matthew Hotopf]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 1996 || [http://www.ncbi.nlm.nih.gov/pubmed/8873490 Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups] || [[Anthony Komaroff]], Fagioli LR, Doolittle TH, Gandek B, Gleit MA, Guerriero RT, Kornish RJ 2nd, Ware NC, Ware JE Jr, Bates DW || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2015 || [http://www.ncbi.nlm.nih.gov/m/pubmed/26615570/ Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome] || Landi A, Broadhurst D, [[Suzanne Vernon]], Tyrrell DL, Houghton M || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2015 || [http://www.ncbi.nlm.nih.gov/pubmed/?term=26079000 Distinct plasma immune signatures in ME/CFS are present early in the course of illness] || [[Mady Hornig]], [[Jose Montoya]], [[Nancy Klimas]], Levine S, Felsenstein D, [[Lucinda Bateman]], [[Daniel Peterson]], Gottschalk CG, Schultz AF, Che X, Eddy ML, [[Anthony Komaroff]], [[Ian Lipkin]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2014 || [http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0085387 Deficient EBV-specific B-and T-cell response in patients with chronic fatigue syndrome] || Madlen Loebel, Kristin Strohschein, Carolin Giannini, Uwe Koelsch, Sandra Bauer, Cornelia Doebis, Sybill Thomas, Nadine Unterwalder, Volker von Baehr, Petra Reinke, Michael Knops, Leif G. Hanitsch, Christian Meisel, Hans-Dieter Volk, [[Carmen Scheibenbogen]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2012 || [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464733/ Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis] || Ekua W Brenu, Mieke L van Driel, [[Donald Staines]], Kevin J Ashton, Sharni L Hardcastle, James Keane, Lotti Tajouri, [[Daniel Peterson]], Sandra B Ramos, [[Sonya Marshall-Gradisnik]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2011 || [http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0026358 Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study] || [[Øystein Fluge]] , Ove Bruland, Kristin Risa, Anette Storstein, Einar K. Kristoffersen, Dipak Sapkota, Halvor Næss, Olav Dahl, Harald Nyland, [[Olav Mella]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2010 || [http://www.ncbi.nlm.nih.gov/pubmed/20520837 Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26] || Fletcher MA, Zeng XR, Maher K || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2008 || [http://www.ncbi.nlm.nih.gov/pubmed/18775774 Neuroendocrine and immune network remodeling in chronic fatigue syndrome: an exploratory analysis] || Fuite J, [[Susan Vernon]], [[Gordon Broderick]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2008 || [http://www.ncbi.nlm.nih.gov/pubmed/18937577 Cytokine Polymorphisms Have a Synergistic Effect on Severity of the Acute Sickness Response to Infection] || Vollmer‐Conna U, Piraino B, Cameron B || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2007 || [http://www.ncbi.nlm.nih.gov/pubmed/17712757 Postinfective fatigue syndrome is not associated with altered cytokine production] || Vollmer-Conna U, Cameron B, Pavlovic D || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2006 || [http://www.ncbi.nlm.nih.gov/pubmed/16762155 A first study of cytokine genomic polymorphisms in CFS: positive association of TNF‐857 and IFNgamma 874 rare alleles] || Carlo‐Stella N, Badulli C, De S || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2005 || [http://www.ncbi.nlm.nih.gov/pubmed/16049290 Association of chronic fatigue syndrome with human leucocyte antigen class II alleles] || Smith J, Fritz EL, [[Jonathan Kerr]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: orange; font-weight: bold;&amp;quot; | Metabolic || 2014 || [http://www.ncbi.nlm.nih.gov/pubmed/24755065 Inability of myalgic encephalomyelitis/chronic fatigue syndrome patients to reproduce VO2peak indicates functional impairment] || [[Betsy Keller]], [[John Pryor]], [[Ludovic Giloteaux]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: orange; font-weight: bold;&amp;quot; | Metabolic || 2012 || [http://www.ncbi.nlm.nih.gov/pubmed/22210239 Differences in metabolite-detecting, adrenergic, and immune gene expression after moderate exercise in patients with chronic fatigue syndrome, patients with multiple sclerosis, and healthy controls] || AT White, [[Alan Light]], RW Hughen, TA Vanhaitsma, [[Kathleen Light]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: orange; font-weight: bold;&amp;quot; | Metabolic || 2009 || [http://www.ncbi.nlm.nih.gov/pubmed/19647494 Moderate exercise increases expression for sensory, adrenergic, and immune genes in chronic fatigue syndrome patients but not in normal subjects] || [[Alan Light]], AT White, RW Hughen, [[Kathleen Light]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: gray; font-weight: bold;&amp;quot; | Neurological || 2015 || [https://sciforschenonline.org/journals/clinical-research/CLROA-2-110.php Phase relationships are only measurable by the qEEG, giving us a unique window into the ME disease process] || ML Zinn, MA Zinn. L Jason || See also [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108033/ [Phase Reset of the Default Mode Network.] || ||&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: gray; font-weight: bold;&amp;quot; | Neurological || 2015 || [http://www.ncbi.nlm.nih.gov/pubmed/26411464 There is poor agreement among researchers and clinicians about case definitions. Key domains are discussed. ] || [[Leonard Jason]], ML Zinn, MA Zinn || See also [http://www.tandfonline.com/doi/abs/10.1080/21641846.2015.1041336 Lack of Agreement in Case Definitions hampers research.] || ||&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: gray; font-weight: bold;&amp;quot; | Neurological || 2015 || [http://www.ncbi.nlm.nih.gov/pubmed/?term=25353054 Right arcuate fasciculus abnormality in chronic fatigue syndrome] || [[Michael Zeineh]], Kang J, Atlas SW, Raman MM, Reiss AL, Norris JL, Valencia I, [[Jose Montoya]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: gray; font-weight: bold;&amp;quot; | Neurological || 2007 || [http://www.ncbi.nlm.nih.gov/pubmed/17617647 Symptoms of autonomic dysfunction in chronic fatigue syndrome] || [[Julia Newton]], O Okonkwo, K Sutcliffe, Seth A, Shin J, Jones DE || || || &lt;br /&gt;
|- &lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2015 || [http://www.ncbi.nlm.nih.gov/m/pubmed/26399744/ Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome] || [[Øystein Fluge]], [[Olav Mella]], Loebel M, Grabowski P, Heidecke H, Bauer S, Hanitsch LG, Wittke K, Meisel C, Reinke P, Volk HD, [[Carmen Scheibenbogen]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2015 || [http://www.ncbi.nlm.nih.gov/m/pubmed/26132314/ B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment] || [[Øystein Fluge]], [[Olav Mella]], Risa K, Lunde S, Alme K, Rekeland IG, Sapkota D, Kristoffersen EK, Sørland K, Bruland O, Dahl O || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2013 || [http://www.ncbi.nlm.nih.gov/m/pubmed/23480187/ Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls] || [[Amolak Bansal]], AS Bradley, B Ford || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2013 || [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891387/ Fibromyalgia Symptoms Are Reduced by Low-Dose Naltrexone: A Pilot Study] || [[Jarred Younger]], Sean Mackey || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2012 || [http://www.cdd.com.au/pdf/publications/All%20Publications/2013%20-%20The%20GI%20microbiome%20and%20its%20role%20in%20CFS%20-%20ACNEM%20paper.pdf/ The GI Microbiome and its Role in Chronic Fatigue Syndrome: A Summary of Bacteriotherapy] || Thomas J. Borody, Anna Nowak, Sarah Finalayson || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2011 || [http://www.ncbi.nlm.nih.gov/m/pubmed/22039471/ Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study] || [[Øystein Fluge]], [[Olav Mella]], Bruland O, Risa K, Storstein A, Kristoffersen EK, Sapkota D, Næss H, Dahl O, Nyland H || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2010 || [http://www.ncbi.nlm.nih.gov/pubmed/23359310 Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels] || [[Jarred Younger]], Noor N, McCue R, Mackey S || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2009 || [http://www.ncbi.nlm.nih.gov/m/pubmed/19566965/ Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series] || [[Øystein Fluge]], [[Olav Mella]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2008 || [https://www.researchgate.net/profile/Michael_Maes2/publication/23709068_Normalization_of_leaky_gut_in_chronic_fatigue_syndrome_CFS_is_accompanied_by_a_clinical_improvement_Effects_of_age_duration_of_illness_and_the_translocation_of_LPS_from_gram-negative_bacteria/links/55c0913f08ae092e9666c31b.pdf/ Normalization of leaky gut in Chronic Fatigue Syndrome (CFS) is accompanied by a clinical improvement] || Michael Maes, Jean-Claude Leunis || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightgreen; font-weight: bold;&amp;quot; | Psychological || 2011 || The [[PACE trial]] || [[Peter White]], KA Goldsmith, AL Johnson, L Potts, R Walwyn, JC DeCesare, HL Baber, M Burgess, LV Clark, DL Cox, [[Jessica Bavinton]], BJ Angus, [[Gabrielle Murphy]], M Murphy, H O&#039;Dowd, D Wilks, P McCrone, [[Trudie Chalder]], [[Michael Sharpe]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightgreen; font-weight: bold;&amp;quot; | Psychological || 2005 || [http://simonwessely.com/Downloads/Publications/CFS/176.pdf The Placebo Response in the Treatment of Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis] || Hyong Jin Cho, Matthew Hotopf, Simon Wessely || Found that the placebo response was actually lower in CFS patients || || &lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightgreen; font-weight: bold;&amp;quot; | Psychological || 2014 || [http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD003200.pub4/abstract Exercise therapy for chronic fatigue syndrome] || Cochrane: Lillebeth Larun, Kjetil G. Brurberg, Jan Odgaard-Jensen, Jonathan R Price ||  || || &lt;br /&gt;
&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Notable_studies&amp;diff=8411</id>
		<title>Notable studies</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Notable_studies&amp;diff=8411"/>
		<updated>2016-04-10T02:33:44Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:added article&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;This page lists published ME/CFS studies that are notable, for particularly interesting findings, for controversial findings, or for their quality or their size.&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wikitable sortable&amp;quot;&lt;br /&gt;
! General category&lt;br /&gt;
! Year of publication&lt;br /&gt;
! Study title&lt;br /&gt;
! Author(s)&lt;br /&gt;
! Notes&lt;br /&gt;
! Cohort size&lt;br /&gt;
! Blinded (double, single, not)&lt;br /&gt;
&amp;lt;!--&lt;br /&gt;
! Peer-reviewed&lt;br /&gt;
! Randomized&lt;br /&gt;
! Placebo-controlled&lt;br /&gt;
! Subjects&lt;br /&gt;
! Study summary&lt;br /&gt;
--&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2015 || [[Institute of Medicine report]] || [[Ellen Wright Clayton]] (Chair), [[Margarita Alegría]], [[Lucinda Bateman]], [[Lily Chu]], [[Charles S. Cleeland]], [[Ronald Davis]], [[Betty Diamond]], [[Theodore Ganiats]], [[Betsy Keller]], [[Nancy Klimas]], [[A. Martin Lerner]], [[Cynthia Mulrow]], [[Benjamin Natelson]], [[Peter Rowe]], [[Michael Shelanski]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2015 || [[Pathways to prevention report]] || Green CR, Cowan P, Elk R, O&#039;Neil KM, Rasmussen AL || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2014 || [http://www.ncbi.nlm.nih.gov/pubmed/25274261 Two age peaks in the incidence of chronic fatigue syndrome/myalgic encephalomyelitis: a population-based registry study from Norway 2008–2012] || Bakken IJ, Tveito K, Gunnes N, Ghaderi S, Stoltenberg C, Trogstad L, Håberg SE, Magnus P || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2013 || [http://www.ncbi.nlm.nih.gov/pubmed/23576883 The prevalence of chronic fatigue syndrome/myalgic encephalomyelitis: a meta-analysis] || [[Samantha Johnston]], [[Ekua Weba Brenu]], [[Donald Staines]], [[Sonya Marshall-Gradisnik]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2011 || [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170215/ Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care] || [[Luis Nacul]], [[Eliana Lacerda]], [[Derek Pheby]], Peter Campion, Mariam Molokhia, Shagufta Fayyaz, Jose CDC Leite, Fiona Poland, Amanda Howe, Maria L Drachler || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2007 || [http://www.aihw.gov.au/publication-detail/?id=6442467990 The burden of disease and injury in Australia 2003] || [[Stephen Begg]], [[Theo Vos]], Barker B, Stevenson C, Stanley L, Lopez A || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2006 || [http://jid.oxfordjournals.org/content/193/5/664.full Prolonged Illness after infectious mononucleosis is associated with altered immunity but not with increased viral load] || Cameron, B., Bharadwaj, M., Burrows, J., Fazou, C., Wakefield, D., Hickie, I., Ffrench, R., Khanna, R. and A. Lloyd || See also [http://phoenixrising.me/research-2/the-dubbo-studies-a-model-of-post-infective-fatigue-emerging/model-of-post-infective-fatigue-forming-the-dubbo-studies Model of Post Infective Fatigue Forming: the Dubbo Studies] || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2006 || [http://www.ncbi.nlm.nih.gov/pubmed/16448567 Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr virus] || Vernon, S., Whistler, T., Cameron, B., Hickie, I., Reeves, W. and A. Lloyd || See also [http://phoenixrising.me/research-2/the-dubbo-studies-a-model-of-post-infective-fatigue-emerging/model-of-post-infective-fatigue-forming-the-dubbo-studies Model of Post Infective Fatigue Forming: the Dubbo Studies] || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2006 || [http://www.ncbi.nlm.nih.gov/pubmed/16950834 Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study] || [[I Hickie]], [[T Davenport]], [[D Wakefield]], Vollmer-Conna U, Cameron B, Vernon SD, Reeves WC, Lloyd A || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2005 || [http://www.ncbi.nlm.nih.gov/pubmed/15699087 A systematic review describing the prognosis of chronic fatigue syndrome] || [[Ruth Cairns]], [[Matthew Hotopf]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 1996 || [http://www.ncbi.nlm.nih.gov/pubmed/8873490 Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups] || [[Anthony Komaroff]], Fagioli LR, Doolittle TH, Gandek B, Gleit MA, Guerriero RT, Kornish RJ 2nd, Ware NC, Ware JE Jr, Bates DW || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2015 || [http://www.ncbi.nlm.nih.gov/m/pubmed/26615570/ Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome] || Landi A, Broadhurst D, [[Suzanne Vernon]], Tyrrell DL, Houghton M || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2015 || [http://www.ncbi.nlm.nih.gov/pubmed/?term=26079000 Distinct plasma immune signatures in ME/CFS are present early in the course of illness] || [[Mady Hornig]], [[Jose Montoya]], [[Nancy Klimas]], Levine S, Felsenstein D, [[Lucinda Bateman]], [[Daniel Peterson]], Gottschalk CG, Schultz AF, Che X, Eddy ML, [[Anthony Komaroff]], [[Ian Lipkin]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2014 || [http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0085387 Deficient EBV-specific B-and T-cell response in patients with chronic fatigue syndrome] || Madlen Loebel, Kristin Strohschein, Carolin Giannini, Uwe Koelsch, Sandra Bauer, Cornelia Doebis, Sybill Thomas, Nadine Unterwalder, Volker von Baehr, Petra Reinke, Michael Knops, Leif G. Hanitsch, Christian Meisel, Hans-Dieter Volk, [[Carmen Scheibenbogen]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2012 || [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464733/ Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis] || Ekua W Brenu, Mieke L van Driel, [[Donald Staines]], Kevin J Ashton, Sharni L Hardcastle, James Keane, Lotti Tajouri, [[Daniel Peterson]], Sandra B Ramos, [[Sonya Marshall-Gradisnik]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2011 || [http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0026358 Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study] || [[Øystein Fluge]] , Ove Bruland, Kristin Risa, Anette Storstein, Einar K. Kristoffersen, Dipak Sapkota, Halvor Næss, Olav Dahl, Harald Nyland, [[Olav Mella]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2010 || [http://www.ncbi.nlm.nih.gov/pubmed/20520837 Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26] || Fletcher MA, Zeng XR, Maher K || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2008 || [http://www.ncbi.nlm.nih.gov/pubmed/18775774 Neuroendocrine and immune network remodeling in chronic fatigue syndrome: an exploratory analysis] || Fuite J, [[Susan Vernon]], [[Gordon Broderick]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2008 || [http://www.ncbi.nlm.nih.gov/pubmed/18937577 Cytokine Polymorphisms Have a Synergistic Effect on Severity of the Acute Sickness Response to Infection] || Vollmer‐Conna U, Piraino B, Cameron B || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2007 || [http://www.ncbi.nlm.nih.gov/pubmed/17712757 Postinfective fatigue syndrome is not associated with altered cytokine production] || Vollmer-Conna U, Cameron B, Pavlovic D || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2006 || [http://www.ncbi.nlm.nih.gov/pubmed/16762155 A first study of cytokine genomic polymorphisms in CFS: positive association of TNF‐857 and IFNgamma 874 rare alleles] || Carlo‐Stella N, Badulli C, De S || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2005 || [http://www.ncbi.nlm.nih.gov/pubmed/16049290 Association of chronic fatigue syndrome with human leucocyte antigen class II alleles] || Smith J, Fritz EL, [[Jonathan Kerr]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: orange; font-weight: bold;&amp;quot; | Metabolic || 2014 || [http://www.ncbi.nlm.nih.gov/pubmed/24755065 Inability of myalgic encephalomyelitis/chronic fatigue syndrome patients to reproduce VO2peak indicates functional impairment] || [[Betsy Keller]], [[John Pryor]], [[Ludovic Giloteaux]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: orange; font-weight: bold;&amp;quot; | Metabolic || 2012 || [http://www.ncbi.nlm.nih.gov/pubmed/22210239 Differences in metabolite-detecting, adrenergic, and immune gene expression after moderate exercise in patients with chronic fatigue syndrome, patients with multiple sclerosis, and healthy controls] || AT White, [[Alan Light]], RW Hughen, TA Vanhaitsma, [[Kathleen Light]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: orange; font-weight: bold;&amp;quot; | Metabolic || 2009 || [http://www.ncbi.nlm.nih.gov/pubmed/19647494 Moderate exercise increases expression for sensory, adrenergic, and immune genes in chronic fatigue syndrome patients but not in normal subjects] || [[Alan Light]], AT White, RW Hughen, [[Kathleen Light]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: gray; font-weight: bold;&amp;quot; | Neurological || 2015 || [https://sciforschenonline.org/journals/clinical-research/CLROA-2-110.php Phase relationships are only measurable by the qEEG, giving us a unique window into the ME disease process] || ML Zinn, MA Zinn. L Jason || See also [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108033/ [Phase Reset of the Default Mode Network.] || ||&lt;br /&gt;
| style=&amp;quot;background-color: gray; font-weight: bold;&amp;quot; | Neurological || 2015 || [http://www.ncbi.nlm.nih.gov/pubmed/26411464 There is poor agreement among researchers and clinicians about case definitions. Key domains are discussed. ] || [[Leonard Jason]], ML Zinn, MA Zinn || See also [http://www.tandfonline.com/doi/abs/10.1080/21641846.2015.1041336 Lack of Agreement in Case Definitions hampers research.] || ||&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: gray; font-weight: bold;&amp;quot; | Neurological || 2015 || [http://www.ncbi.nlm.nih.gov/pubmed/?term=25353054 Right arcuate fasciculus abnormality in chronic fatigue syndrome] || [[Michael Zeineh]], Kang J, Atlas SW, Raman MM, Reiss AL, Norris JL, Valencia I, [[Jose Montoya]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: gray; font-weight: bold;&amp;quot; | Neurological || 2007 || [http://www.ncbi.nlm.nih.gov/pubmed/17617647 Symptoms of autonomic dysfunction in chronic fatigue syndrome] || [[Julia Newton]], O Okonkwo, K Sutcliffe, Seth A, Shin J, Jones DE || || || &lt;br /&gt;
|- &lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2015 || [http://www.ncbi.nlm.nih.gov/m/pubmed/26399744/ Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome] || [[Øystein Fluge]], [[Olav Mella]], Loebel M, Grabowski P, Heidecke H, Bauer S, Hanitsch LG, Wittke K, Meisel C, Reinke P, Volk HD, [[Carmen Scheibenbogen]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2015 || [http://www.ncbi.nlm.nih.gov/m/pubmed/26132314/ B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment] || [[Øystein Fluge]], [[Olav Mella]], Risa K, Lunde S, Alme K, Rekeland IG, Sapkota D, Kristoffersen EK, Sørland K, Bruland O, Dahl O || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2013 || [http://www.ncbi.nlm.nih.gov/m/pubmed/23480187/ Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls] || [[Amolak Bansal]], AS Bradley, B Ford || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2013 || [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891387/ Fibromyalgia Symptoms Are Reduced by Low-Dose Naltrexone: A Pilot Study] || [[Jarred Younger]], Sean Mackey || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2012 || [http://www.cdd.com.au/pdf/publications/All%20Publications/2013%20-%20The%20GI%20microbiome%20and%20its%20role%20in%20CFS%20-%20ACNEM%20paper.pdf/ The GI Microbiome and its Role in Chronic Fatigue Syndrome: A Summary of Bacteriotherapy] || Thomas J. Borody, Anna Nowak, Sarah Finalayson || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2011 || [http://www.ncbi.nlm.nih.gov/m/pubmed/22039471/ Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study] || [[Øystein Fluge]], [[Olav Mella]], Bruland O, Risa K, Storstein A, Kristoffersen EK, Sapkota D, Næss H, Dahl O, Nyland H || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2010 || [http://www.ncbi.nlm.nih.gov/pubmed/23359310 Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels] || [[Jarred Younger]], Noor N, McCue R, Mackey S || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2009 || [http://www.ncbi.nlm.nih.gov/m/pubmed/19566965/ Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series] || [[Øystein Fluge]], [[Olav Mella]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2008 || [https://www.researchgate.net/profile/Michael_Maes2/publication/23709068_Normalization_of_leaky_gut_in_chronic_fatigue_syndrome_CFS_is_accompanied_by_a_clinical_improvement_Effects_of_age_duration_of_illness_and_the_translocation_of_LPS_from_gram-negative_bacteria/links/55c0913f08ae092e9666c31b.pdf/ Normalization of leaky gut in Chronic Fatigue Syndrome (CFS) is accompanied by a clinical improvement] || Michael Maes, Jean-Claude Leunis || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightgreen; font-weight: bold;&amp;quot; | Psychological || 2011 || The [[PACE trial]] || [[Peter White]], KA Goldsmith, AL Johnson, L Potts, R Walwyn, JC DeCesare, HL Baber, M Burgess, LV Clark, DL Cox, [[Jessica Bavinton]], BJ Angus, [[Gabrielle Murphy]], M Murphy, H O&#039;Dowd, D Wilks, P McCrone, [[Trudie Chalder]], [[Michael Sharpe]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightgreen; font-weight: bold;&amp;quot; | Psychological || 2005 || [http://simonwessely.com/Downloads/Publications/CFS/176.pdf The Placebo Response in the Treatment of Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis] || Hyong Jin Cho, Matthew Hotopf, Simon Wessely || Found that the placebo response was actually lower in CFS patients || || &lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightgreen; font-weight: bold;&amp;quot; | Psychological || 2014 || [http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD003200.pub4/abstract Exercise therapy for chronic fatigue syndrome] || Cochrane: Lillebeth Larun, Kjetil G. Brurberg, Jan Odgaard-Jensen, Jonathan R Price ||  || || &lt;br /&gt;
&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Notable_studies&amp;diff=8410</id>
		<title>Notable studies</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Notable_studies&amp;diff=8410"/>
		<updated>2016-04-10T02:15:28Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:added article&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;This page lists published ME/CFS studies that are notable, for particularly interesting findings, for controversial findings, or for their quality or their size.&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wikitable sortable&amp;quot;&lt;br /&gt;
! General category&lt;br /&gt;
! Year of publication&lt;br /&gt;
! Study title&lt;br /&gt;
! Author(s)&lt;br /&gt;
! Notes&lt;br /&gt;
! Cohort size&lt;br /&gt;
! Blinded (double, single, not)&lt;br /&gt;
&amp;lt;!--&lt;br /&gt;
! Peer-reviewed&lt;br /&gt;
! Randomized&lt;br /&gt;
! Placebo-controlled&lt;br /&gt;
! Subjects&lt;br /&gt;
! Study summary&lt;br /&gt;
--&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2015 || [[Institute of Medicine report]] || [[Ellen Wright Clayton]] (Chair), [[Margarita Alegría]], [[Lucinda Bateman]], [[Lily Chu]], [[Charles S. Cleeland]], [[Ronald Davis]], [[Betty Diamond]], [[Theodore Ganiats]], [[Betsy Keller]], [[Nancy Klimas]], [[A. Martin Lerner]], [[Cynthia Mulrow]], [[Benjamin Natelson]], [[Peter Rowe]], [[Michael Shelanski]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2015 || [[Pathways to prevention report]] || Green CR, Cowan P, Elk R, O&#039;Neil KM, Rasmussen AL || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2014 || [http://www.ncbi.nlm.nih.gov/pubmed/25274261 Two age peaks in the incidence of chronic fatigue syndrome/myalgic encephalomyelitis: a population-based registry study from Norway 2008–2012] || Bakken IJ, Tveito K, Gunnes N, Ghaderi S, Stoltenberg C, Trogstad L, Håberg SE, Magnus P || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2013 || [http://www.ncbi.nlm.nih.gov/pubmed/23576883 The prevalence of chronic fatigue syndrome/myalgic encephalomyelitis: a meta-analysis] || [[Samantha Johnston]], [[Ekua Weba Brenu]], [[Donald Staines]], [[Sonya Marshall-Gradisnik]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2011 || [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170215/ Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care] || [[Luis Nacul]], [[Eliana Lacerda]], [[Derek Pheby]], Peter Campion, Mariam Molokhia, Shagufta Fayyaz, Jose CDC Leite, Fiona Poland, Amanda Howe, Maria L Drachler || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2007 || [http://www.aihw.gov.au/publication-detail/?id=6442467990 The burden of disease and injury in Australia 2003] || [[Stephen Begg]], [[Theo Vos]], Barker B, Stevenson C, Stanley L, Lopez A || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2006 || [http://jid.oxfordjournals.org/content/193/5/664.full Prolonged Illness after infectious mononucleosis is associated with altered immunity but not with increased viral load] || Cameron, B., Bharadwaj, M., Burrows, J., Fazou, C., Wakefield, D., Hickie, I., Ffrench, R., Khanna, R. and A. Lloyd || See also [http://phoenixrising.me/research-2/the-dubbo-studies-a-model-of-post-infective-fatigue-emerging/model-of-post-infective-fatigue-forming-the-dubbo-studies Model of Post Infective Fatigue Forming: the Dubbo Studies] || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2006 || [http://www.ncbi.nlm.nih.gov/pubmed/16448567 Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr virus] || Vernon, S., Whistler, T., Cameron, B., Hickie, I., Reeves, W. and A. Lloyd || See also [http://phoenixrising.me/research-2/the-dubbo-studies-a-model-of-post-infective-fatigue-emerging/model-of-post-infective-fatigue-forming-the-dubbo-studies Model of Post Infective Fatigue Forming: the Dubbo Studies] || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2006 || [http://www.ncbi.nlm.nih.gov/pubmed/16950834 Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study] || [[I Hickie]], [[T Davenport]], [[D Wakefield]], Vollmer-Conna U, Cameron B, Vernon SD, Reeves WC, Lloyd A || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2005 || [http://www.ncbi.nlm.nih.gov/pubmed/15699087 A systematic review describing the prognosis of chronic fatigue syndrome] || [[Ruth Cairns]], [[Matthew Hotopf]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 1996 || [http://www.ncbi.nlm.nih.gov/pubmed/8873490 Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups] || [[Anthony Komaroff]], Fagioli LR, Doolittle TH, Gandek B, Gleit MA, Guerriero RT, Kornish RJ 2nd, Ware NC, Ware JE Jr, Bates DW || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2015 || [http://www.ncbi.nlm.nih.gov/m/pubmed/26615570/ Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome] || Landi A, Broadhurst D, [[Suzanne Vernon]], Tyrrell DL, Houghton M || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2015 || [http://www.ncbi.nlm.nih.gov/pubmed/?term=26079000 Distinct plasma immune signatures in ME/CFS are present early in the course of illness] || [[Mady Hornig]], [[Jose Montoya]], [[Nancy Klimas]], Levine S, Felsenstein D, [[Lucinda Bateman]], [[Daniel Peterson]], Gottschalk CG, Schultz AF, Che X, Eddy ML, [[Anthony Komaroff]], [[Ian Lipkin]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2014 || [http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0085387 Deficient EBV-specific B-and T-cell response in patients with chronic fatigue syndrome] || Madlen Loebel, Kristin Strohschein, Carolin Giannini, Uwe Koelsch, Sandra Bauer, Cornelia Doebis, Sybill Thomas, Nadine Unterwalder, Volker von Baehr, Petra Reinke, Michael Knops, Leif G. Hanitsch, Christian Meisel, Hans-Dieter Volk, [[Carmen Scheibenbogen]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2012 || [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464733/ Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis] || Ekua W Brenu, Mieke L van Driel, [[Donald Staines]], Kevin J Ashton, Sharni L Hardcastle, James Keane, Lotti Tajouri, [[Daniel Peterson]], Sandra B Ramos, [[Sonya Marshall-Gradisnik]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2011 || [http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0026358 Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study] || [[Øystein Fluge]] , Ove Bruland, Kristin Risa, Anette Storstein, Einar K. Kristoffersen, Dipak Sapkota, Halvor Næss, Olav Dahl, Harald Nyland, [[Olav Mella]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2010 || [http://www.ncbi.nlm.nih.gov/pubmed/20520837 Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26] || Fletcher MA, Zeng XR, Maher K || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2008 || [http://www.ncbi.nlm.nih.gov/pubmed/18775774 Neuroendocrine and immune network remodeling in chronic fatigue syndrome: an exploratory analysis] || Fuite J, [[Susan Vernon]], [[Gordon Broderick]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2008 || [http://www.ncbi.nlm.nih.gov/pubmed/18937577 Cytokine Polymorphisms Have a Synergistic Effect on Severity of the Acute Sickness Response to Infection] || Vollmer‐Conna U, Piraino B, Cameron B || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2007 || [http://www.ncbi.nlm.nih.gov/pubmed/17712757 Postinfective fatigue syndrome is not associated with altered cytokine production] || Vollmer-Conna U, Cameron B, Pavlovic D || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2006 || [http://www.ncbi.nlm.nih.gov/pubmed/16762155 A first study of cytokine genomic polymorphisms in CFS: positive association of TNF‐857 and IFNgamma 874 rare alleles] || Carlo‐Stella N, Badulli C, De S || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2005 || [http://www.ncbi.nlm.nih.gov/pubmed/16049290 Association of chronic fatigue syndrome with human leucocyte antigen class II alleles] || Smith J, Fritz EL, [[Jonathan Kerr]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: orange; font-weight: bold;&amp;quot; | Metabolic || 2014 || [http://www.ncbi.nlm.nih.gov/pubmed/24755065 Inability of myalgic encephalomyelitis/chronic fatigue syndrome patients to reproduce VO2peak indicates functional impairment] || [[Betsy Keller]], [[John Pryor]], [[Ludovic Giloteaux]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: orange; font-weight: bold;&amp;quot; | Metabolic || 2012 || [http://www.ncbi.nlm.nih.gov/pubmed/22210239 Differences in metabolite-detecting, adrenergic, and immune gene expression after moderate exercise in patients with chronic fatigue syndrome, patients with multiple sclerosis, and healthy controls] || AT White, [[Alan Light]], RW Hughen, TA Vanhaitsma, [[Kathleen Light]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: orange; font-weight: bold;&amp;quot; | Metabolic || 2009 || [http://www.ncbi.nlm.nih.gov/pubmed/19647494 Moderate exercise increases expression for sensory, adrenergic, and immune genes in chronic fatigue syndrome patients but not in normal subjects] || [[Alan Light]], AT White, RW Hughen, [[Kathleen Light]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: gray; font-weight: bold;&amp;quot; | Neurological || 2015 || [http://www.ncbi.nlm.nih.gov/pubmed/26411464 There is poor agreement among researchers and clinicians about case definitions. ] || [[Leonard Jason]], ML Zinn, MA Zinn || See also [http://www.tandfonline.com/doi/abs/10.1080/21641846.2015.1041336 Lack of Agreement in Case Definitions hampers research.] || ||&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: gray; font-weight: bold;&amp;quot; | Neurological || 2015 || [http://www.ncbi.nlm.nih.gov/pubmed/?term=25353054 Right arcuate fasciculus abnormality in chronic fatigue syndrome] || [[Michael Zeineh]], Kang J, Atlas SW, Raman MM, Reiss AL, Norris JL, Valencia I, [[Jose Montoya]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: gray; font-weight: bold;&amp;quot; | Neurological || 2007 || [http://www.ncbi.nlm.nih.gov/pubmed/17617647 Symptoms of autonomic dysfunction in chronic fatigue syndrome] || [[Julia Newton]], O Okonkwo, K Sutcliffe, Seth A, Shin J, Jones DE || || || &lt;br /&gt;
|- &lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2015 || [http://www.ncbi.nlm.nih.gov/m/pubmed/26399744/ Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome] || [[Øystein Fluge]], [[Olav Mella]], Loebel M, Grabowski P, Heidecke H, Bauer S, Hanitsch LG, Wittke K, Meisel C, Reinke P, Volk HD, [[Carmen Scheibenbogen]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2015 || [http://www.ncbi.nlm.nih.gov/m/pubmed/26132314/ B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment] || [[Øystein Fluge]], [[Olav Mella]], Risa K, Lunde S, Alme K, Rekeland IG, Sapkota D, Kristoffersen EK, Sørland K, Bruland O, Dahl O || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2013 || [http://www.ncbi.nlm.nih.gov/m/pubmed/23480187/ Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls] || [[Amolak Bansal]], AS Bradley, B Ford || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2013 || [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891387/ Fibromyalgia Symptoms Are Reduced by Low-Dose Naltrexone: A Pilot Study] || [[Jarred Younger]], Sean Mackey || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2012 || [http://www.cdd.com.au/pdf/publications/All%20Publications/2013%20-%20The%20GI%20microbiome%20and%20its%20role%20in%20CFS%20-%20ACNEM%20paper.pdf/ The GI Microbiome and its Role in Chronic Fatigue Syndrome: A Summary of Bacteriotherapy] || Thomas J. Borody, Anna Nowak, Sarah Finalayson || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2011 || [http://www.ncbi.nlm.nih.gov/m/pubmed/22039471/ Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study] || [[Øystein Fluge]], [[Olav Mella]], Bruland O, Risa K, Storstein A, Kristoffersen EK, Sapkota D, Næss H, Dahl O, Nyland H || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2010 || [http://www.ncbi.nlm.nih.gov/pubmed/23359310 Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels] || [[Jarred Younger]], Noor N, McCue R, Mackey S || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2009 || [http://www.ncbi.nlm.nih.gov/m/pubmed/19566965/ Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series] || [[Øystein Fluge]], [[Olav Mella]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2008 || [https://www.researchgate.net/profile/Michael_Maes2/publication/23709068_Normalization_of_leaky_gut_in_chronic_fatigue_syndrome_CFS_is_accompanied_by_a_clinical_improvement_Effects_of_age_duration_of_illness_and_the_translocation_of_LPS_from_gram-negative_bacteria/links/55c0913f08ae092e9666c31b.pdf/ Normalization of leaky gut in Chronic Fatigue Syndrome (CFS) is accompanied by a clinical improvement] || Michael Maes, Jean-Claude Leunis || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightgreen; font-weight: bold;&amp;quot; | Psychological || 2011 || The [[PACE trial]] || [[Peter White]], KA Goldsmith, AL Johnson, L Potts, R Walwyn, JC DeCesare, HL Baber, M Burgess, LV Clark, DL Cox, [[Jessica Bavinton]], BJ Angus, [[Gabrielle Murphy]], M Murphy, H O&#039;Dowd, D Wilks, P McCrone, [[Trudie Chalder]], [[Michael Sharpe]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightgreen; font-weight: bold;&amp;quot; | Psychological || 2005 || [http://simonwessely.com/Downloads/Publications/CFS/176.pdf The Placebo Response in the Treatment of Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis] || Hyong Jin Cho, Matthew Hotopf, Simon Wessely || Found that the placebo response was actually lower in CFS patients || || &lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightgreen; font-weight: bold;&amp;quot; | Psychological || 2014 || [http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD003200.pub4/abstract Exercise therapy for chronic fatigue syndrome] || Cochrane: Lillebeth Larun, Kjetil G. Brurberg, Jan Odgaard-Jensen, Jonathan R Price ||  || || &lt;br /&gt;
&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Notable_studies&amp;diff=8409</id>
		<title>Notable studies</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Notable_studies&amp;diff=8409"/>
		<updated>2016-04-10T02:11:00Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:added article&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;This page lists published ME/CFS studies that are notable, for particularly interesting findings, for controversial findings, or for their quality or their size.&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wikitable sortable&amp;quot;&lt;br /&gt;
! General category&lt;br /&gt;
! Year of publication&lt;br /&gt;
! Study title&lt;br /&gt;
! Author(s)&lt;br /&gt;
! Notes&lt;br /&gt;
! Cohort size&lt;br /&gt;
! Blinded (double, single, not)&lt;br /&gt;
&amp;lt;!--&lt;br /&gt;
! Peer-reviewed&lt;br /&gt;
! Randomized&lt;br /&gt;
! Placebo-controlled&lt;br /&gt;
! Subjects&lt;br /&gt;
! Study summary&lt;br /&gt;
--&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2015 || [[Institute of Medicine report]] || [[Ellen Wright Clayton]] (Chair), [[Margarita Alegría]], [[Lucinda Bateman]], [[Lily Chu]], [[Charles S. Cleeland]], [[Ronald Davis]], [[Betty Diamond]], [[Theodore Ganiats]], [[Betsy Keller]], [[Nancy Klimas]], [[A. Martin Lerner]], [[Cynthia Mulrow]], [[Benjamin Natelson]], [[Peter Rowe]], [[Michael Shelanski]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2015 || [[Pathways to prevention report]] || Green CR, Cowan P, Elk R, O&#039;Neil KM, Rasmussen AL || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2014 || [http://www.ncbi.nlm.nih.gov/pubmed/25274261 Two age peaks in the incidence of chronic fatigue syndrome/myalgic encephalomyelitis: a population-based registry study from Norway 2008–2012] || Bakken IJ, Tveito K, Gunnes N, Ghaderi S, Stoltenberg C, Trogstad L, Håberg SE, Magnus P || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2013 || [http://www.ncbi.nlm.nih.gov/pubmed/23576883 The prevalence of chronic fatigue syndrome/myalgic encephalomyelitis: a meta-analysis] || [[Samantha Johnston]], [[Ekua Weba Brenu]], [[Donald Staines]], [[Sonya Marshall-Gradisnik]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2011 || [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170215/ Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care] || [[Luis Nacul]], [[Eliana Lacerda]], [[Derek Pheby]], Peter Campion, Mariam Molokhia, Shagufta Fayyaz, Jose CDC Leite, Fiona Poland, Amanda Howe, Maria L Drachler || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2007 || [http://www.aihw.gov.au/publication-detail/?id=6442467990 The burden of disease and injury in Australia 2003] || [[Stephen Begg]], [[Theo Vos]], Barker B, Stevenson C, Stanley L, Lopez A || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2006 || [http://jid.oxfordjournals.org/content/193/5/664.full Prolonged Illness after infectious mononucleosis is associated with altered immunity but not with increased viral load] || Cameron, B., Bharadwaj, M., Burrows, J., Fazou, C., Wakefield, D., Hickie, I., Ffrench, R., Khanna, R. and A. Lloyd || See also [http://phoenixrising.me/research-2/the-dubbo-studies-a-model-of-post-infective-fatigue-emerging/model-of-post-infective-fatigue-forming-the-dubbo-studies Model of Post Infective Fatigue Forming: the Dubbo Studies] || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2006 || [http://www.ncbi.nlm.nih.gov/pubmed/16448567 Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr virus] || Vernon, S., Whistler, T., Cameron, B., Hickie, I., Reeves, W. and A. Lloyd || See also [http://phoenixrising.me/research-2/the-dubbo-studies-a-model-of-post-infective-fatigue-emerging/model-of-post-infective-fatigue-forming-the-dubbo-studies Model of Post Infective Fatigue Forming: the Dubbo Studies] || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2006 || [http://www.ncbi.nlm.nih.gov/pubmed/16950834 Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study] || [[I Hickie]], [[T Davenport]], [[D Wakefield]], Vollmer-Conna U, Cameron B, Vernon SD, Reeves WC, Lloyd A || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2005 || [http://www.ncbi.nlm.nih.gov/pubmed/15699087 A systematic review describing the prognosis of chronic fatigue syndrome] || [[Ruth Cairns]], [[Matthew Hotopf]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 1996 || [http://www.ncbi.nlm.nih.gov/pubmed/8873490 Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups] || [[Anthony Komaroff]], Fagioli LR, Doolittle TH, Gandek B, Gleit MA, Guerriero RT, Kornish RJ 2nd, Ware NC, Ware JE Jr, Bates DW || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2015 || [http://www.ncbi.nlm.nih.gov/m/pubmed/26615570/ Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome] || Landi A, Broadhurst D, [[Suzanne Vernon]], Tyrrell DL, Houghton M || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2015 || [http://www.ncbi.nlm.nih.gov/pubmed/?term=26079000 Distinct plasma immune signatures in ME/CFS are present early in the course of illness] || [[Mady Hornig]], [[Jose Montoya]], [[Nancy Klimas]], Levine S, Felsenstein D, [[Lucinda Bateman]], [[Daniel Peterson]], Gottschalk CG, Schultz AF, Che X, Eddy ML, [[Anthony Komaroff]], [[Ian Lipkin]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2014 || [http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0085387 Deficient EBV-specific B-and T-cell response in patients with chronic fatigue syndrome] || Madlen Loebel, Kristin Strohschein, Carolin Giannini, Uwe Koelsch, Sandra Bauer, Cornelia Doebis, Sybill Thomas, Nadine Unterwalder, Volker von Baehr, Petra Reinke, Michael Knops, Leif G. Hanitsch, Christian Meisel, Hans-Dieter Volk, [[Carmen Scheibenbogen]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2012 || [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464733/ Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis] || Ekua W Brenu, Mieke L van Driel, [[Donald Staines]], Kevin J Ashton, Sharni L Hardcastle, James Keane, Lotti Tajouri, [[Daniel Peterson]], Sandra B Ramos, [[Sonya Marshall-Gradisnik]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2011 || [http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0026358 Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study] || [[Øystein Fluge]] , Ove Bruland, Kristin Risa, Anette Storstein, Einar K. Kristoffersen, Dipak Sapkota, Halvor Næss, Olav Dahl, Harald Nyland, [[Olav Mella]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2010 || [http://www.ncbi.nlm.nih.gov/pubmed/20520837 Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26] || Fletcher MA, Zeng XR, Maher K || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2008 || [http://www.ncbi.nlm.nih.gov/pubmed/18775774 Neuroendocrine and immune network remodeling in chronic fatigue syndrome: an exploratory analysis] || Fuite J, [[Susan Vernon]], [[Gordon Broderick]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2008 || [http://www.ncbi.nlm.nih.gov/pubmed/18937577 Cytokine Polymorphisms Have a Synergistic Effect on Severity of the Acute Sickness Response to Infection] || Vollmer‐Conna U, Piraino B, Cameron B || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2007 || [http://www.ncbi.nlm.nih.gov/pubmed/17712757 Postinfective fatigue syndrome is not associated with altered cytokine production] || Vollmer-Conna U, Cameron B, Pavlovic D || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2006 || [http://www.ncbi.nlm.nih.gov/pubmed/16762155 A first study of cytokine genomic polymorphisms in CFS: positive association of TNF‐857 and IFNgamma 874 rare alleles] || Carlo‐Stella N, Badulli C, De S || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2005 || [http://www.ncbi.nlm.nih.gov/pubmed/16049290 Association of chronic fatigue syndrome with human leucocyte antigen class II alleles] || Smith J, Fritz EL, [[Jonathan Kerr]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: orange; font-weight: bold;&amp;quot; | Metabolic || 2014 || [http://www.ncbi.nlm.nih.gov/pubmed/24755065 Inability of myalgic encephalomyelitis/chronic fatigue syndrome patients to reproduce VO2peak indicates functional impairment] || [[Betsy Keller]], [[John Pryor]], [[Ludovic Giloteaux]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: orange; font-weight: bold;&amp;quot; | Metabolic || 2012 || [http://www.ncbi.nlm.nih.gov/pubmed/22210239 Differences in metabolite-detecting, adrenergic, and immune gene expression after moderate exercise in patients with chronic fatigue syndrome, patients with multiple sclerosis, and healthy controls] || AT White, [[Alan Light]], RW Hughen, TA Vanhaitsma, [[Kathleen Light]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: orange; font-weight: bold;&amp;quot; | Metabolic || 2009 || [http://www.ncbi.nlm.nih.gov/pubmed/19647494 Moderate exercise increases expression for sensory, adrenergic, and immune genes in chronic fatigue syndrome patients but not in normal subjects] || [[Alan Light]], AT White, RW Hughen, [[Kathleen Light]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: gray; font-weight: bold;&amp;quot; | Neurological || 2015 || [http://www.ncbi.nlm.nih.gov/pubmed/26411464 There is poor agreement among researchers and clinicians about case definitions. ] || [[Leonard Jason]], ML Zinn, MA Zinn. || See also http://www.tandfonline.com/doi/abs/10.1080/21641846.2015.1041336 Lack of Agreement in Case Definitions hampers research.] || ||&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: gray; font-weight: bold;&amp;quot; | Neurological || 2015 || [http://www.ncbi.nlm.nih.gov/pubmed/?term=25353054 Right arcuate fasciculus abnormality in chronic fatigue syndrome] || [[Michael Zeineh]], Kang J, Atlas SW, Raman MM, Reiss AL, Norris JL, Valencia I, [[Jose Montoya]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: gray; font-weight: bold;&amp;quot; | Neurological || 2007 || [http://www.ncbi.nlm.nih.gov/pubmed/17617647 Symptoms of autonomic dysfunction in chronic fatigue syndrome] || [[Julia Newton]], O Okonkwo, K Sutcliffe, Seth A, Shin J, Jones DE || || || &lt;br /&gt;
|- &lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2015 || [http://www.ncbi.nlm.nih.gov/m/pubmed/26399744/ Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome] || [[Øystein Fluge]], [[Olav Mella]], Loebel M, Grabowski P, Heidecke H, Bauer S, Hanitsch LG, Wittke K, Meisel C, Reinke P, Volk HD, [[Carmen Scheibenbogen]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2015 || [http://www.ncbi.nlm.nih.gov/m/pubmed/26132314/ B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment] || [[Øystein Fluge]], [[Olav Mella]], Risa K, Lunde S, Alme K, Rekeland IG, Sapkota D, Kristoffersen EK, Sørland K, Bruland O, Dahl O || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2013 || [http://www.ncbi.nlm.nih.gov/m/pubmed/23480187/ Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls] || [[Amolak Bansal]], AS Bradley, B Ford || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2013 || [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891387/ Fibromyalgia Symptoms Are Reduced by Low-Dose Naltrexone: A Pilot Study] || [[Jarred Younger]], Sean Mackey || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2012 || [http://www.cdd.com.au/pdf/publications/All%20Publications/2013%20-%20The%20GI%20microbiome%20and%20its%20role%20in%20CFS%20-%20ACNEM%20paper.pdf/ The GI Microbiome and its Role in Chronic Fatigue Syndrome: A Summary of Bacteriotherapy] || Thomas J. Borody, Anna Nowak, Sarah Finalayson || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2011 || [http://www.ncbi.nlm.nih.gov/m/pubmed/22039471/ Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study] || [[Øystein Fluge]], [[Olav Mella]], Bruland O, Risa K, Storstein A, Kristoffersen EK, Sapkota D, Næss H, Dahl O, Nyland H || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2010 || [http://www.ncbi.nlm.nih.gov/pubmed/23359310 Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels] || [[Jarred Younger]], Noor N, McCue R, Mackey S || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2009 || [http://www.ncbi.nlm.nih.gov/m/pubmed/19566965/ Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series] || [[Øystein Fluge]], [[Olav Mella]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2008 || [https://www.researchgate.net/profile/Michael_Maes2/publication/23709068_Normalization_of_leaky_gut_in_chronic_fatigue_syndrome_CFS_is_accompanied_by_a_clinical_improvement_Effects_of_age_duration_of_illness_and_the_translocation_of_LPS_from_gram-negative_bacteria/links/55c0913f08ae092e9666c31b.pdf/ Normalization of leaky gut in Chronic Fatigue Syndrome (CFS) is accompanied by a clinical improvement] || Michael Maes, Jean-Claude Leunis || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightgreen; font-weight: bold;&amp;quot; | Psychological || 2011 || The [[PACE trial]] || [[Peter White]], KA Goldsmith, AL Johnson, L Potts, R Walwyn, JC DeCesare, HL Baber, M Burgess, LV Clark, DL Cox, [[Jessica Bavinton]], BJ Angus, [[Gabrielle Murphy]], M Murphy, H O&#039;Dowd, D Wilks, P McCrone, [[Trudie Chalder]], [[Michael Sharpe]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightgreen; font-weight: bold;&amp;quot; | Psychological || 2005 || [http://simonwessely.com/Downloads/Publications/CFS/176.pdf The Placebo Response in the Treatment of Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis] || Hyong Jin Cho, Matthew Hotopf, Simon Wessely || Found that the placebo response was actually lower in CFS patients || || &lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightgreen; font-weight: bold;&amp;quot; | Psychological || 2014 || [http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD003200.pub4/abstract Exercise therapy for chronic fatigue syndrome] || Cochrane: Lillebeth Larun, Kjetil G. Brurberg, Jan Odgaard-Jensen, Jonathan R Price ||  || || &lt;br /&gt;
&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Notable_studies&amp;diff=8408</id>
		<title>Notable studies</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Notable_studies&amp;diff=8408"/>
		<updated>2016-04-10T01:51:10Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:added article&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;This page lists published ME/CFS studies that are notable, for particularly interesting findings, for controversial findings, or for their quality or their size.&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wikitable sortable&amp;quot;&lt;br /&gt;
! General category&lt;br /&gt;
! Year of publication&lt;br /&gt;
! Study title&lt;br /&gt;
! Author(s)&lt;br /&gt;
! Notes&lt;br /&gt;
! Cohort size&lt;br /&gt;
! Blinded (double, single, not)&lt;br /&gt;
&amp;lt;!--&lt;br /&gt;
! Peer-reviewed&lt;br /&gt;
! Randomized&lt;br /&gt;
! Placebo-controlled&lt;br /&gt;
! Subjects&lt;br /&gt;
! Study summary&lt;br /&gt;
--&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2015 || [[Institute of Medicine report]] || [[Ellen Wright Clayton]] (Chair), [[Margarita Alegría]], [[Lucinda Bateman]], [[Lily Chu]], [[Charles S. Cleeland]], [[Ronald Davis]], [[Betty Diamond]], [[Theodore Ganiats]], [[Betsy Keller]], [[Nancy Klimas]], [[A. Martin Lerner]], [[Cynthia Mulrow]], [[Benjamin Natelson]], [[Peter Rowe]], [[Michael Shelanski]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2015 || [[Pathways to prevention report]] || Green CR, Cowan P, Elk R, O&#039;Neil KM, Rasmussen AL || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2014 || [http://www.ncbi.nlm.nih.gov/pubmed/25274261 Two age peaks in the incidence of chronic fatigue syndrome/myalgic encephalomyelitis: a population-based registry study from Norway 2008–2012] || Bakken IJ, Tveito K, Gunnes N, Ghaderi S, Stoltenberg C, Trogstad L, Håberg SE, Magnus P || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2013 || [http://www.ncbi.nlm.nih.gov/pubmed/23576883 The prevalence of chronic fatigue syndrome/myalgic encephalomyelitis: a meta-analysis] || [[Samantha Johnston]], [[Ekua Weba Brenu]], [[Donald Staines]], [[Sonya Marshall-Gradisnik]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2011 || [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170215/ Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care] || [[Luis Nacul]], [[Eliana Lacerda]], [[Derek Pheby]], Peter Campion, Mariam Molokhia, Shagufta Fayyaz, Jose CDC Leite, Fiona Poland, Amanda Howe, Maria L Drachler || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2007 || [http://www.aihw.gov.au/publication-detail/?id=6442467990 The burden of disease and injury in Australia 2003] || [[Stephen Begg]], [[Theo Vos]], Barker B, Stevenson C, Stanley L, Lopez A || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2006 || [http://jid.oxfordjournals.org/content/193/5/664.full Prolonged Illness after infectious mononucleosis is associated with altered immunity but not with increased viral load] || Cameron, B., Bharadwaj, M., Burrows, J., Fazou, C., Wakefield, D., Hickie, I., Ffrench, R., Khanna, R. and A. Lloyd || See also [http://phoenixrising.me/research-2/the-dubbo-studies-a-model-of-post-infective-fatigue-emerging/model-of-post-infective-fatigue-forming-the-dubbo-studies Model of Post Infective Fatigue Forming: the Dubbo Studies] || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2006 || [http://www.ncbi.nlm.nih.gov/pubmed/16448567 Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr virus] || Vernon, S., Whistler, T., Cameron, B., Hickie, I., Reeves, W. and A. Lloyd || See also [http://phoenixrising.me/research-2/the-dubbo-studies-a-model-of-post-infective-fatigue-emerging/model-of-post-infective-fatigue-forming-the-dubbo-studies Model of Post Infective Fatigue Forming: the Dubbo Studies] || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2006 || [http://www.ncbi.nlm.nih.gov/pubmed/16950834 Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study] || [[I Hickie]], [[T Davenport]], [[D Wakefield]], Vollmer-Conna U, Cameron B, Vernon SD, Reeves WC, Lloyd A || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2005 || [http://www.ncbi.nlm.nih.gov/pubmed/15699087 A systematic review describing the prognosis of chronic fatigue syndrome] || [[Ruth Cairns]], [[Matthew Hotopf]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 1996 || [http://www.ncbi.nlm.nih.gov/pubmed/8873490 Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups] || [[Anthony Komaroff]], Fagioli LR, Doolittle TH, Gandek B, Gleit MA, Guerriero RT, Kornish RJ 2nd, Ware NC, Ware JE Jr, Bates DW || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2015 || [http://www.ncbi.nlm.nih.gov/m/pubmed/26615570/ Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome] || Landi A, Broadhurst D, [[Suzanne Vernon]], Tyrrell DL, Houghton M || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2015 || [http://www.ncbi.nlm.nih.gov/pubmed/?term=26079000 Distinct plasma immune signatures in ME/CFS are present early in the course of illness] || [[Mady Hornig]], [[Jose Montoya]], [[Nancy Klimas]], Levine S, Felsenstein D, [[Lucinda Bateman]], [[Daniel Peterson]], Gottschalk CG, Schultz AF, Che X, Eddy ML, [[Anthony Komaroff]], [[Ian Lipkin]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2014 || [http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0085387 Deficient EBV-specific B-and T-cell response in patients with chronic fatigue syndrome] || Madlen Loebel, Kristin Strohschein, Carolin Giannini, Uwe Koelsch, Sandra Bauer, Cornelia Doebis, Sybill Thomas, Nadine Unterwalder, Volker von Baehr, Petra Reinke, Michael Knops, Leif G. Hanitsch, Christian Meisel, Hans-Dieter Volk, [[Carmen Scheibenbogen]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2012 || [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464733/ Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis] || Ekua W Brenu, Mieke L van Driel, [[Donald Staines]], Kevin J Ashton, Sharni L Hardcastle, James Keane, Lotti Tajouri, [[Daniel Peterson]], Sandra B Ramos, [[Sonya Marshall-Gradisnik]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2011 || [http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0026358 Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study] || [[Øystein Fluge]] , Ove Bruland, Kristin Risa, Anette Storstein, Einar K. Kristoffersen, Dipak Sapkota, Halvor Næss, Olav Dahl, Harald Nyland, [[Olav Mella]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2010 || [http://www.ncbi.nlm.nih.gov/pubmed/20520837 Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26] || Fletcher MA, Zeng XR, Maher K || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2008 || [http://www.ncbi.nlm.nih.gov/pubmed/18775774 Neuroendocrine and immune network remodeling in chronic fatigue syndrome: an exploratory analysis] || Fuite J, [[Susan Vernon]], [[Gordon Broderick]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2008 || [http://www.ncbi.nlm.nih.gov/pubmed/18937577 Cytokine Polymorphisms Have a Synergistic Effect on Severity of the Acute Sickness Response to Infection] || Vollmer‐Conna U, Piraino B, Cameron B || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2007 || [http://www.ncbi.nlm.nih.gov/pubmed/17712757 Postinfective fatigue syndrome is not associated with altered cytokine production] || Vollmer-Conna U, Cameron B, Pavlovic D || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2006 || [http://www.ncbi.nlm.nih.gov/pubmed/16762155 A first study of cytokine genomic polymorphisms in CFS: positive association of TNF‐857 and IFNgamma 874 rare alleles] || Carlo‐Stella N, Badulli C, De S || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2005 || [http://www.ncbi.nlm.nih.gov/pubmed/16049290 Association of chronic fatigue syndrome with human leucocyte antigen class II alleles] || Smith J, Fritz EL, [[Jonathan Kerr]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: orange; font-weight: bold;&amp;quot; | Metabolic || 2014 || [http://www.ncbi.nlm.nih.gov/pubmed/24755065 Inability of myalgic encephalomyelitis/chronic fatigue syndrome patients to reproduce VO2peak indicates functional impairment] || [[Betsy Keller]], [[John Pryor]], [[Ludovic Giloteaux]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: orange; font-weight: bold;&amp;quot; | Metabolic || 2012 || [http://www.ncbi.nlm.nih.gov/pubmed/22210239 Differences in metabolite-detecting, adrenergic, and immune gene expression after moderate exercise in patients with chronic fatigue syndrome, patients with multiple sclerosis, and healthy controls] || AT White, [[Alan Light]], RW Hughen, TA Vanhaitsma, [[Kathleen Light]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: orange; font-weight: bold;&amp;quot; | Metabolic || 2009 || [http://www.ncbi.nlm.nih.gov/pubmed/19647494 Moderate exercise increases expression for sensory, adrenergic, and immune genes in chronic fatigue syndrome patients but not in normal subjects] || [[Alan Light]], AT White, RW Hughen, [[Kathleen Light]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: gray; font-weight: bold;&amp;quot; | Neurological || 2015 || [http://www.ncbi.nlm.nih.gov/pubmed/?term=25353054 Right arcuate fasciculus abnormality in chronic fatigue syndrome] || [[Michael Zeineh]], Kang J, Atlas SW, Raman MM, Reiss AL, Norris JL, Valencia I, [[Jose Montoya]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: gray; font-weight: bold;&amp;quot; | Neurological || 2007 || [http://www.ncbi.nlm.nih.gov/pubmed/17617647 Symptoms of autonomic dysfunction in chronic fatigue syndrome] || [[Julia Newton]], O Okonkwo, K Sutcliffe, Seth A, Shin J, Jones DE || || || &lt;br /&gt;
|- &lt;br /&gt;
| style=&amp;quot;background-color: gray; font-weight: bold;&amp;quot; | Neurological || 2015 || [http://www.ncbi.nlm.nih.gov/pubmed/26411464 There is poor agreement among researchers and clinicians about case definitions. ] || [[Leonard Jason]], ML Zinn, MA Zinn.&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2015 || [http://www.ncbi.nlm.nih.gov/m/pubmed/26399744/ Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome] || [[Øystein Fluge]], [[Olav Mella]], Loebel M, Grabowski P, Heidecke H, Bauer S, Hanitsch LG, Wittke K, Meisel C, Reinke P, Volk HD, [[Carmen Scheibenbogen]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2015 || [http://www.ncbi.nlm.nih.gov/m/pubmed/26132314/ B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment] || [[Øystein Fluge]], [[Olav Mella]], Risa K, Lunde S, Alme K, Rekeland IG, Sapkota D, Kristoffersen EK, Sørland K, Bruland O, Dahl O || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2013 || [http://www.ncbi.nlm.nih.gov/m/pubmed/23480187/ Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls] || [[Amolak Bansal]], AS Bradley, B Ford || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2013 || [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891387/ Fibromyalgia Symptoms Are Reduced by Low-Dose Naltrexone: A Pilot Study] || [[Jarred Younger]], Sean Mackey || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2012 || [http://www.cdd.com.au/pdf/publications/All%20Publications/2013%20-%20The%20GI%20microbiome%20and%20its%20role%20in%20CFS%20-%20ACNEM%20paper.pdf/ The GI Microbiome and its Role in Chronic Fatigue Syndrome: A Summary of Bacteriotherapy] || Thomas J. Borody, Anna Nowak, Sarah Finalayson || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2011 || [http://www.ncbi.nlm.nih.gov/m/pubmed/22039471/ Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study] || [[Øystein Fluge]], [[Olav Mella]], Bruland O, Risa K, Storstein A, Kristoffersen EK, Sapkota D, Næss H, Dahl O, Nyland H || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2010 || [http://www.ncbi.nlm.nih.gov/pubmed/23359310 Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels] || [[Jarred Younger]], Noor N, McCue R, Mackey S || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2009 || [http://www.ncbi.nlm.nih.gov/m/pubmed/19566965/ Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series] || [[Øystein Fluge]], [[Olav Mella]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2008 || [https://www.researchgate.net/profile/Michael_Maes2/publication/23709068_Normalization_of_leaky_gut_in_chronic_fatigue_syndrome_CFS_is_accompanied_by_a_clinical_improvement_Effects_of_age_duration_of_illness_and_the_translocation_of_LPS_from_gram-negative_bacteria/links/55c0913f08ae092e9666c31b.pdf/ Normalization of leaky gut in Chronic Fatigue Syndrome (CFS) is accompanied by a clinical improvement] || Michael Maes, Jean-Claude Leunis || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightgreen; font-weight: bold;&amp;quot; | Psychological || 2011 || The [[PACE trial]] || [[Peter White]], KA Goldsmith, AL Johnson, L Potts, R Walwyn, JC DeCesare, HL Baber, M Burgess, LV Clark, DL Cox, [[Jessica Bavinton]], BJ Angus, [[Gabrielle Murphy]], M Murphy, H O&#039;Dowd, D Wilks, P McCrone, [[Trudie Chalder]], [[Michael Sharpe]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightgreen; font-weight: bold;&amp;quot; | Psychological || 2005 || [http://simonwessely.com/Downloads/Publications/CFS/176.pdf The Placebo Response in the Treatment of Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis] || Hyong Jin Cho, Matthew Hotopf, Simon Wessely || Found that the placebo response was actually lower in CFS patients || || &lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightgreen; font-weight: bold;&amp;quot; | Psychological || 2014 || [http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD003200.pub4/abstract Exercise therapy for chronic fatigue syndrome] || Cochrane: Lillebeth Larun, Kjetil G. Brurberg, Jan Odgaard-Jensen, Jonathan R Price ||  || || &lt;br /&gt;
&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Notable_studies&amp;diff=8407</id>
		<title>Notable studies</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Notable_studies&amp;diff=8407"/>
		<updated>2016-04-10T01:46:00Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:added article&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;This page lists published ME/CFS studies that are notable, for particularly interesting findings, for controversial findings, or for their quality or their size.&lt;br /&gt;
&lt;br /&gt;
{| class=&amp;quot;wikitable sortable&amp;quot;&lt;br /&gt;
! General category&lt;br /&gt;
! Year of publication&lt;br /&gt;
! Study title&lt;br /&gt;
! Author(s)&lt;br /&gt;
! Notes&lt;br /&gt;
! Cohort size&lt;br /&gt;
! Blinded (double, single, not)&lt;br /&gt;
&amp;lt;!--&lt;br /&gt;
! Peer-reviewed&lt;br /&gt;
! Randomized&lt;br /&gt;
! Placebo-controlled&lt;br /&gt;
! Subjects&lt;br /&gt;
! Study summary&lt;br /&gt;
--&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2015 || [[Institute of Medicine report]] || [[Ellen Wright Clayton]] (Chair), [[Margarita Alegría]], [[Lucinda Bateman]], [[Lily Chu]], [[Charles S. Cleeland]], [[Ronald Davis]], [[Betty Diamond]], [[Theodore Ganiats]], [[Betsy Keller]], [[Nancy Klimas]], [[A. Martin Lerner]], [[Cynthia Mulrow]], [[Benjamin Natelson]], [[Peter Rowe]], [[Michael Shelanski]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2015 || [[Pathways to prevention report]] || Green CR, Cowan P, Elk R, O&#039;Neil KM, Rasmussen AL || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2014 || [http://www.ncbi.nlm.nih.gov/pubmed/25274261 Two age peaks in the incidence of chronic fatigue syndrome/myalgic encephalomyelitis: a population-based registry study from Norway 2008–2012] || Bakken IJ, Tveito K, Gunnes N, Ghaderi S, Stoltenberg C, Trogstad L, Håberg SE, Magnus P || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2013 || [http://www.ncbi.nlm.nih.gov/pubmed/23576883 The prevalence of chronic fatigue syndrome/myalgic encephalomyelitis: a meta-analysis] || [[Samantha Johnston]], [[Ekua Weba Brenu]], [[Donald Staines]], [[Sonya Marshall-Gradisnik]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2011 || [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170215/ Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care] || [[Luis Nacul]], [[Eliana Lacerda]], [[Derek Pheby]], Peter Campion, Mariam Molokhia, Shagufta Fayyaz, Jose CDC Leite, Fiona Poland, Amanda Howe, Maria L Drachler || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2007 || [http://www.aihw.gov.au/publication-detail/?id=6442467990 The burden of disease and injury in Australia 2003] || [[Stephen Begg]], [[Theo Vos]], Barker B, Stevenson C, Stanley L, Lopez A || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2006 || [http://jid.oxfordjournals.org/content/193/5/664.full Prolonged Illness after infectious mononucleosis is associated with altered immunity but not with increased viral load] || Cameron, B., Bharadwaj, M., Burrows, J., Fazou, C., Wakefield, D., Hickie, I., Ffrench, R., Khanna, R. and A. Lloyd || See also [http://phoenixrising.me/research-2/the-dubbo-studies-a-model-of-post-infective-fatigue-emerging/model-of-post-infective-fatigue-forming-the-dubbo-studies Model of Post Infective Fatigue Forming: the Dubbo Studies] || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2006 || [http://www.ncbi.nlm.nih.gov/pubmed/16448567 Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr virus] || Vernon, S., Whistler, T., Cameron, B., Hickie, I., Reeves, W. and A. Lloyd || See also [http://phoenixrising.me/research-2/the-dubbo-studies-a-model-of-post-infective-fatigue-emerging/model-of-post-infective-fatigue-forming-the-dubbo-studies Model of Post Infective Fatigue Forming: the Dubbo Studies] || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2006 || [http://www.ncbi.nlm.nih.gov/pubmed/16950834 Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study] || [[I Hickie]], [[T Davenport]], [[D Wakefield]], Vollmer-Conna U, Cameron B, Vernon SD, Reeves WC, Lloyd A || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 2005 || [http://www.ncbi.nlm.nih.gov/pubmed/15699087 A systematic review describing the prognosis of chronic fatigue syndrome] || [[Ruth Cairns]], [[Matthew Hotopf]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: tan; font-weight: bold;&amp;quot; | Epidemiological || 1996 || [http://www.ncbi.nlm.nih.gov/pubmed/8873490 Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups] || [[Anthony Komaroff]], Fagioli LR, Doolittle TH, Gandek B, Gleit MA, Guerriero RT, Kornish RJ 2nd, Ware NC, Ware JE Jr, Bates DW || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2015 || [http://www.ncbi.nlm.nih.gov/m/pubmed/26615570/ Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome] || Landi A, Broadhurst D, [[Suzanne Vernon]], Tyrrell DL, Houghton M || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2015 || [http://www.ncbi.nlm.nih.gov/pubmed/?term=26079000 Distinct plasma immune signatures in ME/CFS are present early in the course of illness] || [[Mady Hornig]], [[Jose Montoya]], [[Nancy Klimas]], Levine S, Felsenstein D, [[Lucinda Bateman]], [[Daniel Peterson]], Gottschalk CG, Schultz AF, Che X, Eddy ML, [[Anthony Komaroff]], [[Ian Lipkin]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2014 || [http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0085387 Deficient EBV-specific B-and T-cell response in patients with chronic fatigue syndrome] || Madlen Loebel, Kristin Strohschein, Carolin Giannini, Uwe Koelsch, Sandra Bauer, Cornelia Doebis, Sybill Thomas, Nadine Unterwalder, Volker von Baehr, Petra Reinke, Michael Knops, Leif G. Hanitsch, Christian Meisel, Hans-Dieter Volk, [[Carmen Scheibenbogen]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2012 || [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464733/ Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis] || Ekua W Brenu, Mieke L van Driel, [[Donald Staines]], Kevin J Ashton, Sharni L Hardcastle, James Keane, Lotti Tajouri, [[Daniel Peterson]], Sandra B Ramos, [[Sonya Marshall-Gradisnik]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2011 || [http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0026358 Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study] || [[Øystein Fluge]] , Ove Bruland, Kristin Risa, Anette Storstein, Einar K. Kristoffersen, Dipak Sapkota, Halvor Næss, Olav Dahl, Harald Nyland, [[Olav Mella]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2010 || [http://www.ncbi.nlm.nih.gov/pubmed/20520837 Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26] || Fletcher MA, Zeng XR, Maher K || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2008 || [http://www.ncbi.nlm.nih.gov/pubmed/18775774 Neuroendocrine and immune network remodeling in chronic fatigue syndrome: an exploratory analysis] || Fuite J, [[Susan Vernon]], [[Gordon Broderick]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2008 || [http://www.ncbi.nlm.nih.gov/pubmed/18937577 Cytokine Polymorphisms Have a Synergistic Effect on Severity of the Acute Sickness Response to Infection] || Vollmer‐Conna U, Piraino B, Cameron B || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2007 || [http://www.ncbi.nlm.nih.gov/pubmed/17712757 Postinfective fatigue syndrome is not associated with altered cytokine production] || Vollmer-Conna U, Cameron B, Pavlovic D || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2006 || [http://www.ncbi.nlm.nih.gov/pubmed/16762155 A first study of cytokine genomic polymorphisms in CFS: positive association of TNF‐857 and IFNgamma 874 rare alleles] || Carlo‐Stella N, Badulli C, De S || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: pink; font-weight: bold;&amp;quot; | Immunological || 2005 || [http://www.ncbi.nlm.nih.gov/pubmed/16049290 Association of chronic fatigue syndrome with human leucocyte antigen class II alleles] || Smith J, Fritz EL, [[Jonathan Kerr]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: orange; font-weight: bold;&amp;quot; | Metabolic || 2014 || [http://www.ncbi.nlm.nih.gov/pubmed/24755065 Inability of myalgic encephalomyelitis/chronic fatigue syndrome patients to reproduce VO2peak indicates functional impairment] || [[Betsy Keller]], [[John Pryor]], [[Ludovic Giloteaux]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: orange; font-weight: bold;&amp;quot; | Metabolic || 2012 || [http://www.ncbi.nlm.nih.gov/pubmed/22210239 Differences in metabolite-detecting, adrenergic, and immune gene expression after moderate exercise in patients with chronic fatigue syndrome, patients with multiple sclerosis, and healthy controls] || AT White, [[Alan Light]], RW Hughen, TA Vanhaitsma, [[Kathleen Light]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: orange; font-weight: bold;&amp;quot; | Metabolic || 2009 || [http://www.ncbi.nlm.nih.gov/pubmed/19647494 Moderate exercise increases expression for sensory, adrenergic, and immune genes in chronic fatigue syndrome patients but not in normal subjects] || [[Alan Light]], AT White, RW Hughen, [[Kathleen Light]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: gray; font-weight: bold;&amp;quot; | Neurological || 2015 || [http://www.ncbi.nlm.nih.gov/pubmed/?term=25353054 Right arcuate fasciculus abnormality in chronic fatigue syndrome] || [[Michael Zeineh]], Kang J, Atlas SW, Raman MM, Reiss AL, Norris JL, Valencia I, [[Jose Montoya]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: gray; font-weight: bold;&amp;quot; | Neurological || 2007 || [http://www.ncbi.nlm.nih.gov/pubmed/17617647 Symptoms of autonomic dysfunction in chronic fatigue syndrome] || [[Julia Newton]], O Okonkwo, K Sutcliffe, Seth A, Shin J, Jones DE || || || &lt;br /&gt;
|- &lt;br /&gt;
| style=&amp;quot;background-color: gray; font-weight: bold;&amp;quot; | Neurological || 2015 || [http://www.ncbi.nlm.nih.gov/pubmed/26411464] || [[Leonard Jason]], M L Zinn, MA Zinn.&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2015 || [http://www.ncbi.nlm.nih.gov/m/pubmed/26399744/ Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome] || [[Øystein Fluge]], [[Olav Mella]], Loebel M, Grabowski P, Heidecke H, Bauer S, Hanitsch LG, Wittke K, Meisel C, Reinke P, Volk HD, [[Carmen Scheibenbogen]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2015 || [http://www.ncbi.nlm.nih.gov/m/pubmed/26132314/ B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment] || [[Øystein Fluge]], [[Olav Mella]], Risa K, Lunde S, Alme K, Rekeland IG, Sapkota D, Kristoffersen EK, Sørland K, Bruland O, Dahl O || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2013 || [http://www.ncbi.nlm.nih.gov/m/pubmed/23480187/ Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls] || [[Amolak Bansal]], AS Bradley, B Ford || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2013 || [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891387/ Fibromyalgia Symptoms Are Reduced by Low-Dose Naltrexone: A Pilot Study] || [[Jarred Younger]], Sean Mackey || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2012 || [http://www.cdd.com.au/pdf/publications/All%20Publications/2013%20-%20The%20GI%20microbiome%20and%20its%20role%20in%20CFS%20-%20ACNEM%20paper.pdf/ The GI Microbiome and its Role in Chronic Fatigue Syndrome: A Summary of Bacteriotherapy] || Thomas J. Borody, Anna Nowak, Sarah Finalayson || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2011 || [http://www.ncbi.nlm.nih.gov/m/pubmed/22039471/ Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study] || [[Øystein Fluge]], [[Olav Mella]], Bruland O, Risa K, Storstein A, Kristoffersen EK, Sapkota D, Næss H, Dahl O, Nyland H || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2010 || [http://www.ncbi.nlm.nih.gov/pubmed/23359310 Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels] || [[Jarred Younger]], Noor N, McCue R, Mackey S || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2009 || [http://www.ncbi.nlm.nih.gov/m/pubmed/19566965/ Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series] || [[Øystein Fluge]], [[Olav Mella]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightblue; font-weight: bold;&amp;quot; | Treatment || 2008 || [https://www.researchgate.net/profile/Michael_Maes2/publication/23709068_Normalization_of_leaky_gut_in_chronic_fatigue_syndrome_CFS_is_accompanied_by_a_clinical_improvement_Effects_of_age_duration_of_illness_and_the_translocation_of_LPS_from_gram-negative_bacteria/links/55c0913f08ae092e9666c31b.pdf/ Normalization of leaky gut in Chronic Fatigue Syndrome (CFS) is accompanied by a clinical improvement] || Michael Maes, Jean-Claude Leunis || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightgreen; font-weight: bold;&amp;quot; | Psychological || 2011 || The [[PACE trial]] || [[Peter White]], KA Goldsmith, AL Johnson, L Potts, R Walwyn, JC DeCesare, HL Baber, M Burgess, LV Clark, DL Cox, [[Jessica Bavinton]], BJ Angus, [[Gabrielle Murphy]], M Murphy, H O&#039;Dowd, D Wilks, P McCrone, [[Trudie Chalder]], [[Michael Sharpe]] || || || &lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightgreen; font-weight: bold;&amp;quot; | Psychological || 2005 || [http://simonwessely.com/Downloads/Publications/CFS/176.pdf The Placebo Response in the Treatment of Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis] || Hyong Jin Cho, Matthew Hotopf, Simon Wessely || Found that the placebo response was actually lower in CFS patients || || &lt;br /&gt;
&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;background-color: lightgreen; font-weight: bold;&amp;quot; | Psychological || 2014 || [http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD003200.pub4/abstract Exercise therapy for chronic fatigue syndrome] || Cochrane: Lillebeth Larun, Kjetil G. Brurberg, Jan Odgaard-Jensen, Jonathan R Price ||  || || &lt;br /&gt;
&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=EEG&amp;diff=8403</id>
		<title>EEG</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=EEG&amp;diff=8403"/>
		<updated>2016-04-09T21:31:01Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:will resume tomorrow&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[https://en.wikipedia.org/wiki/Electroencephalography Electroencephalography] (EEG)  is an electrophysiological monitoring method to record electrical activity of the brain. EEG is the only direct measure of neural activity (i.e., collections of  neurons) and operates in the millisecond time domain, which is the same time domain of the brain and central nervous system. Due to these properties, it is the best and most sensitive measure of neural dynamics (activities of neural networks). &lt;br /&gt;
 &lt;br /&gt;
The last 70 years of neuroscience has established that most of brain&#039;s metabolism is used to create brain cell activity (summated synaptic potentials) operating on on the least-effort principle. This activity is mostly excitatory, some is inhibitory (slows things down) but it achieves a balance that optimizes the excitation and inhibition and produced electrical potentials, which we see at the scalp, in the form of the EEG. The EEG is a function of the electrical potentials in our brain, at the scalp. LORETA looks at the electrical potentials deeper into the brain. Only pyramidal neurons generate these potentials, and over 85% of our brains are made up of pyramidal neurons. All neurons generate all EEG frequencies, so the most important thing to remember is whether there is deregulation in a given region or network, with the frequency being secondary. &lt;br /&gt;
&lt;br /&gt;
2 Billion dollars during 1990s (decade of the brain) resulted in huge proliferation of knowledge and understanding in a much for fundamental way how the brain is wired, how the neurons are synchronized and how they “talk” to each other. We are very privileged to be able to take advantage of it. It has matured to the point that we can now apply it. The ultimate goal of bringing together all imaging modalities is good clinical outcome. In order to achieve that, it requires putting together all the imaging modalities and understanding where we are and understanding where the EEG is with respect to the other imaging modalities (structural MRI, functional MRI, PET scans, SPECT scans, EEG, MEG) and at all levels of phylogeny (animals to humans). There is a common coordinate system so we can relate the EEG to networks inside the brain and nodes and connections between nodes within the brain that are related to symptoms.&lt;br /&gt;
&lt;br /&gt;
The brain is organized in networks which operate on a millisecond time-scale. These networks are physical systems containing interdependent brain regions connected by nerves (bundles of nerve cells). Electrical neuroimaging of modules and hubs within the brain using structural MRI, DTI—this forms the infrastructure for the foundation for our understanding of the EEG. However, DTI, MRI structural imaging is the same whether you are alive or dead. Only the EEG, fMRI capture neuronal dynamics; however, the difference is that the fMRI has 10-20 second latency in order to measure anything whereas the EEG is in milliseconds. This near-instantaneous measurement aspect of EEG is crucial for examining brain dynamics, which, given the articles presented here appear to be very relevant for the study of ME. The time it takes for the brain to recruit a billion neurons across different network nodes varies from about 20ms to 80ms. Therefore, this means that network phase measures are completely INVISIBLE to the fMRI.Furthermore, the EEG spatial resolution, although not as high as fMRI, is quite accurate and sufficient for us to evaluate the dynamics of communication between large groups of neurons. What this means is that, if one is interested in brain dynamics and function, the EEG is the only modality that will capture it.&lt;br /&gt;
&lt;br /&gt;
The brain is not like a computer, as we once thought. It depends on information that flows in regulated loops which continually change, not in fixed circuits like computers. The brain primary task is prediction, by matching what is previously learned with new information &#039;on the fly.&#039; Our awareness is one step behind these predictions in that the brain has already represented our actions milliseconds before we perform them. Information flow is therefore a continual re-mapping that takes information from sensory systems and sends it to higher-order systems, which results in regulatory control which bring about adaption in homeostasis of feelings, actions, perceptions and consciousness. The EEG is therefore the only non-invasive and inexpensive measure of this continual temporal evolution of brain information in real time that is crucial for the understanding of cognitive and emotional functioning for healthy individuals as well as people with neurocognitive dysfunction.&lt;br /&gt;
&lt;br /&gt;
==Cortico-thalamic Integration==&lt;br /&gt;
&lt;br /&gt;
EEG patterns (rhythms) are primarily a fundamental property of brainstem-thalamo-cortical and corticothalamic dynamics regulated by many sub-thalamic brainstem systems including the ascending reticular activating system (ARAS), the locus coeruleus (LC) and the globus pallidus. It is these and other subcortical structures which regulate brain rhythms that produce the states of consciousness and cognition, producing cognitive abilities. More specifically, the networks which modulate arousal (vigilance) rhythms are some of the most important networks in the brain due to their function in the shift between arousal states ranging from the completely disconnected state to the fully alert, vigilant state [23-25]. The thalamus, part of the ascending reticular activating system (RAS)  provides two important functions within this circuit; first, to mediate sleep or low arousal (triggering sleep and wakefulness) and to perform memory consolidation during sleep. Therefore, any failure of the ability of the ARAS to regulate the thalamus efficiently  results in generalized reduction in information flow in extensive cortical regions causing reduced overall efficiency, slowed information processing speed, memory failures, attention problems and overall cognitive deficits.  &lt;br /&gt;
&lt;br /&gt;
Network, Central Executive Network, Default Mode Network, Intrinsic Connectivity Network, Salience Network, Small-world Network, Structural Connectivity, Functional Connectivity.&lt;br /&gt;
&lt;br /&gt;
==Notable Studies==&lt;br /&gt;
*2016, [https://www.dovepress.com/electroencephalogram-characteristics-in-patients-with-chronic-fatigue--peer-reviewed-article-NDT Electroencephalogram characteristics in patients with chronic fatigue syndrome] (January 28) &amp;quot;The spontaneous brain electrical activities in CFS patients were significantly reduced. The abnormal changes in the cerebral functions were localized at the right frontal and left occipital regions in CFS patients&amp;quot;&lt;br /&gt;
&lt;br /&gt;
*2016, [https://link.springer.com/article/10.1007%2Fs10484-016-9331-3]-Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with Myalgic Encephalomyelitis: A Pilot Study](February 11). &amp;quot;We found support for all three core networks of the Menon triple network model-the central executive network (CEN), salience network (SN), and the default mode network (DMN)- indicating hypo-connectivity in the Delta, Alpha, and Alpha-2 frequency bands in patients with ME compared to controls. In addition to the current source density resting state dysfunction in the occipital, parietal, posterior temporal and posterior cingulate, the disrupted connectivity of the CEN, SN, and DMN appears to be involved in cognitive impairment for patients with ME. This research suggests that disruptions in these regions and networks could be a core neurobiological feature of the disorder, representing underlying neural dysfunction.&amp;quot;  &lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[qEEG]]&lt;br /&gt;
&lt;br /&gt;
[[Category:Tests]]&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=MEpedia:Contents&amp;diff=8400</id>
		<title>MEpedia:Contents</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=MEpedia:Contents&amp;diff=8400"/>
		<updated>2016-04-09T21:10:30Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:added names&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;We are crowd-sourcing a knowledge base on the history, science and medicine of ME and CFS around the world. MEpedia is a patient community project being built by patients, founded by #[[MEAction]]. Read more [[MEpedia:About|about MEpedia and its principles]].&lt;br /&gt;
&lt;br /&gt;
Want to take a look around? See our most [[Special:PopularPages|popular pages]], check our [[Special:NewPages|newest pages]], or visit a [[Special:random|random page]]. You can also browse a [[Special:AllPages|list of all pages]].&lt;br /&gt;
&lt;br /&gt;
==Please contribute==&lt;br /&gt;
Anyone can create pages, write content, add links/citations, fact-check, or even just fix typos. Get involved and help the patient community identify all of the best and most important resources for our disease and its research, treatment and history. Start now, read [[How to contribute]]. Please join the MEpedia [http://my.meaction.net/local_chapters/mepedia online forum], [https://www.facebook.com/mepedia/ Facebook group], and follow us on [https://twitter.com/MEencyclopedia Twitter].&lt;br /&gt;
&lt;br /&gt;
==Five minute tasks==&lt;br /&gt;
&lt;br /&gt;
Only have a five minute spoon to give? Here is a [[List of small tasks|list of small tasks]] you can help us with in roughly one to ten minutes of time.&lt;br /&gt;
&lt;br /&gt;
==Priority pages for expansion==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Science:&#039;&#039;&#039; [[Citric acid cycle]], [[Mitochondria]], [[Exercise]], [[Ampligen]], [[Natural killer cell]], [[Central nervous system]], [[Nitric oxide hypothesis]], [[Brain]], [[Brain imaging]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;History and politics:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==A note on ME v. CFS==&lt;br /&gt;
&lt;br /&gt;
We have separate pages for [[Myalgic Encephalomyelitis]], [[ME/CFS]] and [[Chronic Fatigue Syndrome]] as well as [[SEID]]. The convention is that the terminology used in an ME-pedia article should match the terminology used in the underlying source. Where there is a tension between the term used in the source and the definition (e.g., [[ME]] defined by the [[Oxford criteria]] or [[CFS]] defined by the [[Canadian Consensus Criteria]]), it may be useful for clarity to mention the definition used.&lt;br /&gt;
&lt;br /&gt;
==Primers==&lt;br /&gt;
*[[Primer for doctors and researchers]]&lt;br /&gt;
*[[Primer for patients]]&lt;br /&gt;
*[[Primer for science journalists]]&lt;br /&gt;
*[[Primer for the public]]&lt;br /&gt;
*[[Primer for family, friends and care providers]]&lt;br /&gt;
&lt;br /&gt;
==The Disease==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Infectious agents:&#039;&#039;&#039; [[Borrelia]], [[Babesia]], [[Bartonella]], [[Borna Disease Virus]], [[Chlamydia pneumoniae]], [[Coxsackie A]],  [[Coxsackie B]], [[cytomegalovirus]], [[Ebola virus]], [[echovirus]], [[enterovirus]], [[Epstein-Barr virus]], [[H1N1]], [[Herpesvirus]], [[HHV-6]], [[HHV-7]], [[HSV-1]], [[HSV-2]], [[influenza]], [[parvovirus B19]],  [[Q Fever]], [[Ross River Virus]], [[Chlamydia Pneumonia]], [[Mycoplasma Pneumonia]], [[streptococcus]], [[fungal infection]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Triggers and risk factors:&#039;&#039;&#039; [[Blood donation]], [[Candidiasis]], [[Causes of death]], [[Epidemiology]], [[Genetics]], [[Menstrual cycle]], [[Mold]], [[Pediatric]], [[Pregnancy]], [[Stress]], [[Toxic exposure]], [[Trauma]],  [[Vaccine]], [[Viral onset]], [[bacterial disease onset]], [[fungal disease onset]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Signs and symptoms:&#039;&#039;&#039; [[Ataxia]], [[attention deficits]], [[auditory sequencing problems]], [[balance problems]], [[Cognitive dysfunction]], [[Chronic pain]], [[Chronic fatigue]], [[concentration problems]], [[difficulty comprehending social cues]], [[dyslexia]], [[executive function problems]], [[Fatigue]], [[Food intolerance]], [[Irritable bowel syndrome]], [[low motivation]], [[Migraine Syndrome]], [[multi-tasking problems]], [[Muscle fatigability]], [[Neurally mediated hypotension]], [[Nonepileptic seizure]], [[Optical dysfunction]], [[Orientation in Space problems]], [[Orthostatic intolerance]], [[Planning problems]], [[Post-exertional malaise]], [[Postural orthostatic tachycardia]], [[Receptive language problems]], [[Seizure]], [[Sleep disturbance]], [[Slowed thought]], [[Unrefreshing sleep]], [[Word-finding problems]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Medical hypotheses:&#039;&#039;&#039;  [[Amygdala hypothesis]],  [[Autoimmune hypothesis]], [[encephalitis]], [[autoimmune encephalitis]], [[Fatty acid hypothesis]], [[Hygiene hypothesis]], [[Immune exhaustion hypothesis]], [[Infectious disease hypothesis]], [[Ken Lassesen&#039;s model]], [[Methylation cycle hypothesis]], [[Microbiome hypothesis]], [[Mold hypothesis]], [[Patricia Kane protocol]], [[Vagus nerve hypothesis]], [[Viral onset hypothesis]] [[Hypercoagulation hypothesis]] [[Acquired immune and mitochondrial dysfunction hypothesis]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Body systems:&#039;&#039;&#039; [[Antibody]], [[Autoantibody]], [[Blood]], [[Brain]], [[B cell]], [[Central sensitization]], [[Cytokine]], [[Chemokine]], [[Cardiovascular system]], [[Gastrointestinal system]], [[Glutamate excitotoxicity]], [[HPA axis]],  [[Immune system]], [[IL-1]], [[IL-2]], [[IL-6]], [[IL-8]], [[IL-10]], [[IL-16]], [[IL-17]], [[IL-18]], [[interferon]], [[Leaky brain]], [[Leaky gut]], [[Macrophage]], [[Microglia]],  [[Microbiome]],  [[Mucosal immune system]], [[Nervous system]], [[Natural killer cell]], [[Neuroinflammation]], [[Ribonuclease L]], [[Spinal cord]], [[Tumor necrosis factors]], [[VEGF]], [[T cell]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Tests:&#039;&#039;&#039; [[Brain imaging]], [[Cardiopulmonary exercise test]], [[CellTrend diagnostic test]], [[C reactive protein]], [[qEEG/LORETA]], [[Erythrocyte sedimentation rate]], [[Exercise]], [[National Centre for Neuroimmunology and Emerging Diseases#Potential biomarker|NCNED Griffith University diagnostic test]], [[MRI]], [[Orosomucoid]], [[qEEG]], [[SF-36]], [[SPECT]], [[Tilt Table]], [[Two day exercise test]], [[Natural Killer Cell (NKC) Function]], [[arginine vasopressin]], [[MTHFR and other methylation mutations]], [[infectious disesases]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Citizen science:&#039;&#039;&#039; [[23andMe]], [[American Gut]], [[Any Treatment]], [[Mendus]], [[Phoenix Rising]], [[UBiome]], [[Know Your Genetics: Dr. Amy Yasko]], [[WellnessFX]], [[CH3Nutrigenomics; Dr. Amy Yasko]], [[MTHFR.net]], [[Genetic Genie]], [[LiveWello]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Biochemistry and cell biology:&#039;&#039;&#039; [[ATP]], [[Cellular respiration]], [[Citric acid cycle]], [[D lactate]], [[Endocannabinoid]], [[Glucocorticoid]], [[Glutathione]], [[Histamine]], [[Methylation cycle]], [[Mitochondria]], [[Nitric oxide]], [[Oxidative phosphorylation]], [[Phenylalanine]], [[Tyrosine]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Nutrients:&#039;&#039;&#039; [[Copper]], [[Deadlock quartet]], [[Folate]], [[L-carnitine]], [[Magnesium]], [[Sam-e]], [[TMG]], [[Vitamin B2]], [[Vitamin B6]], [[Vitamin B12]], [[Vitamin C]], [[Vitamin D]], [[Zinc]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Neurotransmitters and hormones&#039;&#039;&#039;: [[Acetylcholine]], [[Alpha-Melanocyte-stimulating hormone]], [[Calicitriol]], [[Calcidiol]], [[Cortisol]], [[Dopamine]], [[Estriadol]], [[Epinephrine]], [[Estrogen]], [[Glucocorticoid]], [[Glutamate]], [[Histamine]], [[Hormones]], [[Leptin]], [[Melatonin]], [[Neurotransmitters]], [[Norepinephrine]], [[Oxytocin]], [[Progesterone]], [[Prolactin]], [[Prostaglandins]], [[Serotonin]], [[Testosterone]], [[Vasopressin]], [[Thyroid]], [[MSH]], [[HGH]]&lt;br /&gt;
&lt;br /&gt;
[[Blood donation]]&lt;br /&gt;
&lt;br /&gt;
==Names &amp;amp; Definitions==&lt;br /&gt;
&#039;&#039;&#039;Names:&#039;&#039;&#039; [[Myalgic Encephalomyelitis]], [[Chronic Fatigue Syndrome]], [[ME/CFS]], [[Systemic Exertion Intolerance Disease]], [[Chronic Fatigue Immune Deficiency Syndrome]], [[Chronic epstein barr]], [[Neuro-Inflammatory and Oxidative Fatigue]], [[Yuppie Flu]], [[Neurasthenia]], [[Chronic Fatigue]], [[Infectious Venulitis]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Related conditions:&#039;&#039;&#039; [[Chronic lyme disease]], [[Mold illness]], [[Biotoxin illness]], [[Environmental illness]], [[Multiple Chemical Sensitivity]], [[Gulf War Illness]], [[Mast cell activation disorder]], [[Mastocytosis]], [[Ehlers Danlos Syndrome]], [[Fibromyalgia]], [[Small intestine bacterial overgrowth]], [[Lactic acidosis]], [[Autoimmune disease]], [[Cancer]], [[Thyroid disease]], [[Non-Hodgkin&#039;s lymphoma]], [[Multiple Sclerosis]], [[Dysautonomia]], [[Mitochondrial disorders]], [[Chronic Epstein Barr]], [[Raynaud&#039;s Syndrome]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Definitions:&#039;&#039;&#039; [[Definitions of ME and CFS]], [[Canadian Consensus Criteria]], [[International Consensus Criteria]], [[Oxford criteria]],  [[Fukuda criteria]], [[Holmes criteria]], [[Empirical definition]], [[Ramsay definition]], [[London criteria]], [[Nightingale definition]], [[Reeves criteria]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Acronyms:&#039;&#039;&#039; [[List of acronyms]]&lt;br /&gt;
&lt;br /&gt;
==Potential treatments==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Category page&#039;&#039;&#039;: [[Treatments|Potential treatments]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Supplements:&#039;&#039;&#039; [[Probiotics]], [[AHCC]], [[CoQ10]], [[L-carnitine]], [[MitoQ]], [[NADH]], [[PrescriptAssist]], [[Mutaflor]], [[GcMAF]], [[Colostrum]], [[Transfer factors]], [[Fish oil]], [[EPA]], [[DHA]], [[Taurine]], [[L-Glutamine]], [[Glutathione]], [[Niacinamide]], [[B Vitamin Complex]], [[Adaptogens]] ([[Eleuthro]], [[Ginseng]], [[Ashwaganda]], [[Rhodiola]], [[Licorice]]), [[Mangosteen]], [[Vegan/non-whey Protein Powders with Amino Acid Complex]], [[Greens Powders]], [[D-Ribose]], [[Quercetin]], [[Nexavir]], [[5-Hydroxytryptophan]], [[Melatonin]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Supplement Sources:&#039;&#039;&#039; [[Pure Formulas]], [[Be Well By Dr Frank Lipman]], [[Seeking Health]], [[MITOQ]], [[Aloha]], [[ProHealth]], [[Thrive Marketplace]], [[HolisticHeal]], [[Vitacost.com]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Foods:&#039;&#039;&#039; [[Cocoa|Cocoa (Dark chocolate)]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Herbs:&#039;&#039;&#039; [[Medical marijuana]], [[Kampo]], [[Equilibrium]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Diets:&#039;&#039;&#039; [[GAPS diet]], [[Ketogenic diet]], [[Low FODMAP diet|Low FODMAP Diet]], [[Low histamine diet|Low Histamine Diet]], [[Paleo diet]], [[RPAH elimination diet|RPAH Elimination Diet]], [[Specific carbohydrate diet]], [[Vegan diet]], [[Vegetarian diet]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Antivirals:&#039;&#039;&#039; [[Valgancyclovir]], [[Famciclovir]], [[Valaciclovir]], [[Acyclovir]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Immunomodulators and immunostimulants:&#039;&#039;&#039; [[Ampligen]], [[Low dose naltrexone]], [[Equilibrant]], [[Intravenous immunoglobulin]], [[Staphylococcal vaccine]], [[Immunovir]], [[Medicinal mushrooms]], [[Interferon]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Anti-inflammatory drugs:&#039;&#039;&#039; [[Sulfasalazine]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Anti-fungal drugs:&#039;&#039;&#039; [[fluconazole]], [[itraconazole]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Other drug treatments:&#039;&#039;&#039; [[Chelation]], [[Cyclophosphamide]], [[Prednisone]], [[Rituximab]], [[Trazodone]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Toxin avoidance/removal:&#039;&#039;&#039; [[Fasting]], [[Mold avoidance]], [[Coffee enema]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Uncategorized interventions:&#039;&#039;&#039; [[Traditional Chinese medicine]], [[Cold immersion]], [[Fecal matter transplant]]/[[Faecal bacteriotherapy]], [[Helminthic therapy]], [[Pacing]], [[Energy envelope]], [[Hyperbaric oxygen]], [[Ozone]], [[Altitude]], [[Exercise]], [[Vagus nerve stimulation]], [[Exercise based on 2-day CPET]], [[Lipid replacement therapy]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Management guides:&#039;&#039;&#039; [https://www.actionforme.org.uk/uploads/taming-the-gorilla-booklet.pdf Taming the Gorilla] ([[Action for ME]]), [http://stonebird.co.uk/Notes/index.html Notes for Carers] ([[Greg Crowhurst]]), [http://www.meassociation.org.uk/2014/07/our-purple-booklet-clear-clinical-guidance-and-the-latest-research-all-wrapped-up-in-52-pages/ The Purple Booklet] ([[ME Association]])&lt;br /&gt;
&lt;br /&gt;
==Doctors==&lt;br /&gt;
&#039;&#039;&#039;Clinical Doctors, USA:&#039;&#039;&#039; [[Lucinda Bateman]] (UT) [[Derek Enlander]]; [[Susan Levine]] (NY) &lt;br /&gt;
[[Nancy Klimas]] (FL) [[Courtney Craig]]; [[Daniel Peterson]] (NV) [[Phillipe Bottello]]; [[John Chia]]; [[OMI Clinic: David Kaufman and Andy Kogelnick]] (CA) [[Jacob Teitelbaum]]; [[Richard Podell]] (NJ) [[Laura Black]] (NC); [[Amy Yasko]]; [[Jose Montoya]]  (CA)&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Clinical Doctors, UK:&#039;&#039;&#039; [[Sarah Myhill]], [[William Weir]], [[Nigel Speight]], [[Peter Behan]], [[Charles Shepherd]], [[Gabrielle Murphy]], [[Amolak Bansal]], [[Breakspear Medical]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Clinical Doctors, Germany:&#039;&#039;&#039; [[Anna Dorothea Hoeck]], [[Carmen Scheibenbogen]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Clinical Doctors, Belgium:&#039;&#039;&#039; [[Kenny de Meirleir]], [[Annemie Uyttersprot (GP)]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Clinical Doctors, South Africa:&#039;&#039;&#039; [[Cecile Jadin]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Clinical Doctors, Sweden:&#039;&#039;&#039; [[Carl-Gerhard Gottfries]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Clinical Doctors, Italy:&#039;&#039;&#039; [[Umberto Tirelli]], [[Lorenzo Lorusso]], [[Eligio Pizzigallo]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Clinical Doctors, Australia:&#039;&#039;&#039; [[Donald P Lewis]] (VIC), [[John Whiting]], [[Rashmi Cabena]] (VIC), [[Richard Schloeffel]] (NSW)&lt;br /&gt;
&lt;br /&gt;
==Research==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;[[Notable studies]]&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039; Research initiatives USA:&#039;&#039;&#039; [[Chronic Fatigue Syndrome Project]], [[Open Medicine Foundation]], [[Chronic Fatigue Initiative]], [[Stanford ME/CFS Initiative]], [[Microbe Discovery Project]], [[Bateman Horne Center]], [[Workwell Foundation]], [[Center for Infection &amp;amp; Immunity]], [[Solve ME/CFS Initiative]], [[Simmaron Research]], [[Treatment Center for CFS]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039; Researchers USA:&#039;&#039;&#039; [[Marcie Zinn]], [[Ronald Davis]], [[Jarred Younger]], [[Alan Light]], [[Kathleen Light]], [[Andreas Kogelnik]], [[Leonard Jason]], [[Jose Montoya]], [[David Bell]], [[Mady Hornig]], [[Eric Schadt]], [[Ian Lipkin]], [[John Chia]], [[Rosemary Underhill]], [[Suzanne Vernon]], [[David Berg]], [[Nancy Klimas]], [[Dane Cook]], [[Staci Stevens]], [[Mark VanNess]], [[Christopher Snell]], [[Zaher Nahle]], [[Rich Van Konyenburg]], [[Judy Mikovits]], [[Paul Cheney]], [[Michael Van ElZakker]], [[Zaher Nahle]], [[Michael Zeineh]], [[Anthony Komaroff]], [[A Martin Lerner]], [[Garth Nicolson]], [[Mark Zinn]],&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039; Research initiatives Europe:&#039;&#039;&#039; [[ME Research UK]], [[Cure ME]] (UK), [[Invest in ME]] (UK), [[UK CFS/ME Collaborative]], [[Grand Challenge]], [[Invest in ME Conference]] (UK), [[Ramsay Research Fund]] (UK), [[European ME Research Group]], [[Charité Berlin]] (Germany), [[Wake-Up Call]] (Belgium)&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Research initiatives Australia:&#039;&#039;&#039; [[National Centre for Neuroimmunology and Emerging Diseases]], [[Victoria University]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Research initiatives Canada:&#039;&#039;&#039; [[Nightingale Research Foundation]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039; Researchers UK:&#039;&#039;&#039;  [[Melvin Ramsay]], [[Donald Acheson]], [[Gordon Parish]], [[Jonathan Kerr]], [[Amolak Bansal]], [[Julia Newton]], [[Elizabeth Dowsett]], [[Simon Carding]], [[James Mowbray]], [[John Richardson]], [[Luis Nacul]], [[Derek Pheby]], [[Jonathan Edwards]], [[Geraldine Cambridge]], [[George Davey Smith]], [[Neil Harrison]], [[Fane Mensah]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039; Researchers Australia:&#039;&#039;&#039; [[Amy Wallis]], [[Donald P Lewis]], [[Donald Staines]], [[Dorothy Bruck]], [[Elaine DeFreitas]], [[Henry Butt]], [[Melinda L Jackson]], [[Michael Maes]], [[Sonya Marshall-Gradisnik]], [[Sarah Knight]], [[Brett Lidbury]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039; Researchers Germany:&#039;&#039;&#039; [[Carmen Scheibenbogen]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039; Researchers Norway:&#039;&#039;&#039; [[Olav Mella]], [[Øystein Fluge]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039; Researchers Canada:&#039;&#039;&#039; [[Byron Hyde]], [[Patrick O. McGowan]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Researchers Japan:&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Biobanks &amp;amp; patient registries&#039;&#039;&#039;: [[CURE ME]] (UK), [[OMI OpenMedNet]] (US), [[CFI CFS BioBank]] (US), [[SolveCFS BioBank]] (US), [[Simmaron Research BioBank]] (US)&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Researcher mailing lists:&#039;&#039;&#039; [[CureME mailing list]]&lt;br /&gt;
&lt;br /&gt;
==Psychological Paradigm==&lt;br /&gt;
&#039;&#039;&#039;Psychological paradigm, mind-body approaches and related interventions:&#039;&#039;&#039; [[FINE trial]], [[PACE trial]], [[Graded exercise therapy|Graded Exercise Therapy]], [[cognitive behavioral therapy|Cognitive Behavioral Therapy]], [[Biopsychosocial Model]], [[Deconditioning]], [[Mickel therapy]], [[Lightning process]], [[Gupta programme]], [[Psychoneuroimmunology]], [[Meditation]], [[Bodily distress syndrome]], [[Functional somatic syndrome]], [[Psychosomatic illness]], [[Neurasthenia]], [[Medically unexplained symptoms]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Psychological paradigm proponents:&#039;&#039;&#039; [[Simon Wessely]], [[Michael Sharpe]], [[Peter White]], [[Trudie Chalder]], [[Rona Moss-Morris]], [[Jessica Bavinton]], [[Esther Crawley]], [[Anthony Cleare]], [[Ben Goldacre]], [[Peter Manu]], [[Brian Walitt]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Psychological paradigm critics:&#039;&#039;&#039; [[James Coyne]], [[Keith Laws]], [[David Tuller]], [[Ronald Davis]], [[Bruce Levin]], [[Arthur Reingold]], [[Jonathan Edwards]], [[Leonard Jason]], [[Ellen Goudsmit]], [[Angela Kennedy]], [[Mark Zinn]], [[Marcie Zinn]]&lt;br /&gt;
&lt;br /&gt;
[[Patient mental health]]&lt;br /&gt;
&lt;br /&gt;
==Around the world==&lt;br /&gt;
*&#039;&#039;&#039;Asia:&#039;&#039;&#039; [[China]], [[India]], [[Indonesia]], [[Israel]], [[Japan]], [[Russia]]&lt;br /&gt;
*&#039;&#039;&#039;Africa:&#039;&#039;&#039; [[Kenya]], [[Nigeria]]&lt;br /&gt;
*&#039;&#039;&#039;Europe:&#039;&#039;&#039; [[Austria]], [[Belgium]], [[Bulgaria]], [[Czech Republic]], [[Denmark]], [[Finland]], [[France]] [[Germany]], [[Greece]], [[Hungary]], [[Ireland]], [[Italy]], [[Netherlands]], [[Norway]], [[Poland]], [[Romania]], [[Slovakia]], [[Slovenia]], [[Spain]], [[Sweden]], [[Ukraine]], [[United Kingdom]]&lt;br /&gt;
*&#039;&#039;&#039;North America:&#039;&#039;&#039; [[Canada]], [[Mexico]], [[United States]]&lt;br /&gt;
*&#039;&#039;&#039;South America:&#039;&#039;&#039; [[Argentina]], [[Brazil]]&lt;br /&gt;
*&#039;&#039;&#039;Australia &amp;amp; New Zealand:&#039;&#039;&#039; [[Australia]], [[New Zealand]]&lt;br /&gt;
&lt;br /&gt;
==History==&lt;br /&gt;
&lt;br /&gt;
[[Important events timeline]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Historical records&#039;&#039;&#039;: [[Osler&#039;s Web]], [[Thirty Years of Disdain]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Outbreaks:&#039;&#039;&#039; [[List of myalgic encephalomyelitis and chronic fatigue syndrome outbreaks|Outbreaks]]: [[Incline village|Incline village 1984]], [[1985 Lyndonville outbreak|Lyndonville 1985]], [[Akureyri]], [[1934 Los Angeles outbreak|Los Angeles 1934]], [[Royal Free Hospital outbreak|Royal Free Hospital 1955]], [[1955 Dalston outbreak|Dalston 1955]], [[1949 Adelaide outbreak|Adelaide 1949]], [[1980-81 Ayrshire outbreak|Ayrshire 1980]], [[1975 Sacramento outbreak|Sacramento 1975]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Deceased patients:&#039;&#039;&#039; [[Sophia Mirza]], [[Thomas Hennessy, Jr.]], [[Vanessa Li]], [[Lynn Gilderdale]], [[Emily Collingridge]],  [[Chardale Dotson Irvine]], [[Oliver Coles]], [[Brynmor John]], [[Victoria Elsbury-Legg]], [[Roger Cicero]], [[Memorial Lists]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Major developments/controversies:&#039;&#039;&#039; [[PACE trial]], [[XMRV]]&lt;br /&gt;
&lt;br /&gt;
[[ME and CFS in popular culture]]&lt;br /&gt;
&lt;br /&gt;
==Patient Advocacy==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups Australia:&#039;&#039;&#039; [[Emerge Australia]], [[ME/CFS Australia (SA) Inc]], [[ME/CFS Society of Western Australia]], [[ME/CFS Society of NSW]], [[ME/CFS Society of ACT]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups Belgium:&#039;&#039;&#039; [[Wake Up Call Beweging]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups Canada:&#039;&#039;&#039; [[National ME/FM Action Network]], [[May12th.org]], [[Action CIND]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups Ireland:&#039;&#039;&#039; [[Irish ME/CFS Association]], [[Irish ME Trust]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups Italy:&#039;&#039;&#039; [[Associazione Malati CFS onlus]], [[CFS Associazione Italiana onlus]], [[CFS Italia]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups Netherlands:&#039;&#039;&#039; [[ME Vereniging Nederland]] &lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups New Zealand:&#039;&#039;&#039; [[Associated New Zealand ME Society]] (ANZMES)&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups Norway:&#039;&#039;&#039; [[ME-Forskning]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups Sweden:&#039;&#039;&#039; [[Riksföreningen för ME-patienter]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups UK:&#039;&#039;&#039; [[Action for ME]], [[Invest in ME]], [[Change For M.E. Change For Us]], [[Norfolk &amp;amp; Suffolk ME]], [[ME Association]], [[Tymes Trust]], [[MEActionUK]], [[Forward-ME]], [[Hope 4 ME &amp;amp; Fibro NI]], [[Welsh Association of ME &amp;amp; CFS Support]], [[Sussex &amp;amp; Kent ME/CFS Society]], [[Association of Young People with ME]], [[Tyne &amp;amp; Wear ME/CFS Support Group]], [[Edinburgh MESH]], [[Leeds ME Network]], [[The York ME Community]], [[25 Percent ME Group]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups USA:&#039;&#039;&#039; #[[MEAction]], [[MEadvocacy]], [[National Alliance for Myalgic Encephalomyelitis]], [[Massachusetts CFIDS/ME &amp;amp; FM Association]], [[May12.org]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Advocacy/Fundraising Initiatives:&#039;&#039;&#039; [[Chilli ME Challenge]], [[ME Foggy Dog]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Famous patients&#039;&#039;&#039;: [[Laura Hillenbrand]], [[Martine McCutcheon]], [[Stuart Murdoch]], [[Charles Darwin]], [[Florence Nightingale]], [[Roger Cicero]], [[Shirley Conran]], [[Michael Crawford]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Notable patients:&#039;&#039;&#039; [[Karina Hansen]], [[Joanne]], [[Sophia Mirza]], [[Thomas Hennessy, JR.]], [[Vanessa Li]], [[Lynn Gilderdale]], [[Emily Collingridge]], [[Whitney Dafoe]], [[Tom Kindlon]], [[Graham McPhee]], [[Jennie Spotila]], [[Naomi Whittingham]], [[Jane Colby]], [[Countess of Mar]], [[Brian Vastag]], [[Jennifer Brea]], [[Ryan Prior]], [[Hillary Johnson]], [[Julie Rehmeyer]], [[Leonard Jason]], [[Charles Shepherd]], [[Nasim Marie Jafry]], [[Ken Lassesen]], [[Cort Johnson]], [[Valerie Eliot Smith]], [[Doctor Speedy]], [[Tanya Marlow]], [[Deborah Waroff]], [[Beth Mazur]], [[Catherine Hale]], [[Mary Schweitzer]], [[Toni Bernhard]], [[Guido den Broeder]], [[Frank Twisk]], [[Steven Lubet]], [[Giada Da Ros]], [[Roberta Pelletta]], [[Carol Head]], [[Ean Proctor]], [[Jessica Taylor]], [[Clark Ellis]], [[Alem Matthews]], [[Peter Kemp]], [[Mindy Kitei]] [[Jeanette Burmeister]], [[Giles Meehan]], [[Erik Johnson]], [[Lisa Petrison]], [[Mary Ann Kindel]], [[Gabby Klein]], [[Eileen Holderman]], [[Susan Kreutzer]], [[Maryann Spurgin]], [[Wendy Boutiler]], [[L.A. Cooper]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Notable healthy advocates:&#039;&#039;&#039; [[Angela Kennedy]], [[Mary Dimmock]], [[Greg Crowhurst]], [[Malcolm Hooper]], [[Nicole Castillo]], [[Llewellyn King]], [[Erica Verrillo]], [[Tom Whittingham]], [[Mike Harley]], [[Ian Gibson]], [[Scott Ludlam]], [[Linda and Don Tannenbaum]], [[Jon Campling]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Notable Quotes:&#039;&#039;&#039; [[List of Quotes]], [[Individual Quotes]]&lt;br /&gt;
&lt;br /&gt;
==Journals, TV, Articles, Books, Film, Interviews, Blogs, Discussion Forums==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Journals:&#039;&#039;&#039; &lt;br /&gt;
[[The Lancet]] &lt;br /&gt;
[[Lancet Psychiatry]] [[The BMJ]] [[Journal of Chronic Fatigue Syndrome]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;TV:&#039;&#039;&#039; [[Sick and Tired]] (US), [[Sick and Tired - BBC]] (UK),  [[Toxic Tiredness]], [[I Remember Me]], [[BBC Documentary on life with severe ME/Chronic Fatigue Syndrome]] (UK)&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Articles:&#039;&#039;&#039; [[List of news articles on ME and CFS]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Books:&#039;&#039;&#039; [[Plague]], [[The State of Me]], [[Love and Fatigue in America]], [[Osler&#039;s Web]], [[America&#039;s Biggest Cover-Up]], [[Reviving the Broken Marionette]], [[Why ME?]], [[Stanchi: Vivere con la Sindrome da Fatica Cronica]], [[Stanchi si diventa]], [[Frammenti di ME]], [[Encounters with the Invisible]], [[Chronic Fatigue Syndrome: A Treatment Guide]], [[Chronic Fatigue Syndrome: A Treatment Guide - 2nd Edition]], [[Severe ME/CFS: A Guide to Living]], [[Severe ME - Featuring: &amp;quot;Justice for Karina Hansen&amp;quot;]], [[Severe ME: Notes for Carers]], [[One Last Goodbye]], [[Authors of our Own Misfortune? The Problems with Psychogenic Explanations for Physical Illnesses]].&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Film:&#039;&#039;&#039; [[What About ME]], [[I Remember Me]], [[Forgotten Plague]], [[Canary in a Coal Mine]], [[The Last Great Medical Cover Up]], [[Invisible Illness - Stories of Chronic Fatigue Syndrome]], [[Voices from the Shadows]], [[ME The Hidden Truth]] (UK)&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Interviews:&#039;&#039;&#039; &lt;br /&gt;
[[ME/CFS Alert]], [[Science for Patients]] &lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Blogs:&#039;&#039;&#039; [[Health Rising]], [[Occupy CFS]], [[MEAction]], [[ME Advocacy]], [[Courtney Craig]], [[Cell Fatigue]], [[CFS Patient Advocate]], [[Constant F****** S***]], [[ME Association]], [[Onward Through the Fog]], [[Nice Guidelines]], [[Valerie Eliot Smith Blog]], [[CFS Remission]], [[About.com Health FMS/ME/CFS]], [[Just ME]], [[ME/CFS Ghost]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Discussion Forums:&#039;&#039;&#039; [[Phoenix Rising]], [[CFSItalia]], [[MDJunction]]&lt;br /&gt;
&lt;br /&gt;
== [[Open Letters]] ==&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=EEG&amp;diff=8399</id>
		<title>EEG</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=EEG&amp;diff=8399"/>
		<updated>2016-04-09T21:01:54Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:working on EEG page&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[https://en.wikipedia.org/wiki/Electroencephalography Electroencephalography] (EEG)  is an electrophysiological monitoring method to record electrical activity of the brain. EEG is the only direct measure of neural activity (i.e., collections of  neurons) and operates in the millisecond time domain, which is the same time domain of the brain and central nervous system. Due to these properties, it is the best and most sensitive measure of neural dynamics (activities of neural networks). &lt;br /&gt;
 &lt;br /&gt;
The last 70 years of neuroscience has established that most of brain&#039;s metabolism is used to create brain cell activity (summated synaptic potentials) operating on on the least-effort principle. This activity is mostly excitatory, some is inhibitory (slows things down) but it achieves a balance that optimizes the excitation and inhibition and produced electrical potentials, which we see at the scalp, in the form of the EEG. The EEG is a function of the electrical potentials in our brain, at the scalp. LORETA looks at the electrical potentials deeper into the brain. Only pyramidal neurons generate these potentials, and over 85% of our brains are made up of pyramidal neurons. All neurons generate all EEG frequencies, so the most important thing to remember is whether there is deregulation in a given region or network, with the frequency being secondary. &lt;br /&gt;
&lt;br /&gt;
2 Billion dollars during 1990s (decade of the brain) resulted in huge proliferation of knowledge and understanding in a much for fundamental way how the brain is wired, how the neurons are synchronized and how they “talk” to each other. We are very privileged to be able to take advantage of it. It has matured to the point that we can now apply it. The ultimate goal of bringing together all imaging modalities is good clinical outcome. In order to achieve that, it requires putting together all the imaging modalities and understanding where we are and understanding where the EEG is with respect to the other imaging modalities (structural MRI, functional MRI, PET scans, SPECT scans, EEG, MEG) and at all levels of phylogeny (animals to humans). There is a common coordinate system so we can relate the EEG to networks inside the brain and nodes and connections between nodes within the brain that are related to symptoms.&lt;br /&gt;
&lt;br /&gt;
The brain is organized in networks which operate on a millisecond time-scale. These networks are physical systems containing interdependent brain regions connected by nerves (bundles of nerve cells). Electrical neuroimaging of modules and hubs within the brain using structural MRI, DTI—this forms the infrastructure for the foundation for our understanding of the EEG. However, DTI, MRI structural imaging is the same whether you are alive or dead. Only the EEG, fMRI capture neuronal dynamics; however, the difference is that the fMRI has 10-20 second latency in order to measure anything whereas the EEG is in milliseconds. This near-instantaneous measurement aspect of EEG is crucial for examining brain dynamics, which, given the articles presented here appear to be very relevant for the study of ME. The time it takes for the brain to recruit a billion neurons across different network nodes varies from about 20ms to 80ms. Therefore, this means that network phase measures are completely INVISIBLE to the fMRI.Furthermore, the EEG spatial resolution, although not as high as fMRI, is quite accurate and sufficient for us to evaluate the dynamics of communication between large groups of neurons. What this means is that, if one is interested in brain dynamics and function, the EEG is the only modality that will capture it.&lt;br /&gt;
&lt;br /&gt;
The brain is not like a computer, as we once thought. It depends on information that flows in regulated loops which continually change, not in fixed circuits like computers. The brain primary task is prediction, by matching what is previously learned with new information &#039;on the fly.&#039; Our awareness is one step behind these predictions in that the brain has already represented our actions milliseconds before we perform them. Information flow is therefore a continual re-mapping that takes information from sensory systems and sends it to higher-order systems, which results in regulatory control which bring about adaption in homeostasis of feelings, actions, perceptions and consciousness. The EEG is therefore the only non-invasive and inexpensive measure of this continual temporal evolution of brain information in real time that is crucial for the understanding of cognitive and emotional functioning for healthy individuals as well as people with neurocognitive dysfunction. &lt;br /&gt;
&lt;br /&gt;
Network, Central Executive Network, Default Mode Network, Intrinsic Connectivity Network, Salience Network, Small-world Network, Structural Connectivity, Functional Connectivity.&lt;br /&gt;
&lt;br /&gt;
==Notable Studies==&lt;br /&gt;
*2016, [https://www.dovepress.com/electroencephalogram-characteristics-in-patients-with-chronic-fatigue--peer-reviewed-article-NDT Electroencephalogram characteristics in patients with chronic fatigue syndrome] (January 28) &amp;quot;The spontaneous brain electrical activities in CFS patients were significantly reduced. The abnormal changes in the cerebral functions were localized at the right frontal and left occipital regions in CFS patients&amp;quot;&lt;br /&gt;
&lt;br /&gt;
*2016, [https://link.springer.com/article/10.1007%2Fs10484-016-9331-3]-Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with Myalgic Encephalomyelitis: A Pilot Study](February 11). &amp;quot;We found support for all three core networks of the Menon triple network model-the central executive network (CEN), salience network (SN), and the default mode network (DMN)- indicating hypo-connectivity in the Delta, Alpha, and Alpha-2 frequency bands in patients with ME compared to controls. In addition to the current source density resting state dysfunction in the occipital, parietal, posterior temporal and posterior cingulate, the disrupted connectivity of the CEN, SN, and DMN appears to be involved in cognitive impairment for patients with ME. This research suggests that disruptions in these regions and networks could be a core neurobiological feature of the disorder, representing underlying neural dysfunction.&amp;quot;  &lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[qEEG]]&lt;br /&gt;
&lt;br /&gt;
[[Category:Tests]]&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=EEG&amp;diff=8398</id>
		<title>EEG</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=EEG&amp;diff=8398"/>
		<updated>2016-04-09T20:47:07Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:ADDED Keywords&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[https://en.wikipedia.org/wiki/Electroencephalography Electroencephalography] (EEG)  is an electrophysiological monitoring method to record electrical activity of the brain.&lt;br /&gt;
&lt;br /&gt;
The last 70 years of neuroscience has established that most of brain&#039;s metabolism is used to create brain cell activity (summated synaptic potentials) operating on on the least-effort principle. This activity is mostly excitatory, some is inhibitory (slows things down) but it achieves a balance that optimizes the excitation and inhibition and produced electrical potentials, which we see at the scalp, in the form of the EEG. The EEG is a function of the electrical potentials in our brain, at the scalp. LORETA looks at the electrical potentials deeper into the brain. Only pyramidal neurons generate these potentials, and over 85% of our brains are made up of pyramidal neurons. All neurons generate all EEG frequencies, so the most important thing to remember is whether there is deregulation in a given region or network, with the frequency being secondary. &lt;br /&gt;
&lt;br /&gt;
2 Billion dollars during 1990s (decade of the brain) resulted in huge proliferation of knowledge and understanding in a much for fundamental way how the brain is wired, how the neurons are synchronized and how they “talk” to each other. We are very privileged to be able to take advantage of it. It has matured to the point that we can now apply it. The ultimate goal of bringing together all imaging modalities is good clinical outcome. In order to achieve that, it requires putting together all the imaging modalities and understanding where we are and understanding where the EEG is with respect to the other imaging modalities (structural MRI, functional MRI, PET scans, SPECT scans, EEG, MEG) and at all levels of phylogeny (animals to humans). There is a common coordinate system so we can relate the EEG to networks inside the brain and nodes and connections between nodes within the brain that are related to symptoms.&lt;br /&gt;
&lt;br /&gt;
Electrical neuroimaging of modules and hubs within the brain using structural MRI, DTI—this forms the infrastructure for the foundation for our understanding of the EEG. However, DTI, MRI structural imaging is the same whether you are alive or dead. Only the EEG, fMRI capture neuronal dynamics; however, the difference is that the fMRI has 10-20 second latency in order to measure anything whereas the EEG is in milliseconds. This near-instantaneous measurement aspect of EEG is crucial for examining brain dynamics, which, given the articles presented here appear to be very relevant for the study of ME. The time it takes for the brain to recruit a billion neurons across different network nodes varies from about 20ms to 80ms. Therefore, this means that network phase measures are completely INVISIBLE to the fMRI.Furthermore, the EEG spatial resolution, although not as high as fMRI, is quite accurate and sufficient for us to evaluate the dynamics of communication between large groups of neurons. What this means is that, if one is interested in brain dynamics and function, the EEG is the only modality that will capture it.&lt;br /&gt;
&lt;br /&gt;
The brain is not like a computer, as we once thought. It depends on information that flows in regulated loops which continually change, not in fixed circuits like computers. The brain primary task is prediction, by matching what is previously learned with new information &#039;on the fly.&#039; Our awareness is one step behind these predictions in that the brain has already represented our actions milliseconds before we perform them. Information flow is therefore a continual re-mapping that takes information from sensory systems and sends it to higher-order systems, which results in regulatory control which bring about adaption in homeostasis of feelings, actions, perceptions and consciousness. The EEG is therefore the only non-invasive and inexpensive measure of this continual temporal evolution of brain information in real time that is crucial for the understanding of cognitive and emotional functioning for healthy individuals as well as people with neurocognitive dysfunction. &lt;br /&gt;
&lt;br /&gt;
Network, Central Executive Network, Default Mode Network, Intrinsic Connectivity Network, Salience Network, Small-world Network, Structural Connectivity, Functional Connectivity.&lt;br /&gt;
&lt;br /&gt;
==Notable Studies==&lt;br /&gt;
*2016, [https://www.dovepress.com/electroencephalogram-characteristics-in-patients-with-chronic-fatigue--peer-reviewed-article-NDT Electroencephalogram characteristics in patients with chronic fatigue syndrome] (January 28) &amp;quot;The spontaneous brain electrical activities in CFS patients were significantly reduced. The abnormal changes in the cerebral functions were localized at the right frontal and left occipital regions in CFS patients&amp;quot;&lt;br /&gt;
&lt;br /&gt;
*2016, [https://link.springer.com/article/10.1007%2Fs10484-016-9331-3]-Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with Myalgic Encephalomyelitis: A Pilot Study](February 11). &amp;quot;We found support for all three core networks of the Menon triple network model-the central executive network (CEN), salience network (SN), and the default mode network (DMN)- indicating hypo-connectivity in the Delta, Alpha, and Alpha-2 frequency bands in patients with ME compared to controls. In addition to the current source density resting state dysfunction in the occipital, parietal, posterior temporal and posterior cingulate, the disrupted connectivity of the CEN, SN, and DMN appears to be involved in cognitive impairment for patients with ME. This research suggests that disruptions in these regions and networks could be a core neurobiological feature of the disorder, representing underlying neural dysfunction.&amp;quot;  &lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[qEEG]]&lt;br /&gt;
&lt;br /&gt;
[[Category:Tests]]&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Brain&amp;diff=8272</id>
		<title>Brain</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Brain&amp;diff=8272"/>
		<updated>2016-04-04T22:13:59Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:started page about the brain&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;br /&gt;
==Brain Facts==&lt;br /&gt;
&lt;br /&gt;
How does the brain operate? What happens when it is compromised, such as having a tumor or stroke? Does the presence of cognitive impairment represent compromise? What about dementia that is not Alzheimer&#039;s?&lt;br /&gt;
&lt;br /&gt;
The National Institute of Neurological Disorders and Stroke ([http://www.ninds.nih.gov/disorders/disorder_index.htm] estimates that there are over 600 brain disorders and the World Health Organization is calling neurological disorders one of the greatest public health challenges today. Among the neurological disorders, over half of the burden of having a disorder is contributed to by cerebrovascular disease, 12% by Alzheimer&#039;s and other dementias, and 8% by epilepsy and migraine. Neurological disorders are a significant cause of mortality, contributing to over 12% of the total deaths globally. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Microglia==&lt;br /&gt;
&lt;br /&gt;
* [http://chronicfatigue.about.com/od/glossary/fl/Microglia-in-Fibromyalgia-amp-Chronic-Fatigue-Syndrome.htm &amp;quot;Microglia in Fibromyalgia &amp;amp; Chronic Fatigue Syndrome&amp;quot;], &#039;&#039;About Health&#039;&#039;, 22 Feb 2016.&lt;br /&gt;
* see also [[Low dose naltrexone|Low Dose Naltrexone]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Body systems]]&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Brain&amp;diff=8271</id>
		<title>Brain</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Brain&amp;diff=8271"/>
		<updated>2016-04-04T21:15:55Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:CREATE link&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;br /&gt;
==Brain Facts==&lt;br /&gt;
&lt;br /&gt;
How does the brain operate? What happens when it is compromised, such as having a tumor or stroke? Does the presence of cognitive impairment represent compromise? What about dementia that is not Alzheimer&#039;s?&lt;br /&gt;
&lt;br /&gt;
The National Institute of Neurological Disorders and Stroke ([http://www.ninds.nih.gov/disorders/disorder_index.htm] estimates that there are over 600 brain disorders&lt;br /&gt;
&lt;br /&gt;
==Microglia==&lt;br /&gt;
&lt;br /&gt;
* [http://chronicfatigue.about.com/od/glossary/fl/Microglia-in-Fibromyalgia-amp-Chronic-Fatigue-Syndrome.htm &amp;quot;Microglia in Fibromyalgia &amp;amp; Chronic Fatigue Syndrome&amp;quot;], &#039;&#039;About Health&#039;&#039;, 22 Feb 2016.&lt;br /&gt;
* see also [[Low dose naltrexone|Low Dose Naltrexone]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Body systems]]&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Brain&amp;diff=8270</id>
		<title>Brain</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Brain&amp;diff=8270"/>
		<updated>2016-04-04T21:13:11Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:/* Brain Facts */ small change&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;br /&gt;
==Brain Facts==&lt;br /&gt;
&lt;br /&gt;
How does the brain operate? What happens when it is compromised, such as having a tumor or stroke? Does the presence of cognitive impairment represent compromise? What about dementia that is not Alzheimer&#039;s?&lt;br /&gt;
&lt;br /&gt;
==Microglia==&lt;br /&gt;
&lt;br /&gt;
* [http://chronicfatigue.about.com/od/glossary/fl/Microglia-in-Fibromyalgia-amp-Chronic-Fatigue-Syndrome.htm &amp;quot;Microglia in Fibromyalgia &amp;amp; Chronic Fatigue Syndrome&amp;quot;], &#039;&#039;About Health&#039;&#039;, 22 Feb 2016.&lt;br /&gt;
* see also [[Low dose naltrexone|Low Dose Naltrexone]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Body systems]]&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=Brain&amp;diff=8269</id>
		<title>Brain</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=Brain&amp;diff=8269"/>
		<updated>2016-04-04T21:00:52Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:minor edit&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;br /&gt;
==Brain Facts==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Microglia==&lt;br /&gt;
&lt;br /&gt;
* [http://chronicfatigue.about.com/od/glossary/fl/Microglia-in-Fibromyalgia-amp-Chronic-Fatigue-Syndrome.htm &amp;quot;Microglia in Fibromyalgia &amp;amp; Chronic Fatigue Syndrome&amp;quot;], &#039;&#039;About Health&#039;&#039;, 22 Feb 2016.&lt;br /&gt;
* see also [[Low dose naltrexone|Low Dose Naltrexone]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Body systems]]&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=MEpedia:Contents&amp;diff=8268</id>
		<title>MEpedia:Contents</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=MEpedia:Contents&amp;diff=8268"/>
		<updated>2016-04-04T20:58:45Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:added names&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;We are crowd-sourcing a knowledge base on the history, science and medicine of ME and CFS around the world. MEpedia is a patient community project being built by patients, founded by #[[MEAction]]. Read more [[MEpedia:About|about MEpedia and its principles]].&lt;br /&gt;
&lt;br /&gt;
Want to take a look around? See our most [[Special:PopularPages|popular pages]], check our [[Special:NewPages|newest pages]], or visit a [[Special:random|random page]]. You can also browse a [[Special:AllPages|list of all pages]].&lt;br /&gt;
&lt;br /&gt;
==Please contribute==&lt;br /&gt;
Anyone can create pages, write content, add links/citations, fact-check, or even just fix typos. Get involved and help the patient community identify all of the best and most important resources for our disease and its research, treatment and history. Start now, read [[How to contribute]]. Please join the MEpedia [http://my.meaction.net/local_chapters/mepedia online forum], [https://www.facebook.com/mepedia/ Facebook group], and follow us on [https://twitter.com/MEencyclopedia Twitter].&lt;br /&gt;
&lt;br /&gt;
==Five minute tasks==&lt;br /&gt;
&lt;br /&gt;
Only have a five minute spoon to give? Here is a [[List of small tasks|list of small tasks]] you can help us with in roughly one to ten minutes of time.&lt;br /&gt;
&lt;br /&gt;
==Priority pages for expansion==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Science:&#039;&#039;&#039; [[Citric acid cycle]], [[Mitochondria]], [[Exercise]], [[Ampligen]], [[Natural killer cell]], [[Central nervous system]], [[Nitric oxide hypothesis]], [[Brain]], [[Brain imaging]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;History and politics:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==A note on ME v. CFS==&lt;br /&gt;
&lt;br /&gt;
We have separate pages for [[Myalgic Encephalomyelitis]], [[ME/CFS]] and [[Chronic Fatigue Syndrome]] as well as [[SEID]]. The convention is that the terminology used in an ME-pedia article should match the terminology used in the underlying source. Where there is a tension between the term used in the source and the definition (e.g., [[ME]] defined by the [[Oxford criteria]] or [[CFS]] defined by the [[Canadian Consensus Criteria]]), it may be useful for clarity to mention the definition used.&lt;br /&gt;
&lt;br /&gt;
==Primers==&lt;br /&gt;
*[[Primer for doctors and researchers]]&lt;br /&gt;
*[[Primer for patients]]&lt;br /&gt;
*[[Primer for science journalists]]&lt;br /&gt;
*[[Primer for the public]]&lt;br /&gt;
*[[Primer for family, friends and care providers]]&lt;br /&gt;
&lt;br /&gt;
==The Disease==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Infectious agents:&#039;&#039;&#039; [[Borrelia]], [[Babesia]], [[Bartonella]], [[Borna Disease Virus]], [[Chlamydia pneumoniae]], [[Coxsackie A]],  [[Coxsackie B]], [[cytomegalovirus]], [[Ebola virus]], [[echovirus]], [[enterovirus]], [[Epstein-Barr virus]], [[H1N1]], [[Herpesvirus]], [[HHV-6]], [[HHV-7]], [[HSV-1]], [[HSV-2]], [[influenza]], [[parvovirus B19]],  [[Q Fever]], [[Ross River Virus]], [[Chlamydia Pneumonia]], [[Mycoplasma Pneumonia]], [[streptococcus]], [[fungal infection]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Triggers and risk factors:&#039;&#039;&#039; [[Blood donation]], [[Candidiasis]], [[Causes of death]], [[Epidemiology]], [[Genetics]], [[Menstrual cycle]], [[Mold]], [[Pediatric]], [[Pregnancy]], [[Stress]], [[Toxic exposure]], [[Trauma]],  [[Vaccine]], [[Viral onset]], [[bacterial disease onset]], [[fungal disease onset]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Signs and symptoms:&#039;&#039;&#039; [[Ataxia]], [[attention deficits]], [[auditory sequencing problems]], [[balance problems]], [[Cognitive dysfunction]], [[Chronic pain]], [[Chronic fatigue]], [[concentration problems]], [[difficulty comprehending social cues]], [[dyslexia]], [[executive function problems]], [[Fatigue]], [[Food intolerance]], [[Irritable bowel syndrome]], [[low motivation]], [[Migraine Syndrome]], [[multi-tasking problems]], [[Muscle fatigability]], [[Neurally mediated hypotension]], [[Nonepileptic seizure]], [[Optical dysfunction]], [[Orientation in Space problems]], [[Orthostatic intolerance]], [[Planning problems]], [[Post-exertional malaise]], [[Postural orthostatic tachycardia]], [[Receptive language problems]], [[Seizure]], [[Sleep disturbance]], [[Slowed thought]], [[Unrefreshing sleep]], [[Word-finding problems]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Medical hypotheses:&#039;&#039;&#039;  [[Amygdala hypothesis]],  [[Autoimmune hypothesis]], [[encephalitis]], [[autoimmune encephalitis]], [[Fatty acid hypothesis]], [[Hygiene hypothesis]], [[Immune exhaustion hypothesis]], [[Infectious disease hypothesis]], [[Ken Lassesen&#039;s model]], [[Methylation cycle hypothesis]], [[Microbiome hypothesis]], [[Mold hypothesis]], [[Patricia Kane protocol]], [[Vagus nerve hypothesis]], [[Viral onset hypothesis]] [[Hypercoagulation hypothesis]] [[Acquired immune and mitochondrial dysfunction hypothesis]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Body systems:&#039;&#039;&#039; [[Antibody]], [[Autoantibody]], [[Blood]], [[Brain]], [[B cell]], [[Central sensitization]], [[Cytokine]], [[Chemokine]], [[Cardiovascular system]], [[Gastrointestinal system]], [[Glutamate excitotoxicity]], [[HPA axis]],  [[Immune system]], [[IL-1]], [[IL-2]], [[IL-6]], [[IL-8]], [[IL-10]], [[IL-16]], [[IL-17]], [[IL-18]], [[interferon]], [[Leaky brain]], [[Leaky gut]], [[Macrophage]], [[Microglia]],  [[Microbiome]],  [[Mucosal immune system]], [[Nervous system]], [[Natural killer cell]], [[Neuroinflammation]], [[Ribonuclease L]], [[Spinal cord]], [[Tumor necrosis factors]], [[VEGF]], [[T cell]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Tests:&#039;&#039;&#039; [[Brain imaging]], [[Cardiopulmonary exercise test]], [[CellTrend diagnostic test]], [[C reactive protein]], [[qEEG/LORETA]], [[Erythrocyte sedimentation rate]], [[Exercise]], [[National Centre for Neuroimmunology and Emerging Diseases#Potential biomarker|NCNED Griffith University diagnostic test]], [[MRI]], [[Orosomucoid]], [[qEEG]], [[SF-36]], [[SPECT]], [[Tilt Table]], [[Two day exercise test]], [[Natural Killer Cell (NKC) Function]], [[arginine vasopressin]], [[MTHFR and other methylation mutations]], [[infectious disesases]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Citizen science:&#039;&#039;&#039; [[23andMe]], [[American Gut]], [[Any Treatment]], [[Mendus]], [[Phoenix Rising]], [[UBiome]], [[Know Your Genetics: Dr. Amy Yasko]], [[WellnessFX]], [[CH3Nutrigenomics; Dr. Amy Yasko]], [[MTHFR.net]], [[Genetic Genie]], [[LiveWello]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Biochemistry and cell biology:&#039;&#039;&#039; [[ATP]], [[Cellular respiration]], [[Citric acid cycle]], [[D lactate]], [[Endocannabinoid]], [[Glucocorticoid]], [[Glutathione]], [[Histamine]], [[Methylation cycle]], [[Mitochondria]], [[Nitric oxide]], [[Oxidative phosphorylation]], [[Phenylalanine]], [[Tyrosine]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Nutrients:&#039;&#039;&#039; [[Copper]], [[Deadlock quartet]], [[Folate]], [[L-carnitine]], [[Magnesium]], [[Sam-e]], [[TMG]], [[Vitamin B2]], [[Vitamin B6]], [[Vitamin B12]], [[Vitamin C]], [[Vitamin D]], [[Zinc]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Neurotransmitters and hormones&#039;&#039;&#039;: [[Acetylcholine]], [[Alpha-Melanocyte-stimulating hormone]], [[Calicitriol]], [[Calcidiol]], [[Cortisol]], [[Dopamine]], [[Estriadol]], [[Epinephrine]], [[Estrogen]], [[Glucocorticoid]], [[Glutamate]], [[Histamine]], [[Hormones]], [[Leptin]], [[Melatonin]], [[Neurotransmitters]], [[Norepinephrine]], [[Oxytocin]], [[Progesterone]], [[Prolactin]], [[Prostaglandins]], [[Serotonin]], [[Testosterone]], [[Vasopressin]], [[Thyroid]], [[MSH]], [[HGH]]&lt;br /&gt;
&lt;br /&gt;
[[Blood donation]]&lt;br /&gt;
&lt;br /&gt;
==Names &amp;amp; Definitions==&lt;br /&gt;
&#039;&#039;&#039;Names:&#039;&#039;&#039; [[Myalgic Encephalomyelitis]], [[Chronic Fatigue Syndrome]], [[ME/CFS]], [[Systemic Exertion Intolerance Disease]], [[Chronic Fatigue Immune Deficiency Syndrome]], [[Chronic epstein barr]], [[Neuro-Inflammatory and Oxidative Fatigue]], [[Yuppie Flu]], [[Neurasthenia]], [[Chronic Fatigue]], [[Infectious Venulitis]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Related conditions:&#039;&#039;&#039; [[Chronic lyme disease]], [[Mold illness]], [[Biotoxin illness]], [[Environmental illness]], [[Multiple Chemical Sensitivity]], [[Gulf War Illness]], [[Mast cell activation disorder]], [[Mastocytosis]], [[Ehlers Danlos Syndrome]], [[Fibromyalgia]], [[Small intestine bacterial overgrowth]], [[Lactic acidosis]], [[Autoimmune disease]], [[Cancer]], [[Thyroid disease]], [[Non-Hodgkin&#039;s lymphoma]], [[Multiple Sclerosis]], [[Dysautonomia]], [[Mitochondrial disorders]], [[Chronic Epstein Barr]], [[Raynaud&#039;s Syndrome]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Definitions:&#039;&#039;&#039; [[Definitions of ME and CFS]], [[Canadian Consensus Criteria]], [[International Consensus Criteria]], [[Oxford criteria]],  [[Fukuda criteria]], [[Holmes criteria]], [[Empirical definition]], [[Ramsay definition]], [[London criteria]], [[Nightingale definition]], [[Reeves criteria]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Acronyms:&#039;&#039;&#039; [[List of acronyms]]&lt;br /&gt;
&lt;br /&gt;
==Potential treatments==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Category page&#039;&#039;&#039;: [[Treatments|Potential treatments]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Supplements:&#039;&#039;&#039; [[Probiotics]], [[AHCC]], [[CoQ10]], [[L-carnitine]], [[MitoQ]], [[NADH]], [[PrescriptAssist]], [[Mutaflor]], [[GcMAF]], [[Colostrum]], [[Transfer factors]], [[Fish oil]], [[EPA]], [[DHA]], [[Taurine]], [[L-Glutamine]], [[Glutathione]], [[Niacinamide]], [[B Vitamin Complex]], [[Adaptogens]] ([[Eleuthro]], [[Ginseng]], [[Ashwaganda]], [[Rhodiola]], [[Licorice]]), [[Mangosteen]], [[Vegan/non-whey Protein Powders with Amino Acid Complex]], [[Greens Powders]], [[D-Ribose]], [[Quercetin]], [[Nexavir]], [[5-Hydroxytryptophan]], [[Melatonin]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Supplement Sources:&#039;&#039;&#039; [[Pure Formulas]], [[Be Well By Dr Frank Lipman]], [[Seeking Health]], [[MITOQ]], [[Aloha]], [[ProHealth]], [[Thrive Marketplace]], [[HolisticHeal]], [[Vitacost.com]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Foods:&#039;&#039;&#039; [[Cocoa|Cocoa (Dark chocolate)]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Herbs:&#039;&#039;&#039; [[Medical marijuana]], [[Kampo]], [[Equilibrium]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Diets:&#039;&#039;&#039; [[GAPS diet]], [[Ketogenic diet]], [[Low FODMAP diet|Low FODMAP Diet]], [[Low histamine diet|Low Histamine Diet]], [[Paleo diet]], [[RPAH elimination diet|RPAH Elimination Diet]], [[Specific carbohydrate diet]], [[Vegan diet]], [[Vegetarian diet]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Antivirals:&#039;&#039;&#039; [[Valgancyclovir]], [[Famciclovir]], [[Valaciclovir]], [[Acyclovir]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Immunomodulators and immunostimulants:&#039;&#039;&#039; [[Ampligen]], [[Low dose naltrexone]], [[Equilibrant]], [[Intravenous immunoglobulin]], [[Staphylococcal vaccine]], [[Immunovir]], [[Medicinal mushrooms]], [[Interferon]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Anti-inflammatory drugs:&#039;&#039;&#039; [[Sulfasalazine]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Anti-fungal drugs:&#039;&#039;&#039; [[fluconazole]], [[itraconazole]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Other drug treatments:&#039;&#039;&#039; [[Chelation]], [[Cyclophosphamide]], [[Prednisone]], [[Rituximab]], [[Trazodone]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Toxin avoidance/removal:&#039;&#039;&#039; [[Fasting]], [[Mold avoidance]], [[Coffee enema]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Uncategorized interventions:&#039;&#039;&#039; [[Traditional Chinese medicine]], [[Cold immersion]], [[Fecal matter transplant]]/[[Faecal bacteriotherapy]], [[Helminthic therapy]], [[Pacing]], [[Energy envelope]], [[Hyperbaric oxygen]], [[Ozone]], [[Altitude]], [[Exercise]], [[Vagus nerve stimulation]], [[Exercise based on 2-day CPET]], [[Lipid replacement therapy]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Management guides:&#039;&#039;&#039; [https://www.actionforme.org.uk/uploads/taming-the-gorilla-booklet.pdf Taming the Gorilla] ([[Action for ME]]), [http://stonebird.co.uk/Notes/index.html Notes for Carers] ([[Greg Crowhurst]]), [http://www.meassociation.org.uk/2014/07/our-purple-booklet-clear-clinical-guidance-and-the-latest-research-all-wrapped-up-in-52-pages/ The Purple Booklet] ([[ME Association]])&lt;br /&gt;
&lt;br /&gt;
==Doctors==&lt;br /&gt;
&#039;&#039;&#039;Clinical Doctors, USA:&#039;&#039;&#039; [[Lucinda Bateman]] (UT) [[Derek Enlander]]; [[Susan Levine]] (NY) &lt;br /&gt;
[[Nancy Klimas]] (FL) [[Courtney Craig]]; [[Daniel Peterson]] (NV) [[Phillipe Bottello]]; [[John Chia]]; [[OMI Clinic: David Kaufman and Andy Kogelnick]] (CA) [[Jacob Teitelbaum]]; [[Richard Podell]] (NJ) [[Laura Black]] (NC); [[Amy Yasko]]; [[Jose Montoya]]  (CA)&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Clinical Doctors, UK:&#039;&#039;&#039; [[Sarah Myhill]], [[William Weir]], [[Nigel Speight]], [[Peter Behan]], [[Charles Shepherd]], [[Gabrielle Murphy]], [[Amolak Bansal]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Clinical Doctors, Germany:&#039;&#039;&#039; [[Anna Dorothea Hoeck]], [[Carmen Scheibenbogen]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Clinical Doctors, Belgium:&#039;&#039;&#039; [[Kenny de Meirleir]], [[Annemie Uyttersprot (GP)]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Clinical Doctors, South Africa:&#039;&#039;&#039; [[Cecile Jadin]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Clinical Doctors, Sweden:&#039;&#039;&#039; [[Carl-Gerhard Gottfries]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Clinical Doctors, Italy:&#039;&#039;&#039; [[Umberto Tirelli]], [[Lorenzo Lorusso]], [[Eligio Pizzigallo]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Clinical Doctors, Australia:&#039;&#039;&#039; [[Donald P Lewis]] (VIC), [[John Whiting]], [[Rashmi Cabena]] (VIC), [[Richard Schloeffel]] (NSW)&lt;br /&gt;
&lt;br /&gt;
==Research==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;[[Notable studies]]&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039; Research initiatives USA:&#039;&#039;&#039; [[Chronic Fatigue Syndrome Project]], [[Open Medicine Foundation]], [[Chronic Fatigue Initiative]], [[Stanford ME/CFS Initiative]], [[Microbe Discovery Project]], [[Bateman Horne Center]], [[Workwell Foundation]], [[Center for Infection &amp;amp; Immunity]], [[Solve ME/CFS Initiative]], [[Simmaron Research]], [[Treatment Center for CFS]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039; Researchers USA:&#039;&#039;&#039; }[Marcie Zinn]][Ronald Davis]], [[Jarred Younger]], [[Alan Light]], [[Kathleen Light]], [[Andreas Kogelnik]], [[Jose Montoya]], [[David Bell]], [[Mady Hornig]], [[Eric Schadt]], [[Ian Lipkin]], [[John Chia]], [[Rosemary Underhill]], [[Suzanne Vernon]], [[David Berg]], [[Nancy Klimas]], [[Dane Cook]], [[Staci Stevens]], [[Mark VanNess]], [[Christopher Snell]], [[Zaher Nahle]], [[Rich Van Konyenburg]], [[Judy Mikovits]], [[Paul Cheney]], [[Michael Van ElZakker]], [[Zaher Nahle]], [[Michael Zeineh]], [[Anthony Komaroff]], [[A Martin Lerner]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039; Research initiatives Europe:&#039;&#039;&#039; [[ME Research UK]], [[Cure ME]] (UK), [[Invest in ME]] (UK), [[UK CFS/ME Collaborative]], [[Grand Challenge]], [[Invest in ME Conference]] (UK), [[Ramsay Research Fund]] (UK), [[European ME Research Group]], [[Charité Berlin]] (Germany), [[Wake-Up Call]] (Belgium)&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Research initiatives Australia:&#039;&#039;&#039; [[National Centre for Neuroimmunology and Emerging Diseases]], [[Victoria University]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Research initiatives Canada:&#039;&#039;&#039; [[Nightingale Research Foundation]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039; Researchers UK:&#039;&#039;&#039;  [[Melvin Ramsay]], [[Donald Acheson]], [[Gordon Parish]], [[Jonathan Kerr]], [[Amolak Bansal]], [[Julia Newton]], [[Elizabeth Dowsett]], [[Simon Carding]], [[James Mowbray]], [[John Richardson]], [[Luis Nacul]], [[Derek Pheby]], [[Jonathan Edwards]], [[Geraldine Cambridge]], [[George Davey Smith]], [[Neil Harrison]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039; Researchers Australia:&#039;&#039;&#039; [[Amy Wallis]], [[Donald P Lewis]], [[Donald Staines]], [[Dorothy Bruck]], [[Elaine DeFreitas]], [[Henry Butt]], [[Melinda L Jackson]], [[Michael Maes]], [[Sonya Marshall-Gradisnik]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039; Researchers Germany:&#039;&#039;&#039; [[Carmen Scheibenbogen]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039; Researchers Norway:&#039;&#039;&#039; [[Olav Mella]], [[Øystein Fluge]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039; Researchers Canada:&#039;&#039;&#039; [[Byron Hyde]], [[Patrick O. McGowan]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Researchers Japan:&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Biobanks &amp;amp; patient registries&#039;&#039;&#039;: [[CURE ME]] (UK), [[OMI OpenMedNet]] (US), [[CFI CFS BioBank]] (US), [[SolveCFS BioBank]] (US), [[Simmaron Research BioBank]] (US)&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Researcher mailing lists:&#039;&#039;&#039; [[CureME mailing list]]&lt;br /&gt;
&lt;br /&gt;
==Psychological Paradigm==&lt;br /&gt;
&#039;&#039;&#039;Psychological paradigm, mind-body approaches and related interventions:&#039;&#039;&#039; [[FINE trial]], [[PACE trial]], [[Graded exercise therapy|Graded Exercise Therapy]], [[cognitive behavioral therapy|Cognitive Behavioral Therapy]], [[biopsychosocial]], [[Deconditioning]], [[Mickel therapy]], [[Lightning process]], [[Gupta programme]], [[Psychoneuroimmunology]], [[Meditation]], [[Bodily distress syndrome]], [[Functional somatic syndrome]], [[Psychosomatic illness]], [[Neurasthenia]], [[Medically unexplained symptoms]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Psychological paradigm proponents:&#039;&#039;&#039; [[Simon Wessely]], [[Michael Sharpe]], [[Peter White]], [[Trudie Chalder]], [[Rona Moss-Morris]], [[Jessica Bavinton]], [[Esther Crawley]], [[Anthony Cleare]], [[Ben Goldacre]], [[Peter Manu]], [[Brian Walitt]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Psychological paradigm critics:&#039;&#039;&#039; [[James Coyne]], [[Keith Laws]], [[David Tuller]], [[Ronald Davis]], [[Bruce Levin]], [[Arthur Reingold]], [[Jonathan Edwards]], [[Leonard Jason]], [[Ellen Goudsmit]], [[Angela Kennedy]]&lt;br /&gt;
&lt;br /&gt;
[[Patient mental health]]&lt;br /&gt;
&lt;br /&gt;
==Around the world==&lt;br /&gt;
*&#039;&#039;&#039;Asia:&#039;&#039;&#039; [[China]], [[India]], [[Indonesia]], [[Israel]], [[Japan]], [[Russia]]&lt;br /&gt;
*&#039;&#039;&#039;Africa:&#039;&#039;&#039; [[Kenya]], [[Nigeria]]&lt;br /&gt;
*&#039;&#039;&#039;Europe:&#039;&#039;&#039; [[Austria]], [[Belgium]], [[Bulgaria]], [[Czech Republic]], [[Denmark]], [[Finland]], [[France]] [[Germany]], [[Greece]], [[Hungary]], [[Ireland]], [[Italy]], [[Netherlands]], [[Norway]], [[Poland]], [[Romania]], [[Slovakia]], [[Slovenia]], [[Spain]], [[Sweden]], [[Ukraine]], [[United Kingdom]]&lt;br /&gt;
*&#039;&#039;&#039;North America:&#039;&#039;&#039; [[Canada]], [[Mexico]], [[United States]]&lt;br /&gt;
*&#039;&#039;&#039;South America:&#039;&#039;&#039; [[Argentina]], [[Brazil]]&lt;br /&gt;
*&#039;&#039;&#039;Australia &amp;amp; New Zealand:&#039;&#039;&#039; [[Australia]], [[New Zealand]]&lt;br /&gt;
&lt;br /&gt;
==History==&lt;br /&gt;
&lt;br /&gt;
[[Important events timeline]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Historical records&#039;&#039;&#039;: [[Osler&#039;s Web]], [[Thirty Years of Disdain]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Outbreaks:&#039;&#039;&#039; [[List of myalgic encephalomyelitis and chronic fatigue syndrome outbreaks|Outbreaks]]: [[Incline village|Incline village 1984]], [[1985 Lyndonville outbreak|Lyndonville 1985]], [[Akureyri]], [[1934 Los Angeles outbreak|Los Angeles 1934]], [[Royal Free Hospital outbreak|Royal Free Hospital 1955]], [[1955 Dalston outbreak|Dalston 1955]], [[1949 Adelaide outbreak|Adelaide 1949]], [[1980-81 Ayrshire outbreak|Ayrshire 1980]], [[1975 Sacramento outbreak|Sacramento 1975]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Deceased patients:&#039;&#039;&#039; [[Sophia Mirza]], [[Thomas Hennessy, Jr.]], [[Vanessa Li]], [[Lynn Gilderdale]], [[Emily Collingridge]],  [[Chardale Dotson Irvine]], [[Oliver Coles]], [[Brynmor John]], [[Victoria Elsbury-Legg]], [[Roger Cicero]], [[Memorial Lists]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Major developments/controversies:&#039;&#039;&#039; [[PACE trial]], [[XMRV]]&lt;br /&gt;
&lt;br /&gt;
[[ME and CFS in popular culture]]&lt;br /&gt;
&lt;br /&gt;
==Patient Advocacy==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups Australia:&#039;&#039;&#039; [[Emerge Australia]], [[ME/CFS Australia (SA) Inc]], [[ME/CFS Society of Western Australia]], [[ME/CFS Society of NSW]], [[ME/CFS Society of ACT]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups Belgium:&#039;&#039;&#039; [[Wake Up Call Beweging]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups Canada:&#039;&#039;&#039; [[National ME/FM Action Network]], [[May12th.org]], [[Action CIND]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups Ireland:&#039;&#039;&#039; [[Irish ME/CFS Association]], [[Irish ME Trust]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups Italy:&#039;&#039;&#039; [[Associazione Malati CFS onlus]], [[CFS Associazione Italiana onlus]], [[CFS Italia]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups Netherlands:&#039;&#039;&#039; [[ME Vereniging Nederland]] &lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups New Zealand:&#039;&#039;&#039; [[Associated New Zealand ME Society]] (ANZMES)&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups Norway:&#039;&#039;&#039; [[ME-Forskning]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups Sweden:&#039;&#039;&#039; [[Riksföreningen för ME-patienter]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups UK:&#039;&#039;&#039; [[Action for ME]], [[Invest in ME]], [[Change For M.E. Change For Us]], [[Norfolk &amp;amp; Suffolk ME]], [[ME Association]], [[Tymes Trust]], [[MEActionUK]], [[Forward-ME]], [[Hope 4 ME &amp;amp; Fibro NI]], [[Welsh Association of ME &amp;amp; CFS Support]], [[Sussex &amp;amp; Kent ME/CFS Society]], [[Association of Young People with ME]], [[Tyne &amp;amp; Wear ME/CFS Support Group]], [[Edinburgh MESH]], [[Leeds ME Network]], [[The York ME Community]], [[25 Percent ME Group]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups USA:&#039;&#039;&#039; #[[MEAction]], [[MEadvocacy]], [[National Alliance for Myalgic Encephalomyelitis]], [[Massachusetts CFIDS/ME &amp;amp; FM Association]], [[May12.org]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Advocacy/Fundraising Initiatives:&#039;&#039;&#039; [[Chilli ME Challenge]], [[ME Foggy Dog]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Famous patients&#039;&#039;&#039;: [[Laura Hillenbrand]], [[Martine McCutcheon]], [[Stuart Murdoch]], [[Charles Darwin]], [[Florence Nightingale]], [[Roger Cicero]], [[Shirley Conran]], [[Michael Crawford]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Notable patients:&#039;&#039;&#039; [[Karina Hansen]], [[Joanne]], [[Sophia Mirza]], [[Thomas Hennessy, JR.]], [[Vanessa Li]], [[Lynn Gilderdale]], [[Emily Collingridge]], [[Whitney Dafoe]], [[Tom Kindlon]], [[Graham McPhee]], [[Jennie Spotila]], [[Naomi Whittingham]], [[Jane Colby]], [[Countess of Mar]], [[Brian Vastag]], [[Jennifer Brea]], [[Ryan Prior]], [[Hillary Johnson]], [[Julie Rehmeyer]], [[Leonard Jason]], [[Charles Shepherd]], [[Nasim Marie Jafry]], [[Ken Lassesen]], [[Cort Johnson]], [[Valerie Eliot Smith]], [[Doctor Speedy]], [[Tanya Marlow]], [[Deborah Waroff]], [[Beth Mazur]], [[Catherine Hale]], [[Mary Schweitzer]], [[Toni Bernhard]], [[Guido den Broeder]], [[Frank Twisk]], [[Steven Lubet]], [[Giada Da Ros]], [[Roberta Pelletta]], [[Carol Head]], [[Ean Proctor]], [[Jessica Taylor]], [[Clark Ellis]], [[Alem Matthews]], [[Peter Kemp]], [[Mindy Kitei]] [[Jeanette Burmeister]], [[Giles Meehan]], [[Erik Johnson]], [[Lisa Petrison]], [[Mary Ann Kindel]], [[Gabby Klein]], [[Eileen Holderman]], [[Susan Kreutzer]], [[Maryann Spurgin]], [[Wendy Boutiler]], [[L.A. Cooper]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Notable healthy advocates:&#039;&#039;&#039; [[Angela Kennedy]], [[Mary Dimmock]], [[Greg Crowhurst]], [[Malcolm Hooper]], [[Nicole Castillo]], [[Llewellyn King]], [[Erica Verrillo]], [[Tom Whittingham]], [[Mike Harley]], [[Ian Gibson]], [[Scott Ludlam]], [[Linda and Don Tannenbaum]], [[Jon Campling]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Notable Quotes:&#039;&#039;&#039; [[List of Quotes]], [[Individual Quotes]]&lt;br /&gt;
&lt;br /&gt;
==Journals, TV, Articles, Books, Film, Interviews, Blogs, Discussion Forums==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Journals:&#039;&#039;&#039; &lt;br /&gt;
[[The Lancet]] &lt;br /&gt;
[[Lancet Psychiatry]] [[The BMJ]] [[Journal of Chronic Fatigue Syndrome]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;TV:&#039;&#039;&#039; [[Sick and Tired]] (US), [[Sick and Tired - BBC]] (UK),  [[Toxic Tiredness]], [[I Remember Me]], [[BBC Documentary on life with severe ME/Chronic Fatigue Syndrome]] (UK)&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Articles:&#039;&#039;&#039; [[List of news articles on ME and CFS]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Books:&#039;&#039;&#039; [[Plague]], [[The State of Me]], [[Love and Fatigue in America]], [[Osler&#039;s Web]], [[America&#039;s Biggest Cover-Up]], [[Reviving the Broken Marionette]], [[Why ME?]], [[Stanchi: Vivere con la Sindrome da Fatica Cronica]], [[Stanchi si diventa]], [[Frammenti di ME]], [[Encounters with the Invisible]], [[Chronic Fatigue Syndrome: A Treatment Guide]], [[Chronic Fatigue Syndrome: A Treatment Guide - 2nd Edition]], [[Severe ME/CFS: A Guide to Living]], [[Severe ME - Featuring: &amp;quot;Justice for Karina Hansen&amp;quot;]], [[Severe ME: Notes for Carers]], [[One Last Goodbye]], [[Authors of our Own Misfortune? The Problems with Psychogenic Explanations for Physical Illnesses]].&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Film:&#039;&#039;&#039; [[What About ME]], [[I Remember Me]], [[Forgotten Plague]], [[Canary in a Coal Mine]], [[The Last Great Medical Cover Up]], [[Invisible Illness - Stories of Chronic Fatigue Syndrome]], [[Voices from the Shadows]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Interviews:&#039;&#039;&#039; &lt;br /&gt;
[[ME/CFS Alert]], [[Science for Patients]] &lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Blogs:&#039;&#039;&#039; [[Health Rising]], [[Occupy CFS]], [[MEAction]], [[ME Advocacy]], [[Courtney Craig]], [[Cell Fatigue]], [[CFS Patient Advocate]], [[Constant F****** S***]], [[ME Association]], [[Onward Through the Fog]], [[Nice Guidelines]], [[Valerie Eliot Smith Blog]], [[CFS Remission]], [[About.com Health FMS/ME/CFS]], [[Just ME]], [[ME/CFS Ghost]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Discussion Forums:&#039;&#039;&#039; [[Phoenix Rising]], [[CFSItalia]], [[MDJunction]]&lt;br /&gt;
&lt;br /&gt;
== [[Open Letters]] ==&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=MEpedia:Contents&amp;diff=8267</id>
		<title>MEpedia:Contents</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=MEpedia:Contents&amp;diff=8267"/>
		<updated>2016-04-04T20:30:50Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:/* The Disease */ added terms&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;We are crowd-sourcing a knowledge base on the history, science and medicine of ME and CFS around the world. MEpedia is a patient community project being built by patients, founded by #[[MEAction]]. Read more [[MEpedia:About|about MEpedia and its principles]].&lt;br /&gt;
&lt;br /&gt;
Want to take a look around? See our most [[Special:PopularPages|popular pages]], check our [[Special:NewPages|newest pages]], or visit a [[Special:random|random page]]. You can also browse a [[Special:AllPages|list of all pages]].&lt;br /&gt;
&lt;br /&gt;
==Please contribute==&lt;br /&gt;
Anyone can create pages, write content, add links/citations, fact-check, or even just fix typos. Get involved and help the patient community identify all of the best and most important resources for our disease and its research, treatment and history. Start now, read [[How to contribute]]. Please join the MEpedia [http://my.meaction.net/local_chapters/mepedia online forum], [https://www.facebook.com/mepedia/ Facebook group], and follow us on [https://twitter.com/MEencyclopedia Twitter].&lt;br /&gt;
&lt;br /&gt;
==Five minute tasks==&lt;br /&gt;
&lt;br /&gt;
Only have a five minute spoon to give? Here is a [[List of small tasks|list of small tasks]] you can help us with in roughly one to ten minutes of time.&lt;br /&gt;
&lt;br /&gt;
==Priority pages for expansion==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Science:&#039;&#039;&#039; [[Citric acid cycle]], [[Mitochondria]], [[Exercise]], [[Ampligen]], [[Natural killer cell]], [[Central nervous system]], [[Nitric oxide hypothesis]], [[Brain]], [[Brain imaging]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;History and politics:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==A note on ME v. CFS==&lt;br /&gt;
&lt;br /&gt;
We have separate pages for [[Myalgic Encephalomyelitis]], [[ME/CFS]] and [[Chronic Fatigue Syndrome]] as well as [[SEID]]. The convention is that the terminology used in an ME-pedia article should match the terminology used in the underlying source. Where there is a tension between the term used in the source and the definition (e.g., [[ME]] defined by the [[Oxford criteria]] or [[CFS]] defined by the [[Canadian Consensus Criteria]]), it may be useful for clarity to mention the definition used.&lt;br /&gt;
&lt;br /&gt;
==Primers==&lt;br /&gt;
*[[Primer for doctors and researchers]]&lt;br /&gt;
*[[Primer for patients]]&lt;br /&gt;
*[[Primer for science journalists]]&lt;br /&gt;
*[[Primer for the public]]&lt;br /&gt;
*[[Primer for family, friends and care providers]]&lt;br /&gt;
&lt;br /&gt;
==The Disease==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Infectious agents:&#039;&#039;&#039; [[Borrelia]], [[Babesia]], [[Bartonella]], [[Borna Disease Virus]], [[Chlamydia pneumoniae]], [[Coxsackie A]],  [[Coxsackie B]], [[cytomegalovirus]], [[Ebola virus]], [[echovirus]], [[enterovirus]], [[Epstein-Barr virus]], [[H1N1]], [[Herpesvirus]], [[HHV-6]], [[HHV-7]], [[HSV-1]], [[HSV-2]], [[influenza]], [[parvovirus B19]],  [[Q Fever]], [[Ross River Virus]], [[Chlamydia Pneumonia]], [[Mycoplasma Pneumonia]], [[streptococcus]], [[fungal infection]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Triggers and risk factors:&#039;&#039;&#039; [[Blood donation]], [[Candidiasis]], [[Causes of death]], [[Epidemiology]], [[Genetics]], [[Menstrual cycle]], [[Mold]], [[Pediatric]], [[Pregnancy]], [[Stress]], [[Toxic exposure]], [[Trauma]],  [[Vaccine]], [[Viral onset]], [[bacterial disease onset]], [[fungal disease onset]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Signs and symptoms:&#039;&#039;&#039; [[Ataxia]], [[attention deficits]], [[auditory sequencing problems]], [[balance problems]], [[Cognitive dysfunction]], [[Chronic pain]], [[Chronic fatigue]], [[concentration problems]], [[difficulty comprehending social cues]], [[dyslexia]], [[executive function problems]], [[Fatigue]], [[Food intolerance]], [[Irritable bowel syndrome]], [[low motivation]], [[Migraine Syndrome]], [[multi-tasking problems]], [[Muscle fatigability]], [[Neurally mediated hypotension]], [[Nonepileptic seizure]], [[Optical dysfunction]], [[Orientation in Space problems]], [[Orthostatic intolerance]], [[Planning problems]], [[Post-exertional malaise]], [[Postural orthostatic tachycardia]], [[Receptive language problems]], [[Seizure]], [[Sleep disturbance]], [[Slowed thought]], [[Unrefreshing sleep]], [[Word-finding problems]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Medical hypotheses:&#039;&#039;&#039;  [[Amygdala hypothesis]],  [[Autoimmune hypothesis]], [[encephalitis]], [[autoimmune encephalitis]], [[Fatty acid hypothesis]], [[Hygiene hypothesis]], [[Immune exhaustion hypothesis]], [[Infectious disease hypothesis]], [[Ken Lassesen&#039;s model]], [[Methylation cycle hypothesis]], [[Microbiome hypothesis]], [[Mold hypothesis]], [[Patricia Kane protocol]], [[Vagus nerve hypothesis]], [[Viral onset hypothesis]] [[Hypercoagulation hypothesis]] [[Acquired immune and mitochondrial dysfunction hypothesis]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Body systems:&#039;&#039;&#039; [[Antibody]], [[Autoantibody]], [[Blood]], [[Brain]], [[B cell]], [[Central sensitization]], [[Cytokine]], [[Chemokine]], [[Cardiovascular system]], [[Gastrointestinal system]], [[Glutamate excitotoxicity]], [[HPA axis]],  [[Immune system]], [[IL-1]], [[IL-2]], [[IL-6]], [[IL-8]], [[IL-10]], [[IL-16]], [[IL-17]], [[IL-18]], [[interferon]], [[Leaky brain]], [[Leaky gut]], [[Macrophage]], [[Microglia]],  [[Microbiome]],  [[Mucosal immune system]], [[Nervous system]], [[Natural killer cell]], [[Neuroinflammation]], [[Ribonuclease L]], [[Spinal cord]], [[Tumor necrosis factors]], [[VEGF]], [[T cell]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Tests:&#039;&#039;&#039; [[Brain imaging]], [[Cardiopulmonary exercise test]], [[CellTrend diagnostic test]], [[C reactive protein]], [[qEEG/LORETA]], [[Erythrocyte sedimentation rate]], [[Exercise]], [[National Centre for Neuroimmunology and Emerging Diseases#Potential biomarker|NCNED Griffith University diagnostic test]], [[MRI]], [[Orosomucoid]], [[qEEG]], [[SF-36]], [[SPECT]], [[Tilt Table]], [[Two day exercise test]], [[Natural Killer Cell (NKC) Function]], [[arginine vasopressin]], [[MTHFR and other methylation mutations]], [[infectious disesases]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Citizen science:&#039;&#039;&#039; [[23andMe]], [[American Gut]], [[Any Treatment]], [[Mendus]], [[Phoenix Rising]], [[UBiome]], [[Know Your Genetics: Dr. Amy Yasko]], [[WellnessFX]], [[CH3Nutrigenomics; Dr. Amy Yasko]], [[MTHFR.net]], [[Genetic Genie]], [[LiveWello]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Biochemistry and cell biology:&#039;&#039;&#039; [[ATP]], [[Cellular respiration]], [[Citric acid cycle]], [[D lactate]], [[Endocannabinoid]], [[Glucocorticoid]], [[Glutathione]], [[Histamine]], [[Methylation cycle]], [[Mitochondria]], [[Nitric oxide]], [[Oxidative phosphorylation]], [[Phenylalanine]], [[Tyrosine]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Nutrients:&#039;&#039;&#039; [[Copper]], [[Deadlock quartet]], [[Folate]], [[L-carnitine]], [[Magnesium]], [[Sam-e]], [[TMG]], [[Vitamin B2]], [[Vitamin B6]], [[Vitamin B12]], [[Vitamin C]], [[Vitamin D]], [[Zinc]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Neurotransmitters and hormones&#039;&#039;&#039;: [[Acetylcholine]], [[Alpha-Melanocyte-stimulating hormone]], [[Calicitriol]], [[Calcidiol]], [[Cortisol]], [[Dopamine]], [[Estriadol]], [[Epinephrine]], [[Estrogen]], [[Glucocorticoid]], [[Glutamate]], [[Histamine]], [[Hormones]], [[Leptin]], [[Melatonin]], [[Neurotransmitters]], [[Norepinephrine]], [[Oxytocin]], [[Progesterone]], [[Prolactin]], [[Prostaglandins]], [[Serotonin]], [[Testosterone]], [[Vasopressin]], [[Thyroid]], [[MSH]], [[HGH]]&lt;br /&gt;
&lt;br /&gt;
[[Blood donation]]&lt;br /&gt;
&lt;br /&gt;
==Names &amp;amp; Definitions==&lt;br /&gt;
&#039;&#039;&#039;Names:&#039;&#039;&#039; [[Myalgic Encephalomyelitis]], [[Chronic Fatigue Syndrome]], [[ME/CFS]], [[Systemic Exertion Intolerance Disease]], [[Chronic Fatigue Immune Deficiency Syndrome]], [[Chronic epstein barr]], [[Neuro-Inflammatory and Oxidative Fatigue]], [[Yuppie Flu]], [[Neurasthenia]], [[Chronic Fatigue]], [[Infectious Venulitis]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Related conditions:&#039;&#039;&#039; [[Chronic lyme disease]], [[Mold illness]], [[Biotoxin illness]], [[Environmental illness]], [[Multiple Chemical Sensitivity]], [[Gulf War Illness]], [[Mast cell activation disorder]], [[Mastocytosis]], [[Ehlers Danlos Syndrome]], [[Fibromyalgia]], [[Small intestine bacterial overgrowth]], [[Lactic acidosis]], [[Autoimmune disease]], [[Cancer]], [[Thyroid disease]], [[Non-Hodgkin&#039;s lymphoma]], [[Multiple Sclerosis]], [[Dysautonomia]], [[Mitochondrial disorders]], [[Chronic Epstein Barr]], [[Raynaud&#039;s Syndrome]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Definitions:&#039;&#039;&#039; [[Definitions of ME and CFS]], [[Canadian Consensus Criteria]], [[International Consensus Criteria]], [[Oxford criteria]],  [[Fukuda criteria]], [[Holmes criteria]], [[Empirical definition]], [[Ramsay definition]], [[London criteria]], [[Nightingale definition]], [[Reeves criteria]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Acronyms:&#039;&#039;&#039; [[List of acronyms]]&lt;br /&gt;
&lt;br /&gt;
==Potential treatments==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Category page&#039;&#039;&#039;: [[Treatments|Potential treatments]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Supplements:&#039;&#039;&#039; [[Probiotics]], [[AHCC]], [[CoQ10]], [[L-carnitine]], [[MitoQ]], [[NADH]], [[PrescriptAssist]], [[Mutaflor]], [[GcMAF]], [[Colostrum]], [[Transfer factors]], [[Fish oil]], [[EPA]], [[DHA]], [[Taurine]], [[L-Glutamine]], [[Glutathione]], [[Niacinamide]], [[B Vitamin Complex]], [[Adaptogens]] ([[Eleuthro]], [[Ginseng]], [[Ashwaganda]], [[Rhodiola]], [[Licorice]]), [[Mangosteen]], [[Vegan/non-whey Protein Powders with Amino Acid Complex]], [[Greens Powders]], [[D-Ribose]], [[Quercetin]], [[Nexavir]], [[5-Hydroxytryptophan]], [[Melatonin]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Supplement Sources:&#039;&#039;&#039; [[Pure Formulas]], [[Be Well By Dr Frank Lipman]], [[Seeking Health]], [[MITOQ]], [[Aloha]], [[ProHealth]], [[Thrive Marketplace]], [[HolisticHeal]], [[Vitacost.com]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Foods:&#039;&#039;&#039; [[Cocoa|Cocoa (Dark chocolate)]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Herbs:&#039;&#039;&#039; [[Medical marijuana]], [[Kampo]], [[Equilibrium]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Diets:&#039;&#039;&#039; [[GAPS diet]], [[Ketogenic diet]], [[Low FODMAP diet|Low FODMAP Diet]], [[Low histamine diet|Low Histamine Diet]], [[Paleo diet]], [[RPAH elimination diet|RPAH Elimination Diet]], [[Specific carbohydrate diet]], [[Vegan diet]], [[Vegetarian diet]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Antivirals:&#039;&#039;&#039; [[Valgancyclovir]], [[Famciclovir]], [[Valaciclovir]], [[Acyclovir]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Immunomodulators and immunostimulants:&#039;&#039;&#039; [[Ampligen]], [[Low dose naltrexone]], [[Equilibrant]], [[Intravenous immunoglobulin]], [[Staphylococcal vaccine]], [[Immunovir]], [[Medicinal mushrooms]], [[Interferon]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Anti-inflammatory drugs:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Other drug treatments:&#039;&#039;&#039; [[Chelation]], [[Cyclophosphamide]], [[Prednisone]], [[Rituximab]], [[Trazodone]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Toxin avoidance/removal:&#039;&#039;&#039; [[Fasting]], [[Mold avoidance]], [[Coffee enema]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Uncategorized interventions:&#039;&#039;&#039; [[Traditional Chinese medicine]], [[Cold immersion]], [[Fecal matter transplant]]/[[Faecal bacteriotherapy]], [[Helminthic therapy]], [[Pacing]], [[Energy envelope]], [[Hyperbaric oxygen]], [[Ozone]], [[Altitude]], [[Exercise]], [[Vagus nerve stimulation]], [[Exercise based on 2-day CPET]], [[Lipid replacement therapy]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Management guides:&#039;&#039;&#039; [https://www.actionforme.org.uk/uploads/taming-the-gorilla-booklet.pdf Taming the Gorilla] ([[Action for ME]]), [http://stonebird.co.uk/Notes/index.html Notes for Carers] ([[Greg Crowhurst]]), [http://www.meassociation.org.uk/2014/07/our-purple-booklet-clear-clinical-guidance-and-the-latest-research-all-wrapped-up-in-52-pages/ The Purple Booklet] ([[ME Association]])&lt;br /&gt;
&lt;br /&gt;
==Doctors==&lt;br /&gt;
&#039;&#039;&#039;Clinical Doctors, USA:&#039;&#039;&#039; [[Lucinda Bateman]] (UT) [[Derek Enlander]]; [[Susan Levine]] (NY) &lt;br /&gt;
[[Nancy Klimas]] (FL) [[Courtney Craig]]; [[Daniel Peterson]] (NV) [[Phillipe Bottello]]; [[John Chia]]; [[OMI Clinic: David Kaufman and Andy Kogelnick]] (CA) [[Jacob Teitelbaum]]; [[Richard Podell]] (NJ) [[Laura Black]] (NC); [[Amy Yasko]]; [[Jose Montoya]]  (CA)&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Clinical Doctors, UK:&#039;&#039;&#039; [[Sarah Myhill]], [[William Weir]], [[Nigel Speight]], [[Peter Behan]], [[Charles Shepherd]], [[Gabrielle Murphy]], [[Amolak Bansal]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Clinical Doctors, Germany:&#039;&#039;&#039; [[Anna Dorothea Hoeck]], [[Carmen Scheibenbogen]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Clinical Doctors, Belgium:&#039;&#039;&#039; [[Kenny de Meirleir]], [[Annemie Uyttersprot (GP)]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Clinical Doctors, South Africa:&#039;&#039;&#039; [[Cecile Jadin]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Clinical Doctors, Sweden:&#039;&#039;&#039; [[Carl-Gerhard Gottfries]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Clinical Doctors, Italy:&#039;&#039;&#039; [[Umberto Tirelli]], [[Lorenzo Lorusso]], [[Eligio Pizzigallo]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Clinical Doctors, Australia:&#039;&#039;&#039; [[Donald P Lewis]] (VIC), [[John Whiting]], [[Rashmi Cabena]] (VIC), [[Richard Schloeffel]] (NSW)&lt;br /&gt;
&lt;br /&gt;
==Research==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;[[Notable studies]]&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039; Research initiatives USA:&#039;&#039;&#039; [[Open Medicine Foundation]], [[Chronic Fatigue Initiative]], [[Stanford ME/CFS Initiative]], [[Microbe Discovery Project]], [[Bateman Horne Center]], [[Workwell Foundation]], [[Center for Infection &amp;amp; Immunity]], [[Solve ME/CFS Initiative]], [[Simmaron Research]], [[Treatment Center for CFS]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039; Researchers USA:&#039;&#039;&#039; }[Marcie Zinn]][Ronald Davis]], [[Jarred Younger]], [[Alan Light]], [[Kathleen Light]], [[Andreas Kogelnik]], [[Jose Montoya]], [[David Bell]], [[Mady Hornig]], [[Eric Schadt]], [[Ian Lipkin]], [[John Chia]], [[Rosemary Underhill]], [[Suzanne Vernon]], [[David Berg]], [[Nancy Klimas]], [[Dane Cook]], [[Staci Stevens]], [[Mark VanNess]], [[Christopher Snell]], [[Zaher Nahle]], [[Rich Van Konyenburg]], [[Judy Mikovits]], [[Paul Cheney]], [[Michael Van ElZakker]], [[Zaher Nahle]], [[Michael Zeineh]], [[Anthony Komaroff]], [[A Martin Lerner]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039; Research initiatives Europe:&#039;&#039;&#039; [[ME Research UK]], [[Cure ME]] (UK), [[Invest in ME]] (UK), [[UK CFS/ME Collaborative]], [[Grand Challenge]], [[Invest in ME Conference]] (UK), [[Ramsay Research Fund]] (UK), [[European ME Research Group]], [[Charité Berlin]] (Germany), [[Wake-Up Call]] (Belgium)&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Research initiatives Australia:&#039;&#039;&#039; [[National Centre for Neuroimmunology and Emerging Diseases]], [[Victoria University]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Research initiatives Canada:&#039;&#039;&#039; [[Nightingale Research Foundation]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039; Researchers UK:&#039;&#039;&#039;  [[Melvin Ramsay]], [[Donald Acheson]], [[Gordon Parish]], [[Jonathan Kerr]], [[Amolak Bansal]], [[Julia Newton]], [[Elizabeth Dowsett]], [[Simon Carding]], [[James Mowbray]], [[John Richardson]], [[Luis Nacul]], [[Derek Pheby]], [[Jonathan Edwards]], [[Geraldine Cambridge]], [[George Davey Smith]], [[Neil Harrison]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039; Researchers Australia:&#039;&#039;&#039; [[Amy Wallis]], [[Donald P Lewis]], [[Donald Staines]], [[Dorothy Bruck]], [[Elaine DeFreitas]], [[Henry Butt]], [[Melinda L Jackson]], [[Michael Maes]], [[Sonya Marshall-Gradisnik]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039; Researchers Germany:&#039;&#039;&#039; [[Carmen Scheibenbogen]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039; Researchers Norway:&#039;&#039;&#039; [[Olav Mella]], [[Øystein Fluge]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039; Researchers Canada:&#039;&#039;&#039; [[Byron Hyde]], [[Patrick O. McGowan]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Researchers Japan:&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Biobanks &amp;amp; patient registries&#039;&#039;&#039;: [[CURE ME]] (UK), [[OMI OpenMedNet]] (US), [[CFI CFS BioBank]] (US), [[SolveCFS BioBank]] (US), [[Simmaron Research BioBank]] (US)&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Researcher mailing lists:&#039;&#039;&#039; [[CureME mailing list]]&lt;br /&gt;
&lt;br /&gt;
==Psychological Paradigm==&lt;br /&gt;
&#039;&#039;&#039;Psychological paradigm, mind-body approaches and related interventions:&#039;&#039;&#039; [[FINE trial]], [[PACE trial]], [[Graded exercise therapy|Graded Exercise Therapy]], [[cognitive behavioral therapy|Cognitive Behavioral Therapy]], [[biopsychosocial]], [[Deconditioning]], [[Mickel therapy]], [[Lightning process]], [[Gupta programme]], [[Psychoneuroimmunology]], [[Meditation]], [[Bodily distress syndrome]], [[Functional somatic syndrome]], [[Psychosomatic illness]], [[Neurasthenia]], [[Medically unexplained symptoms]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Psychological paradigm proponents:&#039;&#039;&#039; [[Simon Wessely]], [[Michael Sharpe]], [[Peter White]], [[Trudie Chalder]], [[Rona Moss-Morris]], [[Jessica Bavinton]], [[Esther Crawley]], [[Anthony Cleare]], [[Ben Goldacre]], [[Peter Manu]], [[Brian Walitt]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Psychological paradigm critics:&#039;&#039;&#039; [[James Coyne]], [[Keith Laws]], [[David Tuller]], [[Ronald Davis]], [[Bruce Levin]], [[Arthur Reingold]], [[Jonathan Edwards]], [[Leonard Jason]], [[Ellen Goudsmit]], [[Angela Kennedy]]&lt;br /&gt;
&lt;br /&gt;
[[Patient mental health]]&lt;br /&gt;
&lt;br /&gt;
==Around the world==&lt;br /&gt;
*&#039;&#039;&#039;Asia:&#039;&#039;&#039; [[China]], [[India]], [[Indonesia]], [[Israel]], [[Japan]], [[Russia]]&lt;br /&gt;
*&#039;&#039;&#039;Africa:&#039;&#039;&#039; [[Kenya]], [[Nigeria]]&lt;br /&gt;
*&#039;&#039;&#039;Europe:&#039;&#039;&#039; [[Austria]], [[Belgium]], [[Bulgaria]], [[Czech Republic]], [[Denmark]], [[Finland]], [[France]] [[Germany]], [[Greece]], [[Hungary]], [[Ireland]], [[Italy]], [[Netherlands]], [[Norway]], [[Poland]], [[Romania]], [[Slovakia]], [[Slovenia]], [[Spain]], [[Sweden]], [[Ukraine]], [[United Kingdom]]&lt;br /&gt;
*&#039;&#039;&#039;North America:&#039;&#039;&#039; [[Canada]], [[Mexico]], [[United States]]&lt;br /&gt;
*&#039;&#039;&#039;South America:&#039;&#039;&#039; [[Argentina]], [[Brazil]]&lt;br /&gt;
*&#039;&#039;&#039;Australia &amp;amp; New Zealand:&#039;&#039;&#039; [[Australia]], [[New Zealand]]&lt;br /&gt;
&lt;br /&gt;
==History==&lt;br /&gt;
&lt;br /&gt;
[[Important events timeline]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Historical records&#039;&#039;&#039;: [[Osler&#039;s Web]], [[Thirty Years of Disdain]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Outbreaks:&#039;&#039;&#039; [[List of myalgic encephalomyelitis and chronic fatigue syndrome outbreaks|Outbreaks]]: [[Incline village|Incline village 1984]], [[1985 Lyndonville outbreak|Lyndonville 1985]], [[Akureyri]], [[1934 Los Angeles outbreak|Los Angeles 1934]], [[Royal Free Hospital outbreak|Royal Free Hospital 1955]], [[1955 Dalston outbreak|Dalston 1955]], [[1949 Adelaide outbreak|Adelaide 1949]], [[1980-81 Ayrshire outbreak|Ayrshire 1980]], [[1975 Sacramento outbreak|Sacramento 1975]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Deceased patients:&#039;&#039;&#039; [[Sophia Mirza]], [[Thomas Hennessy, Jr.]], [[Vanessa Li]], [[Lynn Gilderdale]], [[Emily Collingridge]],  [[Chardale Dotson Irvine]], [[Oliver Coles]], [[Brynmor John]], [[Victoria Elsbury-Legg]], [[Roger Cicero]], [[Memorial Lists]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Major developments/controversies:&#039;&#039;&#039; [[PACE trial]], [[XMRV]]&lt;br /&gt;
&lt;br /&gt;
[[ME and CFS in popular culture]]&lt;br /&gt;
&lt;br /&gt;
==Patient Advocacy==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups Australia:&#039;&#039;&#039; [[Emerge Australia]], [[ME/CFS Australia (SA) Inc]], [[ME/CFS Society of Western Australia]], [[ME/CFS Society of NSW]], [[ME/CFS Society of ACT]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups Belgium:&#039;&#039;&#039; [[Wake Up Call Beweging]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups Canada:&#039;&#039;&#039; [[National ME/FM Action Network]], [[May12th.org]], [[Action CIND]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups Ireland:&#039;&#039;&#039; [[Irish ME/CFS Association]], [[Irish ME Trust]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups Italy:&#039;&#039;&#039; [[Associazione Malati CFS onlus]], [[CFS Associazione Italiana onlus]], [[CFS Italia]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups Netherlands:&#039;&#039;&#039; [[ME Vereniging Nederland]] &lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups New Zealand:&#039;&#039;&#039; [[Associated New Zealand ME Society]] (ANZMES)&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups Norway:&#039;&#039;&#039; [[ME-Forskning]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups Sweden:&#039;&#039;&#039; [[Riksföreningen för ME-patienter]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups UK:&#039;&#039;&#039; [[Action for ME]], [[Invest in ME]], [[Change For M.E. Change For Us]], [[Norfolk &amp;amp; Suffolk ME]], [[ME Association]], [[Tymes Trust]], [[MEActionUK]], [[Forward-ME]], [[Hope 4 ME &amp;amp; Fibro NI]], [[Welsh Association of ME &amp;amp; CFS Support]], [[Sussex &amp;amp; Kent ME/CFS Society]], [[Association of Young People with ME]], [[Tyne &amp;amp; Wear ME/CFS Support Group]], [[Edinburgh MESH]], [[Leeds ME Network]], [[The York ME Community]], [[25 Percent ME Group]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups USA:&#039;&#039;&#039; #[[MEAction]], [[MEadvocacy]], [[National Alliance for Myalgic Encephalomyelitis]], [[Massachusetts CFIDS/ME &amp;amp; FM Association]], [[May12.org]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Advocacy/Fundraising Initiatives:&#039;&#039;&#039; [[Chilli ME Challenge]], [[ME Foggy Dog]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Famous patients&#039;&#039;&#039;: [[Laura Hillenbrand]], [[Martine McCutcheon]], [[Stuart Murdoch]], [[Charles Darwin]], [[Florence Nightingale]], [[Roger Cicero]], [[Shirley Conran]], [[Michael Crawford]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Notable patients:&#039;&#039;&#039; [[Karina Hansen]], [[Joanne]], [[Sophia Mirza]], [[Thomas Hennessy, JR.]], [[Vanessa Li]], [[Lynn Gilderdale]], [[Emily Collingridge]], [[Whitney Dafoe]], [[Tom Kindlon]], [[Graham McPhee]], [[Jennie Spotila]], [[Naomi Whittingham]], [[Jane Colby]], [[Countess of Mar]], [[Brian Vastag]], [[Jennifer Brea]], [[Ryan Prior]], [[Hillary Johnson]], [[Julie Rehmeyer]], [[Leonard Jason]], [[Charles Shepherd]], [[Nasim Marie Jafry]], [[Ken Lassesen]], [[Cort Johnson]], [[Valerie Eliot Smith]], [[Doctor Speedy]], [[Tanya Marlow]], [[Deborah Waroff]], [[Beth Mazur]], [[Catherine Hale]], [[Mary Schweitzer]], [[Toni Bernhard]], [[Guido den Broeder]], [[Frank Twisk]], [[Steven Lubet]], [[Giada Da Ros]], [[Roberta Pelletta]], [[Carol Head]], [[Ean Proctor]], [[Jessica Taylor]], [[Clark Ellis]], [[Alem Matthews]], [[Peter Kemp]], [[Mindy Kitei]] [[Jeanette Burmeister]], [[Giles Meehan]], [[Erik Johnson]], [[Lisa Petrison]], [[Mary Ann Kindel]], [[Gabby Klein]], [[Eileen Holderman]], [[Susan Kreutzer]], [[Maryann Spurgin]], [[Wendy Boutiler]], [[L.A. Cooper]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Notable healthy advocates:&#039;&#039;&#039; [[Angela Kennedy]], [[Mary Dimmock]], [[Greg Crowhurst]], [[Malcolm Hooper]], [[Nicole Castillo]], [[Llewellyn King]], [[Erica Verrillo]], [[Tom Whittingham]], [[Mike Harley]], [[Ian Gibson]], [[Scott Ludlam]], [[Linda and Don Tannenbaum]], [[Jon Campling]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Notable Quotes:&#039;&#039;&#039; [[List of Quotes]], [[Individual Quotes]]&lt;br /&gt;
&lt;br /&gt;
==Journals, TV, Articles, Books, Film, Interviews, Blogs, Discussion Forums==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Journals:&#039;&#039;&#039; &lt;br /&gt;
[[The Lancet]] &lt;br /&gt;
[[Lancet Psychiatry]] [[The BMJ]] [[Journal of Chronic Fatigue Syndrome]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;TV:&#039;&#039;&#039; [[Sick and Tired]] (US), [[Sick and Tired - BBC]] (UK),  [[Toxic Tiredness]], [[I Remember Me]], [[BBC Documentary on life with severe ME/Chronic Fatigue Syndrome]] (UK)&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Articles:&#039;&#039;&#039; [[List of news articles on ME and CFS]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Books:&#039;&#039;&#039; [[Plague]], [[The State of Me]], [[Love and Fatigue in America]], [[Osler&#039;s Web]], [[America&#039;s Biggest Cover-Up]], [[Reviving the Broken Marionette]], [[Why ME?]], [[Stanchi: Vivere con la Sindrome da Fatica Cronica]], [[Stanchi si diventa]], [[Frammenti di ME]], [[Encounters with the Invisible]], [[Chronic Fatigue Syndrome: A Treatment Guide]], [[Chronic Fatigue Syndrome: A Treatment Guide - 2nd Edition]], [[Severe ME/CFS: A Guide to Living]], [[Severe ME - Featuring: &amp;quot;Justice for Karina Hansen&amp;quot;]], [[Severe ME: Notes for Carers]], [[One Last Goodbye]], [[Authors of our Own Misfortune? The Problems with Psychogenic Explanations for Physical Illnesses]].&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Film:&#039;&#039;&#039; [[What About ME]], [[I Remember Me]], [[Forgotten Plague]], [[Canary in a Coal Mine]], [[The Last Great Medical Cover Up]], [[Invisible Illness - Stories of Chronic Fatigue Syndrome]], [[Voices from the Shadows]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Interviews:&#039;&#039;&#039; &lt;br /&gt;
[[ME/CFS Alert]], [[Science for Patients]] &lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Blogs:&#039;&#039;&#039; [[Health Rising]], [[Occupy CFS]], [[MEAction]], [[ME Advocacy]], [[Courtney Craig]], [[Cell Fatigue]], [[CFS Patient Advocate]], [[Constant F****** S***]], [[ME Association]], [[Onward Through the Fog]], [[Nice Guidelines]], [[Valerie Eliot Smith Blog]], [[CFS Remission]], [[About.com Health FMS/ME/CFS]], [[Just ME]], [[ME/CFS Ghost]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Discussion Forums:&#039;&#039;&#039; [[Phoenix Rising]], [[CFSItalia]], [[MDJunction]]&lt;br /&gt;
&lt;br /&gt;
== [[Open Letters]] ==&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=MEpedia:Contents&amp;diff=8266</id>
		<title>MEpedia:Contents</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=MEpedia:Contents&amp;diff=8266"/>
		<updated>2016-04-04T18:52:23Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:/* Research */ added names&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;We are crowd-sourcing a knowledge base on the history, science and medicine of ME and CFS around the world. MEpedia is a patient community project being built by patients, founded by #[[MEAction]]. Read more [[MEpedia:About|about MEpedia and its principles]].&lt;br /&gt;
&lt;br /&gt;
Want to take a look around? See our most [[Special:PopularPages|popular pages]], check our [[Special:NewPages|newest pages]], or visit a [[Special:random|random page]]. You can also browse a [[Special:AllPages|list of all pages]].&lt;br /&gt;
&lt;br /&gt;
==Please contribute==&lt;br /&gt;
Anyone can create pages, write content, add links/citations, fact-check, or even just fix typos. Get involved and help the patient community identify all of the best and most important resources for our disease and its research, treatment and history. Start now, read [[How to contribute]]. Please join the MEpedia [http://my.meaction.net/local_chapters/mepedia online forum], [https://www.facebook.com/mepedia/ Facebook group], and follow us on [https://twitter.com/MEencyclopedia Twitter].&lt;br /&gt;
&lt;br /&gt;
==Five minute tasks==&lt;br /&gt;
&lt;br /&gt;
Only have a five minute spoon to give? Here is a [[List of small tasks|list of small tasks]] you can help us with in roughly one to ten minutes of time.&lt;br /&gt;
&lt;br /&gt;
==Priority pages for expansion==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Science:&#039;&#039;&#039; [[Citric acid cycle]], [[Mitochondria]], [[Exercise]], [[Ampligen]], [[Natural killer cell]], [[Central nervous system]], [[Nitric oxide hypothesis]], [[Brain]], [[Brain imaging]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;History and politics:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
==A note on ME v. CFS==&lt;br /&gt;
&lt;br /&gt;
We have separate pages for [[Myalgic Encephalomyelitis]], [[ME/CFS]] and [[Chronic Fatigue Syndrome]] as well as [[SEID]]. The convention is that the terminology used in an ME-pedia article should match the terminology used in the underlying source. Where there is a tension between the term used in the source and the definition (e.g., [[ME]] defined by the [[Oxford criteria]] or [[CFS]] defined by the [[Canadian Consensus Criteria]]), it may be useful for clarity to mention the definition used.&lt;br /&gt;
&lt;br /&gt;
==Primers==&lt;br /&gt;
*[[Primer for doctors and researchers]]&lt;br /&gt;
*[[Primer for patients]]&lt;br /&gt;
*[[Primer for science journalists]]&lt;br /&gt;
*[[Primer for the public]]&lt;br /&gt;
*[[Primer for family, friends and care providers]]&lt;br /&gt;
&lt;br /&gt;
==The Disease==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Infectious agents:&#039;&#039;&#039; [[Borrelia]], [[Babesia]], [[Bartonella]], [[Borna Disease Virus]], [[Chlamydia pneumoniae]], [[Coxsackie A]],  [[Coxsackie B]], [[cytomegalovirus]], [[Ebola virus]], [[echovirus]], [[enterovirus]], [[Epstein-Barr virus]], [[H1N1]], [[Herpesvirus]], [[HHV-6]], [[HHV-7]], [[HSV-1]], [[HSV-2]], [[influenza]], [[parvovirus B19]],  [[Q Fever]], [[Ross River Virus]], [[Chlamydia Pneumonia]], [[Mycoplasma Pneumonia]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Triggers and risk factors:&#039;&#039;&#039; [[Blood donation]], [[Candidiasis]], [[Causes of death]], [[Epidemiology]], [[Genetics]], [[Menstrual cycle]], [[Mold]], [[Pediatric]], [[Pregnancy]], [[Stress]], [[Toxic exposure]], [[Trauma]],  [[Vaccine]], [[Viral onset]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Signs and symptoms:&#039;&#039;&#039; [[Ataxia]], [[Cognitive dysfunction]], [[Chronic pain]], [[Chronic fatigue]], [[Fatigue]], [[Food intolerance]], [[Irritable bowel syndrome]], [[Migraine]], [[Muscle fatigability]], [[Neurally mediated hypotension]], [[Nonepileptic seizure]], [[Optical dysfunction]], [[Orthostatic intolerance]], [[Post-exertional malaise]], [[Postural orthostatic tachycardia]], [[Seizure]], [[Sleep disturbance]], [[Unrefreshing sleep]], &lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Medical hypotheses:&#039;&#039;&#039;  [[Amygdala hypothesis]],  [[Autoimmune hypothesis]], [[Fatty acid hypothesis]], [[Hygiene hypothesis]], [[Immune exhaustion hypothesis]], [[Infectious disease hypothesis]], [[Ken Lassesen&#039;s model]], [[Methylation cycle hypothesis]], [[Microbiome hypothesis]], [[Mold hypothesis]], [[Patricia Kane protocol]], [[Vagus nerve hypothesis]], [[Viral onset hypothesis]] [[Hypercoagulation hypothesis]] [[Acquired immune and mitochondrial dysfunction hypothesis]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Body systems:&#039;&#039;&#039; [[Antibody]], [[Autoantibody]], [[Blood]], [[Brain]], [[B cell]], [[Central sensitization]], [[Cytokine]], [[Chemokine]], [[Cardiovascular system]], [[Gastrointestinal system]], [[Glutamate excitotoxicity]], [[HPA axis]],  [[Immune system]], [[IL-1]], [[IL-2]], [[IL-6]], [[IL-8]], [[IL-10]], [[IL-16]], [[IL-17]], [[IL-18]], [[interferon]], [[Leaky brain]], [[Leaky gut]], [[Macrophage]], [[Microglia]],  [[Microbiome]],  [[Mucosal immune system]], [[Nervous system]], [[Natural killer cell]], [[Neuroinflammation]], [[Ribonuclease L]], [[Spinal cord]], [[Tumor necrosis factors]], [[VEGF]], [[T cell]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Tests:&#039;&#039;&#039; [[Brain imaging]], [[Cardiopulmonary exercise test]], [[CellTrend diagnostic test]], [[C reactive protein]], [[EEG]], [[Erythrocyte sedimentation rate]], [[Exercise]], [[National Centre for Neuroimmunology and Emerging Diseases#Potential biomarker|NCNED Griffith University diagnostic test]], [[MRI]], [[Orosomucoid]], [[qEEG]], [[SF-36]], [[SPECT]], [[Tilt Table]], [[Two day exercise test]], [[Natural Killer Cell (NKC) Function]], [[arginine vasopressin]], [[MTHFR and other methylation mutations]], [[infectious disesases]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Citizen science:&#039;&#039;&#039; [[23andMe]], [[American Gut]], [[Any Treatment]], [[Mendus]], [[Phoenix Rising]], [[UBiome]], [[Know Your Genetics: Dr. Amy Yasko]], [[WellnessFX]], [[CH3Nutrigenomics; Dr. Amy Yasko]], [[MTHFR.net]], [[Genetic Genie]], [[LiveWello]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Biochemistry and cell biology:&#039;&#039;&#039; [[ATP]], [[Cellular respiration]], [[Citric acid cycle]], [[D lactate]], [[Endocannabinoid]], [[Glucocorticoid]], [[Glutathione]], [[Histamine]], [[Methylation cycle]], [[Mitochondria]], [[Nitric oxide]], [[Oxidative phosphorylation]], [[Phenylalanine]], [[Tyrosine]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Nutrients:&#039;&#039;&#039; [[Copper]], [[Deadlock quartet]], [[Folate]], [[L-carnitine]], [[Magnesium]], [[Sam-e]], [[TMG]], [[Vitamin B2]], [[Vitamin B6]], [[Vitamin B12]], [[Vitamin C]], [[Vitamin D]], [[Zinc]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Neurotransmitters and hormones&#039;&#039;&#039;: [[Acetylcholine]], [[Alpha-Melanocyte-stimulating hormone]], [[Calicitriol]], [[Calcidiol]], [[Cortisol]], [[Dopamine]], [[Estriadol]], [[Epinephrine]], [[Estrogen]], [[Glucocorticoid]], [[Glutamate]], [[Histamine]], [[Hormones]], [[Leptin]], [[Melatonin]], [[Neurotransmitters]], [[Norepinephrine]], [[Oxytocin]], [[Progesterone]], [[Prolactin]], [[Prostaglandins]], [[Serotonin]], [[Testosterone]], [[Vasopressin]], [[Thyroid]], [[MSH]], [[HGH]]&lt;br /&gt;
&lt;br /&gt;
[[Blood donation]]&lt;br /&gt;
&lt;br /&gt;
==Names &amp;amp; Definitions==&lt;br /&gt;
&#039;&#039;&#039;Names:&#039;&#039;&#039; [[Myalgic Encephalomyelitis]], [[Chronic Fatigue Syndrome]], [[ME/CFS]], [[Systemic Exertion Intolerance Disease]], [[Chronic Fatigue Immune Deficiency Syndrome]], [[Chronic epstein barr]], [[Neuro-Inflammatory and Oxidative Fatigue]], [[Yuppie Flu]], [[Neurasthenia]], [[Chronic Fatigue]], [[Infectious Venulitis]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Related conditions:&#039;&#039;&#039; [[Chronic lyme disease]], [[Mold illness]], [[Biotoxin illness]], [[Environmental illness]], [[Multiple Chemical Sensitivity]], [[Gulf War Illness]], [[Mast cell activation disorder]], [[Mastocytosis]], [[Ehlers Danlos Syndrome]], [[Fibromyalgia]], [[Small intestine bacterial overgrowth]], [[Lactic acidosis]], [[Autoimmune disease]], [[Cancer]], [[Thyroid disease]], [[Non-Hodgkin&#039;s lymphoma]], [[Multiple Sclerosis]], [[Dysautonomia]], [[Mitochondrial disorders]], [[Chronic Epstein Barr]], [[Raynaud&#039;s Syndrome]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Definitions:&#039;&#039;&#039; [[Definitions of ME and CFS]], [[Canadian Consensus Criteria]], [[International Consensus Criteria]], [[Oxford criteria]],  [[Fukuda criteria]], [[Holmes criteria]], [[Empirical definition]], [[Ramsay definition]], [[London criteria]], [[Nightingale definition]], [[Reeves criteria]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Acronyms:&#039;&#039;&#039; [[List of acronyms]]&lt;br /&gt;
&lt;br /&gt;
==Potential treatments==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Category page&#039;&#039;&#039;: [[Treatments|Potential treatments]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Supplements:&#039;&#039;&#039; [[Probiotics]], [[AHCC]], [[CoQ10]], [[L-carnitine]], [[MitoQ]], [[NADH]], [[PrescriptAssist]], [[Mutaflor]], [[GcMAF]], [[Colostrum]], [[Transfer factors]], [[Fish oil]], [[EPA]], [[DHA]], [[Taurine]], [[L-Glutamine]], [[Glutathione]], [[Niacinamide]], [[B Vitamin Complex]], [[Adaptogens]] ([[Eleuthro]], [[Ginseng]], [[Ashwaganda]], [[Rhodiola]], [[Licorice]]), [[Mangosteen]], [[Vegan/non-whey Protein Powders with Amino Acid Complex]], [[Greens Powders]], [[D-Ribose]], [[Quercetin]], [[Nexavir]], [[5-Hydroxytryptophan]], [[Melatonin]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Supplement Sources:&#039;&#039;&#039; [[Pure Formulas]], [[Be Well By Dr Frank Lipman]], [[Seeking Health]], [[MITOQ]], [[Aloha]], [[ProHealth]], [[Thrive Marketplace]], [[HolisticHeal]], [[Vitacost.com]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Foods:&#039;&#039;&#039; [[Cocoa|Cocoa (Dark chocolate)]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Herbs:&#039;&#039;&#039; [[Medical marijuana]], [[Kampo]], [[Equilibrium]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Diets:&#039;&#039;&#039; [[GAPS diet]], [[Ketogenic diet]], [[Low FODMAP diet|Low FODMAP Diet]], [[Low histamine diet|Low Histamine Diet]], [[Paleo diet]], [[RPAH elimination diet|RPAH Elimination Diet]], [[Specific carbohydrate diet]], [[Vegan diet]], [[Vegetarian diet]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Antivirals:&#039;&#039;&#039; [[Valgancyclovir]], [[Famciclovir]], [[Valaciclovir]], [[Acyclovir]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Immunomodulators and immunostimulants:&#039;&#039;&#039; [[Ampligen]], [[Low dose naltrexone]], [[Equilibrant]], [[Intravenous immunoglobulin]], [[Staphylococcal vaccine]], [[Immunovir]], [[Medicinal mushrooms]], [[Interferon]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Anti-inflammatory drugs:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Other drug treatments:&#039;&#039;&#039; [[Chelation]], [[Cyclophosphamide]], [[Prednisone]], [[Rituximab]], [[Trazodone]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Toxin avoidance/removal:&#039;&#039;&#039; [[Fasting]], [[Mold avoidance]], [[Coffee enema]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Uncategorized interventions:&#039;&#039;&#039; [[Traditional Chinese medicine]], [[Cold immersion]], [[Fecal matter transplant]]/[[Faecal bacteriotherapy]], [[Helminthic therapy]], [[Pacing]], [[Energy envelope]], [[Hyperbaric oxygen]], [[Ozone]], [[Altitude]], [[Exercise]], [[Vagus nerve stimulation]], [[Exercise based on 2-day CPET]], [[Lipid replacement therapy]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Management guides:&#039;&#039;&#039; [https://www.actionforme.org.uk/uploads/taming-the-gorilla-booklet.pdf Taming the Gorilla] ([[Action for ME]]), [http://stonebird.co.uk/Notes/index.html Notes for Carers] ([[Greg Crowhurst]]), [http://www.meassociation.org.uk/2014/07/our-purple-booklet-clear-clinical-guidance-and-the-latest-research-all-wrapped-up-in-52-pages/ The Purple Booklet] ([[ME Association]])&lt;br /&gt;
&lt;br /&gt;
==Doctors==&lt;br /&gt;
&#039;&#039;&#039;Clinical Doctors, USA:&#039;&#039;&#039; [[Lucinda Bateman]] (UT) [[Derek Enlander]]; [[Susan Levine]] (NY) &lt;br /&gt;
[[Nancy Klimas]] (FL) [[Courtney Craig]]; [[Daniel Peterson]] (NV) [[Phillipe Bottello]]; [[John Chia]]; [[OMI Clinic: David Kaufman and Andy Kogelnick]] (CA) [[Jacob Teitelbaum]]; [[Richard Podell]] (NJ) [[Laura Black]] (NC); [[Amy Yasko]]; [[Jose Montoya]]  (CA)&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Clinical Doctors, UK:&#039;&#039;&#039; [[Sarah Myhill]], [[William Weir]], [[Nigel Speight]], [[Peter Behan]], [[Charles Shepherd]], [[Gabrielle Murphy]], [[Amolak Bansal]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Clinical Doctors, Germany:&#039;&#039;&#039; [[Anna Dorothea Hoeck]], [[Carmen Scheibenbogen]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Clinical Doctors, Belgium:&#039;&#039;&#039; [[Kenny de Meirleir]], [[Annemie Uyttersprot (GP)]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Clinical Doctors, South Africa:&#039;&#039;&#039; [[Cecile Jadin]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Clinical Doctors, Sweden:&#039;&#039;&#039; [[Carl-Gerhard Gottfries]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Clinical Doctors, Italy:&#039;&#039;&#039; [[Umberto Tirelli]], [[Lorenzo Lorusso]], [[Eligio Pizzigallo]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Clinical Doctors, Australia:&#039;&#039;&#039; [[Donald P Lewis]] (VIC), [[John Whiting]], [[Rashmi Cabena]] (VIC), [[Richard Schloeffel]] (NSW)&lt;br /&gt;
&lt;br /&gt;
==Research==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;[[Notable studies]]&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039; Research initiatives USA:&#039;&#039;&#039; [[Open Medicine Foundation]], [[Chronic Fatigue Initiative]], [[Stanford ME/CFS Initiative]], [[Microbe Discovery Project]], [[Bateman Horne Center]], [[Workwell Foundation]], [[Center for Infection &amp;amp; Immunity]], [[Solve ME/CFS Initiative]], [[Simmaron Research]], [[Treatment Center for CFS]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039; Researchers USA:&#039;&#039;&#039; }[Marcie Zinn]][Ronald Davis]], [[Jarred Younger]], [[Alan Light]], [[Kathleen Light]], [[Andreas Kogelnik]], [[Jose Montoya]], [[David Bell]], [[Mady Hornig]], [[Eric Schadt]], [[Ian Lipkin]], [[John Chia]], [[Rosemary Underhill]], [[Suzanne Vernon]], [[David Berg]], [[Nancy Klimas]], [[Dane Cook]], [[Staci Stevens]], [[Mark VanNess]], [[Christopher Snell]], [[Zaher Nahle]], [[Rich Van Konyenburg]], [[Judy Mikovits]], [[Paul Cheney]], [[Michael Van ElZakker]], [[Zaher Nahle]], [[Michael Zeineh]], [[Anthony Komaroff]], [[A Martin Lerner]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039; Research initiatives Europe:&#039;&#039;&#039; [[ME Research UK]], [[Cure ME]] (UK), [[Invest in ME]] (UK), [[UK CFS/ME Collaborative]], [[Grand Challenge]], [[Invest in ME Conference]] (UK), [[Ramsay Research Fund]] (UK), [[European ME Research Group]], [[Charité Berlin]] (Germany), [[Wake-Up Call]] (Belgium)&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Research initiatives Australia:&#039;&#039;&#039; [[National Centre for Neuroimmunology and Emerging Diseases]], [[Victoria University]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Research initiatives Canada:&#039;&#039;&#039; [[Nightingale Research Foundation]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039; Researchers UK:&#039;&#039;&#039;  [[Melvin Ramsay]], [[Donald Acheson]], [[Gordon Parish]], [[Jonathan Kerr]], [[Amolak Bansal]], [[Julia Newton]], [[Elizabeth Dowsett]], [[Simon Carding]], [[James Mowbray]], [[John Richardson]], [[Luis Nacul]], [[Derek Pheby]], [[Jonathan Edwards]], [[Geraldine Cambridge]], [[George Davey Smith]], [[Neil Harrison]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039; Researchers Australia:&#039;&#039;&#039; [[Amy Wallis]], [[Donald P Lewis]], [[Donald Staines]], [[Dorothy Bruck]], [[Elaine DeFreitas]], [[Henry Butt]], [[Melinda L Jackson]], [[Michael Maes]], [[Sonya Marshall-Gradisnik]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039; Researchers Germany:&#039;&#039;&#039; [[Carmen Scheibenbogen]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039; Researchers Norway:&#039;&#039;&#039; [[Olav Mella]], [[Øystein Fluge]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039; Researchers Canada:&#039;&#039;&#039; [[Byron Hyde]], [[Patrick O. McGowan]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Researchers Japan:&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Biobanks &amp;amp; patient registries&#039;&#039;&#039;: [[CURE ME]] (UK), [[OMI OpenMedNet]] (US), [[CFI CFS BioBank]] (US), [[SolveCFS BioBank]] (US), [[Simmaron Research BioBank]] (US)&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Researcher mailing lists:&#039;&#039;&#039; [[CureME mailing list]]&lt;br /&gt;
&lt;br /&gt;
==Psychological Paradigm==&lt;br /&gt;
&#039;&#039;&#039;Psychological paradigm, mind-body approaches and related interventions:&#039;&#039;&#039; [[FINE trial]], [[PACE trial]], [[Graded exercise therapy|Graded Exercise Therapy]], [[cognitive behavioral therapy|Cognitive Behavioral Therapy]], [[biopsychosocial]], [[Deconditioning]], [[Mickel therapy]], [[Lightning process]], [[Gupta programme]], [[Psychoneuroimmunology]], [[Meditation]], [[Bodily distress syndrome]], [[Functional somatic syndrome]], [[Psychosomatic illness]], [[Neurasthenia]], [[Medically unexplained symptoms]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Psychological paradigm proponents:&#039;&#039;&#039; [[Simon Wessely]], [[Michael Sharpe]], [[Peter White]], [[Trudie Chalder]], [[Rona Moss-Morris]], [[Jessica Bavinton]], [[Esther Crawley]], [[Anthony Cleare]], [[Ben Goldacre]], [[Peter Manu]], [[Brian Walitt]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Psychological paradigm critics:&#039;&#039;&#039; [[James Coyne]], [[Keith Laws]], [[David Tuller]], [[Ronald Davis]], [[Bruce Levin]], [[Arthur Reingold]], [[Jonathan Edwards]], [[Leonard Jason]], [[Ellen Goudsmit]], [[Angela Kennedy]]&lt;br /&gt;
&lt;br /&gt;
[[Patient mental health]]&lt;br /&gt;
&lt;br /&gt;
==Around the world==&lt;br /&gt;
*&#039;&#039;&#039;Asia:&#039;&#039;&#039; [[China]], [[India]], [[Indonesia]], [[Israel]], [[Japan]], [[Russia]]&lt;br /&gt;
*&#039;&#039;&#039;Africa:&#039;&#039;&#039; [[Kenya]], [[Nigeria]]&lt;br /&gt;
*&#039;&#039;&#039;Europe:&#039;&#039;&#039; [[Austria]], [[Belgium]], [[Bulgaria]], [[Czech Republic]], [[Denmark]], [[Finland]], [[France]] [[Germany]], [[Greece]], [[Hungary]], [[Ireland]], [[Italy]], [[Netherlands]], [[Norway]], [[Poland]], [[Romania]], [[Slovakia]], [[Slovenia]], [[Spain]], [[Sweden]], [[Ukraine]], [[United Kingdom]]&lt;br /&gt;
*&#039;&#039;&#039;North America:&#039;&#039;&#039; [[Canada]], [[Mexico]], [[United States]]&lt;br /&gt;
*&#039;&#039;&#039;South America:&#039;&#039;&#039; [[Argentina]], [[Brazil]]&lt;br /&gt;
*&#039;&#039;&#039;Australia &amp;amp; New Zealand:&#039;&#039;&#039; [[Australia]], [[New Zealand]]&lt;br /&gt;
&lt;br /&gt;
==History==&lt;br /&gt;
&lt;br /&gt;
[[Important events timeline]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Historical records&#039;&#039;&#039;: [[Osler&#039;s Web]], [[Thirty Years of Disdain]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Outbreaks:&#039;&#039;&#039; [[List of myalgic encephalomyelitis and chronic fatigue syndrome outbreaks|Outbreaks]]: [[Incline village|Incline village 1984]], [[1985 Lyndonville outbreak|Lyndonville 1985]], [[Akureyri]], [[1934 Los Angeles outbreak|Los Angeles 1934]], [[Royal Free Hospital outbreak|Royal Free Hospital 1955]], [[1955 Dalston outbreak|Dalston 1955]], [[1949 Adelaide outbreak|Adelaide 1949]], [[1980-81 Ayrshire outbreak|Ayrshire 1980]], [[1975 Sacramento outbreak|Sacramento 1975]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Deceased patients:&#039;&#039;&#039; [[Sophia Mirza]], [[Thomas Hennessy, Jr.]], [[Vanessa Li]], [[Lynn Gilderdale]], [[Emily Collingridge]],  [[Chardale Dotson Irvine]], [[Oliver Coles]], [[Brynmor John]], [[Victoria Elsbury-Legg]], [[Roger Cicero]], [[Memorial Lists]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Major developments/controversies:&#039;&#039;&#039; [[PACE trial]], [[XMRV]]&lt;br /&gt;
&lt;br /&gt;
[[ME and CFS in popular culture]]&lt;br /&gt;
&lt;br /&gt;
==Patient Advocacy==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups Australia:&#039;&#039;&#039; [[Emerge Australia]], [[ME/CFS Australia (SA) Inc]], [[ME/CFS Society of Western Australia]], [[ME/CFS Society of NSW]], [[ME/CFS Society of ACT]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups Belgium:&#039;&#039;&#039; [[Wake Up Call Beweging]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups Canada:&#039;&#039;&#039; [[National ME/FM Action Network]], [[May12th.org]], [[Action CIND]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups Ireland:&#039;&#039;&#039; [[Irish ME/CFS Association]], [[Irish ME Trust]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups Italy:&#039;&#039;&#039; [[Associazione Malati CFS onlus]], [[CFS Associazione Italiana onlus]], [[CFS Italia]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups Netherlands:&#039;&#039;&#039; [[ME Vereniging Nederland]] &lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups New Zealand:&#039;&#039;&#039; [[Associated New Zealand ME Society]] (ANZMES)&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups Norway:&#039;&#039;&#039; [[ME-Forskning]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups Sweden:&#039;&#039;&#039; [[Riksföreningen för ME-patienter]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups UK:&#039;&#039;&#039; [[Action for ME]], [[Invest in ME]], [[Change For M.E. Change For Us]], [[Norfolk &amp;amp; Suffolk ME]], [[ME Association]], [[Tymes Trust]], [[MEActionUK]], [[Forward-ME]], [[Hope 4 ME &amp;amp; Fibro NI]], [[Welsh Association of ME &amp;amp; CFS Support]], [[Sussex &amp;amp; Kent ME/CFS Society]], [[Association of Young People with ME]], [[Tyne &amp;amp; Wear ME/CFS Support Group]], [[Edinburgh MESH]], [[Leeds ME Network]], [[The York ME Community]], [[25 Percent ME Group]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Patient Groups USA:&#039;&#039;&#039; #[[MEAction]], [[MEadvocacy]], [[National Alliance for Myalgic Encephalomyelitis]], [[Massachusetts CFIDS/ME &amp;amp; FM Association]], [[May12.org]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Advocacy/Fundraising Initiatives:&#039;&#039;&#039; [[Chilli ME Challenge]], [[ME Foggy Dog]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Famous patients&#039;&#039;&#039;: [[Laura Hillenbrand]], [[Martine McCutcheon]], [[Stuart Murdoch]], [[Charles Darwin]], [[Florence Nightingale]], [[Roger Cicero]], [[Shirley Conran]], [[Michael Crawford]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Notable patients:&#039;&#039;&#039; [[Karina Hansen]], [[Joanne]], [[Sophia Mirza]], [[Thomas Hennessy, JR.]], [[Vanessa Li]], [[Lynn Gilderdale]], [[Emily Collingridge]], [[Whitney Dafoe]], [[Tom Kindlon]], [[Graham McPhee]], [[Jennie Spotila]], [[Naomi Whittingham]], [[Jane Colby]], [[Countess of Mar]], [[Brian Vastag]], [[Jennifer Brea]], [[Ryan Prior]], [[Hillary Johnson]], [[Julie Rehmeyer]], [[Leonard Jason]], [[Charles Shepherd]], [[Nasim Marie Jafry]], [[Ken Lassesen]], [[Cort Johnson]], [[Valerie Eliot Smith]], [[Doctor Speedy]], [[Tanya Marlow]], [[Deborah Waroff]], [[Beth Mazur]], [[Catherine Hale]], [[Mary Schweitzer]], [[Toni Bernhard]], [[Guido den Broeder]], [[Frank Twisk]], [[Steven Lubet]], [[Giada Da Ros]], [[Roberta Pelletta]], [[Carol Head]], [[Ean Proctor]], [[Jessica Taylor]], [[Clark Ellis]], [[Alem Matthews]], [[Peter Kemp]], [[Mindy Kitei]] [[Jeanette Burmeister]], [[Giles Meehan]], [[Erik Johnson]], [[Lisa Petrison]], [[Mary Ann Kindel]], [[Gabby Klein]], [[Eileen Holderman]], [[Susan Kreutzer]], [[Maryann Spurgin]], [[Wendy Boutiler]], [[L.A. Cooper]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Notable healthy advocates:&#039;&#039;&#039; [[Angela Kennedy]], [[Mary Dimmock]], [[Greg Crowhurst]], [[Malcolm Hooper]], [[Nicole Castillo]], [[Llewellyn King]], [[Erica Verrillo]], [[Tom Whittingham]], [[Mike Harley]], [[Ian Gibson]], [[Scott Ludlam]], [[Linda and Don Tannenbaum]], [[Jon Campling]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Notable Quotes:&#039;&#039;&#039; [[List of Quotes]], [[Individual Quotes]]&lt;br /&gt;
&lt;br /&gt;
==Journals, TV, Articles, Books, Film, Interviews, Blogs, Discussion Forums==&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Journals:&#039;&#039;&#039; &lt;br /&gt;
[[The Lancet]] &lt;br /&gt;
[[Lancet Psychiatry]] [[The BMJ]] [[Journal of Chronic Fatigue Syndrome]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;TV:&#039;&#039;&#039; [[Sick and Tired]] (US), [[Sick and Tired - BBC]] (UK),  [[Toxic Tiredness]], [[I Remember Me]], [[BBC Documentary on life with severe ME/Chronic Fatigue Syndrome]] (UK)&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Articles:&#039;&#039;&#039; [[List of news articles on ME and CFS]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Books:&#039;&#039;&#039; [[Plague]], [[The State of Me]], [[Love and Fatigue in America]], [[Osler&#039;s Web]], [[America&#039;s Biggest Cover-Up]], [[Reviving the Broken Marionette]], [[Why ME?]], [[Stanchi: Vivere con la Sindrome da Fatica Cronica]], [[Stanchi si diventa]], [[Frammenti di ME]], [[Encounters with the Invisible]], [[Chronic Fatigue Syndrome: A Treatment Guide]], [[Chronic Fatigue Syndrome: A Treatment Guide - 2nd Edition]], [[Severe ME/CFS: A Guide to Living]], [[Severe ME - Featuring: &amp;quot;Justice for Karina Hansen&amp;quot;]], [[Severe ME: Notes for Carers]], [[One Last Goodbye]], [[Authors of our Own Misfortune? The Problems with Psychogenic Explanations for Physical Illnesses]].&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Film:&#039;&#039;&#039; [[What About ME]], [[I Remember Me]], [[Forgotten Plague]], [[Canary in a Coal Mine]], [[The Last Great Medical Cover Up]], [[Invisible Illness - Stories of Chronic Fatigue Syndrome]], [[Voices from the Shadows]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Interviews:&#039;&#039;&#039; &lt;br /&gt;
[[ME/CFS Alert]], [[Science for Patients]] &lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Blogs:&#039;&#039;&#039; [[Health Rising]], [[Occupy CFS]], [[MEAction]], [[ME Advocacy]], [[Courtney Craig]], [[Cell Fatigue]], [[CFS Patient Advocate]], [[Constant F****** S***]], [[ME Association]], [[Onward Through the Fog]], [[Nice Guidelines]], [[Valerie Eliot Smith Blog]], [[CFS Remission]], [[About.com Health FMS/ME/CFS]], [[Just ME]], [[ME/CFS Ghost]]&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Discussion Forums:&#039;&#039;&#039; [[Phoenix Rising]], [[CFSItalia]], [[MDJunction]]&lt;br /&gt;
&lt;br /&gt;
== [[Open Letters]] ==&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=EEG&amp;diff=7129</id>
		<title>EEG</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=EEG&amp;diff=7129"/>
		<updated>2016-03-16T19:23:47Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:added information about brain dynamics and how the EEG excels in the measurement of them.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[https://en.wikipedia.org/wiki/Electroencephalography Electroencephalography] (EEG)  is an electrophysiological monitoring method to record electrical activity of the brain.&lt;br /&gt;
&lt;br /&gt;
The last 70 years of neuroscience has established that most of brain&#039;s metabolism is used to create brain cell activity (summated synaptic potentials) operating on on the least-effort principle. This activity is mostly excitatory, some is inhibitory (slows things down) but it achieves a balance that optimizes the excitation and inhibition and produced electrical potentials, which we see at the scalp, in the form of the EEG. The EEG is a function of the electrical potentials in our brain, at the scalp. LORETA looks at the electrical potentials deeper into the brain. Only pyramidal neurons generate these potentials, and over 85% of our brains are made up of pyramidal neurons. All neurons generate all EEG frequencies, so the most important thing to remember is whether there is deregulation in a given region or network, with the frequency being secondary. &lt;br /&gt;
&lt;br /&gt;
2 Billion dollars during 1990s (decade of the brain) resulted in huge proliferation of knowledge and understanding in a much for fundamental way how the brain is wired, how the neurons are synchronized and how they “talk” to each other. We are very privileged to be able to take advantage of it. It has matured to the point that we can now apply it. The ultimate goal of bringing together all imaging modalities is good clinical outcome. In order to achieve that, it requires putting together all the imaging modalities and understanding where we are and understanding where the EEG is with respect to the other imaging modalities (structural MRI, functional MRI, PET scans, SPECT scans, EEG, MEG) and at all levels of phylogeny (animals to humans). There is a common coordinate system so we can relate the EEG to networks inside the brain and nodes and connections between nodes within the brain that are related to symptoms.&lt;br /&gt;
&lt;br /&gt;
Electrical neuroimaging of modules and hubs within the brain using structural MRI, DTI—this forms the infrastructure for the foundation for our understanding of the EEG. However, DTI, MRI structural imaging is the same whether you are alive or dead. Only the EEG, fMRI capture neuronal dynamics; however, the difference is that the fMRI has 10-20 second latency in order to measure anything whereas the EEG is in milliseconds. This near-instantaneous measurement aspect of EEG is crucial for examining brain dynamics, which, given the articles presented here appear to be very relevant for the study of ME. The time it takes for the brain to recruit a billion neurons across different network nodes varies from about 20ms to 80ms. Therefore, this means that network phase measures are completely INVISIBLE to the fMRI.Furthermore, the EEG spatial resolution, although not as high as fMRI, is quite accurate and sufficient for us to evaluate the dynamics of communication between large groups of neurons. What this means is that, if one is interested in brain dynamics and function, the EEG is the only modality that will capture it.&lt;br /&gt;
&lt;br /&gt;
The brain is not like a computer, as we once thought. It depends on information that flows in regulated loops which continually change, not in fixed circuits like computers. The brain primary task is prediction, by matching what is previously learned with new information &#039;on the fly.&#039; Our awareness is one step behind these predictions in that the brain has already represented our actions milliseconds before we perform them. Information flow is therefore a continual re-mapping that takes information from sensory systems and sends it to higher-order systems, which results in regulatory control which bring about adaption in homeostasis of feelings, actions, perceptions and consciousness. The EEG is therefore the only non-invasive and inexpensive measure of this continual temporal evolution of brain information in real time that is crucial for the understanding of cognitive and emotional functioning for healthy individuals as well as people with neurocognitive dysfunction. &lt;br /&gt;
&lt;br /&gt;
==Notable Studies==&lt;br /&gt;
*2016, [https://www.dovepress.com/electroencephalogram-characteristics-in-patients-with-chronic-fatigue--peer-reviewed-article-NDT Electroencephalogram characteristics in patients with chronic fatigue syndrome] (January 28) &amp;quot;The spontaneous brain electrical activities in CFS patients were significantly reduced. The abnormal changes in the cerebral functions were localized at the right frontal and left occipital regions in CFS patients&amp;quot;&lt;br /&gt;
&lt;br /&gt;
*2016, [https://link.springer.com/article/10.1007%2Fs10484-016-9331-3]-Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with Myalgic Encephalomyelitis: A Pilot Study](February 11). &amp;quot;We found support for all three core networks of the Menon triple network model-the central executive network (CEN), salience network (SN), and the default mode network (DMN)- indicating hypo-connectivity in the Delta, Alpha, and Alpha-2 frequency bands in patients with ME compared to controls. In addition to the current source density resting state dysfunction in the occipital, parietal, posterior temporal and posterior cingulate, the disrupted connectivity of the CEN, SN, and DMN appears to be involved in cognitive impairment for patients with ME. This research suggests that disruptions in these regions and networks could be a core neurobiological feature of the disorder, representing underlying neural dysfunction.&amp;quot;  &lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[qEEG]]&lt;br /&gt;
&lt;br /&gt;
[[Category:Tests]]&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=EEG&amp;diff=7127</id>
		<title>EEG</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=EEG&amp;diff=7127"/>
		<updated>2016-03-16T17:44:41Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:Information flow is continual remappings from primary sensory regions of the brain, to higher order systems. Only the EEG can measure this process.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[https://en.wikipedia.org/wiki/Electroencephalography Electroencephalography] (EEG)  is an electrophysiological monitoring method to record electrical activity of the brain.&lt;br /&gt;
&lt;br /&gt;
The last 70 years of neuroscience has established that most of brain&#039;s metabolism is used to create brain cell activity (summated synaptic potentials) operating on on the least-effort principle. This activity is mostly excitatory, some is inhibitory (slows things down) but it achieves a balance that optimizes the excitation and inhibition and produced electrical potentials, which we see at the scalp, in the form of the EEG. &lt;br /&gt;
&lt;br /&gt;
The brain is not like a computer, as we once thought. It depends on information that flows in regulated loops which continually change, not in fixed circuits like computers. The brain primary task is prediction, by matching what is previously learned with new information &#039;on the fly.&#039; Our awareness is one step behind these predictions in that the brain has already represented our actions milliseconds before we perform them. Information flow is therefore a continual re-mapping that takes information from sensory systems and sends it to higher-order systems, which results in regulatory control which bring about adaption in homeostasis of feelings, actions, perceptions and consciousness. The EEG is therefore the only non-invasive and inexpensive measure of this continual temporal evolution of brain information in real time that is crucial for the understanding of cognitive and emotional functioning for healthy individuals as well as people with neurocognitive dysfunction. &lt;br /&gt;
&lt;br /&gt;
==Notable Studies==&lt;br /&gt;
*2016, [https://www.dovepress.com/electroencephalogram-characteristics-in-patients-with-chronic-fatigue--peer-reviewed-article-NDT Electroencephalogram characteristics in patients with chronic fatigue syndrome] (January 28) &amp;quot;The spontaneous brain electrical activities in CFS patients were significantly reduced. The abnormal changes in the cerebral functions were localized at the right frontal and left occipital regions in CFS patients&amp;quot;&lt;br /&gt;
&lt;br /&gt;
*2016, [https://link.springer.com/article/10.1007%2Fs10484-016-9331-3]-Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with Myalgic Encephalomyelitis: A Pilot Study](February 11). &amp;quot;We found support for all three core networks of the Menon triple network model-the central executive network (CEN), salience network (SN), and the default mode network (DMN)- indicating hypo-connectivity in the Delta, Alpha, and Alpha-2 frequency bands in patients with ME compared to controls. In addition to the current source density resting state dysfunction in the occipital, parietal, posterior temporal and posterior cingulate, the disrupted connectivity of the CEN, SN, and DMN appears to be involved in cognitive impairment for patients with ME. This research suggests that disruptions in these regions and networks could be a core neurobiological feature of the disorder, representing underlying neural dysfunction.&amp;quot;  &lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[qEEG]]&lt;br /&gt;
&lt;br /&gt;
[[Category:Tests]]&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=EEG&amp;diff=7126</id>
		<title>EEG</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=EEG&amp;diff=7126"/>
		<updated>2016-03-16T17:17:49Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:This research suggests that disruptions in these regions and networks could be a neurobiological feature of the disorder, representing underlying neural dysfunction.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[https://en.wikipedia.org/wiki/Electroencephalography Electroencephalography] (EEG)  is an electrophysiological monitoring method to record electrical activity of the brain.&lt;br /&gt;
&lt;br /&gt;
==Notable Studies==&lt;br /&gt;
*2016, [https://www.dovepress.com/electroencephalogram-characteristics-in-patients-with-chronic-fatigue--peer-reviewed-article-NDT Electroencephalogram characteristics in patients with chronic fatigue syndrome] (January 28) &amp;quot;The spontaneous brain electrical activities in CFS patients were significantly reduced. The abnormal changes in the cerebral functions were localized at the right frontal and left occipital regions in CFS patients&amp;quot;&lt;br /&gt;
&lt;br /&gt;
*2016, [https://link.springer.com/article/10.1007%2Fs10484-016-9331-3]-Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with Myalgic Encephalomyelitis: A Pilot Study](February 11). &amp;quot;We found support for all three core networks of the Menon triple network model-the central executive network (CEN), salience network (SN), and the default mode network (DMN)- indicating hypo-connectivity in the Delta, Alpha, and Alpha-2 frequency bands in patients with ME compared to controls. In addition to the current source density resting state dysfunction in the occipital, parietal, posterior temporal and posterior cingulate, the disrupted connectivity of the CEN, SN, and DMN appears to be involved in cognitive impairment for patients with ME. This research suggests that disruptions in these regions and networks could be a core neurobiological feature of the disorder, representing underlying neural dysfunction.&amp;quot;  &lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[qEEG]]&lt;br /&gt;
&lt;br /&gt;
[[Category:Tests]]&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=EEG&amp;diff=7125</id>
		<title>EEG</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=EEG&amp;diff=7125"/>
		<updated>2016-03-16T17:16:14Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:This research suggests that disruptions in these regions and networks could be a neurobiological feature of the disorder, representing underlying neural dysfunction.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[https://en.wikipedia.org/wiki/Electroencephalography Electroencephalography] (EEG)  is an electrophysiological monitoring method to record electrical activity of the brain.&lt;br /&gt;
&lt;br /&gt;
==Notable Studies==&lt;br /&gt;
*2016, [https://www.dovepress.com/electroencephalogram-characteristics-in-patients-with-chronic-fatigue--peer-reviewed-article-NDT Electroencephalogram characteristics in patients with chronic fatigue syndrome] (January 28) &amp;quot;The spontaneous brain electrical activities in CFS patients were significantly reduced. The abnormal changes in the cerebral functions were localized at the right frontal and left occipital regions in CFS patients&amp;quot;&lt;br /&gt;
&lt;br /&gt;
*2016, [10.1007/s10484-016-9331-Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with Myalgic Encephalomyelitis: A Pilot Study](February 11). &amp;quot;We found support for all three core networks of the Menon triple network model-the central executive network (CEN), salience network (SN), and the default mode network (DMN)- indicating hypo-connectivity in the Delta, Alpha, and Alpha-2 frequency bands in patients with ME compared to controls. In addition to the current source density resting state dysfunction in the occipital, parietal, posterior temporal and posterior cingulate, the disrupted connectivity of the CEN, SN, and DMN appears to be involved in cognitive impairment for patients with ME. This research suggests that disruptions in these regions and networks could be a core neurobiological feature of the disorder, representing underlying neural dysfunction.&amp;quot;  &lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[qEEG]]&lt;br /&gt;
&lt;br /&gt;
[[Category:Tests]]&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=EEG&amp;diff=7124</id>
		<title>EEG</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=EEG&amp;diff=7124"/>
		<updated>2016-03-16T17:15:02Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:This research suggests that disruptions in these regions and networks could be a neurobiological feature of the disorder, representing underlying neural dysfunction.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[https://en.wikipedia.org/wiki/Electroencephalography Electroencephalography] (EEG)  is an electrophysiological monitoring method to record electrical activity of the brain.&lt;br /&gt;
&lt;br /&gt;
==Notable Studies==&lt;br /&gt;
*2016, [https://www.dovepress.com/electroencephalogram-characteristics-in-patients-with-chronic-fatigue--peer-reviewed-article-NDT Electroencephalogram characteristics in patients with chronic fatigue syndrome] (January 28) &amp;quot;The spontaneous brain electrical activities in CFS patients were significantly reduced. The abnormal changes in the cerebral functions were localized at the right frontal and left occipital regions in CFS patients&amp;quot;&lt;br /&gt;
&lt;br /&gt;
*2016, [10.1007/s10484-016-9331-3-Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with Myalgic Encephalomyelitis: A Pilot Study](February 11). &amp;quot;We found support for all three core networks of the Menon triple network model-the central executive network (CEN), salience network (SN), and the default mode network (DMN)- indicating hypo-connectivity in the Delta, Alpha, and Alpha-2 frequency bands in patients with ME compared to controls. In addition to the current source density resting state dysfunction in the occipital, parietal, posterior temporal and posterior cingulate, the disrupted connectivity of the CEN, SN, and DMN appears to be involved in cognitive impairment for patients with ME. This research suggests that disruptions in these regions and networks could be a core neurobiological feature of the disorder, representing underlying neural dysfunction.&amp;quot;  &lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[qEEG]]&lt;br /&gt;
&lt;br /&gt;
[[Category:Tests]]&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=EEG&amp;diff=7123</id>
		<title>EEG</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=EEG&amp;diff=7123"/>
		<updated>2016-03-16T17:13:52Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:This research suggests that disruptions in these regions and networks could be a neurobiological feature of the disorder, representing underlying neural dysfunction.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[https://en.wikipedia.org/wiki/Electroencephalography Electroencephalography] (EEG)  is an electrophysiological monitoring method to record electrical activity of the brain.&lt;br /&gt;
&lt;br /&gt;
==Notable Studies==&lt;br /&gt;
*2016, [https://www.dovepress.com/electroencephalogram-characteristics-in-patients-with-chronic-fatigue--peer-reviewed-article-NDT Electroencephalogram characteristics in patients with chronic fatigue syndrome] (January 28) &amp;quot;The spontaneous brain electrical activities in CFS patients were significantly reduced. The abnormal changes in the cerebral functions were localized at the right frontal and left occipital regions in CFS patients&amp;quot;&lt;br /&gt;
&lt;br /&gt;
*2016, [https://link.springer.com/article/10.1007%2Fs10484-016-9331-3-Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with Myalgic Encephalomyelitis: A Pilot Study](February 11). &amp;quot;We found support for all three core networks of the Menon triple network model-the central executive network (CEN), salience network (SN), and the default mode network (DMN)- indicating hypo-connectivity in the Delta, Alpha, and Alpha-2 frequency bands in patients with ME compared to controls. In addition to the current source density resting state dysfunction in the occipital, parietal, posterior temporal and posterior cingulate, the disrupted connectivity of the CEN, SN, and DMN appears to be involved in cognitive impairment for patients with ME. This research suggests that disruptions in these regions and networks could be a core neurobiological feature of the disorder, representing underlying neural dysfunction.&amp;quot;  &lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[qEEG]]&lt;br /&gt;
&lt;br /&gt;
[[Category:Tests]]&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=EEG&amp;diff=7122</id>
		<title>EEG</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=EEG&amp;diff=7122"/>
		<updated>2016-03-16T17:12:16Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:This research suggests that disruptions in these regions and networks could be a neurobiological feature of the disorder, representing underlying neural dysfunction.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[https://en.wikipedia.org/wiki/Electroencephalography Electroencephalography] (EEG)  is an electrophysiological monitoring method to record electrical activity of the brain.&lt;br /&gt;
&lt;br /&gt;
==Notable Studies==&lt;br /&gt;
*2016, [https://www.dovepress.com/electroencephalogram-characteristics-in-patients-with-chronic-fatigue--peer-reviewed-article-NDT Electroencephalogram characteristics in patients with chronic fatigue syndrome] (January 28) &amp;quot;The spontaneous brain electrical activities in CFS patients were significantly reduced. The abnormal changes in the cerebral functions were localized at the right frontal and left occipital regions in CFS patients&amp;quot;&lt;br /&gt;
&lt;br /&gt;
*2016, [https://www.ncbi.nlm.nih.gov/pubmed/26869373-Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with Myalgic Encephalomyelitis: A Pilot Study](February 11). &amp;quot;We found support for all three core networks of the Menon triple network model-the central executive network (CEN), salience network (SN), and the default mode network (DMN)- indicating hypo-connectivity in the Delta, Alpha, and Alpha-2 frequency bands in patients with ME compared to controls. In addition to the current source density resting state dysfunction in the occipital, parietal, posterior temporal and posterior cingulate, the disrupted connectivity of the CEN, SN, and DMN appears to be involved in cognitive impairment for patients with ME. This research suggests that disruptions in these regions and networks could be a core neurobiological feature of the disorder, representing underlying neural dysfunction.&amp;quot;  &lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[qEEG]]&lt;br /&gt;
&lt;br /&gt;
[[Category:Tests]]&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=EEG&amp;diff=7121</id>
		<title>EEG</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=EEG&amp;diff=7121"/>
		<updated>2016-03-16T17:08:38Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:We found support for all three networks of the triple network model, namely the central executive network (CEN), salience network (SN), and the default mode network (DMN) indicating hypo-connectivity in the Delta, Alpha, and Alpha-2 frequency bands in pat&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[https://en.wikipedia.org/wiki/Electroencephalography Electroencephalography] (EEG)  is an electrophysiological monitoring method to record electrical activity of the brain.&lt;br /&gt;
&lt;br /&gt;
==Notable Studies==&lt;br /&gt;
*2016, [https://www.dovepress.com/electroencephalogram-characteristics-in-patients-with-chronic-fatigue--peer-reviewed-article-NDT Electroencephalogram characteristics in patients with chronic fatigue syndrome] (January 28) &amp;quot;The spontaneous brain electrical activities in CFS patients were significantly reduced. The abnormal changes in the cerebral functions were localized at the right frontal and left occipital regions in CFS patients&amp;quot;&lt;br /&gt;
&lt;br /&gt;
*2016, [https://www.ncbi.nlm.nih.gov/pubmed/26869373-Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with Myalgic Encephalomyelitis: A Pilot Study](February 11). Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with Myalgic Encephalomyelitis: A Pilot Study.&amp;quot; We found support for all three networks of the triple network model, namely the central executive network (CEN), salience network (SN), and the default mode network (DMN) indicating hypo-connectivity in the Delta, Alpha, and Alpha-2 frequency bands in patients with ME compared to controls. In addition to the current source density resting state dysfunction in the occipital, parietal, posterior temporal and posterior cingulate, the disrupted connectivity of the CEN, SN, and DMN appears to be involved in cognitive impairment for patients with ME. This research suggests that disruptions in these regions and networks could be a neurobiological feature of the disorder, representing underlying neural dysfunction.  &lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[qEEG]]&lt;br /&gt;
&lt;br /&gt;
[[Category:Tests]]&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
	<entry>
		<id>https://me-pedia.org/w/index.php?title=EEG&amp;diff=7120</id>
		<title>EEG</title>
		<link rel="alternate" type="text/html" href="https://me-pedia.org/w/index.php?title=EEG&amp;diff=7120"/>
		<updated>2016-03-16T17:05:37Z</updated>

		<summary type="html">&lt;p&gt;Siggycat:/* Notable Studies */ The Menon Triple Network Model of neuropathology was used to test ME patients vs controls to explore cognitive impairment in ME. All three core networks were significantly dysregulated.&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[https://en.wikipedia.org/wiki/Electroencephalography Electroencephalography] (EEG)  is an electrophysiological monitoring method to record electrical activity of the brain.&lt;br /&gt;
&lt;br /&gt;
==Notable Studies==&lt;br /&gt;
*2016, [https://www.dovepress.com/electroencephalogram-characteristics-in-patients-with-chronic-fatigue--peer-reviewed-article-NDT Electroencephalogram characteristics in patients with chronic fatigue syndrome] (January 28) &amp;quot;The spontaneous brain electrical activities in CFS patients were significantly reduced. The abnormal changes in the cerebral functions were localized at the right frontal and left occipital regions in CFS patients&amp;quot;&lt;br /&gt;
&lt;br /&gt;
*2016, [https://www.ncbi.nlm.nih.gov/pubmed/26869373] Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with Myalgic Encephalomyelitis: A Pilot Study. (February 11)&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[qEEG]]&lt;br /&gt;
&lt;br /&gt;
[[Category:Tests]]&lt;/div&gt;</summary>
		<author><name>Siggycat</name></author>
	</entry>
</feed>